Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23408.Triglycerides in VLDL,AGRP,Agouti-related protein,42296,0.298084131612683,0.00479743040429,0.288681168020274,0.307487095205091,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCL27,C-C motif chemokine 27,42145,0.265229752858561,0.0061622305157465,0.253151781047698,0.277307724669424,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCN1,CCN family member 1,42047,0.374823252948774,0.00681277442734408,0.36147021507118,0.388176290826369,0
NMR metabolomics,X23408.Triglycerides in VLDL,CES1,Liver carboxylesterase 1,42163,0.3464786706407,0.00842637983020649,0.329962966173495,0.362994375107904,0
NMR metabolomics,X23408.Triglycerides in VLDL,GCG,Pro-glucagon,41843,0.538412972386387,0.0122253157508579,0.514451353514705,0.562374591258068,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF9,Protein turtle homolog A,39958,0.350709021070271,0.00845652863614917,0.334134224943419,0.367283817197124,0
NMR metabolomics,X23408.Triglycerides in VLDL,LDLR,Low-density lipoprotein receptor,42170,0.402781469317517,0.00410722127578485,0.394731315616978,0.410831623018055,0
NMR metabolomics,X23408.Triglycerides in VLDL,LPL,Lipoprotein lipase,42145,-0.194607071209632,0.00477345936406689,-0.203963051563203,-0.185251090856061,0
NMR metabolomics,X23408.Triglycerides in VLDL,MFGE8,Lactadherin,42137,0.271392700138313,0.00416360441926719,0.263232035476549,0.279553364800076,0
NMR metabolomics,X23408.Triglycerides in VLDL,NPY,Pro-neuropeptide Y,42262,0.372507883887218,0.0058708487296442,0.361001020377116,0.384014747397321,0
NMR metabolomics,X23408.Triglycerides in VLDL,GHR,Growth hormone receptor,39736,0.110341864383204,0.0027896686755397,0.104874113779146,0.115809614987262,1.112536929255e-308
NMR metabolomics,X23408.Triglycerides in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.084629163912326,0.00214155055864818,0.0804317248173755,0.0888266030072764,1.11253692925535e-308
NMR metabolomics,X23408.Triglycerides in VLDL,PTH,Parathyroid hormone,39649,0.32450748549754,0.00822532258827162,0.308385853224528,0.340629117770553,1.1125369293213e-308
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.124209436668511,0.00322940940939749,0.117879794226092,0.13053907911093,2.17735360204994e-307
NMR metabolomics,X23408.Triglycerides in VLDL,F7,Coagulation factor VII,42194,0.118231649041278,0.00310197010283249,0.112151787639726,0.12431151044283,4.21664142137507e-302
NMR metabolomics,X23408.Triglycerides in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.289125206231949,0.00764656816675044,0.274137932625118,0.30411247983878,9.58069014982472e-295
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.181018308945788,0.00484270460170485,0.171526607926446,0.190510009965129,3.22683414721854e-291
NMR metabolomics,X23408.Triglycerides in VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.144321703048699,0.00389124909218682,0.136694854828013,0.151948551269385,2.46558250995358e-284
NMR metabolomics,X23408.Triglycerides in VLDL,FURIN,Furin,42181,0.122260711124433,0.00331417714064497,0.115764923928769,0.128756498320097,5.34666369980058e-284
NMR metabolomics,X23408.Triglycerides in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.155218209520317,0.00430364449006944,0.146783066319781,0.163653352720853,3.86871708445024e-272
NMR metabolomics,X23408.Triglycerides in VLDL,C9,Complement component C9,39990,-0.206663285605427,0.00575073817643426,-0.217934732431238,-0.195391838779616,5.2958662368183e-268
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.115752947372618,0.00323713948686691,0.109408153978359,0.122097740766877,1.14902114784587e-267
NMR metabolomics,X23408.Triglycerides in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.289740138125722,0.00822092798347805,0.273627119278105,0.305853156973339,3.20676712325981e-260
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.516884682928372,0.0147345392789009,0.488004985941726,0.545764379915017,6.13396082400582e-258
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.294492159970185,0.00847307223331108,0.277884938392895,0.311099381547474,2.23388127286571e-253
NMR metabolomics,X23408.Triglycerides in VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.101197796058358,0.00293041132447619,0.0954541898623844,0.106941402254331,1.67543323571441e-250
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.182826538927615,0.00536165623571201,0.17231769270562,0.193335385149611,1.49604420669753e-244
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.29010222420726,0.00862621368380481,0.273194845387003,0.307009603027518,3.68757609711137e-238
NMR metabolomics,X23408.Triglycerides in VLDL,INHBC,Inhibin beta C chain,42137,0.13397552989485,0.00402275740667371,0.126090925377769,0.14186013441193,7.93743270779104e-234
NMR metabolomics,X23408.Triglycerides in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.266167743256944,0.0080954624777631,0.250300636800529,0.28203484971336,4.05455590510252e-228
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.421288541589923,0.0128530752110619,-0.446480569003604,-0.396096514176242,6.51589216619664e-227
NMR metabolomics,X23408.Triglycerides in VLDL,PROC,Vitamin K-dependent protein C,42199,0.0850123871504036,0.00259990134526425,0.0799165805136857,0.0901081937871215,8.10948548329327e-226
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.110602648018264,0.00338648413790158,0.103965139107977,0.117240156928551,2.3734416741191e-225
NMR metabolomics,X23408.Triglycerides in VLDL,BCHE,Cholinesterase,39806,0.0883999549612111,0.00270970528701136,0.0830889325986688,0.0937109773237534,4.22588975631492e-223
NMR metabolomics,X23408.Triglycerides in VLDL,GPR37,Prosaposin receptor GPR37,41900,0.214534321832201,0.00660149284063387,0.201595395864558,0.227473247799843,5.30952952311611e-223
NMR metabolomics,X23408.Triglycerides in VLDL,CCL23,C-C motif chemokine 23,42185,0.138788826990908,0.004285267005,0.130389703661108,0.147187950320708,9.93639996725257e-222
NMR metabolomics,X23408.Triglycerides in VLDL,APCS,Serum amyloid P-component,39870,0.104570011265672,0.00328961552312628,0.0981223648403449,0.111017657691,1.9160792478863e-212
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.193163964750538,0.00614401473173281,-0.205206233624734,-0.181121695876341,1.51388070474919e-209
NMR metabolomics,X23408.Triglycerides in VLDL,ADIPOQ,Adiponectin,39979,-0.218829646435238,0.00696274582705368,-0.232476628256263,-0.205182664614212,5.45089255862165e-208
NMR metabolomics,X23408.Triglycerides in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.216297630974956,0.00697899474893666,0.20261880126704,0.229976460682872,8.84498767439511e-204
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.335238884367997,0.0108539367129238,0.313965168410666,0.356512600325328,1.91142523590988e-202
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS15,Enteropeptidase,42070,0.275956500700296,0.0089363131857209,0.258441326856283,0.293471674544309,2.27518334348758e-202
NMR metabolomics,X23408.Triglycerides in VLDL,NRP1,Neuropilin-1,42230,-0.0854215896047477,0.00277931272482856,-0.0908690425454117,-0.0799741366640837,1.26179272610128e-200
NMR metabolomics,X23408.Triglycerides in VLDL,TTR,Transthyretin,39862,0.0773823547164657,0.00251500303937585,0.072452948759289,0.0823117606736423,1.10866992938104e-199
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0937111426754469,0.00305435293555349,0.0877246109217621,0.0996976744291317,1.37079478350141e-198
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA4,Kallistatin,39802,0.072838124450058,0.00237391087591607,0.0681852591332625,0.0774909897668535,1.38120689064053e-198
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN3,Contactin-3,42137,0.0878977105800397,0.0028858273866609,0.0822414889021843,0.093553932257895,3.84014781677266e-197
NMR metabolomics,X23408.Triglycerides in VLDL,DSG2,Desmoglein-2,42137,-0.0832161875313496,0.00275662248277236,-0.0886191675975834,-0.0778132074651158,8.42940566278988e-194
NMR metabolomics,X23408.Triglycerides in VLDL,AFM,Afamin,39979,0.0617231188196643,0.00205083510225011,0.0577034820192541,0.0657427556200746,1.52500742248922e-191
NMR metabolomics,X23408.Triglycerides in VLDL,PLTP,Phospholipid transfer protein,42267,-0.115163783154055,0.00385565199080986,-0.122720861056042,-0.107606705252068,5.93533565306997e-190
NMR metabolomics,X23408.Triglycerides in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.182101806488315,0.00611334687870931,0.170119646606044,0.194083966370585,8.84998280324584e-189
NMR metabolomics,X23408.Triglycerides in VLDL,PLAT,Tissue-type plasminogen activator,42272,0.154498016874918,0.00522022270470425,0.144266380373698,0.164729653376139,1.21125515679324e-186
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0583617674002375,0.00197681502060987,0.0544872099598422,0.0622363248406329,1.10105048484697e-185
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.17182477608841,0.00582212947718955,0.160413402313118,0.183236149863701,1.65101475835167e-184
NMR metabolomics,X23408.Triglycerides in VLDL,ACY1,Aminoacylase-1,42145,0.188525335421216,0.00640991729946663,0.175961897514262,0.201088773328171,2.29283842181058e-184
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0614159349432681,0.00210260712936675,0.0572948249697092,0.0655370449168269,8.92638110415355e-182
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA3,Glutathione S-transferase A3,41843,0.229902957407098,0.00787851992987615,0.21446105834454,0.245344856469655,1.75457834749107e-181
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.224450031027687,0.00771025203839124,0.209337937032441,0.239562125022934,7.98896511675856e-181
NMR metabolomics,X23408.Triglycerides in VLDL,CRIP2,Cysteine-rich protein 2,42016,0.107616424555715,0.00371751725258702,0.100330090740644,0.114902758370786,8.6658090579723e-179
NMR metabolomics,X23408.Triglycerides in VLDL,CPM,Carboxypeptidase M,42195,0.100311275443334,0.00347121286769435,0.0935076982226529,0.107114852664015,2.92360637231241e-178
NMR metabolomics,X23408.Triglycerides in VLDL,GUSB,Beta-glucuronidase,42211,0.178735502693835,0.00623732209009819,0.166510351397243,0.190960653990428,2.07538106894748e-175
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0714745254660733,0.00249499250543109,0.0665843401554284,0.0763647107767182,2.68750102982486e-175
NMR metabolomics,X23408.Triglycerides in VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0892889039583285,0.00313206579392632,-0.0954277529144241,-0.0831500550022329,1.34119358349699e-172
NMR metabolomics,X23408.Triglycerides in VLDL,SNCA,Alpha-synuclein,39736,0.338901823152053,0.0119992791507149,0.315383236016652,0.362420410287454,1.4816157600362e-169
NMR metabolomics,X23408.Triglycerides in VLDL,GH1,Somatotropin,42129,-0.510493441538963,0.0181655731004297,-0.546097964815805,-0.47488891826212,6.22983292443957e-169
NMR metabolomics,X23408.Triglycerides in VLDL,ELN,Elastin,39958,0.0991183423178289,0.00354174067668785,0.0921765305915207,0.106060154044137,1.01350093156497e-166
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA1,Glutathione S-transferase A1,42119,0.241002829771362,0.008664057559866,0.224021276954024,0.257984382588699,1.21165804687218e-165
NMR metabolomics,X23408.Triglycerides in VLDL,NCS1,Neuronal calcium sensor 1,42262,0.0796384423954535,0.00289578824287837,0.0739626974394119,0.0853141873514952,4.20191688032229e-162
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.0854542165150021,0.00310800647751937,0.0793625238190641,0.09154590921094,5.97012906373995e-162
NMR metabolomics,X23408.Triglycerides in VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.0824991947898479,0.00300702998815531,-0.0883929735666323,-0.0766054160130635,2.4816550362318e-161
NMR metabolomics,X23408.Triglycerides in VLDL,UPB1,Beta-ureidopropionase,39958,0.251767316898933,0.00925743224864654,0.233622749691586,0.269911884106281,7.65167370268446e-158
NMR metabolomics,X23408.Triglycerides in VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.309893801627514,0.0114493354023214,0.287453104238964,0.332334499016064,4.40029372390722e-157
NMR metabolomics,X23408.Triglycerides in VLDL,GRP,Gastrin-releasing peptide,39638,0.146882959621728,0.00545821207602172,0.136184863952726,0.157581055290731,1.50147390088116e-154
NMR metabolomics,X23408.Triglycerides in VLDL,CCL16,C-C motif chemokine 16,42310,0.140659584869224,0.00526133436446946,0.130347369514864,0.150971800223584,1.55654153942892e-153
NMR metabolomics,X23408.Triglycerides in VLDL,KYNU,Kynureninase,42296,0.124283305120846,0.004664220298946,0.115141433334911,0.13342517690678,1.48692670099706e-152
NMR metabolomics,X23408.Triglycerides in VLDL,ENO3,Beta-enolase,39638,0.171526684738416,0.00642951917300885,0.158924827159319,0.184128542317513,5.24635515585514e-152
NMR metabolomics,X23408.Triglycerides in VLDL,FGF21,Fibroblast growth factor 21,42247,0.326669059016563,0.0123161689912257,0.30252936779376,0.350808750239365,3.40775244618613e-151
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.156107389856585,0.00589710773206071,0.144549058701746,0.167665721011424,1.25597457559425e-150
NMR metabolomics,X23408.Triglycerides in VLDL,SORT1,Sortilin,42129,0.103458374164221,0.00391102528882645,0.0957927645981216,0.111123983730321,2.17643793918865e-150
NMR metabolomics,X23408.Triglycerides in VLDL,SHBG,Sex hormone-binding globulin,39990,-0.126936729818047,0.00478911621155628,-0.136323397592697,-0.117550062043397,2.87488615753845e-150
NMR metabolomics,X23408.Triglycerides in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.197323543859575,0.00750612298374423,0.182611542811436,0.212035544907714,1.45953964011347e-148
NMR metabolomics,X23408.Triglycerides in VLDL,CKB,Creatine kinase B-type,39966,-0.154590795250058,0.00587627207804057,-0.166108288523017,-0.143073301977098,4.03846303758102e-148
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.139841071572559,0.00534828788152176,0.129358427324776,0.150323715820341,4.34482050611328e-147
NMR metabolomics,X23408.Triglycerides in VLDL,CFH,Complement factor H,39418,0.062832231310233,0.00239940457230423,0.0581293983485167,0.0675350642719493,1.31698548787383e-146
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.102966758272929,0.00396762743098915,-0.110743308037668,-0.0951902085081903,5.65434353547803e-145
NMR metabolomics,X23408.Triglycerides in VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0704685858934451,0.00271616631284507,0.0651448999202688,0.0757922718666214,7.14542199964697e-145
NMR metabolomics,X23408.Triglycerides in VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.335495377872149,0.0129555184007613,0.310102561806656,0.360888193937641,2.44622207135756e-144
NMR metabolomics,X23408.Triglycerides in VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.134601393213482,0.00519769233554752,0.124413916235809,0.144788870191155,2.77514890918177e-144
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.0827025105284631,0.00320190049546489,0.0764267855573519,0.0889782354995742,1.21172744997912e-143
NMR metabolomics,X23408.Triglycerides in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.22911137741446,0.0088680679271926,0.211729964277163,0.246492790551758,4.75157415069694e-143
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.109459553628629,0.0042515901528023,0.101126436929137,0.117792670328122,9.94905090653185e-143
NMR metabolomics,X23408.Triglycerides in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0866963451576659,0.00336795807068805,0.0800951473391173,0.0932975429762145,1.09876357208418e-142
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.186943751867186,0.00727975545594957,0.172675431173525,0.201212072560847,2.09096539802914e-141
NMR metabolomics,X23408.Triglycerides in VLDL,NUMB,Protein numb homolog,39657,0.220043308787346,0.00859355170620969,0.203199947443175,0.236886670131517,1.56521038774199e-140
NMR metabolomics,X23408.Triglycerides in VLDL,F9,Coagulation factor IX,42199,0.0480002439537736,0.00188445629256618,0.0443067096203439,0.0516937782872033,7.52576457986865e-140
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS1,Protein MTSS 1,39930,0.291678459344426,0.0114266520420478,0.269282221342013,0.31407469734684,8.62222532266032e-140
NMR metabolomics,X23408.Triglycerides in VLDL,CFI,Complement factor I,39979,0.0507832806161187,0.00199021320327131,0.0468824627377069,0.0546840984945305,1.04863615502169e-139
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0876208424975538,0.00344302221463199,-0.0943691660382325,-0.0808725189568751,1.23743581863544e-139
NMR metabolomics,X23408.Triglycerides in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0574541003952093,0.00225899446009794,0.0530264712534173,0.0618817295370012,9.37548324406402e-139
NMR metabolomics,X23408.Triglycerides in VLDL,HEG1,Protein HEG homolog 1,39736,0.0717927606665664,0.00282407115464706,0.0662575812034581,0.0773279401296746,1.24427229730009e-138
NMR metabolomics,X23408.Triglycerides in VLDL,PPY,Pancreatic prohormone,42089,0.26794106385662,0.0105786371214689,0.247206935098541,0.288675192614699,2.58143094323287e-138
NMR metabolomics,X23408.Triglycerides in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.177617624555023,0.00702588198209171,0.163846895870123,0.191388353239923,9.42167313604791e-138
NMR metabolomics,X23408.Triglycerides in VLDL,RBP5,Retinol-binding protein 5,42070,0.146124842334848,0.00578559077050682,0.134785084424655,0.157464600245041,1.48107284234905e-137
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.187733582094178,0.00743585794766717,0.173159300516751,0.202307863671606,1.94222487293064e-137
NMR metabolomics,X23408.Triglycerides in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.16966989493267,0.00677459245789109,0.156391693715203,0.182948096150137,8.62683943612196e-135
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0504769425645703,0.0020202179171372,0.0465173154469814,0.0544365696821592,8.98134248693439e-135
NMR metabolomics,X23408.Triglycerides in VLDL,PROS1,Vitamin K-dependent protein S,39979,0.065074088471224,0.00260538604290916,0.0599675318271221,0.070180645115326,4.30024062267852e-134
NMR metabolomics,X23408.Triglycerides in VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0664011961409464,0.00267463071557791,0.0611589199384137,0.0716434723434791,4.51823676107461e-133
NMR metabolomics,X23408.Triglycerides in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0810553203900588,0.00326894653148158,0.0746481851883549,0.0874624555917627,8.55002294125992e-133
NMR metabolomics,X23408.Triglycerides in VLDL,NPPC,C-type natriuretic peptide,42119,0.134223461337883,0.0054210494031656,0.123598204507679,0.144848718168088,2.12223251729285e-132
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0668914463954668,0.00269600533712205,0.0616072759347076,0.072175616856226,2.40909454893951e-132
NMR metabolomics,X23408.Triglycerides in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.166350403768008,0.00671920507297044,0.153180761824986,0.17952004571103,2.5655924674641e-132
NMR metabolomics,X23408.Triglycerides in VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.220640279980709,0.0089021829879808,0.203192001324266,0.238088558637151,5.0132365773907e-132
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR2,Cadherin-related family member 2,42070,0.167337058129451,0.00677450517676651,0.154059027982989,0.180615088275913,8.73047197508776e-132
NMR metabolomics,X23408.Triglycerides in VLDL,CFP,Properdin,39979,0.0601486643968,0.00243046945201899,0.0553849442708427,0.0649123845227572,9.60506979040347e-132
NMR metabolomics,X23408.Triglycerides in VLDL,SERPIND1,Heparin cofactor 2,39959,0.0739966887413666,0.00299463897006516,0.0681271963600389,0.0798661811226944,2.38041250719859e-131
NMR metabolomics,X23408.Triglycerides in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.314361892505718,0.0127551717759098,0.289361755824934,0.339362029186501,3.12778750221475e-131
NMR metabolomics,X23408.Triglycerides in VLDL,DTYMK,Thymidylate kinase,39958,0.170304459259855,0.00690953417408137,0.156761772278656,0.183847146241055,1.01946091480941e-130
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0783693764137116,0.00319314153982417,0.0721108189956563,0.084627933831767,3.50593156824537e-130
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.14294637981971,0.00581197032794329,0.131554917976941,0.154337841662479,3.58337854744497e-130
NMR metabolomics,X23408.Triglycerides in VLDL,AGR3,Anterior gradient protein 3,41827,0.149211000126295,0.0060993783772381,0.137256218506908,0.161165781745681,2.65345682009563e-129
NMR metabolomics,X23408.Triglycerides in VLDL,MME,Neprilysin,42070,0.195422378605148,0.00801553604099848,0.179711927964791,0.211132829245505,1.64675200680772e-128
NMR metabolomics,X23408.Triglycerides in VLDL,EEF1D,Elongation factor 1-delta,39958,0.228723375553506,0.00937227717464258,0.210353712291206,0.247093038815805,2.98980342086023e-128
NMR metabolomics,X23408.Triglycerides in VLDL,ATRN,"Attractin, Isoform 2",39979,0.0417414491736263,0.00171151349858258,0.0383868827164044,0.0450960156308482,4.24044032096685e-128
NMR metabolomics,X23408.Triglycerides in VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0628684025807414,0.00258382906831932,0.0578040976068356,0.0679327075546473,4.91649337421048e-128
NMR metabolomics,X23408.Triglycerides in VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.190637106230488,0.00783115383262919,0.175288044718534,0.205986167742441,1.4164504012396e-127
NMR metabolomics,X23408.Triglycerides in VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.285180161016866,0.0117531439826678,0.262143998810837,0.308216323222895,2.48494208811735e-127
NMR metabolomics,X23408.Triglycerides in VLDL,OXT,Oxytocin-neurophysin 1,42249,0.360606179569278,0.014931242993573,0.331340943301875,0.389871415836681,3.17721554322324e-126
NMR metabolomics,X23408.Triglycerides in VLDL,MYH9,Myosin-9,39966,0.282004833391344,0.0116786570900364,0.259114665494873,0.304895001287816,1.13742931415502e-125
NMR metabolomics,X23408.Triglycerides in VLDL,NOMO1,Nodal modulator 1,42137,0.0576634168817829,0.0023989889005901,0.0529613986366263,0.0623654351269395,4.72892915635901e-125
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0794306035950125,0.00332024675642785,0.0729229199524139,0.085938287237611,6.24315190213538e-124
NMR metabolomics,X23408.Triglycerides in VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.143505493096125,0.00599759198348707,0.131750212808491,0.15526077338376,1.78621521239552e-123
NMR metabolomics,X23408.Triglycerides in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.345010732668483,0.0144234435805409,0.316740783250623,0.373280682086344,2.10287390563058e-123
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.225200793893703,0.00943476063991065,0.206708663039479,0.243692924747928,2.18325123919984e-123
NMR metabolomics,X23408.Triglycerides in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.127441507718208,0.00534657465302955,0.11696222139827,0.137920794038146,4.80527381951615e-123
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0972057955998296,0.00407998381431325,0.0892090273237756,0.105202563875884,6.12136418935919e-123
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0728840382098975,0.00306195053028568,0.0668826151705375,0.0788854612492574,2.96559544423449e-122
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.140764376384503,0.00591451935748118,0.12917191844384,0.152356834325166,3.87792916045134e-122
NMR metabolomics,X23408.Triglycerides in VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.26759785698667,0.011322979696068,0.245404816782377,0.289790897190963,1.42546273969019e-120
NMR metabolomics,X23408.Triglycerides in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.119223953765658,0.00505982542796411,0.109306695926848,0.129141211604467,2.58557685828803e-120
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.0545819600811483,0.00232010553859346,0.0500345532255051,0.0591293669367915,5.51057136125865e-120
NMR metabolomics,X23408.Triglycerides in VLDL,F10,Coagulation factor X,39990,0.0701626751088318,0.00298180910512519,0.0643183292627865,0.0760070209548772,1.3876127677045e-119
NMR metabolomics,X23408.Triglycerides in VLDL,MVK,Mevalonate kinase,41913,0.19989123827364,0.00853469740272319,0.183163231364303,0.216619245182978,6.51830331019742e-119
NMR metabolomics,X23408.Triglycerides in VLDL,FYB1,FYN-binding protein 1,42115,0.222846744942501,0.00955081215500353,0.204127153118694,0.241566336766308,4.38544538991715e-118
NMR metabolomics,X23408.Triglycerides in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.164649635945802,0.00704675242253796,0.150838001197628,0.178461270693976,7.05326300894466e-118
NMR metabolomics,X23408.Triglycerides in VLDL,GLA,Alpha-galactosidase A,39713,0.0940671705970648,0.00402912644624767,0.0861700827624194,0.10196425843171,9.84995856169526e-118
NMR metabolomics,X23408.Triglycerides in VLDL,P4HB,Protein disulfide-isomerase,42073,0.0927434127809071,0.00398262844257211,0.0849374610334657,0.100549364528348,1.24524793193423e-117
NMR metabolomics,X23408.Triglycerides in VLDL,KHK,Ketohexokinase,39638,0.151031404556435,0.0064900310258114,0.138310943745845,0.163751865367025,5.51765720897805e-117
NMR metabolomics,X23408.Triglycerides in VLDL,MLN,Promotilin,42119,0.213776196095287,0.00922788125616768,0.195689548833199,0.231862843357376,1.81995090572172e-116
NMR metabolomics,X23408.Triglycerides in VLDL,SORD,Sorbitol dehydrogenase,42204,0.164232671091041,0.00709145765055381,0.150333414095956,0.178131928086127,2.06642213690873e-116
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0888718481020006,0.00385336596251193,-0.096424445388524,-0.0813192508154773,1.78963008336959e-115
NMR metabolomics,X23408.Triglycerides in VLDL,SOST,Sclerostin,42129,0.0921259365308682,0.00399664652162916,0.084292509348475,0.0999593637132613,2.37629968145604e-115
NMR metabolomics,X23408.Triglycerides in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.188312830038907,0.00818919090660563,0.17226201586196,0.204363644215854,2.12275149124099e-114
NMR metabolomics,X23408.Triglycerides in VLDL,HJV,Hemojuvelin,39934,0.0996456038920946,0.00433620633514607,0.0911466394752083,0.108144568308981,2.95529090193613e-114
NMR metabolomics,X23408.Triglycerides in VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.202654379005369,0.00884422214943563,0.185319703592476,0.219989054418263,5.35947932238078e-114
NMR metabolomics,X23408.Triglycerides in VLDL,KLKB1,Plasma kallikrein,39759,0.0579296860083836,0.00252523794881275,0.0529802196287106,0.0628791523880566,7.72808416975801e-114
NMR metabolomics,X23408.Triglycerides in VLDL,SCLY,Selenocysteine lyase,42224,0.114957421951043,0.00502356761814468,0.105111229419479,0.124803614482607,9.31798069979698e-114
NMR metabolomics,X23408.Triglycerides in VLDL,LEP,Leptin,42145,0.163872697757442,0.00718145510803467,0.149797045745694,0.17794834976919,3.99403753314965e-113
NMR metabolomics,X23408.Triglycerides in VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.158655665425048,0.0069646187534069,0.145005012668371,0.172306318181726,9.59393816817606e-113
NMR metabolomics,X23408.Triglycerides in VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.289825500853558,0.012699716160828,0.264934057178335,0.314716944528781,1.10492333603869e-112
NMR metabolomics,X23408.Triglycerides in VLDL,SYAP1,Synapse-associated protein 1,39736,0.137004415440085,0.00603194765427692,0.125181798037703,0.148827032842468,1.11867452124657e-111
NMR metabolomics,X23408.Triglycerides in VLDL,DPY30,Protein dpy-30 homolog,42216,0.140559046704866,0.00620526834555936,0.12839672074757,0.152721372662163,1.53169712440394e-111
NMR metabolomics,X23408.Triglycerides in VLDL,IL16,Pro-interleukin-16,42296,0.0987038079004306,0.00437146816834483,0.0901357302904747,0.107271885510386,7.2598905034868e-111
NMR metabolomics,X23408.Triglycerides in VLDL,PYY,Peptide YY,39575,0.232747927094377,0.0103080718909233,0.212544106188168,0.252951748000587,2.21616798577997e-110
NMR metabolomics,X23408.Triglycerides in VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0654543831339575,0.00290480340624521,0.0597609684577169,0.0711477978101981,4.9668630761043e-110
NMR metabolomics,X23408.Triglycerides in VLDL,F11R,Junctional adhesion molecule A,42137,0.128461811969385,0.00576124968501563,0.117169762586754,0.139753861352015,3.42335223748839e-108
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0741736397052308,0.00333437750996393,0.0676382597857015,0.0807090196247602,1.05008913758014e-107
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS2,Protein MTSS 2,39919,0.230849773270413,0.0103686110228279,0.21052729566567,0.251172250875156,1.63489692436479e-107
NMR metabolomics,X23408.Triglycerides in VLDL,TJAP1,Tight junction-associated protein 1,42181,0.190813435553022,0.00859048258462352,0.17397608968716,0.207650781418884,2.11829734622061e-107
NMR metabolomics,X23408.Triglycerides in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.127787440554181,0.00575737638564334,0.11650298283832,0.139071898270042,3.3227424432147e-107
NMR metabolomics,X23408.Triglycerides in VLDL,CD2AP,CD2-associated protein,42145,0.144653450077255,0.00651932510777584,0.131875572866014,0.157431327288495,3.56965650323249e-107
NMR metabolomics,X23408.Triglycerides in VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0635553442259701,0.00287957968066808,0.0579113680518606,0.0691993204000795,4.43515863476196e-106
NMR metabolomics,X23408.Triglycerides in VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.124252891010503,0.00563932043145447,0.113199822964853,0.135305959056154,1.06256948328746e-105
NMR metabolomics,X23408.Triglycerides in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.227103907155038,0.0102927668928798,0.206930084044994,0.247277730265083,1.14365382192088e-105
NMR metabolomics,X23408.Triglycerides in VLDL,FN1,Fibronectin,39979,0.0620175307382814,0.00281224787793734,0.0565055248975242,0.0675295365790386,1.43899658665325e-105
NMR metabolomics,X23408.Triglycerides in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.124584662491049,0.00566272450096109,0.113485722469165,0.135683602512932,2.20203474252873e-105
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.0454443294546141,0.00207109095702568,0.0413849911788438,0.0495036677303844,6.92730542956675e-105
NMR metabolomics,X23408.Triglycerides in VLDL,ISM1,Isthmin-1,42119,0.0896413735412711,0.00408781718952971,0.0816292518497929,0.0976534952327493,9.13550888017144e-105
NMR metabolomics,X23408.Triglycerides in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.221383318170803,0.0101009815671252,0.201585394299238,0.241181242042369,1.19350124202807e-104
NMR metabolomics,X23408.Triglycerides in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.203934163119197,0.0093115300109645,0.185683564297707,0.222184761940688,1.70709588612134e-104
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.258024603157914,0.0117720551984752,0.234951374968903,0.281097831346926,2.70316025858651e-104
NMR metabolomics,X23408.Triglycerides in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.240771709060631,0.0110101691766778,0.219191777474343,0.26235164064692,3.31294038314056e-104
NMR metabolomics,X23408.Triglycerides in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0676376219772607,0.00310107744820947,0.0615595101787702,0.0737157337757513,2.39783834697099e-103
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0928762245961162,0.00426108795282697,0.0845244922085754,0.101227956983657,3.26101771986867e-103
NMR metabolomics,X23408.Triglycerides in VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.136150157229087,0.00627216786637373,0.123856708210994,0.148443606247179,2.45654014497382e-102
NMR metabolomics,X23408.Triglycerides in VLDL,STAB2,Stabilin-2,39966,0.0629029144431596,0.00290251865436448,0.0572139778806052,0.068591851005714,4.34047529815591e-102
NMR metabolomics,X23408.Triglycerides in VLDL,STC1,Stanniocalcin-1,42249,0.102337934519398,0.00474110993935668,0.093045359038259,0.111630510000537,1.22734739883069e-101
NMR metabolomics,X23408.Triglycerides in VLDL,TXLNA,Alpha-taxilin,42016,0.196595484086178,0.00911096488514453,0.178737992911294,0.214452975261061,1.52853109869466e-101
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.175015440723168,0.00809858609542959,0.159142211976126,0.19088866947021,1.58976380914322e-101
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.223354890501761,0.0103597083603612,0.203049862115454,0.243659918888069,2.15899811285394e-101
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.188356460021613,0.0087641533205119,0.171178719513409,0.205534200529816,2.09251479785718e-100
NMR metabolomics,X23408.Triglycerides in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0814297572598212,0.00380743149565279,0.0739671915283417,0.0888923229913007,7.99384745257521e-100
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.128854139360649,0.00602596416365057,-0.140665029121405,-0.117043249599894,8.79798873765171e-100
NMR metabolomics,X23408.Triglycerides in VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.106590437680308,0.00498266841623184,0.096824407584494,0.116356467776123,1.44968526481863e-99
NMR metabolomics,X23408.Triglycerides in VLDL,CES3,Carboxylesterase 3,42070,0.156990326616379,0.00735092635800221,0.142582510954694,0.171398142278063,1.50435484089163e-99
NMR metabolomics,X23408.Triglycerides in VLDL,DCXR,L-xylulose reductase,42181,0.119768787301,0.00561492731781739,0.108763529758078,0.130774044843922,2.50537053307328e-99
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4R,Reticulon-4 receptor,42262,0.07422385942027,0.00349031939589968,0.0673828334043066,0.0810648854362334,9.34837400095686e-99
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.161345273909985,0.00758699256540723,0.146474768481787,0.176215779338183,1.03884498738528e-98
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.145018884177364,0.00682452591275563,0.131642813388363,0.158394954966365,1.32619829853734e-98
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0940887015391203,0.00443866971064301,0.08538890890626,0.102788494171981,3.9499715970147e-98
NMR metabolomics,X23408.Triglycerides in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.109271739057575,0.0051586109716573,0.0991608615531265,0.119382616562023,1.15514243346345e-97
NMR metabolomics,X23408.Triglycerides in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.134097278332176,0.0063490198305928,0.121653199464214,0.146541357200138,2.04915676281197e-97
NMR metabolomics,X23408.Triglycerides in VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.142450250499395,0.00674654819331645,0.129227016040494,0.155673484958295,2.33369001820647e-97
NMR metabolomics,X23408.Triglycerides in VLDL,BECN1,Beclin-1,39638,0.12958907833304,0.00615030976883877,0.117534471186116,0.141643685479964,1.17397966769193e-96
NMR metabolomics,X23408.Triglycerides in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.10566957032657,0.00501557883133054,0.0958390358171617,0.115500104835977,1.18279725726918e-96
NMR metabolomics,X23408.Triglycerides in VLDL,AXIN1,Axin-1,42119,0.21027906858525,0.0100043560408152,0.190670530745252,0.229887606425247,1.53629158663573e-96
NMR metabolomics,X23408.Triglycerides in VLDL,FCN2,Ficolin-2,42116,0.0882010595598977,0.00419652844409739,0.0799758638094668,0.0964262553103286,1.5732117903797e-96
NMR metabolomics,X23408.Triglycerides in VLDL,CEP20,Centrosomal protein 20,41843,0.163719902524438,0.0077922976233562,0.14844699918266,0.178992805866216,1.95490262500077e-96
NMR metabolomics,X23408.Triglycerides in VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.146923587730097,0.00698282190613223,0.133237256794078,0.160609918666116,2.19354683451975e-96
NMR metabolomics,X23408.Triglycerides in VLDL,ARF6,ADP-ribosylation factor 6,39930,0.236053350132387,0.0112370684491095,0.214028695972132,0.258078004292641,3.82928198187255e-96
NMR metabolomics,X23408.Triglycerides in VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.0716099315783745,0.00342205107322445,0.0649027114748546,0.0783171516818945,9.70730799730787e-96
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.176132424540122,0.00844460726670122,0.159580994297388,0.192683854782856,3.94413856009135e-95
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3F,Semaphorin-3F,42145,0.0573581876456227,0.00276095534737662,0.0519467151647645,0.0627696601264808,2.15576688211158e-94
NMR metabolomics,X23408.Triglycerides in VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0496247865896852,0.00238941509952491,0.0449415329946164,0.054308040184754,2.5323999242834e-94
NMR metabolomics,X23408.Triglycerides in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.142944821034145,0.00688708434387218,0.129446135720155,0.156443506348134,3.42828282326231e-94
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0606977069326635,0.00292155402014111,0.0549714610531869,0.0664239528121401,4.02167462655538e-94
NMR metabolomics,X23408.Triglycerides in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.1128669830958,0.00544647833511918,0.102191885558966,0.123542080632634,6.32442722729529e-94
NMR metabolomics,X23408.Triglycerides in VLDL,F13B,Coagulation factor XIII B chain,39925,0.0549647381815559,0.00264929793664868,0.0497721142257245,0.0601573621373874,7.19374833173622e-94
NMR metabolomics,X23408.Triglycerides in VLDL,HGF,Hepatocyte growth factor,42296,0.0739166015239765,0.00357771232641673,0.0669042853641997,0.0809289176837533,2.08278362899087e-93
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0598424542415939,0.00289659489925371,0.0541651282390566,0.0655197802441312,2.3574955745571e-93
NMR metabolomics,X23408.Triglycerides in VLDL,CLUL1,Clusterin-like protein 1,42123,-0.0954353570121369,0.00462868707846358,-0.104507583685926,-0.0863631303383483,5.04464353506953e-93
NMR metabolomics,X23408.Triglycerides in VLDL,CTSD,Cathepsin D,41225,0.0884486187913601,0.00428775856009254,0.0800446120135787,0.0968526255691415,5.19858653920336e-93
NMR metabolomics,X23408.Triglycerides in VLDL,CD63,CD63 antigen,41992,0.107636687206155,0.00522967831370138,0.0973865177113,0.117886856701009,1.07741457049783e-92
NMR metabolomics,X23408.Triglycerides in VLDL,KAZN,Kazrin,39930,0.223581934272951,0.0108514067479004,0.202313177047066,0.244850691498836,1.24734196167203e-92
NMR metabolomics,X23408.Triglycerides in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.112403552650565,0.00546836158180361,0.10168556395023,0.1231215413509,1.90434678095584e-92
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN1,Dynactin subunit 1,42262,0.135957936694752,0.00662062035497523,0.122981520799001,0.148934352590504,2.55366224788872e-92
NMR metabolomics,X23408.Triglycerides in VLDL,BTD,Biotinidase,39979,0.0435837786086559,0.0021229602801926,0.0394227764594784,0.0477447807578334,5.36682844115201e-92
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR5,Cadherin-related family member 5,42145,0.0821703618235258,0.00401118110118475,0.0743084468652037,0.0900322767818479,7.13930547013961e-92
NMR metabolomics,X23408.Triglycerides in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.112985059285608,0.00550931905791002,0.102186793932104,0.123783324639111,8.42266066461972e-92
NMR metabolomics,X23408.Triglycerides in VLDL,DKK1,Dickkopf-related protein 1,42249,0.124915318457047,0.00610987842327693,0.112939956747424,0.136890680166669,1.56130312156895e-91
NMR metabolomics,X23408.Triglycerides in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.154056315327546,0.00755756741563486,0.139243483192902,0.16886914746219,5.21302475467031e-91
NMR metabolomics,X23408.Triglycerides in VLDL,S100A4,Protein S100-A4,42181,0.118368372911159,0.00580768676418134,0.106985306853363,0.129751438968954,5.59183755275064e-91
NMR metabolomics,X23408.Triglycerides in VLDL,EHBP1,EH domain-binding protein 1,39958,0.158213043607291,0.00775987349383434,0.143003691559376,0.173422395655207,8.80675286131679e-91
NMR metabolomics,X23408.Triglycerides in VLDL,FUOM,Fucose mutarotase,39736,0.135779787716046,0.00666751558696532,0.122711457165594,0.148848118266498,1.5261697453511e-90
NMR metabolomics,X23408.Triglycerides in VLDL,ANG,Angiogenin,42152,0.0689866873894304,0.00339847742104857,0.0623256716441752,0.0756477031346856,2.85304220323796e-90
NMR metabolomics,X23408.Triglycerides in VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.178381514543159,0.00879988646482057,0.16113373707211,0.195629292014207,5.08986578775604e-90
NMR metabolomics,X23408.Triglycerides in VLDL,EZR,Ezrin,42249,0.0509767179278941,0.00252033803327707,0.046036855382671,0.0559165804731171,1.18141514351853e-89
NMR metabolomics,X23408.Triglycerides in VLDL,APOC1,Apolipoprotein C-I,39959,0.0808391117829263,0.00399265091555561,0.0730135159884373,0.0886647075774153,1.42403885685245e-89
NMR metabolomics,X23408.Triglycerides in VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.165741328792045,0.00820279837647895,0.149663843974146,0.181818813609943,1.94435677020888e-89
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0417229671917921,0.00206589022780176,0.0376738223453006,0.0457721120382835,2.21761340495931e-89
NMR metabolomics,X23408.Triglycerides in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.173471343844992,0.00858077628941854,0.156653022317731,0.190289665372252,2.78714432443232e-89
NMR metabolomics,X23408.Triglycerides in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.227715227343575,0.0112768575957257,0.205612586455952,0.249817868231197,4.12062067798367e-89
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNA4,Plexin-A4,42119,0.167634631526238,0.00835098063688319,0.151266709477947,0.184002553574529,2.41841167282112e-88
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS8,Prostasin,42080,0.0868261239566342,0.00433153588606113,0.0783363136199544,0.095315934293314,4.25740847215843e-88
NMR metabolomics,X23408.Triglycerides in VLDL,APOE,Apolipoprotein E,39979,0.145108287447244,0.00722993749302208,0.130937609960921,0.159278964933567,4.43018389113163e-88
NMR metabolomics,X23408.Triglycerides in VLDL,ERBIN,Erbin,42070,0.212628580479491,0.0106223165217445,0.191808840096872,0.233448320862111,7.35906579757085e-88
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0883051580656019,0.00441871943785138,0.0796444679674132,0.0969658481637907,1.33014642945791e-87
NMR metabolomics,X23408.Triglycerides in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0490425370035018,0.0024545758731637,0.044231568292101,0.0538535057149027,1.47675187730084e-87
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0555885064617433,0.00278447934728359,0.0501309269410675,0.0610460859824191,2.06374735002246e-87
NMR metabolomics,X23408.Triglycerides in VLDL,CCL22,C-C motif chemokine 22,41991,0.107016368908893,0.00538298377538724,0.0964657207091344,0.117567017108652,1.06394837952261e-86
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.258337407429493,0.013007099882038,0.232843491660698,0.283831323198288,1.4828984697798e-86
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0799980638709542,0.0040299141873217,0.0720994320638037,0.0878966956781047,1.77066374048778e-86
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE4,Ribonuclease 4,39645,0.0570191315660619,0.00287157303518656,0.0513908484170963,0.0626474147150276,3.06972065927151e-86
NMR metabolomics,X23408.Triglycerides in VLDL,AGRN,Agrin,42185,0.0735624614887094,0.0037201087663656,0.0662710483066329,0.080853874670786,7.95369408659835e-86
NMR metabolomics,X23408.Triglycerides in VLDL,BCR,Breakpoint cluster region protein,42119,0.189564165197061,0.00958852612347164,0.170770653995056,0.208357676399065,8.76994321280908e-86
NMR metabolomics,X23408.Triglycerides in VLDL,PAXX,Protein PAXX,39736,0.0947078487312581,0.00479173100375388,0.0853160559639005,0.104099641498616,1.72971133194955e-85
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.0274601087006545,0.00139062691597577,0.024734479945342,0.030185737455967,2.41852943539192e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.195058468627885,0.00990964928810977,0.175635556023189,0.21448138123258,4.48326992846912e-85
NMR metabolomics,X23408.Triglycerides in VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.186747911990553,0.00949063593859529,0.168146265550906,0.2053495584302,5.22226405927025e-85
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.15253339926057,0.00774575428456938,0.137351720862814,0.167715077658326,7.22739409838747e-85
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0812549477958575,0.00413428875340334,-0.089358153752528,-0.0731517418391869,8.11141488298122e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CDH2,Cadherin-2,42145,0.0719102196323154,0.0036598273963092,0.0647369579355494,0.0790834813290814,8.97856936301947e-85
NMR metabolomics,X23408.Triglycerides in VLDL,TCTN3,Tectonic-3,39958,0.0619122383265369,0.00315258037443807,0.0557331807926383,0.0680912958604355,1.80859032574359e-84
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.224035292288914,0.0114115350273781,0.201668683635252,0.246401900942575,2.06632651557971e-84
NMR metabolomics,X23408.Triglycerides in VLDL,MMP10,Stromelysin-2,42124,-0.117232867778855,0.00598101783438324,-0.128955662734246,-0.105510072823464,2.24570827635024e-84
NMR metabolomics,X23408.Triglycerides in VLDL,NT5E,5'-nucleotidase,42181,0.109143201044597,0.00558198973524392,0.0982025011635184,0.120083900925675,5.56081856575887e-84
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH2,Neutral ceramidase,42016,0.107778317296517,0.00552287851610217,0.0969534754049572,0.118603159188078,1.18079055459385e-83
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0756612411909861,0.003878727281754,0.0680589357187483,0.083263546663224,2.3500320333361e-83
NMR metabolomics,X23408.Triglycerides in VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.0652283138744256,0.00334502115137898,0.0586720724177228,0.0717845553311284,2.86418350199137e-83
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.21032448998732,0.0108094748954812,0.189137919192177,0.231511060782463,3.44941192092952e-83
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.130252847818082,0.00671694674877882,-0.143418063445688,-0.117087632190475,1.20348864706576e-82
NMR metabolomics,X23408.Triglycerides in VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.173406794418434,0.00893845423795231,0.155887424112047,0.19092616472482,1.66677513047789e-82
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R9B,Neurabin-2,42296,0.190537967756366,0.00984118302926896,0.171249249018999,0.209826686493733,2.06089872550741e-82
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0809663111929963,0.00419673283965711,0.0727407148272683,0.0891919075587242,7.49654354845621e-82
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1A,Meprin A subunit alpha,39930,0.152128081517647,0.00788480420046527,0.136673865284735,0.167582297750559,1.2257905891463e-81
NMR metabolomics,X23408.Triglycerides in VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.27411858122914,0.0142260718394879,0.246235480423743,0.302001682034536,1.22893951107047e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0714347262316203,0.00370801372869026,-0.0787024331398532,-0.0641670193233874,1.30789208966977e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.182869885409555,0.00951578724671607,0.164218942405992,0.201520828413119,3.31809603643796e-81
NMR metabolomics,X23408.Triglycerides in VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.176322227962704,0.00916408749098749,0.158360616480368,0.194283839445039,3.3208565237257e-81
NMR metabolomics,X23408.Triglycerides in VLDL,SLA2,Src-like-adapter 2,39934,0.212711557695845,0.0110651547028822,0.191023854478196,0.234399260913494,4.55711980860106e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0887577240368162,0.00462062324273287,-0.0978141455925726,-0.0797013024810597,5.9745270550373e-81
NMR metabolomics,X23408.Triglycerides in VLDL,AMOT,Angiomotin,39736,0.076100427444116,0.00397179277997496,0.0683157135953651,0.0838851412928669,1.56103732315078e-80
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.172420407019811,0.00901775955592658,0.154745598290195,0.190095215749427,1.96420782450959e-80
NMR metabolomics,X23408.Triglycerides in VLDL,CD6,T-cell differentiation antigen CD6,42284,0.103373358272145,0.00541148783242946,0.0927668421205834,0.113979874423707,2.65843351264589e-80
NMR metabolomics,X23408.Triglycerides in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.209209247137121,0.0109507712256399,0.187745735534867,0.230672758739375,2.66834138654942e-80
NMR metabolomics,X23408.Triglycerides in VLDL,APOA2,Apolipoprotein A-II,39990,-0.0979123049875417,0.00512131286318353,-0.107950078199381,-0.0878745317757019,3.17188303917571e-80
NMR metabolomics,X23408.Triglycerides in VLDL,KITLG,Kit ligand,42145,-0.0756397907206399,0.00396350408523488,-0.0834082587277003,-0.0678713227135796,3.8458094673511e-80
NMR metabolomics,X23408.Triglycerides in VLDL,DAB2,Disabled homolog 2,42262,0.219568053399807,0.011511156763978,0.19700618614241,0.242129920657204,4.51503311176634e-80
NMR metabolomics,X23408.Triglycerides in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.140468514613096,0.00736471983597523,0.126033663734584,0.154903365491607,4.91090450039523e-80
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.177702517018643,0.00931018572624126,0.15945455299521,0.195950481042076,5.79989143419702e-80
NMR metabolomics,X23408.Triglycerides in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.213113876856253,0.0111767865706778,0.191207375177725,0.235020378534782,8.24211538524641e-80
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.187262991093517,0.00985953704229772,0.167938298490614,0.206587683696421,2.07506796671584e-79
NMR metabolomics,X23408.Triglycerides in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.137622416392699,0.00724576812479972,0.123420710868092,0.151824121917306,3.26501347832373e-79
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN1,Perilipin-1,41839,0.066806588662092,0.00352514814450565,0.0598972982988609,0.0737158790253231,4.76614573801961e-79
NMR metabolomics,X23408.Triglycerides in VLDL,BACH1,Transcription regulator protein BACH1,42119,0.147268264072369,0.00779717542787784,0.131985800233729,0.16255072791101,1.48234613089606e-78
NMR metabolomics,X23408.Triglycerides in VLDL,SELP,P-selectin,42217,0.109118280268973,0.00579447220156355,0.0977611147539083,0.120475445784037,4.08869291800377e-78
NMR metabolomics,X23408.Triglycerides in VLDL,CMIP,C-Maf-inducing protein,39919,0.164130793057038,0.00870833424169462,0.147062457943316,0.181199128170759,4.79266685654071e-78
NMR metabolomics,X23408.Triglycerides in VLDL,LEFTY2,Left-right determination factor 2,42247,0.100684303421582,0.00535302140825064,0.0901923814614103,0.111176225381753,6.16255414108325e-78
NMR metabolomics,X23408.Triglycerides in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0965114636257982,0.00513056106700801,0.0864555639344625,0.106567363317134,6.33224284171468e-78
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.12971997112089,0.0069011880575637,0.116193642528065,0.143246299713714,7.62118939907816e-78
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO1,Forkhead box protein O1,42119,0.169145350700951,0.00901057387009209,0.15148462591557,0.186806075486331,1.24167951452007e-77
NMR metabolomics,X23408.Triglycerides in VLDL,NPL,N-acetylneuraminate lyase,39958,0.0905711427547632,0.00482112782453021,0.081121732218684,0.100020553290842,1.45673548518752e-77
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.10547279248971,0.00562364773629867,-0.116495142052855,-0.0944504429265645,1.73772386896665e-77
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.109372069984721,0.00583652346823441,0.0979324839869817,0.120811655982461,2.29681018321145e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CTSO,Cathepsin O,42296,0.0595857272871333,0.00318016960582325,0.0533525948597197,0.0658188597145468,2.30129921739963e-77
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.141871447319632,0.00757128979128159,0.12703171932872,0.156711175310544,3.78877602735394e-77
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.107649300994155,0.00575530157445234,0.0963689099082286,0.118929692080082,4.232278989331e-77
NMR metabolomics,X23408.Triglycerides in VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.127506243490205,0.00683927294965577,0.11410126850888,0.14091121847153,1.30491223336958e-76
NMR metabolomics,X23408.Triglycerides in VLDL,SELE,E-selectin,42310,0.0977612420372217,0.00524582794200097,0.0874794192708997,0.108043064803544,1.44481872091444e-76
NMR metabolomics,X23408.Triglycerides in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.220995694724758,0.011851118006344,0.197767503432324,0.244223886017193,1.83443639565659e-76
NMR metabolomics,X23408.Triglycerides in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.132852078484071,0.00712811546205099,0.118880972178451,0.146823184789691,2.34434373858699e-76
NMR metabolomics,X23408.Triglycerides in VLDL,SRPK2,SRSF protein kinase 2,42119,0.164656088042582,0.00885388349866901,0.147302476385191,0.182009699699973,3.02602457398339e-76
NMR metabolomics,X23408.Triglycerides in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.123270318091104,0.00662791872168088,0.11027959739661,0.136261038785599,3.07403225564466e-76
NMR metabolomics,X23408.Triglycerides in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0386644831187734,0.00208009974518385,0.0345874876182131,0.0427414786193338,3.59987265115407e-76
NMR metabolomics,X23408.Triglycerides in VLDL,AMBP,Protein AMBP,42239,0.0388415389940497,0.00209381641090188,0.034737658828682,0.0429454191594174,6.90512641496577e-76
NMR metabolomics,X23408.Triglycerides in VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.205803994779637,0.011107343132896,0.184033602239161,0.227574387320113,1.03681189598397e-75
NMR metabolomics,X23408.Triglycerides in VLDL,PXN,Paxillin,41839,0.0986902706615483,0.00533107893932487,0.0882413559404716,0.109139185382625,1.47411294412121e-75
NMR metabolomics,X23408.Triglycerides in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.217416522042719,0.0117582079380236,0.194370434484193,0.240462609601245,2.08525108337363e-75
NMR metabolomics,X23408.Triglycerides in VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.110531028312147,0.00598765444845409,0.0987952255931768,0.122266831031117,5.46324127598612e-75
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.045979829144559,0.00249631633310808,0.0410870491316672,0.0508726091574509,7.56711321426981e-75
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.161329842369493,0.00875547330377453,0.144169114694095,0.178490570044892,9.9472968246185e-75
NMR metabolomics,X23408.Triglycerides in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.142018144525851,0.00771084813514202,0.126904882180972,0.157131406870729,1.2308084700044e-74
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINH1,Serpin H1,39757,0.246192031699856,0.0133759606529079,0.219975148820156,0.272408914579555,1.49656631740071e-74
NMR metabolomics,X23408.Triglycerides in VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0773906322063274,0.00421213292797539,0.0691348516674957,0.0856464127451592,1.73063992217174e-74
NMR metabolomics,X23408.Triglycerides in VLDL,THOP1,Thimet oligopeptidase,42081,0.0598188693558348,0.00325574211910252,0.0534376148023938,0.0662001239092757,1.73819337582622e-74
NMR metabolomics,X23408.Triglycerides in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.104468221635397,0.00568823784441008,0.0933192754603533,0.115617167810441,2.04812994394475e-74
NMR metabolomics,X23408.Triglycerides in VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.144682505694334,0.00788135877309461,0.129235042499069,0.1601299688896,2.23516908634027e-74
NMR metabolomics,X23408.Triglycerides in VLDL,CCL5,C-C motif chemokine 5,42217,0.192325099618675,0.01048243741349,0.171779522288235,0.212870676949116,2.71594298307708e-74
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.133010975071005,0.00727354338457278,0.118754830037242,0.147267120104768,8.39696198803016e-74
NMR metabolomics,X23408.Triglycerides in VLDL,CCN2,CCN family member 2,42146,0.107160069730245,0.00587152813456758,0.095651874586493,0.118668264873998,1.54767140174482e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.152663539692768,0.00835441753620411,0.136288881321808,0.169038198063729,1.61987222347838e-73
NMR metabolomics,X23408.Triglycerides in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.077154396781012,0.00422397022443118,0.0688754151411269,0.0854333784208971,1.74692753560714e-73
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.0700702856720469,0.00384756954694344,0.0625290493600378,0.077611521984056,3.15191866700919e-73
NMR metabolomics,X23408.Triglycerides in VLDL,C19orf12,Protein C19orf12,41839,0.126388927667896,0.00694428362574506,0.112778131761435,0.139999723574356,3.97974660546807e-73
NMR metabolomics,X23408.Triglycerides in VLDL,NUCB2,Nucleobindin-2,42231,0.0708922025208998,0.00389631633154824,0.0632554225110652,0.0785289825307343,4.16082511615792e-73
NMR metabolomics,X23408.Triglycerides in VLDL,CPB2,Carboxypeptidase B2,39959,0.0424719587754381,0.00233499297360605,0.0378953725471702,0.0470485450037059,6.75938642567083e-73
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.184681224980645,0.0101679849004988,0.164751974575667,0.204610475385622,7.24364405455138e-73
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.212508410618012,0.0117017597174782,0.189572961571755,0.235443859664269,7.8057593898812e-73
NMR metabolomics,X23408.Triglycerides in VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.137593074142797,0.00758316456159964,0.122730071602062,0.152456076683532,1.50148942428612e-72
NMR metabolomics,X23408.Triglycerides in VLDL,FETUB,Fetuin-B,42199,0.0604534617658368,0.00334402130437651,0.0538991800092588,0.0670077435224147,3.31592278565112e-72
NMR metabolomics,X23408.Triglycerides in VLDL,SH2B3,SH2B adapter protein 3,41843,0.185246676231926,0.0102569523681233,0.165143049590404,0.205350302873447,4.75549672692946e-72
NMR metabolomics,X23408.Triglycerides in VLDL,MINK1,Misshapen-like kinase 1,39929,0.17469131398764,0.00968240433148628,0.155713801497927,0.193668826477353,9.14978197625182e-72
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD5,Programmed cell death protein 5,42249,0.10716498692221,0.00595599489338492,0.0954912369311755,0.118838736913244,1.48584082656906e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.202603735298468,0.0112495217257518,0.180554672715995,0.224652797880942,1.60985483245869e-71
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR,GMP reductase 1,42296,0.0890432396681534,0.00495347748843633,0.0793344237908182,0.0987520555454886,1.98813118059795e-71
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0985159918692878,0.00548295451069218,0.0877694010283311,0.109262582710244,2.36324669565923e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0694826930698347,0.00387404570106106,0.061889563495755,0.0770758226439144,4.11624889404596e-71
NMR metabolomics,X23408.Triglycerides in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.123875827979396,0.00691538357529638,0.110321676171815,0.137429979786977,6.39360179785451e-71
NMR metabolomics,X23408.Triglycerides in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.144290241264255,0.00806362399666672,0.128485538230788,0.160094944297722,8.65419501675869e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.143308316378355,0.00801483714579057,0.127599235572606,0.159017397184105,1.54761993689861e-70
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.190712602609929,0.0106903909143725,0.169759436417759,0.211665768802099,3.35173155287119e-70
NMR metabolomics,X23408.Triglycerides in VLDL,CEP43,Centrosomal protein 43,41797,0.130200066003476,0.00731660351931826,0.115859523105613,0.14454060890134,5.05829301743877e-70
NMR metabolomics,X23408.Triglycerides in VLDL,DOK2,Docking protein 2,42145,0.227301088239821,0.0127767921977565,0.202258575532218,0.252343600947424,5.26245096593182e-70
NMR metabolomics,X23408.Triglycerides in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.154771346755615,0.00870404914247159,0.137711410436371,0.17183128307486,6.17734283334543e-70
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.159901971336828,0.00903729664059888,0.142188869921254,0.177615072752401,2.83338505637052e-69
NMR metabolomics,X23408.Triglycerides in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.114493137218126,0.00651198311778197,0.101729650307274,0.127256624128979,2.71108848993461e-68
NMR metabolomics,X23408.Triglycerides in VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.111344189134142,0.00634579164730667,0.0989064375054214,0.123781940762864,3.7502313866625e-68
NMR metabolomics,X23408.Triglycerides in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.173156414543027,0.00987702876199825,0.153797438169511,0.192515390916544,4.73959128171275e-68
NMR metabolomics,X23408.Triglycerides in VLDL,MUC13,Mucin-13,41839,0.0960096986165053,0.0054842700342886,0.0852605293492996,0.106758867883711,7.43168226525563e-68
NMR metabolomics,X23408.Triglycerides in VLDL,PGF,Placenta growth factor,42296,0.0477088225948105,0.00272603722866954,0.0423657896266182,0.0530518555630028,7.6713785151089e-68
NMR metabolomics,X23408.Triglycerides in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.203418949293563,0.0116375319211142,0.180609386728179,0.226228511858947,1.15355183207352e-67
NMR metabolomics,X23408.Triglycerides in VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.0660336036606639,0.0037794998688471,0.0586257839177236,0.0734414234036042,1.32321692071756e-67
NMR metabolomics,X23408.Triglycerides in VLDL,TPD52L2,Tumor protein D54,39736,0.197844797501908,0.0113132884609594,0.175670752118428,0.220018842885388,1.4136968544792e-67
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.155631490917284,0.00891988465354733,0.138148516996331,0.173114464838236,1.94492103850154e-67
NMR metabolomics,X23408.Triglycerides in VLDL,CCL17,C-C motif chemokine 17,42107,0.166136985219606,0.00952264131373302,0.147472608244689,0.184801362194523,2.00375437301064e-67
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.0966143013424467,0.00554332349638413,0.0857493872895338,0.10747921539536,2.69667198051033e-67
NMR metabolomics,X23408.Triglycerides in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.149335344515022,0.00859072116670533,0.132497531028279,0.166173158001764,6.09703873785358e-67
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.114198339817359,0.00657281051558751,0.101315631206807,0.127081048427911,9.42288546259804e-67
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0432853563916755,0.00250106965166552,0.0383832598744111,0.04818745290894,2.21878275975036e-66
NMR metabolomics,X23408.Triglycerides in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.171335843777715,0.00990292317392899,0.151926114356815,0.190745573198616,2.43420956280984e-66
NMR metabolomics,X23408.Triglycerides in VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.138774399478179,0.00801772792355922,0.123059652748003,0.154489146208355,2.88158529703472e-66
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.184202704008461,0.0106575508212298,0.163313904398851,0.205091503618071,3.16935582950283e-66
NMR metabolomics,X23408.Triglycerides in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.092053211285296,0.00532313281948884,0.0816198709590979,0.102486551611494,3.95906278311625e-66
NMR metabolomics,X23408.Triglycerides in VLDL,USO1,General vesicular transport factor p115,42070,0.159894433913158,0.00926353324538662,0.141737908752201,0.178050959074116,4.7721297096881e-66
NMR metabolomics,X23408.Triglycerides in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.113581251678921,0.00658365078026197,0.100677296149607,0.126485207208234,5.67616904027079e-66
NMR metabolomics,X23408.Triglycerides in VLDL,OPHN1,Oligophrenin-1,39929,0.194692444243525,0.0112855434257059,0.172572779129142,0.216812109357909,7.54279565808128e-66
NMR metabolomics,X23408.Triglycerides in VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0956833373480322,0.00555538210011147,0.0847947884318138,0.106571886264251,9.19349789472269e-66
NMR metabolomics,X23408.Triglycerides in VLDL,SEC31A,Protein transport protein Sec31A,39638,0.138827679274818,0.00806148499269388,0.123027168689138,0.154628189860498,1.32287769059383e-65
NMR metabolomics,X23408.Triglycerides in VLDL,GOLM2,Protein GOLM2,42249,0.0407192918896535,0.00236807156699732,0.0360778716183387,0.0453607121609682,1.4151811599204e-65
NMR metabolomics,X23408.Triglycerides in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0966063273563097,0.00561224706741847,0.0856063231041695,0.10760633160845,1.47314007405697e-65
NMR metabolomics,X23408.Triglycerides in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0755287410559331,0.00439577729331889,0.066913017561028,0.0841444645508381,1.76329451581367e-65
NMR metabolomics,X23408.Triglycerides in VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0492383729563732,0.00286374804921082,0.04362542677992,0.0548513191328264,2.01972532744821e-65
NMR metabolomics,X23408.Triglycerides in VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.130016866088002,0.00757188658352998,0.115175968384284,0.144857763791721,2.90898709379583e-65
NMR metabolomics,X23408.Triglycerides in VLDL,NIT2,Omega-amidase NIT2,39903,0.130382647401762,0.00759676638969777,0.115492985277955,0.14527230952557,3.36224635460537e-65
NMR metabolomics,X23408.Triglycerides in VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.172332510415122,0.0100896880917093,0.152556721755372,0.192108299074872,1.40230694596933e-64
NMR metabolomics,X23408.Triglycerides in VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.150573569530452,0.00883255138586097,0.133261768814165,0.16788537024674,1.72697942030463e-64
NMR metabolomics,X23408.Triglycerides in VLDL,CCL13,C-C motif chemokine 13,42275,0.12093768050445,0.00709556871999848,0.107030365813253,0.134844995195647,1.78839314443638e-64
NMR metabolomics,X23408.Triglycerides in VLDL,CREG1,Protein CREG1,41960,0.0716618999172319,0.00420645581754445,0.0634172465148447,0.079906553319619,2.11666780689862e-64
NMR metabolomics,X23408.Triglycerides in VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.136557194362492,0.00801077158018717,0.120856082065325,0.152258306659659,2.41469012322199e-64
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0708471757017103,0.00416089290498185,0.0626918256079458,0.0790025257954747,3.35727298303906e-64
NMR metabolomics,X23408.Triglycerides in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0673042104474213,0.00396244461459773,0.0595378190028098,0.0750706018920329,4.84542295198382e-64
NMR metabolomics,X23408.Triglycerides in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.113181110555388,0.00666122986353423,0.100125100022861,0.126237121087915,5.91322936194415e-64
NMR metabolomics,X23408.Triglycerides in VLDL,HEXIM1,Protein HEXIM1,42119,0.142750806683315,0.00841249728818287,0.126262311998476,0.159239301368153,6.39433868271053e-64
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GLB2,Endophilin-B2,39929,0.116215877288245,0.00684445549254292,0.102800744522861,0.129631010053629,7.15370790201118e-64
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0861729060699231,0.00508417035341749,0.0762079321772248,0.0961378799626214,9.15076110273472e-64
NMR metabolomics,X23408.Triglycerides in VLDL,METAP2,Methionine aminopeptidase 2,42247,0.0983274718096229,0.00580446626425881,0.0869507179316756,0.10970422568757,1.0209961118333e-63
NMR metabolomics,X23408.Triglycerides in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.143026516284681,0.00843535178441501,0.126493226787228,0.159559805782135,1.06401821374885e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.181055501909647,0.0106839223141766,0.160115014173861,0.201995989645433,1.23754218819729e-63
NMR metabolomics,X23408.Triglycerides in VLDL,RTBDN,Retbindin,42070,0.0527355481094207,0.00312011181635321,0.0466201289493684,0.058850967269473,1.9631491877916e-63
NMR metabolomics,X23408.Triglycerides in VLDL,BRAP,BRCA1-associated protein,39813,0.193782916258941,0.0114595648149477,0.171322169221644,0.216243663296238,2.30345507452135e-63
NMR metabolomics,X23408.Triglycerides in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0343725112334218,0.00203608222239647,-0.0383632323893189,-0.0303817900775247,2.74164963499723e-63
NMR metabolomics,X23408.Triglycerides in VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0977854749833586,0.00578749050863728,0.0864419935864295,0.109128956380288,2.85593337564543e-63
NMR metabolomics,X23408.Triglycerides in VLDL,GIP,Gastric inhibitory polypeptide,39638,0.0890614658081367,0.00527055588667492,0.0787311762702538,0.0993917553460195,2.89967273805006e-63
NMR metabolomics,X23408.Triglycerides in VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.103445206317559,0.00612945804257897,0.0914314685541039,0.115458944081013,2.96095644500942e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0480253433088541,0.00285298560221661,0.0424334915285095,0.0536171950891986,6.07074308806398e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CNST,Consortin,42145,0.190572617693511,0.0113396034867525,0.168346994859476,0.212798240527546,9.53179947310411e-63
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0687404851317706,0.0040903897701271,-0.0767576490812197,-0.0607233211823215,9.6219884956403e-63
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.182023359950568,0.0108328013934505,0.160791069219405,0.203255650681731,9.96569908198184e-63
NMR metabolomics,X23408.Triglycerides in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.126219396789671,0.00751635297511601,0.111487344958444,0.140951448620898,1.57406380495379e-62
NMR metabolomics,X23408.Triglycerides in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0513092651585044,0.00305909861354324,0.0453134318759597,0.0573050984410492,1.70583500796648e-62
NMR metabolomics,X23408.Triglycerides in VLDL,AMN,Protein amnionless,41913,0.0824744657362023,0.00492235876270715,0.0728266425612963,0.0921222889111084,2.26134031316094e-62
NMR metabolomics,X23408.Triglycerides in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.136182200271039,0.00814186089539886,0.120224152916057,0.152140247626021,4.67470301359621e-62
NMR metabolomics,X23408.Triglycerides in VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0919889708719772,0.00551888157535872,0.0811719629842741,0.10280597875968,1.26461454014484e-61
NMR metabolomics,X23408.Triglycerides in VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.126274856166417,0.00759768715890208,0.111383389334969,0.141166322997865,2.07017520133774e-61
NMR metabolomics,X23408.Triglycerides in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.164111882526516,0.00990311166380466,0.144701783665459,0.183521981387573,4.5620212858932e-61
NMR metabolomics,X23408.Triglycerides in VLDL,MSTN,Growth/differentiation factor 8,41900,0.0931618377122209,0.0056229446562792,0.0821408661859137,0.104182809238528,4.83689091306497e-61
NMR metabolomics,X23408.Triglycerides in VLDL,DNMBP,Dynamin-binding protein,42016,0.104616908403813,0.00632017992460972,0.0922293557515778,0.117004461056048,6.13378753508169e-61
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA5,Integrin alpha-5,42137,0.0428413987785641,0.00259187401378583,0.0377613257115439,0.0479214718455844,8.91256957014611e-61
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.188185874668956,0.0113889630808699,0.165863507030451,0.21050824230746,9.7141828624053e-61
NMR metabolomics,X23408.Triglycerides in VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.102725763098601,0.00622701471574212,0.0905208142557461,0.114930711941455,1.51705169218328e-60
NMR metabolomics,X23408.Triglycerides in VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.106679690007955,0.00646499481918609,0.0940083001623506,0.11935107985356,1.82367285540701e-60
NMR metabolomics,X23408.Triglycerides in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.094924418238651,0.00576125211894574,0.0836323640855174,0.106216472391785,2.0670876953679e-60
NMR metabolomics,X23408.Triglycerides in VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.212029146154397,0.0128775273275078,0.186789192592482,0.237269099716312,2.49079924203552e-60
NMR metabolomics,X23408.Triglycerides in VLDL,DAG1,Dystroglycan,42185,0.0812961234012284,0.00494695210724698,0.0716000972710243,0.0909921495314324,4.1768065170536e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.156528994669959,0.00952185599733719,0.137866156915178,0.17519183242474,4.95858737133965e-60
NMR metabolomics,X23408.Triglycerides in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.174182141038266,0.0106149752433735,0.153376789561254,0.194987492515278,6.24388740016583e-60
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.145369641268437,0.00885660255406834,0.128010700262463,0.162728582274411,7.78520032454939e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.105629636687693,0.00644037177822578,0.0930065080023703,0.118252765373015,9.13952215508016e-60
NMR metabolomics,X23408.Triglycerides in VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.130758760201086,0.00797401751948655,0.115129685862892,0.146387834539279,9.59634759551317e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0891358401544219,0.00544104991674008,0.0784713823176113,0.0998002979912325,9.60807564138924e-60
NMR metabolomics,X23408.Triglycerides in VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.116102414050545,0.00709207861974971,0.102201939955835,0.130002888145254,1.14526621723116e-59
NMR metabolomics,X23408.Triglycerides in VLDL,IL32,Interleukin-32,42119,-0.0758402385182989,0.00463648192273193,-0.0849277430868535,-0.0667527339497443,1.43972403609766e-59
NMR metabolomics,X23408.Triglycerides in VLDL,EGLN1,Egl nine homolog 1,42119,0.0952212628108933,0.00583001670513342,0.0837944300688318,0.106648095552955,2.13014189017991e-59
NMR metabolomics,X23408.Triglycerides in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.187966917734237,0.0115269526214486,-0.210559744872276,-0.165374090596198,3.23687696867878e-59
NMR metabolomics,X23408.Triglycerides in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.154412547785748,0.00945886490889989,0.135873172564304,0.172951923007191,3.24046883510895e-59
NMR metabolomics,X23408.Triglycerides in VLDL,STAMBP,STAM-binding protein,41997,0.106957359789647,0.00656880252121549,0.094082506848065,0.11983221273123,4.83239026771912e-59
NMR metabolomics,X23408.Triglycerides in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.043387864740398,0.00266605196628817,0.0381624028864732,0.0486133265943228,7.2731928495938e-59
NMR metabolomics,X23408.Triglycerides in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0561547417656391,0.00345484389813056,0.0493832477253032,0.062926235805975,7.5005884376399e-59
NMR metabolomics,X23408.Triglycerides in VLDL,FAM13A,Protein FAM13A,39930,0.115129190550171,0.0070781954295419,0.101255927508268,0.129002453592073,8.05064677275707e-59
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0582078798979505,0.00358808678820963,0.0511752297930597,0.0652405300028414,1.24124116242807e-58
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.132578569203406,0.00819079875364065,-0.148632534760542,-0.11652460364627,2.21844383778063e-58
NMR metabolomics,X23408.Triglycerides in VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.130984058942015,0.00809010335187211,0.115127456372346,0.146840661511685,2.64175937428992e-58
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0973090402925538,0.00602055693131203,0.0855087487071823,0.109109331877925,3.26965038400308e-58
NMR metabolomics,X23408.Triglycerides in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0745012437565791,0.00461485290995355,0.0654561320530702,0.0835463554600881,4.40138844198831e-58
NMR metabolomics,X23408.Triglycerides in VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.071896231622356,0.00445321501035378,0.0631679302020626,0.0806245330426494,5.73649375419722e-58
NMR metabolomics,X23408.Triglycerides in VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0955845897667807,0.00593119623311958,0.0839594451498663,0.107209734383695,9.04327482441979e-58
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.214245125722768,0.0133186185327143,0.188140633398648,0.240349618046888,1.0877098001408e-57
NMR metabolomics,X23408.Triglycerides in VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.10534118364001,0.00655396745527144,0.092495407427678,0.118186959852342,1.33413403116373e-57
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0686523754628779,0.00427400149933009,0.0602753325241909,0.0770294184015649,2.05009815990791e-57
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.110664954925354,0.00689356498782789,0.0971535675492114,0.124176342301497,2.31815522788592e-57
NMR metabolomics,X23408.Triglycerides in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.141725809749476,0.008837281392512,0.124404738220152,0.159046881278799,2.36098872592771e-57
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.198223030055537,0.0123643833726591,0.173988838645126,0.222457221465949,3.25702767197683e-57
NMR metabolomics,X23408.Triglycerides in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0494974736465067,0.00309320494166725,0.0434347919608389,0.0555601553321745,4.06788939269898e-57
NMR metabolomics,X23408.Triglycerides in VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0578666358884027,0.00362077198994596,-0.0649633489886968,-0.0507699227881087,5.67970224192938e-57
NMR metabolomics,X23408.Triglycerides in VLDL,MITD1,MIT domain-containing protein 1,42016,0.161010806585781,0.0100769931884026,0.141259899936512,0.180761713235051,6.08614219282711e-57
NMR metabolomics,X23408.Triglycerides in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.175762066911575,0.0109904647317201,0.154220756037403,0.197303377785746,6.20136680631723e-57
NMR metabolomics,X23408.Triglycerides in VLDL,COCH,Cochlin,39958,0.0764123569408593,0.0047879205849647,0.0670280325943285,0.0857966812873902,1.01182077193503e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SNX15,Sorting nexin-15,39736,0.0896761596730031,0.00561968636106747,0.0786615744053109,0.100690744940695,1.07183448947628e-56
NMR metabolomics,X23408.Triglycerides in VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.189870494814923,0.0119041045159059,0.166538449963748,0.213202539666099,1.17583809740869e-56
NMR metabolomics,X23408.Triglycerides in VLDL,DLK1,Protein delta homolog 1,42310,0.0959720313174911,0.00603174800806396,0.0841498052216857,0.107794257413296,1.69789952773995e-56
NMR metabolomics,X23408.Triglycerides in VLDL,RLN2,Prorelaxin H2,39709,0.0852279900005489,0.00536391439617515,0.0747147177840456,0.0957412622170522,3.13069460801024e-56
NMR metabolomics,X23408.Triglycerides in VLDL,DBNL,Drebrin-like protein,42185,0.153361581245737,0.00966733121958633,0.134413612055348,0.172309550436126,3.59594382445252e-56
NMR metabolomics,X23408.Triglycerides in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0952751830387727,0.0060091478948347,0.0834972531648967,0.107053112912649,4.12047553609101e-56
NMR metabolomics,X23408.Triglycerides in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0506663466708989,0.00320062497466916,0.0443931217205474,0.0569395716212505,8.07114894703418e-56
NMR metabolomics,X23408.Triglycerides in VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.136187522511348,0.00860611251733199,0.119319541977378,0.153055503045319,8.30671867766305e-56
NMR metabolomics,X23408.Triglycerides in VLDL,NIT1,Deaminated glutathione amidase,39638,0.0732623285759838,0.0046315010210345,0.0641845865747562,0.0823400705772114,9.51794746389903e-56
NMR metabolomics,X23408.Triglycerides in VLDL,MTDH,Protein LYRIC,39657,0.156849092392387,0.0099353755829678,0.13737575624977,0.176322428535004,1.54405348061969e-55
NMR metabolomics,X23408.Triglycerides in VLDL,EREG,Proepiregulin,41997,0.131937519175834,0.00836956571950105,0.115533170365612,0.148341867986056,1.73483939609946e-55
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS8,Galectin-8,42249,0.0999136712115191,0.00634709967546223,0.0874733558476131,0.112353986575425,2.40352369494612e-55
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0722238296101857,0.00458897385684336,0.0632294408507727,0.0812182183695987,2.59211145232303e-55
NMR metabolomics,X23408.Triglycerides in VLDL,SCG2,Secretogranin-2,42193,0.0541505908738796,0.00344140115227199,0.0474054446154265,0.0608957371323327,2.67427558508093e-55
NMR metabolomics,X23408.Triglycerides in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.126920164494527,0.00807183957225648,0.111099358932904,0.142740970056149,3.27703789233404e-55
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0818548675704664,0.00520777029524369,0.0716476377917888,0.092062097349144,3.50818881324603e-55
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.106086809172184,0.00675319415750465,0.0928505486234749,0.119323069720893,3.98153531377063e-55
NMR metabolomics,X23408.Triglycerides in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.100341510974594,0.00638857636119298,0.0878199013066555,0.112863120642532,4.19449103431536e-55
NMR metabolomics,X23408.Triglycerides in VLDL,CRKL,Crk-like protein,42143,0.172708862078587,0.0110007360675257,0.151147419386237,0.194270304770937,4.6396599682003e-55
NMR metabolomics,X23408.Triglycerides in VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.0982256956700569,0.00625209535315546,0.0859715887778723,0.110479802562242,4.84588633943692e-55
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0459617245571798,0.00293591131794814,0.0402073383740014,0.0517161107403581,9.32127752780698e-55
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.127737522246478,0.00815705965573278,0.111749685321242,0.143725359171714,1.06512623455049e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.118696959931141,0.00758742873777244,0.103825599605107,0.133568320257175,1.10213928361185e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SIAE,Sialate O-acetylesterase,42147,0.0758052449731185,0.00484764053589423,0.0663038695227658,0.0853066204234712,1.21269248899923e-54
NMR metabolomics,X23408.Triglycerides in VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.125250327626641,0.00801572680272806,0.109539503093294,0.140961152159988,1.48835293197016e-54
NMR metabolomics,X23408.Triglycerides in VLDL,QDPR,Dihydropteridine reductase,42081,0.0686516228897339,0.0043947398297576,0.0600379328234091,0.0772653129560588,1.565882235108e-54
NMR metabolomics,X23408.Triglycerides in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.123027903703319,0.00788771825661035,0.107567975920363,0.138487831486276,2.26904235384966e-54
NMR metabolomics,X23408.Triglycerides in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0915383333537967,0.00587026497110639,0.0800326140104282,0.103044052697165,2.94885099872855e-54
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB3,Plexin-B3,42099,0.0780008029707115,0.00501040499236816,0.0681804091856699,0.0878211967557531,3.56332956963279e-54
NMR metabolomics,X23408.Triglycerides in VLDL,PENK,Proenkephalin-A,39736,0.0503463995242061,0.00323097151861964,0.0440136953477116,0.0566791037007006,3.57112359008801e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0450949947426202,0.00289731230579816,0.0394162626232558,0.0507737268619846,3.73728132880597e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D23,TBC1 domain family member 23,42070,0.146097763749778,0.00939190302854555,0.127689633813829,0.164505893685728,4.29715889636648e-54
NMR metabolomics,X23408.Triglycerides in VLDL,APOM,Apolipoprotein M,42199,0.0459909060788647,0.00295807141435225,0.0401930861067343,0.0517887260509951,4.81785371898435e-54
NMR metabolomics,X23408.Triglycerides in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.172640162343347,0.0111015937794868,0.150881038535553,0.194399286151141,5.65338790265511e-54
NMR metabolomics,X23408.Triglycerides in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.146659178475104,0.00943266204842574,0.128171160860189,0.165147196090018,5.91402235480173e-54
NMR metabolomics,X23408.Triglycerides in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.117708636358674,0.00757415809925886,0.102863286484127,0.132553986233222,6.58086533675411e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0786424978554198,0.00507442736016262,0.0686966202295011,0.0885883754813385,1.05736719296157e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FUS,RNA-binding protein FUS,41831,0.0642037440328458,0.00414506941680107,0.0560794079759157,0.0723280800897759,1.21301974696407e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.137373271263122,0.00887514516186868,0.119977986745859,0.154768555780384,1.4287068140541e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.11196871621445,0.0072436606346976,0.097771141370443,0.126166291058458,1.92394327082367e-53
NMR metabolomics,X23408.Triglycerides in VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.077045114079231,0.00498351662611349,0.0672774214920486,0.0868128066664134,2.2629363966483e-53
NMR metabolomics,X23408.Triglycerides in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0605424858662425,0.00392272485288618,0.0528539451545856,0.0682310265778994,2.77110126950528e-53
NMR metabolomics,X23408.Triglycerides in VLDL,IDUA,Alpha-L-iduronidase,42262,0.075793149625571,0.00491705200612211,0.0661557276935717,0.0854305715575703,3.67126956006216e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TBCC,Tubulin-specific chaperone C,42016,0.129342153826021,0.00839131189748142,0.112895182506957,0.145789125145084,3.77069772183241e-53
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0535776115403525,0.00347761497758137,0.0467614861842931,0.060393736896412,4.18687941305289e-53
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0693869215489083,0.00450345128288734,0.0605601570344491,0.0782136860633675,5.02583699613431e-53
NMR metabolomics,X23408.Triglycerides in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0786063428017881,0.00510296927225497,0.0686045230281683,0.0886081625754078,5.29628461510419e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.187300005500789,0.0121858379816201,0.163415763056814,0.211184247944765,7.27241964557382e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0463743703552388,0.00301577715574028,0.0404634471299878,0.0522852935804897,8.10441873909517e-53
NMR metabolomics,X23408.Triglycerides in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.100426094969012,0.0065375909137977,0.0876124167779688,0.113239773160056,1.04964741575202e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.138086510414094,0.00899487712093143,0.120456551257068,0.155716469571119,1.1692649419061e-52
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.141924032843282,0.00925751513557651,0.123779303177552,0.160068762509012,1.60344464107618e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.136073495022835,0.00889791008094732,0.118633591264178,0.153513398781492,2.39218337848921e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.152147762695887,0.00995274491934849,0.132640382653964,0.17165514273781,2.55288209361777e-52
NMR metabolomics,X23408.Triglycerides in VLDL,FKBPL,FK506-binding protein-like,39930,0.0946424887587552,0.00619122688627644,0.0825076840616534,0.106777293455857,3.1171178226848e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0406569012506839,0.00266402133678559,0.0354354194305842,0.0458783830707837,3.70713288148927e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ARSB,Arylsulfatase B,42070,0.0883625221584659,0.00579219627025947,0.0770098174687573,0.0997152268481745,4.12691519835328e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ST13,Hsc70-interacting protein,39736,0.0865324187992855,0.00566737065757132,0.0754243723104457,0.0976404652881252,4.17149885058806e-52
NMR metabolomics,X23408.Triglycerides in VLDL,IST1,IST1 homolog,39850,0.156911190559113,0.0102775010297624,0.136767288540779,0.177055092577448,4.18886030202047e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0736105007476306,0.0048314759103894,0.0641408079632674,0.0830801935319938,5.53506321174435e-52
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.133335065638367,0.00874596315983271,0.116192977845095,0.15047715343164,5.79660413420153e-52
NMR metabolomics,X23408.Triglycerides in VLDL,DDHD2,Phospholipase DDHD2,39934,0.105454946159704,0.006919064961752,0.0918935788346697,0.119016313484738,6.15597786754475e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2L,Ataxin-2-like protein,39934,0.0763837225893895,0.00501725855897754,0.0665498958137935,0.0862175493649855,7.94502495925176e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.105640912444071,0.00694567156013539,0.0920273961862055,0.119254428701936,9.88546033174353e-52
NMR metabolomics,X23408.Triglycerides in VLDL,GTPBP2,GTP-binding protein 2,39649,0.130310715143149,0.00857360561841384,0.113506448131058,0.14711498215524,1.19257866744937e-51
NMR metabolomics,X23408.Triglycerides in VLDL,MYDGF,Myeloid-derived growth factor,39958,0.157742642155328,0.0103869099730223,0.137384298608205,0.178100985702452,1.38958169082536e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ELOA,Elongin-A,42070,0.0851123055885569,0.00561092970081905,0.0741148833749515,0.0961097278021622,1.51129621075117e-51
NMR metabolomics,X23408.Triglycerides in VLDL,NFASC,Neurofascin,42296,0.0460470082649858,0.00304267144543572,0.0400833722319317,0.0520106442980398,2.52168437916129e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0932105089539585,0.00616203655202328,0.0811329173119928,0.105288100595924,2.90266730587552e-51
NMR metabolomics,X23408.Triglycerides in VLDL,OGA,Protein O-GlcNAcase,39930,0.112579227520477,0.00745042737975377,0.0979763898561599,0.127182065184795,4.34357504299391e-51
NMR metabolomics,X23408.Triglycerides in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.11350123260519,0.00752553810561991,0.098751177918175,0.128251287292205,6.74507931045632e-51
NMR metabolomics,X23408.Triglycerides in VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.100437512275182,0.00667366194279483,0.0873571348673042,0.11351788968306,8.92651196594867e-51
NMR metabolomics,X23408.Triglycerides in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.194294549723681,0.0129109363720047,0.168989114434552,0.21959998501281,9.30721642900604e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CST3,Cystatin-C,42184,0.045002342910269,0.00299178138287037,0.0391384513998431,0.0508662344206949,9.97618445800982e-51
NMR metabolomics,X23408.Triglycerides in VLDL,BID,BH3-interacting domain death agonist,42119,0.104026813211097,0.00691844969102312,0.0904666518166914,0.117586974605502,1.0929791891681e-50
NMR metabolomics,X23408.Triglycerides in VLDL,OGFR,Opioid growth factor receptor,42070,0.0502801051772152,0.00334943137673968,0.0437152196788054,0.056844990675625,1.58019199185809e-50
NMR metabolomics,X23408.Triglycerides in VLDL,APOF,Apolipoprotein F,39990,-0.0405817536640731,0.00270148729443402,-0.0458766687611637,-0.0352868385669824,1.603526882649e-50
NMR metabolomics,X23408.Triglycerides in VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0599612799354101,0.00399848385773928,0.0521242515742411,0.0677983082965791,2.02162660644364e-50
NMR metabolomics,X23408.Triglycerides in VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0937313855021202,0.0062518100513972,0.0814778378013817,0.105984933202859,2.0826328476731e-50
NMR metabolomics,X23408.Triglycerides in VLDL,GHRL,Appetite-regulating hormone,42145,0.129923826961575,0.00866946276297551,0.112931679946143,0.146915973977007,2.28238961625709e-50
NMR metabolomics,X23408.Triglycerides in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.228301847309452,0.015238805162932,0.198433789190106,0.258169905428799,2.92944359978909e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0609296088488465,0.00407123102673944,0.0529499960364372,0.0689092216612558,3.15795400791692e-50
NMR metabolomics,X23408.Triglycerides in VLDL,FGF19,Fibroblast growth factor 19,42185,0.121344889743809,0.0081108105475073,0.105447701070694,0.137242078416923,3.31910580026458e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.069804566375315,0.0046741966960467,0.0606431408510634,0.0789659918995665,5.05187330798271e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.129413971788038,0.0086697381757888,0.112421284963492,0.146406658612584,6.66345923815764e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CCL4,C-C motif chemokine 4,42148,0.096884472474623,0.00649758584411986,0.084149204220148,0.109619740729098,6.96402404603709e-50
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD1,COMM domain-containing protein 1,39638,0.0950102984873742,0.00637183963510439,0.0825214928025696,0.107499104172179,8.52663736503586e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.091451665676462,0.00615104411339761,0.0793956192142027,0.103507712138721,1.3170831606187e-49
NMR metabolomics,X23408.Triglycerides in VLDL,RBKS,Ribokinase,41830,0.0768368429841651,0.00517141912450086,0.0667008615001434,0.0869728244681868,1.54825136104115e-49
NMR metabolomics,X23408.Triglycerides in VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.141749324777233,0.00953465455937967,0.123061401840848,0.160437247713617,1.63051217409585e-49
NMR metabolomics,X23408.Triglycerides in VLDL,GPC5,Glypican-5,42016,0.0869861518485575,0.00588311783010584,0.0754552409015501,0.0985170627955649,4.40615570256036e-49
NMR metabolomics,X23408.Triglycerides in VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.121420764133394,0.00820559576069995,0.105337796442422,0.137503731824366,4.48788736271414e-49
NMR metabolomics,X23408.Triglycerides in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.108287414986078,0.00732142949559756,0.0939374131747066,0.122637416797449,4.96195615690589e-49
NMR metabolomics,X23408.Triglycerides in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0794012530490113,0.00537016089046936,0.0688757377036914,0.0899267683943312,5.18556403018546e-49
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.087310230512686,0.0059152449226552,0.0757163504642818,0.0989041105610901,6.29941647761616e-49
NMR metabolomics,X23408.Triglycerides in VLDL,KLK10,Kallikrein-10,42138,0.0629282309913378,0.00426693525431359,0.0545650378928832,0.0712914240897925,7.59584125792903e-49
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6AP2,Renin receptor,41843,0.0606344358044325,0.0041117084097243,0.0525754873213729,0.0686933842874921,7.86857311650693e-49
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.101674665336281,0.00689081435884493,0.0881686691929445,0.115180661479617,8.23517764952566e-49
NMR metabolomics,X23408.Triglycerides in VLDL,YJU2,Splicing factor YJU2,39919,0.0509283503284986,0.00345360303177103,0.0441592883862274,0.0576974122707698,9.18269825159632e-49
NMR metabolomics,X23408.Triglycerides in VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.142709069666016,0.00968677576792775,0.123722989160878,0.161695150171155,9.6706373594959e-49
NMR metabolomics,X23408.Triglycerides in VLDL,AP2B1,AP-2 complex subunit beta,39649,0.0748873180705165,0.00508097754148392,0.0649286020892081,0.084846034051825,1.05270212731098e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CD36,Platelet glycoprotein 4,39657,0.0715746126720604,0.00485862424392438,0.0620517091539686,0.0810975161901522,1.16958838337055e-48
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.160245177916632,0.010896811236114,0.138887427893849,0.181602927939416,1.40551952019446e-48
NMR metabolomics,X23408.Triglycerides in VLDL,LPP,Lipoma-preferred partner,39575,0.101398583342415,0.00689345184109212,0.0878874177338749,0.114909748950956,1.62293882334159e-48
NMR metabolomics,X23408.Triglycerides in VLDL,MGLL,Monoglyceride lipase,42166,0.133818217787265,0.00911189862817077,0.11595889647605,0.15167753909848,1.86311984269072e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.147755556321537,0.0100684943060594,0.128021307481661,0.167489805161414,2.58343588525923e-48
NMR metabolomics,X23408.Triglycerides in VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0537978955475129,0.00366982465498306,0.0466050392237461,0.0609907518712797,2.78593259153922e-48
NMR metabolomics,X23408.Triglycerides in VLDL,FABP5,Fatty acid-binding protein 5,42218,0.101921504326036,0.0069538476561344,0.0882919629200127,0.11555104573206,2.8387434687266e-48
NMR metabolomics,X23408.Triglycerides in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.069288294700703,0.00473309960959169,0.0600114194659033,0.0785651699355027,3.70523264780345e-48
NMR metabolomics,X23408.Triglycerides in VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0846484634366938,0.0057810275767847,0.0733176493861957,0.0959792774871918,4.24025604498041e-48
NMR metabolomics,X23408.Triglycerides in VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.138504478452202,0.00947516278888822,0.119933159385981,0.157075797518423,5.12707413239879e-48
NMR metabolomics,X23408.Triglycerides in VLDL,FOXJ3,Forkhead box protein J3,39657,0.0691235169551434,0.00472614462289675,0.0598602734942658,0.078386760416021,5.3940251745039e-48
NMR metabolomics,X23408.Triglycerides in VLDL,DOK1,Docking protein 1,39929,0.209385490365905,0.0143304893546782,0.181297731230736,0.237473249501074,6.49515496450362e-48
NMR metabolomics,X23408.Triglycerides in VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0679635364421096,0.00465550561493506,0.0588387454368369,0.0770883274473824,7.98562347039939e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0768998487877504,0.00527857226041318,0.0665538471573406,0.0872458504181602,1.02631187141747e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.110911769876223,0.00761537933860246,0.0959856263725619,0.125837913379884,1.30925611755052e-47
NMR metabolomics,X23408.Triglycerides in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.110646629151445,0.00760519390909407,0.0957404490896206,0.125552809213269,1.35949745538963e-47
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN3,Ataxin-3,39929,0.0927894037029507,0.00637516412981203,0.0802940820085192,0.105284725397382,1.4608680107842e-47
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA11,Annexin A11,42087,0.100564024749958,0.00692159479917823,0.0869976989435687,0.114130350556347,1.81086063327136e-47
NMR metabolomics,X23408.Triglycerides in VLDL,ADD1,Alpha-adducin,39736,0.105801413698938,0.00727655634324122,0.0915393632661854,0.120063464131691,1.83678374792042e-47
NMR metabolomics,X23408.Triglycerides in VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.115747370265953,0.00797423549336798,0.100117868698952,0.131376871832954,2.578294828574e-47
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS2,Trypsin-2,42217,0.086398102565713,0.00596792612119464,0.0747009673681715,0.0980952377632545,3.78671994586699e-47
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0590217035446836,0.00407953957482981,0.0510258059780171,0.06701760111135,4.33655333376387e-47
NMR metabolomics,X23408.Triglycerides in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.129939075564776,0.00898672265519565,0.112325099160593,0.14755305196896,5.86276615053941e-47
NMR metabolomics,X23408.Triglycerides in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0917691159210953,0.00635363806839327,0.0793159853070445,0.104222246535146,6.13015299462288e-47
NMR metabolomics,X23408.Triglycerides in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0897228371493224,0.00621624457064073,0.0775389977908666,0.101906676507778,7.17956263316846e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TWF2,Twinfilin-2,39966,0.12836223810968,0.00889675190739787,0.11092460437118,0.14579987184818,8.92689724903683e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CD226,CD226 antigen,39657,0.0640853686179815,0.00444644106945769,0.0553703441218444,0.0728003931141186,1.138471154318e-46
NMR metabolomics,X23408.Triglycerides in VLDL,GET3,ATPase GET3,39958,0.0813245512165972,0.0056476216003323,0.0702552128799459,0.0923938895532485,1.33407484883458e-46
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.119233805285683,0.00828766723852678,0.10298997749817,0.135477633073195,1.40379394856013e-46
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.131931101407461,0.00919002695869638,0.113918648568416,0.149943554246506,2.5498301649154e-46
NMR metabolomics,X23408.Triglycerides in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0734090875220222,0.00511573633465487,0.0633822443060987,0.0834359307379458,2.78977028228685e-46
NMR metabolomics,X23408.Triglycerides in VLDL,HPSE,Heparanase,39866,0.142989590780388,0.00997295402265036,0.123442600895994,0.162536580664783,3.24008636781559e-46
NMR metabolomics,X23408.Triglycerides in VLDL,TREH,Trehalase,39966,0.112529910928631,0.00786434009192487,0.0971158043484585,0.127944017508804,4.83268468797293e-46
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.102550077272348,0.00718616932880229,0.0884651853878953,0.1166349691568,7.14437412369634e-46
NMR metabolomics,X23408.Triglycerides in VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.050636165132352,0.0035547913977446,0.0436687739927726,0.0576035562719314,1.03505631405966e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CASC3,Protein CASC3,39649,0.0642920209212288,0.00451183067557373,0.0554488327971043,0.0731352090453533,1.14264248322241e-45
NMR metabolomics,X23408.Triglycerides in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.106821513095249,0.00750689516796451,0.0921079985660387,0.12153502762446,1.27331618718914e-45
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO3,Forkhead box protein O3,41843,0.142834900982915,0.0100460688314506,0.123144606073271,0.162525195892558,1.53230404053761e-45
NMR metabolomics,X23408.Triglycerides in VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0751749718698979,0.00528609950591437,0.0648142168383058,0.0855357269014901,1.70163794767844e-45
NMR metabolomics,X23408.Triglycerides in VLDL,DLG4,Disks large homolog 4,39929,0.107099834050616,0.00753534089370929,0.0923305658989463,0.121869102202287,1.86920054575629e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY4,Protein canopy homolog 4,42070,0.111366493425178,0.0078475834830238,0.0959852297984511,0.126747757051904,2.2053798476941e-45
NMR metabolomics,X23408.Triglycerides in VLDL,HNMT,Histamine N-methyltransferase,41961,0.0709620725247972,0.00500504755770903,0.0611521793116875,0.0807719657379069,2.66627517608083e-45
NMR metabolomics,X23408.Triglycerides in VLDL,WASHC3,WASH complex subunit 3,39929,0.112552076419115,0.00793520495784697,0.0969990747017352,0.128105078136495,2.81132298698276e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SPART,Spartin,39736,0.115136503807356,0.00812114717940133,0.0992190553357289,0.131053952278982,3.12739310182069e-45
NMR metabolomics,X23408.Triglycerides in VLDL,TADA3,Transcriptional adapter 3,39919,0.0598549968800131,0.00422758832262082,0.0515689237676763,0.0681410699923499,4.03116231659999e-45
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0836648260462208,0.00592071451397448,0.0720602255988308,0.0952694264936108,5.20297777256979e-45
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0557009997642593,0.00394377413512095,0.0479712024594222,0.0634307970690964,5.72263962852996e-45
NMR metabolomics,X23408.Triglycerides in VLDL,VNN1,Pantetheinase,39990,0.107903453182861,0.00764271203006277,0.0929237376039379,0.122883168761784,6.98047092270128e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0768057084013393,0.00544564097224604,0.0661322520957371,0.0874791647069416,8.57864058425585e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.128153455480137,0.00909290524827528,0.110331361193517,0.145975549766756,8.62710102440114e-45
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0901961303209946,0.00641219066484427,0.0776282366178998,0.102764024024089,1.26147131253998e-44
NMR metabolomics,X23408.Triglycerides in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0787811406212142,0.00560409986313668,0.0677971048894663,0.0897651763529621,1.42537107950661e-44
NMR metabolomics,X23408.Triglycerides in VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.0969582386601194,0.00689554448732309,0.0834429714649661,0.110473505855273,1.5599777861018e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CCL11,Eotaxin,42296,0.0548298351716505,0.00390580698585878,0.0471744534793673,0.0624852168639337,1.85392470219622e-44
NMR metabolomics,X23408.Triglycerides in VLDL,NEXN,Nexilin,39990,0.102217276612783,0.00728541775579814,0.0879378578114183,0.116496695414147,2.37537473696543e-44
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.138310209406198,0.00985870479704341,0.118987148003993,0.157633270808403,2.42343338350728e-44
NMR metabolomics,X23408.Triglycerides in VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0912123184055759,0.00650715691465061,0.0784582908528607,0.103966345958291,2.48131935305464e-44
NMR metabolomics,X23408.Triglycerides in VLDL,MAX,Protein max,41839,0.155545250966427,0.0110962123007661,0.133796674856926,0.177293827075929,2.51336859737983e-44
NMR metabolomics,X23408.Triglycerides in VLDL,IMPACT,Protein IMPACT,39929,0.0794528808548188,0.00566505907521214,0.068349365067403,0.0905563966422346,2.56862285524098e-44
NMR metabolomics,X23408.Triglycerides in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.129995099986647,0.00926893240948215,0.111827992464062,0.148162207509232,2.57222078181194e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.037613704845675,0.00268460344497418,0.0323518820935256,0.0428755275978244,2.72410750376653e-44
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINC1,Antithrombin-III,39959,0.0211820574228583,0.00151164819403064,0.0182192269625582,0.0241448878831583,3.04808275592456e-44
NMR metabolomics,X23408.Triglycerides in VLDL,NUDC,Nuclear migration protein nudC,42296,0.0929098083194038,0.00663592997461661,0.0799033855691552,0.105916231069652,3.09986811978356e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0675351758513894,0.00482397842751692,0.0580801781334563,0.0769901735693226,3.16162250339157e-44
NMR metabolomics,X23408.Triglycerides in VLDL,KLB,Beta-klotho,41839,-0.109353916433013,0.00781328924057539,-0.124667963344541,-0.0940398695214854,3.40945644795878e-44
NMR metabolomics,X23408.Triglycerides in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.111378789007031,0.00796031148941138,0.0957765784877843,0.126980999526277,3.6092625784667e-44
NMR metabolomics,X23408.Triglycerides in VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.0368656402761494,0.00263535417497255,-0.0420309344590956,-0.0317003460932032,3.67983794688259e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CETN2,Centrin-2,41839,0.0995316266813746,0.00711528345013197,0.0855856711191159,0.113477582243633,3.78078609237331e-44
NMR metabolomics,X23408.Triglycerides in VLDL,RFC4,Replication factor C subunit 4,39919,0.0324257408264367,0.0023166352976286,0.0278851356430846,0.0369663460097887,3.79596491116427e-44
NMR metabolomics,X23408.Triglycerides in VLDL,FGF23,Fibroblast growth factor 23,42250,0.0738173585129205,0.00528000876882973,0.0634685413260143,0.0841661756998268,4.12758915029428e-44
NMR metabolomics,X23408.Triglycerides in VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0467727844425539,0.00334566178998198,-0.0533302815509186,-0.0402152873341892,4.15795456324799e-44
NMR metabolomics,X23408.Triglycerides in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.139945100476205,0.0100155509327678,0.12031462064798,0.15957558030443,4.62656446925849e-44
NMR metabolomics,X23408.Triglycerides in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0467559405276392,0.00335226363083667,-0.0533263772440791,-0.0401855038111993,6.52868628278024e-44
NMR metabolomics,X23408.Triglycerides in VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.092401915607517,0.0066326590449383,0.0794019038794379,0.105401927335596,9.36884701546134e-44
NMR metabolomics,X23408.Triglycerides in VLDL,BMP6,Bone morphogenetic protein 6,41886,0.0582423511701013,0.0041840243716288,0.0500416634017089,0.0664430389384938,9.68742929730817e-44
NMR metabolomics,X23408.Triglycerides in VLDL,TP53,Cellular tumor antigen p53,41843,0.0646720020045005,0.0046519778016067,0.0555541255133514,0.0737898784956496,1.2465402411753e-43
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.10202555592258,0.00734348182253615,0.0876323315504093,0.116418780294751,1.38222006637214e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0424348392872422,0.0030536699537216,0.0364496461779479,0.0484200323965366,1.52412346896368e-43
NMR metabolomics,X23408.Triglycerides in VLDL,RBM17,Splicing factor 45,39934,0.111481089693907,0.00803210402449693,0.0957381658058933,0.127224013581921,1.91215350620892e-43
NMR metabolomics,X23408.Triglycerides in VLDL,F2,Prothrombin,39979,0.0215484555635072,0.00155378955214716,0.0185030280412988,0.0245938830857157,2.21987930133319e-43
NMR metabolomics,X23408.Triglycerides in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0833288565404127,0.00601094737620294,0.0715473996830549,0.0951103133977704,2.43505053704949e-43
NMR metabolomics,X23408.Triglycerides in VLDL,RRAS,Ras-related protein R-Ras,39649,0.190622099610799,0.0137547685839859,0.163662753186186,0.217581446035411,2.59695537220896e-43
NMR metabolomics,X23408.Triglycerides in VLDL,EHD3,EH domain-containing protein 3,39638,0.171034444147305,0.012348521276759,0.146831342444857,0.195237545849752,2.90057957883941e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.116332149539828,0.00841609243043376,0.0998366083761776,0.132827690703478,3.65636794235377e-43
NMR metabolomics,X23408.Triglycerides in VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.186425093124596,0.013487311534466,0.159989962517043,0.21286022373215,3.67278989267667e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ICA1,Islet cell autoantigen 1,41913,0.115555897671707,0.00835992007740381,0.0991704543199952,0.131941341023418,3.69800581866996e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.121254013213847,0.00878250733387064,0.10404029883946,0.138467727588233,4.65698248692489e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CETN3,Centrin-3,39930,0.113492287707997,0.00822120639564342,0.0973787231725354,0.129605852243458,5.30916600975982e-43
NMR metabolomics,X23408.Triglycerides in VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.110611247601469,0.00801981506522911,0.0948924100736204,0.126330085129319,5.5439242230354e-43
NMR metabolomics,X23408.Triglycerides in VLDL,VSNL1,Visinin-like protein 1,39929,0.0559099787961593,0.00405159966786381,0.0479688434471462,0.0638511141451723,5.7107675210175e-43
NMR metabolomics,X23408.Triglycerides in VLDL,EGF,Pro-epidermal growth factor,42081,0.149855173334452,0.0108754228832808,0.128539344483221,0.171171002185682,6.63546430639226e-43
NMR metabolomics,X23408.Triglycerides in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0682193137910499,0.00494815584148812,0.0585209283417332,0.0779176992403667,6.78743961617632e-43
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2,Microtubule-associated protein 2,39929,0.0674812953097237,0.00489508394721597,0.0578869307731804,0.077075659846267,6.90804923586891e-43
NMR metabolomics,X23408.Triglycerides in VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0329709824436529,0.00239386831969911,0.0282790005370426,0.0376629643502631,7.13767493762958e-43
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR2,GMP reductase 2,39736,0.0955692556558571,0.00694051936504311,0.0819658377003726,0.109172673611342,8.68028473369188e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0716400974280565,0.00520697838220819,0.0614344197989284,0.0818457750571845,1.01045488997359e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.0465343328097205,0.00338583121932196,0.0398981036198495,0.0531705619995916,1.24169175784023e-42
NMR metabolomics,X23408.Triglycerides in VLDL,TALDO1,Transaldolase,39948,0.0634429333248305,0.00461959487605675,0.0543885273677592,0.0724973392819017,1.4012133086616e-42
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT1,Angiopoietin-1,42085,0.119862285148371,0.00873463295795478,0.10274240455078,0.136982165745963,1.43511959458087e-42
NMR metabolomics,X23408.Triglycerides in VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0383189572650235,0.00279263195163705,0.0328453986398149,0.0437925158902321,1.64422514083186e-42
NMR metabolomics,X23408.Triglycerides in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0667009305348941,0.00487076630822982,-0.0762476324990245,-0.0571542285707636,2.09800913792286e-42
NMR metabolomics,X23408.Triglycerides in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0506764977764085,0.00369876390115912,0.0434269205301367,0.0579260750226804,2.18217927909728e-42
NMR metabolomics,X23408.Triglycerides in VLDL,C1S,Complement C1s subcomponent,39979,0.0302000680623822,0.002205167209163,0.0258779403324227,0.0345221957923416,2.35069142649813e-42
NMR metabolomics,X23408.Triglycerides in VLDL,SPRY2,Protein sprouty homolog 2,41913,0.132847072813956,0.00970985067151892,0.113815765497779,0.151878380130133,2.52468833100423e-42
NMR metabolomics,X23408.Triglycerides in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.083446952735122,0.00609839265494069,0.0714941031314382,0.0953998023388057,2.81604890064436e-42
NMR metabolomics,X23408.Triglycerides in VLDL,COMT,Catechol O-methyltransferase,41740,0.118849994320477,0.00870320703027344,0.101791708541142,0.135908280099813,3.61177490791677e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.113204698571899,0.00829634455509484,0.0969438632439133,0.129465533899885,4.12170222198777e-42
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.117614800892731,0.0086201650273268,0.100719277439171,0.134510324346292,4.15144317610851e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CASP10,Caspase-10,41839,0.101499220610575,0.00745581016420896,0.0868858326887254,0.116112608532425,6.37921129948236e-42
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.102079779906651,0.00750997886986889,0.0873602213217076,0.116799338491594,8.27115317756868e-42
NMR metabolomics,X23408.Triglycerides in VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0517447795108625,0.00380809665860425,0.0442809100599982,0.0592086489617269,8.86031639938669e-42
NMR metabolomics,X23408.Triglycerides in VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0234628809511976,0.00172789154383436,0.0200762135252822,0.0268495483771129,1.12744265613957e-41
NMR metabolomics,X23408.Triglycerides in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0644680453428112,0.00474911130036184,0.055159787194102,0.0737763034915205,1.19884948270992e-41
NMR metabolomics,X23408.Triglycerides in VLDL,SNCG,Gamma-synuclein,42016,0.0947486353842479,0.00698564197664676,0.0810567771100203,0.108440493658476,1.24246698038322e-41
NMR metabolomics,X23408.Triglycerides in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0653794312692929,0.00481717506295978,0.0559377681458917,0.0748210943926941,1.25431214364635e-41
NMR metabolomics,X23408.Triglycerides in VLDL,RILPL2,RILP-like protein 2,39958,0.140090569909941,0.0103365192091168,0.119830992260072,0.160350147559809,1.59903739441865e-41
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0685386517459856,0.00505796143363024,0.0586250473360703,0.0784522561559009,1.64969333245583e-41
NMR metabolomics,X23408.Triglycerides in VLDL,F12,Coagulation factor XII,39979,0.0584202041232916,0.00431254976347236,0.0499676065868858,0.0668728016596974,1.74030043068853e-41
NMR metabolomics,X23408.Triglycerides in VLDL,UBXN1,UBX domain-containing protein 1,39736,0.0974099742207706,0.00719357593928134,0.0833105653797792,0.111509383061762,1.89875911765319e-41
NMR metabolomics,X23408.Triglycerides in VLDL,PMVK,Phosphomevalonate kinase,41832,0.153725790884623,0.0113649761161436,0.131450437696982,0.176001144072265,2.06193332657351e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.0502867485679674,0.00371861964628066,0.0429982540612573,0.0575752430746775,2.11566718642559e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.111929667281774,0.00827300592159829,0.0957145756754417,0.128144758888107,2.23836316400421e-41
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE2,Glia-derived nexin,39958,0.0916772877118934,0.00678471579269444,0.0783792447582124,0.104975330665575,2.75570201479306e-41
NMR metabolomics,X23408.Triglycerides in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0797392196079095,0.00591349597249706,-0.0913296717140038,-0.0681487675018153,4.09265880978804e-41
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0605993808239335,0.004498457558062,0.0517824040101319,0.069416357637735,4.27681611386968e-41
NMR metabolomics,X23408.Triglycerides in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0946414740365976,0.00702359985066448,0.0808752183292952,0.1084077297439,4.61496414946937e-41
NMR metabolomics,X23408.Triglycerides in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0788837073470223,0.00586757637181877,0.0673832576582575,0.0903841570357871,6.08174097392142e-41
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH9,Protocadherin-9,39930,0.0475894787916365,0.00353947599012254,0.0406521058509963,0.0545268517322766,6.74541432491099e-41
NMR metabolomics,X23408.Triglycerides in VLDL,IL7,Interleukin-7,42119,0.0907272277082346,0.00675732317636633,0.0774828742825566,0.103971581133913,7.7234865727918e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.0515789321065928,0.00384242164529967,0.0440477856818055,0.0591100785313802,7.98367442453198e-41
NMR metabolomics,X23408.Triglycerides in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0795060952184064,0.00592610486117966,0.0678909296904943,0.0911212607463186,8.84952179275423e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CPB1,Carboxypeptidase B,42310,0.0869956272984176,0.00648655779224901,0.0742819740256095,0.0997092805712257,9.33149134580595e-41
NMR metabolomics,X23408.Triglycerides in VLDL,PF4,Platelet factor 4,39914,0.13653699012568,0.010201157712372,0.116542721009431,0.15653125924193,1.51541858113673e-40
NMR metabolomics,X23408.Triglycerides in VLDL,FMNL1,Formin-like protein 1,41839,0.0884081069503953,0.00661154771770402,0.0754494734236954,0.101366740477095,1.61905946351633e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SPARC,SPARC,42181,0.0976959005915852,0.0073081396110992,0.0833719469538308,0.11201985422934,1.6745359274304e-40
NMR metabolomics,X23408.Triglycerides in VLDL,DNM3,Dynamin-3,39934,0.0770315751548716,0.00576144015643025,0.0657391524482683,0.0883239978614749,1.82825721984643e-40
NMR metabolomics,X23408.Triglycerides in VLDL,LARP1,La-related protein 1,39919,0.0868755700676159,0.0065132543124663,0.074109591615182,0.0996415485200499,2.79065863579018e-40
NMR metabolomics,X23408.Triglycerides in VLDL,WDR46,WD repeat-containing protein 46,39919,0.0510837756728019,0.00383007503040446,0.0435768286132091,0.0585907227323946,2.81786573346551e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CTF1,Cardiotrophin-1,41900,0.117635905684743,0.00883450156351047,0.100320282620263,0.134951528749224,3.40080016837907e-40
NMR metabolomics,X23408.Triglycerides in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.136089196415483,0.0102304213433534,0.11603757058251,0.156140822248455,4.05375257544141e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CPA1,Carboxypeptidase A1,42310,0.0899175742485938,0.00676494605908482,0.0766582799727876,0.1031768685244,4.57703114647762e-40
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX2,Heme oxygenase 2,41839,0.0662969476287728,0.00499964492035939,0.0564976435848683,0.0760962516726772,7.05930538561813e-40
NMR metabolomics,X23408.Triglycerides in VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.0768279493735677,0.00579494262035126,0.0654698618376792,0.0881860369094561,8.05584900112804e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.174691134831211,0.01319953951172,0.14882003738824,0.200562232274183,1.10309570257902e-39
NMR metabolomics,X23408.Triglycerides in VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.0937012971364478,0.00708615470962104,0.0798124339055906,0.107590160367305,1.28219854001845e-39
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRD2,Protein ZNRD2,39930,0.0964820363177158,0.00729762058363041,0.0821786999738002,0.110785372661631,1.30311261747437e-39
NMR metabolomics,X23408.Triglycerides in VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.0859400646562811,0.0065040923758531,0.073192043599609,0.0986880857129531,1.31070695220052e-39
NMR metabolomics,X23408.Triglycerides in VLDL,GDF2,Growth/differentiation factor 2,42145,0.0487777444739438,0.00369487521904915,0.0415357890446075,0.0560196999032801,1.50981295738772e-39
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0839365535196434,0.00636035458804976,0.0714702585270659,0.0964028485122209,1.62461914571829e-39
NMR metabolomics,X23408.Triglycerides in VLDL,SPON2,Spondin-2,42070,-0.0480396013348201,0.00364845245973153,-0.0551905681558938,-0.0408886345137463,2.37414560266182e-39
NMR metabolomics,X23408.Triglycerides in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.105769194810418,0.00803550747069398,0.0900196001678579,0.121518789452978,2.50747937199196e-39
NMR metabolomics,X23408.Triglycerides in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0511667226095225,0.00388679994552546,0.0435485947162926,0.0587848505027524,2.7389282329973e-39
NMR metabolomics,X23408.Triglycerides in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0916844079903438,0.00697810095283457,0.0780073301227881,0.1053614858579,3.8470807357537e-39
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0671961956985683,0.00511689547477461,0.0571670805680101,0.0772253108291265,4.15205180307043e-39
NMR metabolomics,X23408.Triglycerides in VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.150194247408213,0.0114513996489386,0.127749504096294,0.172638990720133,4.63122938652752e-39
NMR metabolomics,X23408.Triglycerides in VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.0316856983167684,0.00241551736213918,0.0269512842869756,0.0364201123465612,5.08199934520492e-39
NMR metabolomics,X23408.Triglycerides in VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0728268688091722,0.00555271202423128,0.0619435532416789,0.0837101843766655,5.28726083105458e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0620698822906429,0.00473605425256055,0.0527872159556243,0.0713525486256616,5.33105728595594e-39
NMR metabolomics,X23408.Triglycerides in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0707292762531486,0.005393640220717,0.0601577414205433,0.0813008110857539,5.38550479795189e-39
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0639365656182159,0.0048823261409759,0.0543672063819031,0.0735059248545286,6.80559952494081e-39
NMR metabolomics,X23408.Triglycerides in VLDL,IL18,Interleukin-18,42069,0.0606558125350894,0.00463727432456361,0.0515667548589447,0.069744870211234,7.38367407608224e-39
NMR metabolomics,X23408.Triglycerides in VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0773809403106354,0.00591911595779655,0.0657794730333541,0.0889824075879166,8.16115193754249e-39
NMR metabolomics,X23408.Triglycerides in VLDL,ESYT2,Extended synaptotagmin-2,39929,0.113814690999405,0.00872239181280027,0.0967188030463165,0.130910578952494,1.22911179774964e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CASP7,Caspase-7,39929,0.115040981039319,0.00884333492235106,0.0977080445915108,0.132373917487127,2.05438482479821e-38
NMR metabolomics,X23408.Triglycerides in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.103406683445411,0.00796389670591097,0.0877974459018259,0.119015920988997,2.53646244811322e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.134409583120809,0.0103517664952107,0.114120120790196,0.154699045451422,2.81886427491703e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PPBP,Platelet basic protein,39908,0.116408334935031,0.00896735753210806,0.0988323141720994,0.133984355697963,2.92847970761425e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.10278632044593,0.00792081612122486,0.0872615208483295,0.118311120043531,3.1549581452207e-38
NMR metabolomics,X23408.Triglycerides in VLDL,TMED8,Protein TMED8,39930,0.140205687491112,0.0108100542082874,0.119017981242869,0.161393393739355,3.38715785048418e-38
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0580382009690041,0.00447907048296436,0.0492592228223939,0.0668171791156142,3.57538843145722e-38
NMR metabolomics,X23408.Triglycerides in VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0905263383783653,0.00698825002695082,0.0768293683255417,0.104223308431189,3.73223681712116e-38
NMR metabolomics,X23408.Triglycerides in VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.153033211546033,0.0118065198669671,0.129892432606777,0.176173990485288,3.80330830300761e-38
NMR metabolomics,X23408.Triglycerides in VLDL,KLK13,Kallikrein-13,41839,0.0607393993451995,0.00469411334811394,0.0515389371828962,0.0699398615075029,4.58307572737755e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NID1,Nidogen-1,42189,0.0487563017248421,0.00376838700545298,0.0413702631941543,0.05614234025553,4.59403068632147e-38
NMR metabolomics,X23408.Triglycerides in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0360126180683877,0.00278354143615141,-0.0414683592832445,-0.0305568768535309,5.11029410328228e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CD69,Early activation antigen CD69,42082,0.118411385842391,0.00915889264947642,0.100459956249417,0.136362815435364,5.22321849379246e-38
NMR metabolomics,X23408.Triglycerides in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0765527937899256,0.0059391722290361,0.0649120162210149,0.0881935713588364,8.62858996946183e-38
NMR metabolomics,X23408.Triglycerides in VLDL,TTF2,Transcription termination factor 2,39649,0.0671920943129463,0.00521162623165075,0.0569773068989108,0.0774068817269818,9.25355874801163e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0506908448873419,0.00393491535998619,0.042978410781769,0.0584032789929148,9.51761845929876e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.106390214011418,0.00826239298519541,0.0901959237604348,0.122584504262401,1.02159441191039e-37
NMR metabolomics,X23408.Triglycerides in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0882708801720607,0.00686125057839021,0.0748228290384159,0.101718931305706,1.32163413205659e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PVR,Poliovirus receptor,42249,0.0502893710517861,0.00391210971220823,0.042621636015858,0.0579571060877143,1.33567936553639e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.150028596931709,0.0116722422705587,0.127151002081414,0.172906191782004,1.37993186322506e-37
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.116870405770925,0.00909391457865539,0.0990463331967601,0.134694478345089,1.55845616517128e-37
NMR metabolomics,X23408.Triglycerides in VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.11284697596131,0.0088087490749137,0.0955818277744793,0.130112124148141,2.35274251761884e-37
NMR metabolomics,X23408.Triglycerides in VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.0866270916655327,0.00677865596076907,-0.0999132573486401,-0.0733409259824253,3.84412793818918e-37
NMR metabolomics,X23408.Triglycerides in VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0407699854613689,0.00319270003213742,0.0345122933983795,0.0470276775243582,3.94552906174466e-37
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.04249402514087,0.003340128311829,0.0359473736496852,0.0490406766320548,8.06202570532872e-37
NMR metabolomics,X23408.Triglycerides in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.112062940808652,0.00882398190438284,0.0947679362760619,0.129357945341243,9.70519459629828e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0356742639296959,0.00280764088913896,0.0301712877869836,0.0411772400724083,9.71921922369661e-37
NMR metabolomics,X23408.Triglycerides in VLDL,HEPH,Hephaestin,39958,0.037099650492106,0.00292155018244633,0.0313734121345112,0.0428258888497008,1.06848158554718e-36
NMR metabolomics,X23408.Triglycerides in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0866034394278842,0.00683013241893968,0.0732163798867625,0.099990498969006,1.25220428226657e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CCL3,C-C motif chemokine 3,42119,0.0787610628089166,0.00621358895238035,0.0665824284622512,0.0909396971555821,1.30392642490572e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0266240792243573,0.00210047543478536,0.022507147372178,0.0307410110765366,1.43618314328929e-36
NMR metabolomics,X23408.Triglycerides in VLDL,KIFBP,KIF-binding protein,42070,0.109330125649834,0.00863426816059325,0.0924069600550717,0.126253291244597,1.54374404340029e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0443413696596911,0.00350248947875967,0.0374764902813222,0.0512062490380601,1.58820195294853e-36
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0540796866957669,0.00427503603216566,0.0457006160727222,0.0624587573188116,1.80677633910093e-36
NMR metabolomics,X23408.Triglycerides in VLDL,TBCB,Tubulin-folding cofactor B,42016,0.132280979028969,0.0104689413761887,0.111761853931639,0.152800104126299,2.16628456923193e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.112475813097167,0.00891224974963518,0.0950078035878823,0.129943822606452,2.85862741170242e-36
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0723321810886136,0.00573579719320221,0.0610900185899373,0.08357434358729,2.97209002276788e-36
NMR metabolomics,X23408.Triglycerides in VLDL,LEPR,Leptin receptor,42145,-0.0414301239263479,0.00328849692380739,-0.0478755778970104,-0.0349846699556854,3.43355201356744e-36
NMR metabolomics,X23408.Triglycerides in VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0452238754782323,0.00359088864702988,0.0381857337300538,0.0522620172264109,3.63463745187355e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0677373096401863,0.00538126633283845,0.057190027627823,0.0782845916525497,4.29886463889707e-36
NMR metabolomics,X23408.Triglycerides in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0976405577129724,0.00776788189372818,0.0824155092012651,0.11286560622468,5.42616904263677e-36
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0687670314642013,0.00548088583471017,0.0580244952281694,0.0795095677002333,7.24166601690932e-36
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0420421176891061,0.00335633570693658,-0.0486205356747018,-0.0354636997035104,8.42828768892247e-36
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB1,Heat shock protein beta-1,41949,0.0918621489119868,0.00733566501987823,0.0774842454730255,0.106240052350948,8.91341663989949e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.156912100641233,0.0125272912674082,0.132358609757113,0.181465591525353,9.41275412039847e-36
NMR metabolomics,X23408.Triglycerides in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.129758703953133,0.0103591417763916,0.109454786071405,0.15006262183486,9.43796165238209e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL1,Growth-regulated alpha protein,42117,0.121702937186712,0.00973483098695378,0.102622668452282,0.140783205921141,1.14919383175843e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CCL8,C-C motif chemokine 8,42239,0.0791877259408842,0.00633845502692577,0.0667643540881097,0.0916110977936587,1.27344263330556e-35
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0878171678860816,0.00703583860200358,0.0740269242261546,0.101607411546009,1.49448331748949e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.104381985961812,0.00836797516943544,-0.120783217293905,-0.0879807546297184,1.62214806651617e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ATG4A,Cysteine protease ATG4A,41843,0.0759113565616635,0.0060943224196235,0.0639664846192014,0.0878562285041255,2.04607153731809e-35
NMR metabolomics,X23408.Triglycerides in VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0866059184549098,0.00695738760519374,0.0729694387487301,0.10024239816109,2.48088239207067e-35
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4D,Semaphorin-4D,42249,0.0391517022929516,0.00314822440033748,0.0329811824682901,0.045322222117613,2.58466017509768e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.121841152442853,0.00979693334617619,0.102639163084347,0.141043141801358,2.58699584014366e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0842071165663727,0.00677876158203983,0.0709207438655746,0.0974934892671707,3.07042631130882e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0653406362033943,0.00526551321840119,0.0550202302953279,0.0756610421114606,3.59981702799957e-35
NMR metabolomics,X23408.Triglycerides in VLDL,F11,Coagulation factor XI,39822,0.0407914302581406,0.0032906158928204,0.0343418231082126,0.0472410374080686,4.64115792756144e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0330359333754701,0.00266594822107202,0.0278106748621689,0.0382611918887712,4.87341226948871e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ATOX1,Copper transport protein ATOX1,42181,0.0919520380764354,0.0074367019461012,0.077376102262077,0.106527973890794,6.25925441789135e-35
NMR metabolomics,X23408.Triglycerides in VLDL,GLB1,Beta-galactosidase,42016,0.0557685056176368,0.00451289277056304,0.0469232357873333,0.0646137754479404,6.86075198563359e-35
NMR metabolomics,X23408.Triglycerides in VLDL,BIN2,Bridging integrator 2,42137,0.115407859350075,0.00934214603551034,0.097097253120475,0.133718465579676,7.19047847009259e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL2,Chordin-like protein 2,42145,0.059049040129437,0.00478308213115666,0.04967419915237,0.0684238811065041,7.93805344783817e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.135395680717921,0.0109609874286946,0.113912145357679,0.156879216078162,7.97959460774934e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0598182533059321,0.00484833077370389,0.0503155249894725,0.0693209816223917,8.6746165292294e-35
NMR metabolomics,X23408.Triglycerides in VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0946468892063641,0.00766894618472461,0.0796157546843039,0.109678023728424,9.01897437810619e-35
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.102199799118667,0.00831630652667747,0.085899838326379,0.118499759910955,1.74060668746844e-34
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0382888599465122,0.00311946760124758,0.0321747034480669,0.0444030164449574,1.8976761392028e-34
NMR metabolomics,X23408.Triglycerides in VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0752148461127901,0.00613246733558775,0.0631952101350381,0.0872344820905421,2.11937115729401e-34
NMR metabolomics,X23408.Triglycerides in VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.073256861348761,0.00597943863480786,0.0615371616245376,0.0849765610729844,2.53068347286593e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CACYBP,Calcyclin-binding protein,39713,0.13304645570825,0.0108563404972363,0.111768028333667,0.154324883082833,2.62331024939413e-34
NMR metabolomics,X23408.Triglycerides in VLDL,JAM3,Junctional adhesion molecule C,39736,0.0651830433369631,0.00532144858344305,0.0547530041134147,0.0756130825605114,2.8214018079375e-34
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.062920385608234,0.00513805188440741,0.0528498039147954,0.0729909673016725,2.94233005235991e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DDT,D-dopachrome decarboxylase,39966,0.0520988513548373,0.00425976252951744,0.0437497167969831,0.0604479859126915,3.50407952753141e-34
NMR metabolomics,X23408.Triglycerides in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0849350071806418,0.00695101850753004,0.0713110109058829,0.0985590034554006,4.09433743751508e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.034973271840491,0.00286272844907401,0.0293623240803059,0.0405842196006761,4.13968524882084e-34
NMR metabolomics,X23408.Triglycerides in VLDL,YWHAQ,14-3-3 protein theta,39736,0.0947331702160262,0.00775912146219832,0.0795252921501175,0.109941048281935,4.57817133216149e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CRADD,Death domain-containing protein CRADD,41997,0.0953693911298474,0.00781692077021726,0.0800482264202216,0.110690555839473,4.68952811693868e-34
NMR metabolomics,X23408.Triglycerides in VLDL,MATN2,Matrilin-2,42144,0.0378548566634361,0.00310326784553588,0.0317724516861857,0.0439372616406864,4.78296531753142e-34
NMR metabolomics,X23408.Triglycerides in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0973564575966484,0.00798040235630698,0.0817148689782867,0.11299804621501,5.10746534664407e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB9,Serpin B9,42016,0.0418501988721699,0.00343750435624379,0.0351126903339321,0.0485877074104078,6.40892768428826e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0506365087902594,0.00416237289778123,0.0424782579106081,0.0587947596699106,7.11006000472499e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.031321759216478,0.00257524265213918,0.0262742836182852,0.0363692348146707,7.3799342001591e-34
NMR metabolomics,X23408.Triglycerides in VLDL,THPO,Thrombopoietin,41900,0.0496022071446614,0.00407868659904422,0.0416079814105348,0.0575964328787881,7.55345178347081e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0502369235058839,0.00413385280402749,0.0421345720099901,0.0583392750017778,8.32562561311668e-34
NMR metabolomics,X23408.Triglycerides in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0387637472736657,0.00319213371420213,0.0325071651938295,0.0450203293535019,9.27581137414735e-34
NMR metabolomics,X23408.Triglycerides in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0935909652312743,0.00770247650589287,0.0784941112797243,0.108687819182824,9.3324084000351e-34
NMR metabolomics,X23408.Triglycerides in VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0777150993684831,0.00640483875994396,0.0651616153989929,0.0902685833379732,1.14498910598699e-33
NMR metabolomics,X23408.Triglycerides in VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.079102523021335,0.00653062573307402,0.0663024965845099,0.09190254945816,1.46051740231378e-33
NMR metabolomics,X23408.Triglycerides in VLDL,XCL1,Lymphotactin,42262,0.0691065586168846,0.00570931884945307,0.0579162936719565,0.0802968235618126,1.49052569879971e-33
NMR metabolomics,X23408.Triglycerides in VLDL,THTPA,Thiamine-triphosphatase,39897,0.111284044812493,0.00919266978058319,0.0932664120425503,0.129301677582436,1.58774325446352e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0835079515941698,0.00690485396063164,0.0699744378313318,0.0970414653570078,1.70029470884957e-33
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0466288453461497,0.00385958375373839,0.0390640611888225,0.054193629503477,2.12662260418474e-33
NMR metabolomics,X23408.Triglycerides in VLDL,RBP2,Retinol-binding protein 2,42070,-0.0984005662084126,0.00815541459037961,-0.114385178805557,-0.0824159536112685,2.38228338738253e-33
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0813403870308257,0.0067437852919389,0.0681225678586255,0.094558206203026,2.69622419742691e-33
NMR metabolomics,X23408.Triglycerides in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.113110605610287,0.00938475904152432,0.0947164778888991,0.131504733331674,2.99800868631077e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0583241607698315,0.00484276724399521,0.0488323369716009,0.0678159845680621,3.38243153259238e-33
NMR metabolomics,X23408.Triglycerides in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0908710899567756,0.00754972963023106,0.0760736198815227,0.105668560032028,3.41093354726347e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0722616652700884,0.00600201129143017,0.0604977231388853,0.0840256074012915,3.55055222367888e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.125189370234847,0.0104065083773025,0.104792613815334,0.14558612665436,3.65394861019535e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PLG,Plasminogen,39742,0.0275521180356382,0.00228934303740334,0.0230650056823277,0.0320392303889488,3.73619108623694e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CERT,Ceramide transfer protein,41839,0.0772984124216519,0.00642860255362021,0.0646983514165562,0.0898984734267475,3.94768763746318e-33
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.1255068333022,0.0104377427442811,0.105048857523409,0.145964809080991,4.20932976043318e-33
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA12,Serpin A12,41751,0.135924832116833,0.011345018209354,0.113688596426499,0.158161067807166,6.62778102131915e-33
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.0357762987232243,0.00298802518371396,0.029919769363145,0.0416328280833037,7.17067866234331e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CD22,B-cell receptor CD22,42296,0.0534416990073003,0.00446603479314571,0.0446882708127347,0.0621951272018659,7.78207698779032e-33
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0726775520473967,0.00607183567368969,0.0607767541269649,0.0845783499678285,8.08344770449978e-33
NMR metabolomics,X23408.Triglycerides in VLDL,FEN1,Flap endonuclease 1,41843,0.0806236207148473,0.00673902860177579,0.0674151246553668,0.0938321167743279,8.12715930340091e-33
NMR metabolomics,X23408.Triglycerides in VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.0595612436049464,0.00497965189970851,0.0498011258815177,0.0693213613283751,8.95636863024685e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.120018621593854,0.0100422981628783,0.100335717194612,0.139701525993095,9.33487826722783e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CCN4,CCN family member 4,42262,0.0489323575368679,0.00409479943902022,0.0409065506363883,0.0569581644373475,9.46742232443505e-33
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0394054673361076,0.00330509267438256,0.0329274856943177,0.0458834489778974,1.31306278218788e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0838036142303125,0.00702918420721063,0.0700264131841796,0.0975808152764453,1.31947309068465e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX1,Peroxiredoxin-1,41742,-0.114556747045477,0.00961768597135319,-0.133407411549329,-0.0957060825416246,1.524217845957e-32
NMR metabolomics,X23408.Triglycerides in VLDL,GZMA,Granzyme A,42296,0.042264849838915,0.00355293450899054,0.0353010982012936,0.0492286014765365,1.79933841332063e-32
NMR metabolomics,X23408.Triglycerides in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0583962842984161,0.00490688203438707,0.0487787955110174,0.0680137730858147,1.82710652408555e-32
NMR metabolomics,X23408.Triglycerides in VLDL,ADM,Pro-adrenomedullin,42262,0.0325561425723953,0.00273936298952211,0.027186991112932,0.0379252940318587,2.05638969473309e-32
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D5,TBC1 domain family member 5,42119,0.097082328224633,0.00817167700360312,0.0810658412975709,0.113098815151695,2.17022000734761e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.111325533800929,0.00937906211769558,0.0929425720502452,0.129708495551612,2.46676589147156e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CCL2,C-C motif chemokine 2,41992,0.0644768943085624,0.00543307629634259,0.0538280647677309,0.0751257238493938,2.53600915939299e-32
NMR metabolomics,X23408.Triglycerides in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0859304191841682,0.0072386855166599,0.0717425955715148,0.100118242796822,2.63912665493563e-32
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0665988878099968,0.00561104743854876,0.0556012348304412,0.0775965407895523,2.65664065668469e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB6,Serpin B6,42216,0.072706107613735,0.00612934424089061,0.0606925929015894,0.0847196223258806,2.69008476989867e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.103742637755829,0.0087418543288541,0.0866086032712752,0.120876672240383,2.71660935303971e-32
NMR metabolomics,X23408.Triglycerides in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0459485598417872,0.00387526759059655,0.038353035364218,0.0535440843193564,2.86260293362811e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.0613891783003029,0.00517855635248513,0.0512392078494321,0.0715391487511738,2.94622973203276e-32
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1B,Meprin A subunit beta,42145,0.142219441769402,0.0120008023805276,0.118697869103568,0.165741014435236,3.07457181424722e-32
NMR metabolomics,X23408.Triglycerides in VLDL,POSTN,Periostin,39966,-0.0469728563400866,0.00396360510607238,-0.0547415223479884,-0.0392041903321847,3.28823223953037e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CASP2,Caspase-2,42119,0.0847051394895544,0.00716059622657756,0.0706703708854624,0.0987399080936464,3.96467066678162e-32
NMR metabolomics,X23408.Triglycerides in VLDL,APP,Amyloid-beta precursor protein,42112,0.0819684296487322,0.00692965930744445,0.068386297406141,0.0955505618913233,3.99846359464553e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CD244,Natural killer cell receptor 2B4,42296,0.0340824941701189,0.00288263150494467,0.0284325364204273,0.0397324519198104,4.23267820608861e-32
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,0.0429753951432296,0.00363353703814583,0.0358536625484637,0.0500971277379954,4.34264779679333e-32
NMR metabolomics,X23408.Triglycerides in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.117293402861822,0.00992055103644999,0.0978491228303803,0.136737682893264,4.56817150389877e-32
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.0965389785582779,0.00816581092774619,0.0805339891398954,0.11254396797666,4.6161477081814e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CD164,Sialomucin core protein 24,42137,0.0334205602971931,0.00282932911988465,0.0278750752222192,0.038966045372167,4.85051731565319e-32
NMR metabolomics,X23408.Triglycerides in VLDL,MESD,LRP chaperone MESD,42137,0.150732624104926,0.0127627753133116,0.125717584490835,0.175747663719017,4.95747888430081e-32
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0646849630707424,0.00547685188292384,0.0539503333802116,0.0754195927612731,4.98090600200048e-32
NMR metabolomics,X23408.Triglycerides in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.133553734026865,0.0113058117747834,0.111394342948289,0.15571312510544,5.16447306135631e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SUGT1,Protein SGT1 homolog,41843,0.0987054642918506,0.00837002420053607,0.0823002168587998,0.115110711724901,6.14642385246731e-32
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.111683195328072,0.0094682193384582,0.0931254854246939,0.13024090523145,6.38861323279492e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CCL18,C-C motif chemokine 18,42020,0.0865535463248899,0.00735091322700084,0.0721457563999683,0.100961336249812,7.57512284319655e-32
NMR metabolomics,X23408.Triglycerides in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.113000487899006,0.00959741693538554,0.0941895507056503,0.131811425092362,7.59774036738355e-32
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0650744279335914,0.005530311775127,0.0542350168543425,0.0759138390128403,8.28890281875361e-32
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0772471105019819,0.00656864882809664,0.0643725587989124,0.0901216622050513,8.95640968564296e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.075151570585697,0.00641470477397346,0.062578749228709,0.087724391942685,1.62991885676026e-31
NMR metabolomics,X23408.Triglycerides in VLDL,TSNAX,Translin-associated protein X,39575,0.0482272006790527,0.00411690535313385,0.0401580661869104,0.0562963351711951,1.65539598107185e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0679599591364251,0.00580486908561725,0.0565824157286152,0.0793375025442349,1.79087145648478e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0525641500905212,0.00449060330150998,0.0437625676195617,0.0613657325614808,1.82844948405591e-31
NMR metabolomics,X23408.Triglycerides in VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0585715725692527,0.00500822563616678,0.0487554503223659,0.0683876948161396,2.04195950959996e-31
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0878039742768579,0.00751077767522902,0.0730828500334091,0.102525098520307,2.16173385925287e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PTGR1,Prostaglandin reductase 1,39958,0.102411679529893,0.00876610683655048,0.0852301101302544,0.119593248929532,2.36121772239105e-31
NMR metabolomics,X23408.Triglycerides in VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0585882358649207,0.00501558909893845,0.0487576812310014,0.0684187904988401,2.40370841196091e-31
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0334380161707368,0.00286786865393615,0.027816993609022,0.0390590387324516,3.12368912134643e-31
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.138676905847261,0.0119096552481381,0.11533398156091,0.162019830133611,3.45791412647104e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.110816886059054,0.00951749715682354,0.0921625916316795,0.129471180486428,3.76558311555272e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.030307645133964,0.00260556885380418,0.0252007301805078,0.0354145600874202,3.98568009165878e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BAG6,Large proline-rich protein BAG6,41900,0.044941629055193,0.00386474082173767,0.0373667370445872,0.0525165210657988,4.16858960600029e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PSPN,Persephin,42119,0.105281809727461,0.00906053303228576,0.0875231649841814,0.123040454470742,4.59074436577096e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.118078487287676,0.0101582087530359,0.0981683981317254,0.137988576443626,4.72155262782576e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CALCA,Calcitonin,41997,0.0845250025038809,0.00727760493068852,0.0702608968397314,0.0987891081680305,4.90368889194262e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0623981480477102,0.00537142274084606,-0.0729261366197685,-0.0518701594756519,5.07428658188602e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PKD2,Polycystin-2,39575,0.071173469480322,0.00612927119140654,0.0591600979451651,0.0831868410154788,5.42994127738149e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0603252116982859,0.00521318956002932,0.0501073601606284,0.0705430632359434,8.07061617546218e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA11,Integrin alpha-11,42119,-0.041050014614712,0.00354924852486767,-0.0480065417234526,-0.0340934875059714,8.57071564563235e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.082572476909239,0.00714040427981444,0.0685772845208027,0.0965676692976753,9.31933431552848e-31
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS1,Galectin-1,42145,0.0422910240385017,0.00366530359550207,0.0351070289913176,0.0494750190856857,1.17763260800308e-30
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.135206592680793,0.0117176478890418,0.112240002818271,0.158173182543315,1.17783636037356e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MICALL2,MICAL-like protein 2,39649,0.0829006996740633,0.0071830186144077,0.0688219831898242,0.0969794161583024,1.2250217547762e-30
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA3,Annexin A3,42224,0.0839170860300945,0.00727740199688618,0.0696533781161976,0.0981807939439914,1.27425533841188e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CTRB1,Chymotrypsinogen B,42137,0.0705690463905444,0.00611986425601916,0.0585741124487469,0.082563980332342,1.27753255056896e-30
NMR metabolomics,X23408.Triglycerides in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0401449686511449,0.00348267796084031,0.0333189198478979,0.0469710174543919,1.33499192649157e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0336701794377385,0.00292101609819352,0.0279449878852792,0.0393953709901978,1.33681393986009e-30
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.105878720771251,0.00918535950605574,0.0878754161393814,0.12388202540312,1.43022154035441e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0723385666742328,0.00628870508933193,-0.0846644286493234,-0.0600127046991422,1.76139434132332e-30
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0741768776580386,0.00645166449788299,0.0615316152421879,0.0868221400738893,2.00453099361303e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0775351048144115,0.00674657281479255,0.0643118220974181,0.0907583875314049,2.00539864908252e-30
NMR metabolomics,X23408.Triglycerides in VLDL,C3,Complement C3,39445,0.0554436246624291,0.00482439196551273,0.0459878164100241,0.064899432914834,2.16072236192116e-30
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS9,Galectin-9,42129,0.0377790189620823,0.00329039152369403,0.031329851575642,0.0442281863485226,2.25620487519864e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0805254171011373,0.00701696221579991,0.0667721711581695,0.0942786630441051,2.41240788401152e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SDC4,Syndecan-4,42145,0.0568701550432607,0.00495798046068799,0.0471525133403123,0.0665877967462092,2.56367959977632e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CIAPIN1,Anamorsin,42181,0.073571644581029,0.00641997435211117,0.0609884948508911,0.0861547943111669,2.89254215646402e-30
NMR metabolomics,X23408.Triglycerides in VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0330073359260315,0.00288248971731096,0.0273576560801021,0.038657015771961,3.18992191769536e-30
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0521444925005502,0.00455663181670584,0.0432134941398067,0.0610754908612936,3.50721239339333e-30
NMR metabolomics,X23408.Triglycerides in VLDL,STX8,Syntaxin-8,42119,0.0573116486789033,0.00501504603456296,0.0474821584511599,0.0671411389066466,4.16804490506276e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0764740244637679,0.00669125771849546,0.0633591593355168,0.089588889592019,4.40863412903112e-30
NMR metabolomics,X23408.Triglycerides in VLDL,NBN,Nibrin,41913,0.0650536786857086,0.00569499445440293,0.0538914895550789,0.0762158678163384,4.43331827482256e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CTSZ,Cathepsin Z,42168,0.0385796588791146,0.00337783180421927,0.0319591085428448,0.0452002092153843,4.48424933223945e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0802994573277629,0.00702833566953105,0.066523919415482,0.0940749952400437,4.61962296954933e-30
NMR metabolomics,X23408.Triglycerides in VLDL,C2,Complement C2,42199,0.027008505674883,0.00236600942441217,0.0223711272030351,0.0316458841467309,4.80974307468172e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MMP7,Matrilysin,41881,0.061965070687366,0.00542919236986867,0.0513238536424234,0.0726062877323086,4.95202530864908e-30
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0637032109059331,0.00558772985682633,0.0527512603865535,0.0746551614253127,5.73128131606475e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PARK7,Parkinson disease protein 7,42137,0.0604623793810419,0.00530439110971295,0.0500657728060045,0.0708589859560793,5.82267273695622e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.029167500493809,0.00255942339618023,0.0241510306372958,0.0341839703503223,5.99102326196755e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MENT,Protein MENT,39736,-0.0283358657090006,0.00248952974267093,-0.0332153440046356,-0.0234563874133656,7.51318681542131e-30
NMR metabolomics,X23408.Triglycerides in VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.078486478416689,0.00690131203835882,0.0649599068215058,0.0920130500118723,7.81046324033457e-30
NMR metabolomics,X23408.Triglycerides in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0962949764125317,0.00846790097766551,0.0796978904963073,0.112892062328756,8.46128287010509e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0277506795076871,0.00244278922206724,0.0229628126324353,0.0325385463829389,8.96465652628156e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.143182939506428,0.0126146233217285,0.11845827779584,0.167907601217016,1.00302137824492e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0901000732827941,0.00794110219078251,0.0745355129888604,0.105664633576728,1.12177099269272e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CD72,B-cell differentiation antigen CD72,39736,0.0515417091308662,0.00454775846791399,0.0426281025337547,0.0604553157279776,1.30176647972303e-29
NMR metabolomics,X23408.Triglycerides in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.151638676000956,0.013387093174271,0.125399973379384,0.177877378622527,1.3871722004257e-29
NMR metabolomics,X23408.Triglycerides in VLDL,GMFG,Glia maturation factor gamma,39958,0.0855063298830473,0.00754980697185115,0.070708708218219,0.100303951547876,1.41133569680322e-29
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0365385990933954,0.00323574683437975,0.0301965352980111,0.0428806628887798,2.05967048662287e-29
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.075941574468049,0.00672653228504764,0.0627575711893557,0.0891255777467424,2.11392531754619e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC3B,Tetranectin,39726,0.0248536183424588,0.00220185283311477,0.0205379867895539,0.0291692498953638,2.18270682858741e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.11061590314716,0.00982068666138543,0.091367357290845,0.129864449003476,2.68452176596553e-29
NMR metabolomics,X23408.Triglycerides in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0685918239853464,0.00609221217552903,0.0566510881213095,0.0805325598493833,2.84576847947309e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.098600948388477,0.0087637734747809,0.0814239523779064,0.115777944399048,3.08508541306506e-29
NMR metabolomics,X23408.Triglycerides in VLDL,KLF4,Krueppel-like factor 4,39586,0.0478239151959129,0.00425228357764673,0.0394894393837253,0.0561583910081004,3.47248337915514e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0624282884583553,0.00555141202315251,0.0515475208929763,0.0733090560237342,3.47937562378029e-29
NMR metabolomics,X23408.Triglycerides in VLDL,TCOF1,Treacle protein,39958,0.0382455740319128,0.00340261494728711,0.0315764487352301,0.0449146993285956,3.69426155324585e-29
NMR metabolomics,X23408.Triglycerides in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0460505519198119,0.00410974511892758,0.0379954514867139,0.05410565235291,5.45651333621455e-29
NMR metabolomics,X23408.Triglycerides in VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.103141641216175,0.00921341682265718,0.0850833442437666,0.121199938188583,6.13799940560569e-29
NMR metabolomics,X23408.Triglycerides in VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.0997385390225399,0.0089155901230438,0.082263982381374,0.117213095663706,6.33328574974257e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CASP3,Caspase-3,42310,0.103074461246067,0.00922128554344403,0.085000741580917,0.121148180911218,6.97487031075195e-29
NMR metabolomics,X23408.Triglycerides in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.142428963710226,0.0127491005009314,0.117440726728401,0.167417200692052,7.50452451383058e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0717358238497095,0.00642428180540979,0.0591442315111063,0.0843274161883126,8.41115031029328e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SCRIB,Protein scribble homolog,39638,0.102491218370541,0.00918504292003351,0.0844885342472756,0.120493902493807,9.27424264352396e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.057766764036081,0.00517936220160077,0.0476152141209435,0.0679183139512186,9.74134483265733e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0651155419474013,0.00584509692928922,0.0536591519659944,0.0765719319288081,1.06542405153156e-28
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0673030865271972,0.0060492130783232,0.0554466288936837,0.0791595441607107,1.25190117297721e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0671804960316289,0.00604246547170103,0.0553372637070949,0.0790237283561629,1.37128627734294e-28
NMR metabolomics,X23408.Triglycerides in VLDL,STX4,Syntaxin-4,42070,0.0686894725599086,0.00617845394703825,0.0565797028237136,0.0807992422961035,1.37186988530506e-28
NMR metabolomics,X23408.Triglycerides in VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.0451220643262963,0.00406661857577613,0.0371514919177751,0.0530926367348175,1.75688780875676e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.03288541900211,0.00296608218759756,0.0270718979144188,0.0386989400898012,1.91544350424448e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0806126122330594,0.00727238784186802,0.0663587320629981,0.0948664924031208,2.10452306660295e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.125468927530718,0.0113512647537917,0.103220448613286,0.14771740644815,2.99188996556621e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.102096276184008,0.00924411279334875,0.0839778151090444,0.120214737258971,3.07457568481534e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.068864773141501,0.00623788793632559,0.0566385127863029,0.0810910334966992,3.43971621928987e-28
NMR metabolomics,X23408.Triglycerides in VLDL,RP2,Protein XRP2,42070,0.0491484990099786,0.00446115811499368,0.040404629104591,0.0578923689153662,4.17194430113936e-28
NMR metabolomics,X23408.Triglycerides in VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.050434903480234,0.00457652308949963,0.0414649182248147,0.0594048887356533,4.26921472770865e-28
NMR metabolomics,X23408.Triglycerides in VLDL,OPLAH,5-oxoprolinase,39638,0.0802222761079817,0.00728177471145895,0.0659499976735222,0.0944945545424413,4.43786820208251e-28
NMR metabolomics,X23408.Triglycerides in VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0885291738554115,0.00804026881887395,0.0727702469704185,0.104288100740404,4.46263362879617e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ING1,Inhibitor of growth protein 1,41820,0.0550122278564548,0.00499626962985361,0.0452195393819417,0.0648049163309679,4.49572898222522e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB1,Beta-crystallin B1,39958,0.076395277299281,0.00693696851668389,0.0627988190065806,0.0899917355919814,4.59792836851002e-28
NMR metabolomics,X23408.Triglycerides in VLDL,APOD,Apolipoprotein D,39468,-0.0489840197704242,0.00444831470119749,-0.0577027165847712,-0.0402653229560771,4.71511554393929e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.113725553757657,0.0103325430367502,0.093473769405627,0.133977338109688,4.92378624072236e-28
NMR metabolomics,X23408.Triglycerides in VLDL,DCTD,Deoxycytidylate deaminase,39736,0.110460814905562,0.0100361171864368,0.0907900252201458,0.130131604590978,4.96714295654856e-28
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.0331530047705426,0.0030178226086861,0.0272380724575179,0.0390679370835674,5.88613790906064e-28
NMR metabolomics,X23408.Triglycerides in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.100582250196944,0.00916242007978498,0.0826239068405656,0.118540593553323,6.79888614502246e-28
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0831423566429244,0.00761823087328133,0.068210624131293,0.0980740891545558,1.36026084235548e-27
NMR metabolomics,X23408.Triglycerides in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0380114095961424,0.00348519172397427,0.0311804338171528,0.044842385375132,1.39656101019932e-27
NMR metabolomics,X23408.Triglycerides in VLDL,LAMB1,Laminin subunit beta-1,39638,0.0359187160588137,0.00329218308956705,0.0294660372032623,0.0423713949143651,1.42287768267908e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PALM2,Paralemmin-2,39929,0.0442977361470811,0.00406369936157295,0.0363328853983981,0.0522625868957641,1.56422996899661e-27
NMR metabolomics,X23408.Triglycerides in VLDL,FCN1,Ficolin-1,39978,0.0635930603480913,0.00584180989460498,0.0521431129546655,0.075043007741517,1.83859796017233e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0458121949820386,0.00421483224223014,0.0375511237872675,0.0540732661768097,2.20206350700597e-27
NMR metabolomics,X23408.Triglycerides in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0942852417974106,0.00867940889188264,0.0772736003693206,0.111296883225501,2.24179604611996e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0694740586650825,0.00639693005799613,0.0569360757514101,0.0820120415787549,2.30507188147702e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0482067484970149,0.00444640135622086,0.039491801838822,0.0569216951552078,2.993833171283e-27
NMR metabolomics,X23408.Triglycerides in VLDL,NRGN,Neurogranin,39990,0.104874721382416,0.00968368130217834,0.085894706030146,0.123854736734685,3.36480699265106e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0383476554567732,0.00354147697062639,0.0314063605943454,0.0452889503192009,3.43998318798272e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CCL15,C-C motif chemokine 15,42310,0.0493728192337059,0.00456199418829071,0.0404313106246561,0.0583143278427557,3.46332639952439e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ACYP1,Acylphosphatase-1,39701,0.0738137200114313,0.00681700439819692,0.0604523913909653,0.0871750486318973,3.47170562472133e-27
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0658494767546091,0.00608436844263759,0.0539241146070394,0.0777748389021788,3.49076841075903e-27
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0857017643919822,0.00791760506436426,0.0701832584658282,0.101220270318136,3.58989706040994e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA2,Annexin A2,39492,0.0799590065305689,0.00740038019005891,0.0654542613580534,0.0944637517030843,4.48435540208392e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.115388076459239,0.010689221976603,0.0944372013850972,0.136338951533381,4.96913767710802e-27
NMR metabolomics,X23408.Triglycerides in VLDL,OCLN,Occludin,39934,0.0499568915720543,0.00463785652977383,0.0408666927736976,0.059047090370411,6.33152816604968e-27
NMR metabolomics,X23408.Triglycerides in VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0580215240610399,0.00538894093290446,0.0474591998325472,0.0685838482895327,6.37774267473085e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0340615648761067,0.00316912595590677,0.0278500780025294,0.040273051749684,7.77588260123083e-27
NMR metabolomics,X23408.Triglycerides in VLDL,EPPK1,Epiplakin,39638,0.0835008794299287,0.00776915380901265,0.0682733379642639,0.0987284208955935,8.24112846958984e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0940463634905872,0.00875763840872947,0.0768813922094774,0.111211334771697,9.00231461388214e-27
NMR metabolomics,X23408.Triglycerides in VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0531950717450224,0.0049676194036537,0.0434585377138611,0.0629316057761836,1.19464668411326e-26
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.112143252023528,0.0104913891459455,0.0915801292974751,0.132706374749582,1.5318643163848e-26
NMR metabolomics,X23408.Triglycerides in VLDL,BGLAP,Osteocalcin,39966,0.0943627204066818,0.00883034951049771,0.0770552353661063,0.111670205447257,1.57862672713733e-26
NMR metabolomics,X23408.Triglycerides in VLDL,DBN1,Drebrin,39657,0.0571268612517887,0.00534997449514314,0.0466409112413081,0.0676128112622692,1.73704403568507e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0735418349200567,0.00689220161156739,0.0600331197613846,0.0870505500787288,1.87152501260823e-26
NMR metabolomics,X23408.Triglycerides in VLDL,GBP1,Guanylate-binding protein 1,39911,0.0723263527643957,0.00677851626796096,0.0590404608791922,0.0856122446495992,1.87977201127602e-26
NMR metabolomics,X23408.Triglycerides in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0331088997222286,0.00311157378960278,0.0270102150946071,0.03920758434985,2.45898306243819e-26
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0416168709290401,0.00391150364209595,0.033950323790532,0.0492834180675481,2.60733906159477e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CTSS,Cathepsin S,39358,0.0270640060749634,0.00254606009775694,0.0220737282833598,0.032054283866567,2.92425613833255e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ASS1,Argininosuccinate synthase,39575,0.0861313344690607,0.00810838442248885,0.0702389010009826,0.102023767937139,3.13974700149151e-26
NMR metabolomics,X23408.Triglycerides in VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0961402672218794,0.00906548902726463,0.0783719087284408,0.113908625715318,3.74184498850698e-26
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0586774977470257,0.00553624565568211,0.0478264562618888,0.0695285392321626,4.02986929198062e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0390456367621556,0.0036861506866125,0.0318207814163952,0.0462704921079161,4.08355196190879e-26
NMR metabolomics,X23408.Triglycerides in VLDL,DBI,Acyl-CoA-binding protein,42085,0.086412956675197,0.00816254694763648,0.0704143646578295,0.102411548692565,4.35628755261392e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0225935525143888,0.00213645106251781,-0.0267809965969237,-0.0184061084318539,4.8986132892122e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0815905994706956,0.0077195653549656,0.066460251374963,0.0967209475664282,5.48556685883716e-26
NMR metabolomics,X23408.Triglycerides in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.115203759443746,0.0109072056539645,0.0938256363619752,0.136581882525516,5.89059749651441e-26
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.0778894294275767,0.00737484592782741,0.063434731409035,0.0923441274461184,5.98558694596648e-26
NMR metabolomics,X23408.Triglycerides in VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0834990752571871,0.00791618392553682,0.067983354763135,0.0990147957512393,6.58507454441115e-26
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA9,Serpin A9,42025,0.0797694618042857,0.00757543256570534,0.0649216139755032,0.0946173096330681,7.92080110595351e-26
NMR metabolomics,X23408.Triglycerides in VLDL,AFP,Alpha-fetoprotein,41976,0.071935655766327,0.00683521701931898,0.0585386304084618,0.0853326811241922,8.42270749344374e-26
NMR metabolomics,X23408.Triglycerides in VLDL,IL12A_IL12B,Interleukin-12,42070,0.0848725845605289,0.00806695272096477,0.069061357227438,0.10068381189362,8.70155794682603e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MMP3,Stromelysin-1,42137,-0.0548201977520226,0.00521092612818349,-0.0650336129632622,-0.044606782540783,8.76344991620582e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0397069353752894,0.00377366009985671,0.0323105615795702,0.0471033091710085,9.05999565414562e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0682525822438246,0.00649265938395057,0.0555269698512815,0.0809781946363678,1.00326184444677e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0310290947754017,0.00295304191413454,0.025241132623698,0.0368170569271054,1.05642567424861e-25
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0348295123075382,0.00331688763913334,0.0283284125348369,0.0413306120802396,1.08216968252294e-25
NMR metabolomics,X23408.Triglycerides in VLDL,SLIT2,Slit homolog 2 protein,41839,0.0568342661456895,0.00541810993471358,0.0462147706736509,0.0674537616177281,1.21446162758195e-25
NMR metabolomics,X23408.Triglycerides in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0671774894544701,0.00640722654771573,0.0546193254209473,0.079735653487993,1.27539709687449e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN4,Cerebellin-4,42262,0.0348110371267677,0.00332670964233843,0.0282906862277844,0.041331388025751,1.57683419125636e-25
NMR metabolomics,X23408.Triglycerides in VLDL,C1R,Complement C1r subcomponent,39979,0.0206051074991615,0.00197184102172105,0.0167402990965882,0.0244699159017347,1.91642421628853e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0507309698657207,0.00485835037106195,0.0412086031384393,0.0602533365930022,1.99483718492353e-25
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0342003768267252,0.00327465259214195,0.027782057746127,0.0406186959073235,2.03412496476762e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0951284539376907,0.00911081896910917,0.0772712487582367,0.112985659117145,2.09486859004859e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CLTA,Clathrin light chain A,41900,0.0511587335361835,0.00490299189671988,0.0415488694186125,0.0607685976537544,2.16905565310518e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CCL7,C-C motif chemokine 7,42119,0.0614999800137779,0.00589465565509174,0.0499464549297981,0.0730535050977577,2.18411913640397e-25
NMR metabolomics,X23408.Triglycerides in VLDL,BLMH,Bleomycin hydrolase,42310,0.033770633281238,0.0032394599695305,0.0274212917409582,0.0401199748215178,2.37707858124139e-25
NMR metabolomics,X23408.Triglycerides in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0505518558958161,0.00485293184491299,0.0410401094797866,0.0600636023118455,2.60394330724348e-25
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0324322669288289,0.00311757569265105,0.0263218185712329,0.038542715286425,3.11729844100042e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CPA2,Carboxypeptidase A2,42205,0.0722835942341497,0.00697395580333661,0.05861464085961,0.0859525476086895,4.44487609700255e-25
NMR metabolomics,X23408.Triglycerides in VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0440986936989069,0.00425600255770018,0.0357569286858146,0.0524404587119993,4.61353464122343e-25
NMR metabolomics,X23408.Triglycerides in VLDL,BLNK,B-cell linker protein,39657,0.045349621025536,0.00438775642996194,0.0367496184228106,0.0539496236282614,6.32206007958251e-25
NMR metabolomics,X23408.Triglycerides in VLDL,F2R,Proteinase-activated receptor 1,42166,0.0618851706086997,0.00600898265074416,0.0501075646132411,0.0736627766041583,8.80493070329184e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0671419575719011,0.00652107318610966,0.0543606541271262,0.079923261016676,9.03328468216339e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.037374592719192,0.0036338559569875,0.0302522350434965,0.0444969503948875,1.01244399155382e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN6,Dynactin subunit 6,41839,0.0778465888370385,0.0075751099207958,0.0629993733922787,0.0926938042817983,1.11186142928775e-24
NMR metabolomics,X23408.Triglycerides in VLDL,NGRN,Neugrin,39929,0.0241688917252145,0.00235166222213711,0.0195596337698258,0.0287781496806032,1.14365333305598e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CES2,Cocaine esterase,42070,0.0599211886648602,0.00583403525629925,0.0484864795625137,0.0713558977672068,1.17425318665044e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SMTN,Smoothelin,39897,0.099843832833505,0.00972022379046826,0.0807921942041872,0.118895471462823,1.21226516023571e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SWAP70,Switch-associated protein 70,39930,0.0394871715957416,0.00384498209549189,0.0319510066885775,0.0470233365029057,1.23614268515572e-24
NMR metabolomics,X23408.Triglycerides in VLDL,RAB10,Ras-related protein Rab-10,39958,0.0575729218457154,0.0056099464514326,0.0465774268009075,0.0685684168905233,1.32938407420283e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0487742843331638,0.00475419581206321,0.0394560605415199,0.0580925081248077,1.37805291947069e-24
NMR metabolomics,X23408.Triglycerides in VLDL,GLO1,Lactoylglutathione lyase,41900,0.0606394811265206,0.00591962609452581,0.04903701398125,0.0722419482717912,1.55633166555046e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0435236459378481,0.00425170899715889,0.0351902963034167,0.0518569955722796,1.6640074222057e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.0299520545650348,0.00292723892199999,0.0242146662779148,0.0356894428521548,1.75187210642716e-24
NMR metabolomics,X23408.Triglycerides in VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0914165956735895,0.00894990399603818,0.0738747838413547,0.108958407505824,2.19647326683908e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN9,Septin-9,42070,0.0307756920351313,0.00301437293427597,0.0248675210839504,0.0366838629863122,2.20236165203573e-24
NMR metabolomics,X23408.Triglycerides in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0619242397461709,0.00608127105282335,0.0500049484826372,0.0738435310097047,2.90022526685271e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0523106500364851,0.00513800145896055,0.0422401671769224,0.0623811328960477,2.94494683224009e-24
NMR metabolomics,X23408.Triglycerides in VLDL,UNC79,Protein unc-79 homolog,39560,0.0595450912724054,0.00585287750340598,0.0480734513657297,0.0710167311790811,3.33012917439562e-24
NMR metabolomics,X23408.Triglycerides in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.127690582846166,0.0125985522769897,0.102997420383267,0.152383745309066,4.69315062212281e-24
NMR metabolomics,X23408.Triglycerides in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0396524636739496,0.00391128099283916,0.0319863529279848,0.0473185744199143,4.74599550700879e-24
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.104984812067304,0.0103777298671205,0.0846444615277482,0.125325162606861,5.90866104877757e-24
NMR metabolomics,X23408.Triglycerides in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0754084249232582,0.00745523441993441,0.0607961654601867,0.0900206843863296,5.99723191374202e-24
NMR metabolomics,X23408.Triglycerides in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0481403769023984,0.00476129809911535,0.0388082326281323,0.0574725211766645,6.02640855578628e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CTSE,Cathepsin E,39736,0.0562520290381522,0.005563280196377,0.0453479998532533,0.0671560582230512,6.24368790411384e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.126176985324646,0.0125204777787928,0.101636848878212,0.15071712177108,8.41192969666803e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SPAG1,Sperm-associated antigen 1,39934,0.061755848043882,0.00612767617537231,0.0497456027401523,0.0737660933476117,8.68860073568773e-24
NMR metabolomics,X23408.Triglycerides in VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0887513193948336,0.00881043821206706,0.0714828604991822,0.106019778290485,9.10948949669846e-24
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.0247134289800637,0.00245507851252881,0.0199014750955072,0.0295253828646201,9.45078093679887e-24
NMR metabolomics,X23408.Triglycerides in VLDL,APOL1,Apolipoprotein L1,39990,0.0563610731256165,0.00560039075729598,0.0453843072413163,0.0673378390099166,1.00352781819409e-23
NMR metabolomics,X23408.Triglycerides in VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0885540068847136,0.00881146757789954,0.0712835304320305,0.105824483337397,1.16036333500378e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ARSA,Arylsulfatase A,42137,0.047539235262276,0.00473248815123227,0.0382635584858607,0.0568149120386912,1.16618034915083e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0240468892021058,0.00239815389173498,0.0193465075743053,0.0287472708299064,1.3978478265564e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB2,Plexin-B2,42255,0.0257144145442632,0.00256567519366327,0.0206856911646832,0.0307431379238432,1.46462515701294e-23
NMR metabolomics,X23408.Triglycerides in VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0388139727861468,0.0038769869533615,0.0312150783575583,0.0464128672147353,1.63895203682999e-23
NMR metabolomics,X23408.Triglycerides in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0726497635408541,0.00726355763765222,0.0584131905710558,0.0868863365106525,1.87948608869238e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0704929822450797,0.00705304481596956,0.0566690144057794,0.0843169500843801,2.02464145878024e-23
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.036053325093925,0.00360940776308971,0.0289788858782691,0.0431277643095808,2.06018597436143e-23
NMR metabolomics,X23408.Triglycerides in VLDL,RPL14,60S ribosomal protein L14,39638,0.0408195379313872,0.00410039742203324,0.0327827589842021,0.0488563168785724,3.00446259768355e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF6,SLAM family member 6,41843,0.0402465410416391,0.00405775623668146,0.0322933388177435,0.0481997432655348,4.16733616027883e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0500599916718992,0.00505118721651882,0.0401596647275223,0.0599603186162761,4.6804347867112e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0641057430642837,0.00647312749682377,0.0514184131705091,0.0767930729580583,4.8352270251811e-23
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0455662572417847,0.00460370811097437,0.036542989344275,0.0545895251392945,5.27996895825032e-23
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.043174671235006,0.00436447454375233,0.0346203011292514,0.0517290413407605,5.6070752930617e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CFB,Complement factor B,39794,0.0339664394443156,0.00343905546933374,0.0272258907244215,0.0407069881642097,6.51903524371372e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.075287789266035,0.00763014311725085,0.0603327087562233,0.0902428697758467,6.91343886673833e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0458764009506315,0.00465089621243836,0.0367606443742524,0.0549921575270107,7.37105697360469e-23
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0407632140408083,0.0041348532132971,0.032658901742746,0.0488675263388706,7.78625037811264e-23
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0469816250571441,0.00478181989162291,0.0376092580695632,0.056353992044725,1.04889852835792e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0437303090646577,0.00445504574337225,0.0349984194076481,0.0524621987216673,1.14217541372721e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0442560266510739,0.00450949077984163,-0.0530946285795634,-0.0354174247225843,1.16546367843372e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.0796139891467189,0.00811254770111536,0.0637133956525328,0.095514582640905,1.21671342869504e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.0602707567699092,0.00614729848270069,-0.0723194617960026,-0.0482220517438159,1.28022071129037e-22
NMR metabolomics,X23408.Triglycerides in VLDL,DHPS,Deoxyhypusine synthase,39919,0.0413017820811702,0.00422898508586897,0.0330129713128671,0.0495905928494734,1.92520506313037e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CCL19,C-C motif chemokine 19,42249,0.11547426908551,0.011843846948525,0.0922603290664009,0.138688209104619,2.18845060796691e-22
NMR metabolomics,X23408.Triglycerides in VLDL,STX16,Syntaxin-16,41843,0.0584107175009791,0.00599070903247661,0.046668927797325,0.0701525072046333,2.18916862606592e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TF,Serotransferrin,39979,0.0219345193850467,0.00224901744526778,0.0175264451923218,0.0263425935777715,2.19289323997654e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TNF,Tumor necrosis factor,41880,0.0371806318229066,0.00381350156634547,0.0297061687528695,0.0446550948929438,2.19845999529976e-22
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH7,Protocadherin-7,39930,0.0356865617721806,0.00366141454228717,0.0285101892692977,0.0428629342750634,2.33352889462198e-22
NMR metabolomics,X23408.Triglycerides in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0308434144179936,0.00316618944968917,0.0246376830966028,0.0370491457393844,2.37518792830304e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LAP3,Cytosol aminopeptidase,41913,0.049052486257801,0.00503718501873503,0.0391796036210803,0.0589253688945216,2.46282310126645e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0274166732147792,0.00281495255101204,0.0218993662147956,0.0329339802147628,2.51181291702773e-22
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0757858117458474,0.0077916265548964,0.0605142236982504,0.0910573997934443,2.7580514810959e-22
NMR metabolomics,X23408.Triglycerides in VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0455268535865772,0.00467964345828123,0.036354752408346,0.0546989547648084,2.78094138584885e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CD40LG,CD40 ligand,42296,0.0806389271515751,0.00831326861837169,0.0643449206595666,0.0969329336435836,3.55232710508757e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CCL24,C-C motif chemokine 24,42166,0.0838045170081049,0.00863973547838647,0.0668706354704674,0.100738398545742,3.56249983140058e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LPA,Apolipoprotein(a),39775,-0.185541193894159,0.0191568776253759,-0.223088674039895,-0.147993713748422,4.2500508964719e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.049795119370301,0.00514431431973526,0.0397122633036199,0.0598779754369821,4.48019294453631e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0362464915137264,0.00374926839072745,0.0288979254679006,0.0435950575595522,5.05123789143291e-22
NMR metabolomics,X23408.Triglycerides in VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.108641063086354,0.0112410780494071,0.0866085501095159,0.130673576063192,5.18112556513246e-22
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0369661893236392,0.00382548823530657,0.0294682323824383,0.0444641462648401,5.28307523551035e-22
NMR metabolomics,X23408.Triglycerides in VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.0595053990258635,0.00616054584798607,0.0474307291638108,0.0715800688879163,5.31544380811323e-22
NMR metabolomics,X23408.Triglycerides in VLDL,FGF2,Fibroblast growth factor 2,42119,0.0700544429411481,0.00725323229652415,0.0558381076399607,0.0842707782423354,5.33507424467717e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CFC1,Cryptic protein,41843,0.0484977558721544,0.00502400783951446,0.0386507005067061,0.0583448112376028,5.62847249473104e-22
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0451170683293743,0.00467428515950966,0.0359554694167353,0.0542786672420132,5.87331515813118e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.033160655860279,0.00343728473146248,0.0264235777866126,0.0398977339339455,5.94052888827554e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CA14,Carbonic anhydrase 14,42262,-0.0371149917821684,0.00384972975349316,-0.044660462099015,-0.0295695214653218,6.30612052500379e-22
NMR metabolomics,X23408.Triglycerides in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.113837479405509,0.0118266758913689,-0.137017764152592,-0.0906571946584261,7.34359735284741e-22
NMR metabolomics,X23408.Triglycerides in VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0749155014629588,0.00778655406208247,0.0596538555012771,0.0901771474246404,7.91302502734398e-22
NMR metabolomics,X23408.Triglycerides in VLDL,NADK,NAD kinase,42145,0.0550929117245136,0.00573257532275616,0.0438570640919115,0.0663287593571157,8.47352133672773e-22
NMR metabolomics,X23408.Triglycerides in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0893778348207541,0.00930058916475975,0.071148680057825,0.107606989583683,8.83255152424523e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0692063539560489,0.00721463933314158,0.0550656608630914,0.0833470470490063,1.00754486679628e-21
NMR metabolomics,X23408.Triglycerides in VLDL,POMC,Pro-opiomelanocortin,39638,0.0738466737099508,0.00771070095443872,0.0587336998392509,0.0889596475806507,1.21050657875269e-21
NMR metabolomics,X23408.Triglycerides in VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.062668563988674,0.00654425003543089,0.0498418339192295,0.0754952940581186,1.21683706863401e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0234278956230695,0.00244876855515906,0.0186283092549577,0.0282274819911812,1.2828893757037e-21
NMR metabolomics,X23408.Triglycerides in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0497734495186068,0.00520451496404049,0.0395726001890875,0.0599742988481262,1.38549654591316e-21
NMR metabolomics,X23408.Triglycerides in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0532390984231306,0.00557767580030192,0.0423068538545388,0.0641713429917224,1.59150277624203e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0366567138348297,0.00384156596631863,0.0291272445408452,0.0441861831288142,1.63744761563981e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS27,Serine protease 27,42107,0.040197567284755,0.00421413183902334,0.0319378688802693,0.0484572656892408,1.68944631739481e-21
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0534350743349928,0.00560034117189651,0.0424584056380756,0.06441174303191,1.70541950655279e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0559617803928577,0.00587665199239215,0.044443542487769,0.0674800182979463,1.9714437765371e-21
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX,Glutaredoxin-1,42057,0.0553971441765151,0.00582714485281466,0.0439759402649984,0.0668183480880319,2.29579486897193e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CA13,Carbonic anhydrase 13,41967,0.104550278263512,0.0110413516041975,0.0829092291192854,0.126191327407739,3.29329370528839e-21
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0822003092917943,0.00868146087551293,0.0651846459757889,0.0992159726077996,3.30290199622358e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ARFIP1,Arfaptin-1,39934,0.068765565923213,0.00726557083832592,0.0545250470800942,0.0830060847663318,3.5287095142543e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SNX9,Sorting nexin-9,42145,0.0674057278894833,0.00712729085898684,0.0534362378058691,0.0813752179730975,3.66846207254734e-21
NMR metabolomics,X23408.Triglycerides in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0644899804539019,0.00683232101293236,0.0510986312685545,0.0778813296392493,4.38193813032693e-21
NMR metabolomics,X23408.Triglycerides in VLDL,GP6,Platelet glycoprotein VI,42115,0.087241985059069,0.00924575469944893,0.0691203058481491,0.105363664269989,4.50071765471121e-21
NMR metabolomics,X23408.Triglycerides in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.038247505520986,0.00407290868769086,0.0302646044931119,0.0462304065488601,6.88646104746212e-21
NMR metabolomics,X23408.Triglycerides in VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.0865159482708908,0.00921956599212861,0.0684455989263187,0.104586297615463,7.59761807294559e-21
NMR metabolomics,X23408.Triglycerides in VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.0356615257205716,0.00381149005702055,0.0281910052088114,0.0431320462323319,9.80558035299061e-21
NMR metabolomics,X23408.Triglycerides in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.09615852059782,0.0102836005593083,0.0760026635015757,0.116314377694064,1.0058420776904e-20
NMR metabolomics,X23408.Triglycerides in VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0478590739105101,0.00512760439443792,0.0378089692974118,0.0579091785236084,1.21421109552016e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0706343336546094,0.00757292824269411,0.0557913942989289,0.0854772730102898,1.25616921855088e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.0335093088172773,0.0036059204681408,0.0264417046997213,0.0405769129348333,1.78046511484354e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0393607226627893,0.00423712673029608,0.0310559542714089,0.0476654910541696,1.78578778853538e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.0757382189572959,0.00819101723326453,0.0596838251800975,0.0917926127344944,2.65880245788128e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.0327368500948196,0.00354235460822884,0.0257938350626911,0.0396798651269481,2.79041867109943e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CCL26,C-C motif chemokine 26,42119,0.0870581749505635,0.00942866859688939,0.0685779845006603,0.105538365400467,3.00808783600874e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0416896202737491,0.0045156222024828,0.0328390007568828,0.0505402397906154,3.04189853723968e-20
NMR metabolomics,X23408.Triglycerides in VLDL,APOA1,Apolipoprotein A-I,39979,-0.0265900523200121,0.00287961596432408,-0.0322340996100873,-0.0209460050299369,3.07076015821493e-20
NMR metabolomics,X23408.Triglycerides in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0481571943778629,0.00521799882303453,0.0379299166847152,0.0583844720710106,3.12898719988359e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0481733814627928,0.00522140088353783,-0.0584073271945269,-0.0379394357310586,3.21607250945572e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0679240242949884,0.00736858164559189,0.0534816042696283,0.0823664443203485,3.55910228644265e-20
NMR metabolomics,X23408.Triglycerides in VLDL,BST2,Bone marrow stromal antigen 2,42249,0.0492881973683672,0.00535059176138567,0.0388010375160513,0.0597753572206831,3.67088811019848e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SPP1,Osteopontin,42286,-0.0424385883392424,0.00461545775074929,-0.051484885530711,-0.0333922911477738,4.2885120739087e-20
NMR metabolomics,X23408.Triglycerides in VLDL,GP5,Platelet glycoprotein V,39736,0.0352431708723386,0.00383870588970537,0.0277193073285161,0.0427670344161611,5.02430526388394e-20
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3B,Protein FAM3B,42070,0.0338635842219391,0.00369029419963546,0.0266306075906536,0.0410965608532246,5.09779725886464e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0465547657998455,0.00508043822777304,0.0365971068734103,0.0565124247262807,5.88599432324639e-20
NMR metabolomics,X23408.Triglycerides in VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0366835998841893,0.00400806824520352,0.0288277861235904,0.0445394136447882,6.3497606148483e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0505101546297308,0.00551861717032656,0.0396936649758907,0.0613266442835708,6.35674835393583e-20
NMR metabolomics,X23408.Triglycerides in VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0220385573408268,0.00240729654635294,0.0173202561099751,0.0267568585716786,6.36984684712533e-20
NMR metabolomics,X23408.Triglycerides in VLDL,DTNB,Dystrobrevin beta,39900,0.0436868454773202,0.00477376802396578,0.0343302601503472,0.0530434308042931,6.5801938239292e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0417755576971415,0.00456649954939452,0.0328252185803282,0.0507258968139547,6.62030153926368e-20
NMR metabolomics,X23408.Triglycerides in VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0526040599269327,0.00575173165859273,0.041330665876091,0.0638774539777745,6.74361357077146e-20
NMR metabolomics,X23408.Triglycerides in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0233700757458839,0.00255582139968598,0.0183606658024994,0.0283794856892685,6.87846779370514e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0347391158850307,0.00379900402695348,0.0272930679922019,0.0421851637778596,7.05407525987573e-20
NMR metabolomics,X23408.Triglycerides in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0518194457757669,0.00567061907229512,0.0407050323940685,0.0629338591574654,7.2398162758426e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PROK1,Prokineticin-1,42119,0.0476960092092724,0.00522104103233882,0.0374627687858883,0.0579292496326565,7.43487689408964e-20
NMR metabolomics,X23408.Triglycerides in VLDL,HRG,Histidine-rich glycoprotein,39925,0.0297850548811466,0.00326642264192677,0.0233828665029701,0.0361872432593231,8.89423337148614e-20
NMR metabolomics,X23408.Triglycerides in VLDL,INSL5,Insulin-like peptide INSL5,39930,0.097922668901152,0.0107521644977561,0.0768484264855501,0.118996911316754,9.86304494315013e-20
NMR metabolomics,X23408.Triglycerides in VLDL,FST,Follistatin,42166,0.0465432847152652,0.00511374162251231,0.0365203511351411,0.0565662182953893,1.01254444257343e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0628711468049732,0.00693056987243435,0.0492872298550019,0.0764550637549445,1.3308156418996e-19
NMR metabolomics,X23408.Triglycerides in VLDL,TMSB10,Thymosin beta-10,42137,0.0721755769591833,0.00797697389378393,0.0565407081273668,0.0878104457909998,1.65224691505168e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0442582499866807,0.00489180715963534,0.0346703079537955,0.053846192019566,1.66542667332519e-19
NMR metabolomics,X23408.Triglycerides in VLDL,KLK7,Kallikrein-7,39475,0.0375926019569827,0.00415535154458966,0.0294481129295869,0.0457370909843784,1.72249404272657e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PTN,Pleiotrophin,41900,0.0471536473762524,0.00522289942664933,0.0369167645000197,0.0573905302524851,1.98140766931691e-19
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0354072665306665,0.00392278597087597,0.0277186060277496,0.0430959270335834,2.07400069416452e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH1,Acid ceramidase,39876,0.0446800720661876,0.00496358047108592,0.0349514543428592,0.054408689789516,2.58091674859352e-19
NMR metabolomics,X23408.Triglycerides in VLDL,TEK,Angiopoietin-1 receptor,42181,0.0208959189797823,0.00232310216619724,0.0163426387340357,0.0254491992255289,2.67547989838659e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0311004957230225,0.00345944407039863,0.0243199853450412,0.0378810061010038,2.86124469350794e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0558785244642631,0.00623653194913824,0.0436549218439521,0.068102127084574,3.75777787264356e-19
NMR metabolomics,X23408.Triglycerides in VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0427876966025049,0.00477553318046661,0.0334276515687904,0.0521477416362195,3.7629610723016e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.0273616474832082,0.00305515606925662,0.0213735415874653,0.0333497533789512,3.80490492118422e-19
NMR metabolomics,X23408.Triglycerides in VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0259914220211415,0.0029096469725752,-0.0316943300873889,-0.0202885139548941,4.67901528178942e-19
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0410032654818914,0.00459575183918515,0.0319955918770885,0.0500109390866943,5.28187908797254e-19
NMR metabolomics,X23408.Triglycerides in VLDL,FADD,FAS-associated death domain protein,42145,0.0713978905624326,0.00800522687225408,0.0557076458928146,0.0870881352320505,5.30542585273193e-19
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN2,Dynactin subunit 2,42070,0.0886532379292995,0.00995401241157551,0.0691433736026115,0.108163102255987,5.94558984374761e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAL,Integrin alpha-L,39657,0.040879610188975,0.00458990811377773,0.0318833902859706,0.0498758300919793,6.09449968802031e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SDHB,Succinate dehydrogenase,39930,0.0613722536009216,0.00689264564238782,0.0478626681418415,0.0748818390600017,6.20475216724766e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0638102881862461,0.0071691345786109,0.0497587844121687,0.0778617919603234,6.2636651668505e-19
NMR metabolomics,X23408.Triglycerides in VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0450181313395784,0.00506835945068994,0.0350841468162261,0.0549521158629307,7.39140960543067e-19
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0315919779693213,0.00355764251369545,0.0246189986424782,0.0385649572961644,7.51534369944469e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SBSN,Suprabasin,39954,-0.0330652786045888,0.00373037885761691,-0.0403768211655179,-0.0257537360436597,8.88510649069801e-19
NMR metabolomics,X23408.Triglycerides in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0583767701881038,0.00658572948570963,0.0454687403961129,0.0712847999800946,8.89287275635747e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NPPB,Natriuretic peptides B,41900,-0.130315333139526,0.0147142417912653,-0.159155247050406,-0.101475419228646,9.29937299607827e-19
NMR metabolomics,X23408.Triglycerides in VLDL,DENR,Density-regulated protein,39657,0.0534362658014082,0.00603768921023342,0.0416023949493507,0.0652701366534657,1.00425227597802e-18
NMR metabolomics,X23408.Triglycerides in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0641846347316209,0.00726263884396326,0.0499498625974529,0.0784194068657889,1.09741964704926e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0306841309133175,0.0034715757367621,0.0238798424692638,0.0374884193573712,1.11282895518666e-18
NMR metabolomics,X23408.Triglycerides in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0352919232441107,0.00399460680568701,0.0274624939049642,0.0431213525832572,1.12685183354853e-18
NMR metabolomics,X23408.Triglycerides in VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.0438180790887515,0.00496344762380145,0.0340897217461007,0.0535464364314023,1.19227656396326e-18
NMR metabolomics,X23408.Triglycerides in VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0551809626505676,0.00624939737138978,0.0429321438026436,0.0674297814984916,1.20239088720473e-18
NMR metabolomics,X23408.Triglycerides in VLDL,BTC,Probetacellulin,41843,0.0680173651935604,0.00770577120076674,0.0529140536400576,0.0831206767470633,1.210812467402e-18
NMR metabolomics,X23408.Triglycerides in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0443022522427766,0.00501874836707999,0.0344655054432998,0.0541389990422534,1.22895519769424e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PER3,Period circadian protein homolog 3,39657,0.113839348893365,0.0129042358719847,0.0885470465842748,0.139131651202455,1.29465031829586e-18
NMR metabolomics,X23408.Triglycerides in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0300098707744216,0.00340231860514415,0.0233413263083391,0.0366784152405042,1.30648373815276e-18
NMR metabolomics,X23408.Triglycerides in VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.0210312169690686,0.0023941842344464,0.0163386158695536,0.0257238180685835,1.79944693382651e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ABHD14B,Protein ABHD14B,41976,0.0514877498552915,0.00586927519675816,0.0399839704696455,0.0629915292409375,1.95807994060544e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS22,Brain-specific serine protease 4,39657,0.0318339670731513,0.00363654981455729,0.024706329436619,0.0389616047096836,2.3604883833834e-18
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0563553495724386,0.00643950185398466,0.0437339259386287,0.0689767732062486,2.40283875909559e-18
NMR metabolomics,X23408.Triglycerides in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0363232865740547,0.00415196876846175,-0.0444611453602397,-0.0281854277878697,2.4163114939907e-18
NMR metabolomics,X23408.Triglycerides in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0354505120650464,0.00405673514030529,0.027499311190048,0.0434017129400448,2.63296435188239e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0799177528575188,0.00914603360324835,0.0619915269951521,0.0978439787198856,2.71216454565241e-18
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0497923114108495,0.00570141589820611,0.0386175362503656,0.0609670865713335,2.82710279599002e-18
NMR metabolomics,X23408.Triglycerides in VLDL,S100P,Protein S100-P,41900,0.0489763376465268,0.0056145081424833,0.0379719016872596,0.0599807736057941,3.02342781333139e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0256338338015763,0.00293968125213693,0.0198720585473879,0.0313956090557647,3.17005345082222e-18
NMR metabolomics,X23408.Triglycerides in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0370261346912184,0.00424849565893083,0.028699083199714,0.0453531861827228,3.24476897887255e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA2,Integrin alpha-2,39736,0.0316491576508744,0.00363333590690847,0.0245278192733338,0.038770496028415,3.44417683123232e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0289267683683875,0.00332233478097986,0.022414992197667,0.035438544539108,3.48677537660011e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0789466074622179,0.00907535434129946,0.061158912953271,0.0967343019711649,3.73169240339566e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0652421774337381,0.00751492906233663,0.0505129164715583,0.0799714383959179,4.35177162777286e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NID2,Nidogen-2,42137,0.0664043449533918,0.00765505382576782,0.0514004394548868,0.0814082504518967,4.61945386445854e-18
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0520905813750044,0.00600646083018684,0.0403179181478382,0.0638632446021706,4.71602037869563e-18
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3C,Protein FAM3C,42129,0.0276545233911082,0.00318947281641706,0.0214031566709308,0.0339058901112857,4.78459638172495e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB2,Lysosome membrane protein 2,41777,0.0300337606821438,0.00346572233206279,0.0232409449113007,0.0368265764529868,4.99558854085995e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CCL14,C-C motif chemokine 14,42152,0.036751855380019,0.00424364370679197,0.0284343137147068,0.0450693970453313,5.22532749980593e-18
NMR metabolomics,X23408.Triglycerides in VLDL,VGF,Neurosecretory protein VGF,39934,0.0274370603233186,0.00316848561075365,0.0212268285262414,0.0336472921203958,5.38528936246112e-18
NMR metabolomics,X23408.Triglycerides in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0807467084407917,0.00933228475579563,0.0624554303194323,0.0990379865621512,5.61619057749653e-18
NMR metabolomics,X23408.Triglycerides in VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0213029333407588,0.00246445698259487,-0.0261332690266448,-0.0164725976548729,6.02001204691636e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CDH15,Cadherin-15,42230,0.0627210565723932,0.00726159343798338,0.0484883334339458,0.0769537797108407,6.3854618863719e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.0475609650694272,0.00551778929003885,-0.0583758320779033,-0.0367460980609511,7.46046280898745e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1F,Protein phosphatase 1F,39958,0.0482866970541646,0.00560615482660076,0.0372986335940271,0.0592747605143021,8.04460648203416e-18
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA4,Ephrin-A4,41992,0.0292218979132221,0.00339502472532399,0.022567649451587,0.0358761463748571,8.30893437411453e-18
NMR metabolomics,X23408.Triglycerides in VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0193598995471223,0.00224942759401661,0.0149510214628498,0.0237687776313949,8.35314718496765e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0322983735889123,0.00376751058242087,-0.0396826943304573,-0.0249140528473674,1.14022427331208e-17
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0316371453692706,0.0036925753275942,0.0243996977271859,0.0388745930113552,1.16679818763424e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SDK2,Protein sidekick-2,39736,0.0353357261737896,0.00413050791027231,0.0272399306696558,0.0434315216779233,1.33507460749141e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0221880708394888,0.0025967578875884,0.0170984253798156,0.0272777162991621,1.4269813807828e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ENO2,Gamma-enolase,42249,0.0583776611922501,0.00683430572232271,0.0449824219764976,0.0717729004080026,1.45945862602629e-17
NMR metabolomics,X23408.Triglycerides in VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0331119202598101,0.00387661865508864,0.0255137476958363,0.0407100928237838,1.46917556358834e-17
NMR metabolomics,X23408.Triglycerides in VLDL,MMP1,Interstitial collagenase,41693,0.0807860793230069,0.00946320572335633,0.0622381961052285,0.0993339625407853,1.53000912655164e-17
NMR metabolomics,X23408.Triglycerides in VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0665271067753787,0.00779392917506354,0.0512510055922542,0.0818032079585033,1.57251889002165e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO2,Roundabout homolog 2,42249,0.0202189958657779,0.00237612481971087,0.0155617912191446,0.0248762005124112,1.93179570402732e-17
NMR metabolomics,X23408.Triglycerides in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0586750104866534,0.00690940256664265,0.0451325814560338,0.072217439517273,2.28304030843975e-17
NMR metabolomics,X23408.Triglycerides in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0788370832725968,0.00928389353599473,0.0606406519420471,0.0970335146031465,2.28782856993084e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN8,Tetraspanin-8,39930,0.0847820088205857,0.0100196264241982,0.0651435410291572,0.104420476612014,2.96119649588021e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0206126835939588,0.00243759630283616,0.0158349948403999,0.0253903723475177,3.1006092346864e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0607953876216571,0.00718954419844687,0.0467038809927013,0.074886894250613,3.10906813402775e-17
NMR metabolomics,X23408.Triglycerides in VLDL,APLP1,Amyloid-like protein 1,42145,-0.0450420506464148,0.00533456578306817,-0.0554977995812284,-0.0345863017116012,3.39228776724539e-17
NMR metabolomics,X23408.Triglycerides in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0638588392131621,0.00757595093254027,0.0490099753853832,0.078707703040941,3.83454109256667e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.0392444872412782,0.00465848058621106,0.0301138652923045,0.0483751091902519,3.99199608351382e-17
NMR metabolomics,X23408.Triglycerides in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0356150160252064,0.00422951764985904,0.0273251614314827,0.0439048706189301,4.19743208647877e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0495646480886279,0.00589437087090236,0.0380116811816593,0.0611176149955966,4.64309368793052e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0858539919512973,0.0102131636226696,0.065836191250865,0.10587179265173,4.65896526651274e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SMS,Spermine synthase,39586,0.0567542586502713,0.00675056867441148,0.0435231440484248,0.0699853732521178,4.71225658581604e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CCN5,CCN family member 5,42137,0.0334582256543583,0.00398670661726859,0.0256442806845118,0.0412721706242047,5.22987816079121e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SCRN1,Secernin-1,42119,0.0488021447045324,0.00581557688537017,0.0374036140092068,0.0602006753998579,5.2670326105335e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.0277171042907947,0.00330314076928464,0.0212429483829968,0.0341912601985926,5.40128469090208e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.0485911941346988,0.00579245690024986,0.0372379786102091,0.0599444096591885,5.40966284391035e-17
NMR metabolomics,X23408.Triglycerides in VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0357246135178987,0.00426541596043301,-0.0440848288003474,-0.02736439823545,6.04304413655327e-17
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM3,Myomesin-3,39736,-0.0851561682654116,0.0101834955424393,-0.105115819528593,-0.0651965170022306,6.88989095078128e-17
NMR metabolomics,X23408.Triglycerides in VLDL,DPT,Dermatopontin,42310,0.0222743144896972,0.00266544061173234,0.0170500508907018,0.0274985780886926,7.06463231983541e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TPR,Nucleoprotein TPR,39575,0.0428677163945105,0.00513128037312599,0.0328104068631836,0.0529250259258375,7.38089516981193e-17
NMR metabolomics,X23408.Triglycerides in VLDL,VIT,Vitrin,39958,0.0337476652320412,0.00403990077667562,0.025829459709757,0.0416658707543254,7.39046632807727e-17
NMR metabolomics,X23408.Triglycerides in VLDL,EPO,Erythropoietin,42119,0.0638084670338754,0.00766168241237118,0.0487915695056279,0.0788253645621229,8.98747770088116e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CBS,Cystathionine beta-synthase,39638,0.0452845266724576,0.00543604932986238,0.0346298699859273,0.0559391833589878,9.00853699151134e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD84,SLAM family member 5,42119,0.0278500731796413,0.00334797150828779,0.0212880490233973,0.0344120973358854,9.75559793591987e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0250870283623099,0.00301706107793785,0.0191735886495517,0.0310004680750681,1.00545833740969e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CTSL,Cathepsin L1,42145,0.0213163898711577,0.00256861909383861,0.0162818964472341,0.0263508832950814,1.15070412896756e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CORO1A,Coronin-1A,41883,0.0772854713255894,0.00931276391622637,0.0590324540497858,0.0955384886013931,1.15175598607959e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0489176223240536,0.00589509411528767,0.0373632378580897,0.0604720067900174,1.17976391390093e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0493900420047413,0.00595376677830073,0.0377206591192718,0.0610594248902107,1.18414516628839e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DMD,Dystrophin,39638,0.0448684833246923,0.00540815195865583,0.0342685054857269,0.0554684611636577,1.19731591167382e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.0214937925096013,0.00259785625563215,0.0164019942485623,0.0265855907706403,1.44828633190543e-16
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.096414731466786,0.0116593196011312,-0.119266997885003,-0.0735624650485688,1.50705584319777e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ACRBP,Acrosin-binding protein,39919,0.0346461875292799,0.00419489668736783,0.0264241900220389,0.0428681850365208,1.63042677334341e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PPL,Periplakin,39657,0.0279622856747331,0.00339140739137341,0.0213151271876412,0.0346094441618249,1.83772584684894e-16
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0770819902960657,0.00937044129421867,0.0587159253593971,0.0954480552327343,2.14941707932841e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PIGR,Polymeric immunoglobulin receptor,41987,0.032043418246039,0.00389802238178695,0.0244032943777366,0.0396835421143415,2.213162447269e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DNM1,Dynamin-1,39930,0.0998963557858342,0.0121557765722071,0.0760710337043082,0.12372167786736,2.2939042523775e-16
NMR metabolomics,X23408.Triglycerides in VLDL,LGMN,Legumain,42185,0.0312854958939931,0.00381337107351564,0.0238112885899024,0.0387597031980837,2.52954867430976e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0361959228870382,0.00441328339610227,0.0275458874306778,0.0448459583433987,2.58870406141383e-16
NMR metabolomics,X23408.Triglycerides in VLDL,KIF22,Kinesin-like protein KIF22,39575,0.107066981508461,0.0130512146494432,0.081486600795552,0.13264736222137,2.59319274315962e-16
NMR metabolomics,X23408.Triglycerides in VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0715474289946825,0.00873477057847782,0.054427278660866,0.0886675793284991,2.81961003790019e-16
NMR metabolomics,X23408.Triglycerides in VLDL,BGN,Biglycan,41820,-0.101591353373603,0.0124030156192771,-0.125901263987386,-0.07728144275982,2.83041761322975e-16
NMR metabolomics,X23408.Triglycerides in VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0751329372693804,0.0091736688715473,0.0571525462811477,0.0931133282576131,2.84313547186261e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.050660269188798,0.00618951470546757,0.0385288203660816,0.0627917180115145,3.02770566025033e-16
NMR metabolomics,X23408.Triglycerides in VLDL,TSHB,Thyrotropin subunit beta,42145,0.0583521568155369,0.00714758684991449,0.0443428865897046,0.0723614270413693,3.52869267046364e-16
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0376986959534168,0.00461923184132722,0.0286450015444155,0.0467523903624181,3.60810006205385e-16
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0370289005177549,0.00454037839177447,0.0281297588698769,0.0459280421656328,3.85488319196368e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.0237852061212984,0.0029179498518562,-0.0295043878309365,-0.0180660244116602,3.91223599732403e-16
NMR metabolomics,X23408.Triglycerides in VLDL,OMD,Osteomodulin,42185,-0.0351137089308251,0.00431027597678443,-0.0435618498453226,-0.0266655680163276,4.07077817706066e-16
NMR metabolomics,X23408.Triglycerides in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0377972161014421,0.00464200769705051,0.0286988810152231,0.0468955511876611,4.29087273502571e-16
NMR metabolomics,X23408.Triglycerides in VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.0567735440165203,0.00697347162226513,0.0431055396368807,0.07044154839616,4.31720511281258e-16
NMR metabolomics,X23408.Triglycerides in VLDL,TLR3,Toll-like receptor 3,42296,0.0522210882533944,0.00641994974584208,0.039637986751544,0.0648041897552449,4.50163311724762e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0308356444369393,0.00379340696593772,0.0234005667837013,0.0382707220901772,4.71844699472214e-16
NMR metabolomics,X23408.Triglycerides in VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0210630970314542,0.00259341973909218,0.0159799943428335,0.0261461997200748,4.99549971865656e-16
NMR metabolomics,X23408.Triglycerides in VLDL,NRP2,Neuropilin-2,42137,-0.0239882928022708,0.00295407552061771,-0.0297782808226815,-0.0181983047818601,5.04561383696713e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0596862783411014,0.00735528589544546,0.0452699179860283,0.0741026386961745,5.37939311646939e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0486113608231336,0.00599134010178031,0.0368683342236442,0.060354387422623,5.42890913281224e-16
NMR metabolomics,X23408.Triglycerides in VLDL,IL17D,Interleukin-17D,41913,0.0290207545259561,0.00358090126222063,0.0220021880520037,0.0360393209999086,5.76444036413109e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0648771019807181,0.00801264631214767,0.0491723152089087,0.0805818887525276,6.11995973108119e-16
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0440665100181369,0.00545344796059514,0.0333777520153704,0.0547552680209034,6.9882355625487e-16
NMR metabolomics,X23408.Triglycerides in VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0208885554578909,0.0025845623742653,0.0158228132043309,0.0259542977114509,7.0150366156074e-16
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.0425398965557624,0.00526922381328129,0.0322122178817311,0.0528675752297938,7.55937945558233e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CDA,Cytidine deaminase,39946,0.0404145196980859,0.00500827724679798,0.0305982962943618,0.0502307431018099,7.76636928030684e-16
NMR metabolomics,X23408.Triglycerides in VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.0399672660273052,0.00495430977859492,0.0302568188612592,0.0496777131933513,7.78924068503944e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CTSF,Cathepsin F,42181,0.0341150222552985,0.00423285529144051,0.0258186258840751,0.0424114186265219,8.29182743822105e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0504161813559015,0.0062559469847639,0.0381545252657643,0.0626778374460388,8.46689616690888e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CA2,Carbonic anhydrase 2,42103,0.0560541435744093,0.0069668864513578,0.042399046129748,0.0697092410190706,9.27970758890836e-16
NMR metabolomics,X23408.Triglycerides in VLDL,C5,Complement C5,39979,0.0126938522878814,0.00157876671582819,0.00959946952485811,0.0157882350509046,9.84318691142657e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0301608223080312,0.00375349848752316,0.0228039652724858,0.0375176793435766,1.01138376710597e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0402341861085385,0.00500701421918802,0.0304204382389299,0.050047933978147,1.02374550708477e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0274277992063615,0.00341679176914836,0.0207308873388307,0.0341247110738923,1.07655850866026e-15
NMR metabolomics,X23408.Triglycerides in VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0466634002785097,0.0058183141934843,0.0352595044592804,0.0580672960977389,1.16322623052228e-15
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G15,Phospholipase A2 group XV,42181,0.0230950668275348,0.00288627180915349,0.017437974081594,0.0287521595734757,1.32615171555914e-15
NMR metabolomics,X23408.Triglycerides in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0529591891010988,0.00662163781625368,0.0399807789812416,0.065937599220956,1.38818593504298e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CHI3L1,Chitinase-3-like protein 1,41907,0.070231103187836,0.00879360027315809,0.0529956466524461,0.0874665597232258,1.50030547800919e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0362500155893966,0.00454243323199475,0.0273468464546869,0.0451531847241063,1.60025736000261e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CD93,Complement component C1q receptor,41654,-0.0263406433419876,0.00330325961977021,-0.0328150321967373,-0.019866254487238,1.66163014593387e-15
NMR metabolomics,X23408.Triglycerides in VLDL,TREML2,Trem-like transcript 2 protein,42137,0.0288124905243333,0.00362068731057344,0.0217159433956094,0.0359090376530573,1.89071676660321e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.0632719114040207,0.0079501541540503,0.0476896092620822,0.0788542135459593,1.91143388098191e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0335893550826744,0.00422103277038321,0.0253161308527233,0.0418625793126255,1.92643370851263e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.053786872302756,0.00676038660163121,0.0405365145635589,0.0670372300419532,1.94737752566505e-15
NMR metabolomics,X23408.Triglycerides in VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0761848693052898,0.00959317308477925,0.0573822500591225,0.0949874885514571,2.15174227917088e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CA6,Carbonic anhydrase 6,42103,-0.0521819188162133,0.00657686914031749,-0.0650725823312356,-0.039291255301191,2.28537077300387e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0235966606482245,0.00297885092266193,-0.0294352084566418,-0.0177581128398071,2.5309457601851e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CLC,Galectin-10,42119,-0.0557218855351722,0.00704973325721389,-0.0695393627193115,-0.041904408351033,2.90646680638089e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0432091631955709,0.00547853907271739,0.0324712266130448,0.053947099778097,3.38434499980095e-15
NMR metabolomics,X23408.Triglycerides in VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.0488449336566179,0.00620075732229553,0.0366914493049186,0.0609984180083171,3.66017588729381e-15
NMR metabolomics,X23408.Triglycerides in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0312710749620849,0.00397288354409513,0.0234842232156584,0.0390579267085113,3.84321615208697e-15
NMR metabolomics,X23408.Triglycerides in VLDL,UMOD,Uromodulin,42274,-0.0443085874613963,0.00565093560967494,-0.0553844212563592,-0.0332327536664334,4.80191533625539e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.0279528262059528,0.00356972649532975,0.0209561622751065,0.0349494901367991,5.22407074195127e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0341896989751412,0.0043664886296996,0.02563138126093,0.0427480166893524,5.24756660346014e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.0454516739479917,0.00580662443794812,0.0340706900496134,0.0568326578463701,5.41550631681411e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0605047567433641,0.00773364787141182,0.045346806915397,0.0756627065713313,5.52232337763572e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0385620142192329,0.00494302523530289,0.0288736847580392,0.0482503436804265,6.58469393349543e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ENAH,Protein enabled homolog,41913,0.0394562523701126,0.00506243140712685,0.029533886812144,0.0493786179280812,6.97582498801349e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA6,Integrin alpha-6,42119,0.0417125204988455,0.0053520805914277,0.0312224425396472,0.0522025984580438,6.98098826759565e-15
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0279431846946746,0.00359295433076579,0.0209009942063736,0.0349853751829755,7.94599016820304e-15
NMR metabolomics,X23408.Triglycerides in VLDL,TGFA,Protransforming growth factor alpha,42119,0.036963285559732,0.00475594402882375,0.0276416352632375,0.0462849358562265,8.28033813253524e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAM,Integrin alpha-M,42137,-0.0257017318038474,0.00331799320689935,-0.0322049984893701,-0.0191984651183246,1.01421276261075e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0400897892426823,0.00518060860949908,0.0299357963680641,0.0502437821173005,1.07751963536286e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0298264320740162,0.00385768563891528,0.0222653682217422,0.0373874959262901,1.13632311227326e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CDH5,Cadherin-5,42310,-0.0246162163470126,0.00319016880483394,-0.0308689472044871,-0.0183634854895381,1.28029853344848e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CD46,Membrane cofactor protein,42107,0.0232076816655206,0.0030097485110514,0.0173085745838599,0.0291067887471814,1.33712461543913e-14
NMR metabolomics,X23408.Triglycerides in VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0467865931896978,0.00606872399486507,0.0348918941597622,0.0586812922196333,1.35336813217047e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0350558180559247,0.00454894381326971,0.026139888181916,0.0439717479299333,1.38434111630216e-14
NMR metabolomics,X23408.Triglycerides in VLDL,MDK,Midkine,42129,0.0414155726663384,0.00537458088524113,0.0308813941312658,0.051949751201411,1.39029874991613e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ELOB,Elongin-B,39575,0.0316787486234495,0.00412178115822765,0.0236000575533233,0.0397574396935757,1.65150794731579e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB6,Integrin beta-6,41913,0.0247860133777864,0.00322827650566399,0.018458591426685,0.0311134353288879,1.73123106696574e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.053849478962055,0.00701391420550899,0.0401022071192574,0.0675967508048526,1.73559568059446e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CD83,CD83 antigen,42119,0.0278459144176174,0.00362760277019343,0.0207358129880382,0.0349560158471965,1.75198114038092e-14
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0284715924457176,0.0037128920053368,0.0211943241152574,0.0357488607761777,1.88763605728625e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CAT,Catalase,39827,0.0421440263254851,0.00549707269975846,0.0313697638339585,0.0529182888170117,1.91136769876668e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0534945148965856,0.00697940655786492,0.0398148780431704,0.0671741517500009,1.93916613622665e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ITGBL1,Integrin beta-like protein 1,39966,0.0317247326530967,0.00413914867507232,0.023612001249955,0.0398374640562385,1.9404961385924e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0504825368941319,0.0065953554444796,0.0375556402229519,0.0634094335653119,2.10300465791943e-14
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_E,,42119,0.0235920372214923,0.00308443355328513,0.0175465474570535,0.0296375269859312,2.16639792886206e-14
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0744223285767787,0.00973319324385189,0.055345269818829,0.0934993873347284,2.23660270949598e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0818127145816167,0.0107285478566059,0.0607847607826691,0.102840668380564,2.59017239866619e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.0964749852169654,0.0126715500724917,0.0716387470748817,0.121311223359049,2.88642874655677e-14
NMR metabolomics,X23408.Triglycerides in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.050506631621184,0.00665750771483588,0.0374579165001056,0.0635553467422623,3.50791238259341e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0248383926953019,0.00327721720774096,-0.0312617384224742,-0.0184150469681296,3.73674378017363e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0574700887556005,0.00760394916806479,0.0425663483861935,0.0723738291250075,4.35953823422243e-14
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA1,BolA-like protein 1,39586,0.0432402690221754,0.00573085002796846,0.0320078029673572,0.0544727350769936,4.87375508236686e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CA4,Carbonic anhydrase 4,42310,-0.0192056317946425,0.00254795291215296,-0.0241996195024623,-0.0142116440868227,5.08405659069387e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0450740631031737,0.00598241670076082,-0.0567995998366649,-0.0333485263696825,5.2161097689978e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0481127424838939,0.00639313524562951,0.03558219740246,0.0606432875653277,5.65487842187109e-14
NMR metabolomics,X23408.Triglycerides in VLDL,FXN,"Frataxin, mitochondrial",42262,0.057382893190589,0.00763280478445562,0.042422595813056,0.072343190568122,5.91116561175769e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.0373986314234737,0.00497598203309165,0.027645706638614,0.0471515562083333,6.01198465608201e-14
NMR metabolomics,X23408.Triglycerides in VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.0622782718222675,0.00828677778167432,0.0460361873701859,0.0785203562743492,6.11379727549021e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IMPA1,Inositol monophosphatase 1,42016,0.0481371869931512,0.00642355801139091,0.035547013290825,0.0607273606954774,7.10653897708544e-14
NMR metabolomics,X23408.Triglycerides in VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0370006671393044,0.0049438663806001,0.0273106890333282,0.0466906452452806,7.64941445795733e-14
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN2,Nectin-2,42129,0.0242920803647284,0.00324764040029597,0.0179267051801483,0.0306574555493085,7.89472727337354e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.0343228166530347,0.00459442106333217,0.0253177513689036,0.0433278819371657,8.59325964008539e-14
NMR metabolomics,X23408.Triglycerides in VLDL,LTA,Lymphotoxin-alpha,42119,0.0314186772107491,0.00420859256951964,0.0231698357744906,0.0396675186470076,8.81462836535273e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CD302,CD302 antigen,42070,0.0243940069480064,0.00326989452258922,0.0179850136837315,0.0308030002122813,9.16888298577681e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI2,Serpin I2,39930,0.0452828053336405,0.00607436614142117,0.033377047696455,0.057188562970826,9.66099467458178e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ADA,Adenosine deaminase,42296,0.0277606724279447,0.00373031361777889,0.0204492577370981,0.0350720871187913,1.0514586945991e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0317003096947915,0.00425891191015722,0.0233528423508833,0.0400477770386996,1.05504133915611e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN1,Tetraspanin-1,41900,0.05688774282748,0.00764790493971868,0.0418978491456314,0.0718776365093286,1.08200127138394e-13
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0439040752445888,0.00590452999499913,0.0323311964543905,0.0554769540347871,1.10410600617618e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH1,Protocadherin-1,42264,0.0160849817123621,0.00216432283526999,0.0118429089552329,0.0203270544694913,1.1342282369481e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CIT,Citron Rho-interacting kinase,39649,0.0358032296687421,0.00481850291587588,0.0263589639536254,0.0452474953838588,1.16292975551809e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.042158524504506,0.0056762466212058,0.0310330811269427,0.0532839678820694,1.19108365536547e-13
NMR metabolomics,X23408.Triglycerides in VLDL,KLK6,Kallikrein-6,42158,0.0240703779266295,0.00324511769500123,0.0177099472444271,0.0304308086088319,1.26520634305779e-13
NMR metabolomics,X23408.Triglycerides in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0263703308367562,0.00355743099784207,-0.0333428955925266,-0.0193977660809857,1.32763828352285e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.026495274567205,0.00358452122569605,0.0194696129648408,0.0335209361695693,1.53616472464145e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL1,Chordin-like protein 1,42166,0.0253647149775075,0.00343687015338905,0.0186284494768649,0.03210098047815,1.67268110075395e-13
NMR metabolomics,X23408.Triglycerides in VLDL,INSL3,Insulin-like 3,39929,0.0698298541116108,0.00946582706994122,0.051276833054526,0.0883828751686956,1.7314377245433e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.052275340821798,0.00709808354642481,0.0383630970708054,0.0661875845727907,1.87780529604415e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CHGA,Chromogranin-A,39966,-0.0658064728717936,0.00893836002742935,-0.0833256585255551,-0.048287287218032,1.93318569520336e-13
NMR metabolomics,X23408.Triglycerides in VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0505985009844164,0.00689608617644686,0.0370821720785805,0.0641148298902522,2.30601642162964e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0272470811702459,0.00371403473285525,0.0199675730938496,0.0345265892466421,2.32447350684801e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0321387310916545,0.00438211726388597,0.023549781254438,0.040727680928871,2.38597581916933e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LY75,Lymphocyte antigen 75,42119,0.0298229879052216,0.00406730497541839,0.0218510701534015,0.0377949056570416,2.38968292966618e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0303078255327687,0.0041365096451964,0.0222002666281837,0.0384153844373536,2.5192529479468e-13
NMR metabolomics,X23408.Triglycerides in VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,0.027546255709237,0.00376417823355847,0.0201684663714625,0.0349240450470116,2.65684305080702e-13
NMR metabolomics,X23408.Triglycerides in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0340351204666952,0.00466625691243399,0.0248892569183246,0.0431809840150658,3.21753676713653e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CA1,Carbonic anhydrase 1,41890,0.0431359440404435,0.00592137296761953,0.0315300530239092,0.0547418350569778,3.4032976076302e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CASP9,Caspase-9,39657,0.0487847109038242,0.00671186807487056,0.0356294494770779,0.0619399723305705,3.88232606194223e-13
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0393312508222543,0.00542376414655298,0.0287006730950105,0.0499618285494981,4.39276883050244e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PMM2,Phosphomannomutase 2,39575,0.0457411258449549,0.00630768481809061,0.0333780636014973,0.0581041880884125,4.39444994842995e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0140968837257413,0.00194615709117966,0.0102824158270292,0.0179113516244535,4.65723888855236e-13
NMR metabolomics,X23408.Triglycerides in VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0386024658803253,0.00532943760649686,0.0281567681715914,0.0490481635890591,4.67404326851498e-13
NMR metabolomics,X23408.Triglycerides in VLDL,GAST,Gastrin,39929,0.0994550141398508,0.0137566094094774,0.0724920596972752,0.126417968582426,5.15536818843556e-13
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.030770689795166,0.00426361496766474,0.0224140044585431,0.0391273751317889,5.65248804392168e-13
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR2,Folate receptor beta,42249,-0.0220147112293521,0.00305229888601483,-0.0279972170459412,-0.016032205412763,5.78262355230824e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0167124081318766,0.00232130943323536,-0.0212621746210179,-0.0121626416427353,6.36502327199127e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0322889491414352,0.00448646604781461,-0.0410824225951519,-0.0234954756877186,6.48247568406569e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0906957934202121,0.0126160707839635,0.0659682946836435,0.115423292156781,6.94195169107032e-13
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.036553541479588,0.00508698005583186,0.0265830605701575,0.0465240223890184,7.04451785144475e-13
NMR metabolomics,X23408.Triglycerides in VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.0555735793355646,0.00773488557113105,0.0404132036161477,0.0707339550549815,7.07854605483131e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0208250914779019,0.00290204662885036,0.0151370800853552,0.0265131028704486,7.55015442660258e-13
NMR metabolomics,X23408.Triglycerides in VLDL,AGT,Angiotensinogen,39990,0.0164052935346872,0.00228815631935731,0.0119205071487469,0.0208900799206275,7.98402378518386e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MET,Hepatocyte growth factor receptor,42158,-0.0144304235518262,0.00201515448605482,-0.0183801263444937,-0.0104807207591588,8.42467347500775e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0248322219030169,0.00346849467954116,-0.0316304714749176,-0.0180339723311162,8.6049749424143e-13
NMR metabolomics,X23408.Triglycerides in VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0537938056280691,0.00752793059457435,0.0390390616627034,0.0685485495934348,9.49887139778019e-13
NMR metabolomics,X23408.Triglycerides in VLDL,RCOR1,REST corepressor 1,41900,0.0334758297619668,0.00468758407599717,0.0242881649730123,0.0426634945509212,9.7198665057751e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0280869243648147,0.0039331683026471,0.0203779144916264,0.035795934238003,9.83029593421771e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CD248,Endosialin,39966,-0.0303928921852381,0.0042572100747666,-0.0387370239317806,-0.0220487604386955,9.9630398318467e-13
NMR metabolomics,X23408.Triglycerides in VLDL,DSC2,Desmocollin-2,41984,-0.0263828511299415,0.00369749505334313,-0.0336299414344941,-0.019135760825389,1.01523064844178e-12
NMR metabolomics,X23408.Triglycerides in VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0274285137052334,0.00384543188407352,0.0198914672124493,0.0349655601980175,1.0457702741142e-12
NMR metabolomics,X23408.Triglycerides in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.060314774253051,0.00846309676882274,0.0437271045861585,0.0769024439199436,1.07940183059322e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0330250931222228,0.00464128157419952,0.0239281812367917,0.0421220050076539,1.18451792410354e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA4,Annexin A4,42088,0.0541555655302544,0.00761344481682429,0.0392332136892788,0.06907791737123,1.19143570250078e-12
NMR metabolomics,X23408.Triglycerides in VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.0201514957042434,0.00283992061075647,0.0145852513071608,0.0257177401013261,1.36260729395859e-12
NMR metabolomics,X23408.Triglycerides in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0418435632621278,0.00589818945965008,0.0302831119212136,0.053404014603042,1.38011990833468e-12
NMR metabolomics,X23408.Triglycerides in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.017642590808055,0.00248945992608666,0.0127632493529251,0.0225219322631848,1.43864695626957e-12
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0340155048316677,0.00479963667074727,0.0246082169570031,0.0434227927063324,1.45104313328571e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0415260910531074,0.00586067121725899,0.0300391754672797,0.053013006638935,1.46978733028041e-12
NMR metabolomics,X23408.Triglycerides in VLDL,STX6,Syntaxin-6,41843,0.0488452319830089,0.00689776640998462,0.0353256098194391,0.0623648541465788,1.50001307572943e-12
NMR metabolomics,X23408.Triglycerides in VLDL,HMBS,Porphobilinogen deaminase,42262,0.0298519411413657,0.00422340606517412,0.0215740652536244,0.0381298170291069,1.64552943398499e-12
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0232036346709837,0.00328631913827995,0.016762449159955,0.0296448201820124,1.73778699003461e-12
NMR metabolomics,X23408.Triglycerides in VLDL,STX7,Syntaxin-7,39657,0.0364266332533494,0.00515921678698959,0.0263145683508498,0.046538698155849,1.75859531115468e-12
NMR metabolomics,X23408.Triglycerides in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0397166238649378,0.00563260356734093,0.0286767208729496,0.0507565268569261,1.86025411482324e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0462632964395494,0.0065662879138909,0.0333933721283233,0.0591332207507756,1.9568447098679e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LF,CMRF35-like molecule 1,42262,0.0444137906815402,0.00630817916042731,0.0320497595271027,0.0567778218359778,2.00458416709441e-12
NMR metabolomics,X23408.Triglycerides in VLDL,DKK4,Dickkopf-related protein 4,41992,0.0340712297706973,0.00484819234737133,0.0245687727698495,0.0435736867715451,2.20257741518418e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL8,Interleukin-8,42035,0.0500822292585086,0.00712716930902093,0.0361129774128276,0.0640514811041896,2.21279873946222e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CCL20,C-C motif chemokine 20,42296,0.0638502965724261,0.00909229538169721,0.0460293976242996,0.0816711955205526,2.28269870076087e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.035020129520977,0.00498868263733409,0.0252423115518021,0.0447979474901518,2.32819001901698e-12
NMR metabolomics,X23408.Triglycerides in VLDL,S100A12,Protein S100-A12,41910,0.0541417188032192,0.00771419838838574,0.0390218899619831,0.0692615476444552,2.35207248592105e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0395749393796367,0.0056390845349613,0.0285223336911126,0.0506275450681609,2.37958099888766e-12
NMR metabolomics,X23408.Triglycerides in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0466459949724781,0.0066480023507064,-0.0596760795798627,-0.0336159103650936,2.38099316796652e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.0198664496082504,0.00283184721871953,-0.0254168701569407,-0.0143160290595601,2.40242724676399e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0369950063297266,0.00527745508397436,0.0266511943651368,0.0473388182943163,2.51845983345325e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0843365378199854,0.0120548374594063,0.060709056399549,0.107964019240422,2.78074317222283e-12
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0290831764414693,0.00415711024789917,0.020935240355587,0.0372311125273517,2.78441234104297e-12
NMR metabolomics,X23408.Triglycerides in VLDL,BSG,Basigin,42284,0.0153248081304797,0.002194833089375,0.0110229352753047,0.0196266809856547,3.03949041335214e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CST5,Cystatin-D,41846,0.0412302460206514,0.00591214896219258,0.0296424340547539,0.0528180579865488,3.23087822272665e-12
NMR metabolomics,X23408.Triglycerides in VLDL,THBS4,Thrombospondin-4,42189,0.0332546149622209,0.00477427620033681,0.0238970336095607,0.042612196314881,3.42599180862021e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0272541160320775,0.00391384704875987,0.0195829758165082,0.0349252562476469,3.47551335279821e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0276459325837076,0.00397507285458605,0.019854789788719,0.0354370753786963,3.7243699152043e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0276596529593718,0.00397931398674583,0.01986019754535,0.0354591083733936,3.7971440701473e-12
NMR metabolomics,X23408.Triglycerides in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0241046908186504,0.00347031628051775,0.0173028709088356,0.0309065107284652,3.93135881898306e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.0211671379149802,0.00305252842974638,0.0151841821926773,0.027150093637283,4.30477845263511e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SCT,Secretin,39649,0.03509465645647,0.00506587203655395,0.0251655472648242,0.0450237656481157,4.51637919624563e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0521062516145914,0.00753169060336461,0.0373441380319968,0.0668683651971861,4.81865897555376e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.0208240270041032,0.00301783674485109,0.0149090669841951,0.0267389870240114,5.41931094980058e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB8,Serpin B8,42296,0.0422707257946982,0.00614260156485539,0.0302312267275816,0.0543102248618147,6.17709038039925e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0249552211177835,0.00363325250647905,-0.0320763960304824,-0.0178340462050845,6.77349355549513e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1A,Protein phosphatase 1A,41843,0.0226259281672583,0.00329767006741858,0.0161624948351179,0.0290893614993988,7.13269911428067e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0195500062672315,0.00284915752038767,-0.0251343550071913,-0.0139656575272716,7.15853437906086e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0219259203152614,0.00319659770807153,-0.0281912518230816,-0.0156605888074412,7.22896236927514e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0339754410052185,0.00495462098914853,0.0242643838664873,0.0436864981439496,7.39068913985579e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SNX5,Sorting nexin-5,39638,0.0214265430071552,0.00313424793088774,0.0152834170626153,0.0275696689516952,8.55748950779701e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0487675501454186,0.00714080341421899,0.0347715754535493,0.0627635248372878,8.89082070439778e-12
NMR metabolomics,X23408.Triglycerides in VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0440523846574668,0.00646149193999378,0.031387860455079,0.0567169088598546,9.64411224023397e-12
NMR metabolomics,X23408.Triglycerides in VLDL,EGFR,Epidermal growth factor receptor,42310,0.0114352156846787,0.00167744250913491,0.00814742836677429,0.0147230030025831,9.6812687890948e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CDH1,Cadherin-1,41697,0.0287756902874013,0.00422335993830529,0.0204979048083229,0.0370534757664796,9.94452850745784e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CSTB,Cystatin-B,41959,0.0310396033979095,0.00455610152975825,0.0221096443995834,0.0399695623962357,9.98480911537773e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0416022946074592,0.00610726304021019,0.0296320590486472,0.0535725301662712,1.00380637220154e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.024902345064023,0.00365754046675755,0.0177335657491782,0.0320711243788678,1.02780242823206e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0175278936106298,0.00257518637755214,-0.022575258910632,-0.0124805283106276,1.04189472346548e-11
NMR metabolomics,X23408.Triglycerides in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0171989887484105,0.00253144770178017,0.0122373512529213,0.0221606262438996,1.13521486474588e-11
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0293911286315925,0.00433321108933774,0.0208980348964906,0.0378842223666945,1.22803642879735e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TNC,Tenascin,42217,-0.0343868466862988,0.00507366885329117,-0.0443312376387495,-0.0244424557338481,1.27294155172759e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.027053945754692,0.00399367174710036,-0.0348815423790087,-0.0192263491303753,1.312872048445e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CENPF,Centromere protein F,39757,0.0381887849954271,0.00566906174174764,0.0270774239816017,0.0493001460092525,1.70405275230938e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0177933670792402,0.00264208271692749,-0.0229718492044181,-0.0126148849540623,1.7093132942408e-11
NMR metabolomics,X23408.Triglycerides in VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0139359427298931,0.00207399045886154,0.00987092143052451,0.0180009640292617,1.91219368329674e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0353928510352448,0.00526827080368742,0.0250670402600174,0.0457186618104721,1.91612768803678e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0250063940112103,0.00372399827722256,0.0177073573878541,0.0323054306345665,1.95693743820461e-11
NMR metabolomics,X23408.Triglycerides in VLDL,C7,Complement component C7,39722,-0.0235590535866921,0.0035092073897788,-0.0304371000706585,-0.0166810071027256,1.99266219245459e-11
NMR metabolomics,X23408.Triglycerides in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0286901036795215,0.00429208929984501,0.0202776086518252,0.0371025987072177,2.41152598808484e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LXN,Latexin,41960,-0.0481746502149641,0.00721218929929869,-0.0623105412415895,-0.0340387591883387,2.49053124334844e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0145730007373122,0.00218334813883603,0.0102936383851936,0.0188523630894308,2.57589428736861e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PRELP,Prolargin,42123,0.0164250972738205,0.00246141478797475,0.0116007242893899,0.021249470258251,2.60331755169074e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0292319083338143,0.00438348141942014,0.0206402847517509,0.0378235319158778,2.70174278368951e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SPOCK1,Testican-1,42016,0.0182897851987756,0.00274558001163722,0.0129084483759667,0.0236711220215846,2.81542704923914e-11
NMR metabolomics,X23408.Triglycerides in VLDL,COLEC12,Collectin-12,42123,0.0191722864990581,0.00287827954536949,0.0135308585901339,0.0248137144079823,2.82442184118341e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0323641426128388,0.00486770177352419,-0.0419048380889462,-0.0228234471367314,3.0962220979969e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.040390877143701,0.00609620079742975,0.0284423235807387,0.0523394307066634,3.61575338701792e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR3,Small proline-rich protein 3,39929,0.0438078582126775,0.00662472085939056,0.030823405328272,0.056792311097083,3.94118739302431e-11
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0228819709024317,0.0034614916962189,-0.0296664946270207,-0.0160974471778427,3.97538943754903e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0282515437558519,0.00427424380876193,0.0198740258906785,0.0366290616210253,3.99608103771639e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO1,Roundabout homolog 1,42144,0.0165974868935249,0.00251815089881175,0.0116619111318539,0.021533062655196,4.52616230592086e-11
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.040597532311657,0.00616118344841622,0.0285216127527612,0.0526734518705528,4.62170591300398e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GRSF1,G-rich sequence factor 1,39486,0.0574741299046418,0.00875259901063892,0.0403190358437895,0.074629223965494,5.38502337518779e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0362676643113826,0.00552355038770779,0.0254415055514753,0.0470938230712899,5.40031649322371e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0285180754231703,0.00434798278193739,0.019996029170573,0.0370401216757676,5.66171397721934e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0251659544989123,0.00384186574456374,-0.0326960113582573,-0.0176358976395674,5.94552494286246e-11
NMR metabolomics,X23408.Triglycerides in VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.0281727136967747,0.00431670870488148,0.019711964635207,0.0366334627583424,6.97605043264275e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.023238755554109,0.00356329363860148,0.01625470002245,0.0302228110857679,7.20027351763564e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL1,Fc receptor-like protein 1,42145,0.0313829985174851,0.00481352489353548,0.0219484897261555,0.0408175073088146,7.29188552913237e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.0199401124475538,0.00306102219122676,0.0139405089527493,0.0259397159423582,7.61720893353392e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0339164754731281,0.00521344121483884,-0.0441348202542123,-0.023698130692044,8.06490523139275e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.039272814144549,0.00604950291113562,0.0274157884387231,0.0511298398503748,8.83936390623161e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.030296084474791,0.00466759201858917,0.0211476041183563,0.0394445648312258,8.84011298669107e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0480563668371455,0.00741502217748913,-0.0625898103050242,-0.0335229233692668,9.43035522910587e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PSME2,Proteasome activator complex subunit 2,41955,0.0239940372698438,0.00370834234103224,0.0167256862814206,0.031262388258267,1.01229577776984e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0178044000019572,0.00275137260224676,0.0124117097015535,0.0231970903023608,1.01307192277066e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0273221652000281,0.0042260788074721,0.0190390507373828,0.0356052796626734,1.05368862483131e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MARCO,Macrophage receptor MARCO,42145,0.0174739312298239,0.00271497880265314,0.0121525727766238,0.0227952896830241,1.2669263553776e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CD300A,CMRF35-like molecule 8,39736,0.0206338627093805,0.00321447939264425,0.0143334830997978,0.0269342423189633,1.42714059972985e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN2,Alpha-actinin-2,39575,-0.0436013088713585,0.00679354184112492,-0.0569166508799633,-0.0302859668627536,1.43720179194489e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0223905879767132,0.00349013117188775,0.0155499308798132,0.0292312450736132,1.45110117848227e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0251752756649385,0.00393321221570518,0.0174661797221564,0.0328843716077207,1.60937407099166e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CD80,T-lymphocyte activation antigen CD80,39958,0.0230051828064909,0.00360400206622947,0.0159413387566811,0.0300690268563006,1.80145001127463e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CASP8,Caspase-8,42224,0.0409561300762233,0.00641955811978323,0.0283737961614481,0.0535384639909984,1.82934034146138e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0347813304730546,0.00545473634476087,0.0240900472373233,0.0454726137087859,1.87374060477498e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0187097435151912,0.00293938547238169,0.0129485479893231,0.0244709390410593,2.0126502692886e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GPR15L,Protein GPR15L,39930,0.0417153666750075,0.00655886964916033,0.0288599821626533,0.0545707511873618,2.09323945157453e-10
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0327425328151292,0.0051481051888176,0.0226522466450467,0.0428328189852117,2.09576688590344e-10
NMR metabolomics,X23408.Triglycerides in VLDL,RALY,RNA-binding protein Raly,39919,0.032071434321273,0.00506042023181703,0.0221530106669116,0.0419898579756344,2.42081506600704e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CCL25,C-C motif chemokine 25,42296,0.0326832577692504,0.00516287584505079,0.0225640211129508,0.0428024944255499,2.52090924861202e-10
NMR metabolomics,X23408.Triglycerides in VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0193482520697105,0.00305748124531504,-0.0253409153105279,-0.013355588828893,2.55870604205948e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0286334231097142,0.00452566762256995,0.019763114569477,0.0375037316499513,2.58152686142191e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TXN,Thioredoxin,39854,0.0285751537170824,0.00451991100036751,0.0197161281563621,0.0374341792778028,2.67867772397026e-10
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0337576511345582,0.0053491044464215,0.0232734064195721,0.0442418958495443,2.86223840950645e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0249606549371827,0.00395518063228943,0.0172085008978955,0.03271280897647,2.88159721654038e-10
NMR metabolomics,X23408.Triglycerides in VLDL,DGCR6,Protein DGCR6,39586,0.0276441724350882,0.00440466169242237,0.0190110355179404,0.0362773093522361,3.60215086756621e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CALB2,Calretinin,41839,0.0193066616652282,0.00309393690720414,0.0132425453271081,0.0253707780033483,4.50449079136317e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0374131591914197,0.00600003671255617,0.0256530872348096,0.0491732311480298,4.66439066018965e-10
NMR metabolomics,X23408.Triglycerides in VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0341542452965901,0.00548037536278136,-0.0448957810076416,-0.0234127095855386,4.73871880812152e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PKD1,Polycystin-1,39958,0.017830789446223,0.00286249091909908,0.0122203072447888,0.0234412716476572,4.85660182847486e-10
NMR metabolomics,X23408.Triglycerides in VLDL,F3,Tissue factor,42174,-0.0170680784094398,0.00274664289546678,-0.0224514984845547,-0.0116846583343249,5.31085217478548e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CD209,CD209 antigen,42171,-0.0254343342027068,0.00409814503064213,-0.0334666984627654,-0.0174019699426483,5.58235383802847e-10
NMR metabolomics,X23408.Triglycerides in VLDL,RNASET2,Ribonuclease T2,42258,0.0174272139888935,0.00281766728186599,0.0119045861164362,0.0229498418613509,6.38818895379345e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0477597558043283,0.00773325154052615,0.032602582784897,0.0629169288237595,6.76704528456873e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0215656769320933,0.00349392828524806,0.0147175774930071,0.0284137763711795,6.91940390238187e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GC,Vitamin D-binding protein,39979,0.0167606652569275,0.00271663255998386,0.0114360654393591,0.0220852650744959,7.07679665420559e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.016990637155587,0.00275742193393461,-0.0223951841460988,-0.0115860901650752,7.4415714965553e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CLU,Clusterin,39979,0.019504201230355,0.00316611787222779,0.0132986102007885,0.0257097922599214,7.5064734801764e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0184026397656249,0.00298975773829674,-0.0242625649326865,-0.0125427145985633,7.70687334857707e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH1,Neurexophilin-1,41839,0.0251150091979001,0.00408427798176485,0.017109824353641,0.0331201940421592,8.01188510665227e-10
NMR metabolomics,X23408.Triglycerides in VLDL,IL34,Interleukin-34,41814,0.0236292595443443,0.00384429694187444,0.0160944375382704,0.0311640815504182,8.14518240603476e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CX3CL1,Fractalkine,42016,-0.021579586716493,0.00351377883453703,-0.0284665932321856,-0.0146925802008004,8.40973384349844e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0455047156632259,0.00741133737571181,0.0309784944068308,0.0600309369196211,8.5392684098143e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0195257165403999,0.00318252239557429,0.0132879726450743,0.0257634604357255,8.79093153207062e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0171052496847445,0.00278865910704314,0.0116394778349399,0.022571021534549,8.81374344708619e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.017046155649061,0.00277928009752473,0.0115987666579125,0.0224935446402095,8.89294106823161e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ACHE,Acetylcholinesterase,39736,0.0220857611304737,0.00360114930412855,0.0150275084943817,0.0291440137665656,8.91759323105816e-10
NMR metabolomics,X23408.Triglycerides in VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0538025589734875,0.0087894406506809,0.0365752552981529,0.0710298626488221,9.59562288406823e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB2A2,Mammaglobin-A,39575,-0.0200443772308746,0.00327493501766943,-0.0264632498655066,-0.0136255045962425,9.64422751584589e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CR2,Complement receptor type 2,42217,0.0299995016080338,0.00490336592642133,0.020388904392248,0.0396100988238196,9.72654455996581e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK3,NT-3 growth factor receptor,42249,-0.013641753534328,0.00223000480983168,-0.0180125629615981,-0.00927094410705793,9.77347595629989e-10
NMR metabolomics,X23408.Triglycerides in VLDL,AMPD3,AMP deaminase 3,39929,0.0443314040406867,0.00724591152827974,0.0301294174452584,0.058533390636115,9.78077842292142e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0252952342022351,0.00413501333787552,0.0171906080599991,0.0333998603444712,9.8377929391324e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.0158021584916522,0.00258447677603717,0.0107365840106193,0.020867732972685,1.00257960316979e-09
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0215294376880063,0.00352332569442831,0.0146237193269268,0.0284351560490858,1.0199047809893e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CABP2,Calcium-binding protein 2,39649,0.0420236198502473,0.00688779110876752,0.028523549277063,0.0555236904234316,1.08818089287969e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GRN,Progranulin,42077,0.0160905487796701,0.00264250845446834,0.0109112322089122,0.0212698653504281,1.16618998429192e-09
NMR metabolomics,X23408.Triglycerides in VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0223217032786712,0.00366750403375644,0.0151333953725085,0.0295100111848338,1.19373910750614e-09
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0240989854558006,0.00396026677995222,0.0163368625670943,0.0318611083445069,1.19544700928972e-09
NMR metabolomics,X23408.Triglycerides in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.017830028855761,0.0029315763074708,0.0120841392931182,0.0235759184184037,1.21830464005579e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RAB37,Ras-related protein Rab-37,41913,0.0518033293096244,0.00854005186057267,0.035064827662902,0.0685418309563469,1.34750690459393e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0256251480474139,0.00422475123089824,0.0173446356348533,0.0339056604599744,1.35143081277859e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0284377285893522,0.00468871207241751,-0.0376276042512905,-0.0192478529274138,1.35336827073405e-09
NMR metabolomics,X23408.Triglycerides in VLDL,MDM1,Nuclear protein MDM1,39649,0.0200504407346404,0.00331144187240143,0.0135600146647336,0.0265408668045472,1.45073622571846e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0325118444632128,0.00537911956668031,-0.0430549188139063,-0.0219687701125194,1.54198620077956e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.0338904841975496,0.00561128585156876,0.0228923639284748,0.0448886044666244,1.58536641337797e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RGMB,RGM domain family member B,42249,0.0177990308460108,0.00294718369353398,0.0120225508066842,0.0235755108853374,1.5876979510214e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0276390883735317,0.00458046781181358,0.0186613714623771,0.0366168052846864,1.64961626286163e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN3,Calsyntenin-3,39929,0.0192005338545913,0.00318230965791052,0.0129632069250867,0.025437860784096,1.65437127557809e-09
NMR metabolomics,X23408.Triglycerides in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0694032103355065,0.0115391024197444,0.0467865695928076,0.0920198510782055,1.84951193514407e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0283061080009407,0.00471047745740096,0.0190735721844348,0.0375386438174465,1.92202652089656e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0101697300218816,0.00169585397357592,0.00684585623367283,0.0134936038100905,2.06279697729299e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.037855361410469,0.00632599328483407,0.0254564145721942,0.0502543082487438,2.2302579479406e-09
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM2,Myomesin-2,39575,-0.0350785998016614,0.00586247650562631,-0.046569053752689,-0.0235881458506339,2.25100856647729e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0336513678789251,0.00563509374541692,0.022606584137908,0.0446961516199423,2.40549393126684e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA7A,Semaphorin-7A,42272,0.0179196934774961,0.00300200616419608,0.0120357613956718,0.0238036255593204,2.44264875360213e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0334917024923483,0.00561186372640993,0.0224924495885849,0.0444909553961118,2.46185559873786e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0242061662844765,0.00405642024166994,0.0162555826108035,0.0321567499581496,2.48554133585537e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.0201830176200999,0.00338394364155904,-0.0268155471575557,-0.0135504880826442,2.53073883103558e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0226942202986893,0.00380495384511268,0.0152365107622684,0.0301519298351101,2.53123326792894e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0157015240664969,0.0026498118039788,0.0105078929306984,0.0208951552022953,3.18862624609059e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LYZL2,Lysozyme-like protein 2,39560,0.0226690036623021,0.00382697610327571,0.0151681304998816,0.0301698768247225,3.2467576726924e-09
NMR metabolomics,X23408.Triglycerides in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0573518677348028,0.00969043697371239,0.0383586112663266,0.0763451242032791,3.34756167328465e-09
NMR metabolomics,X23408.Triglycerides in VLDL,AGR2,Anterior gradient protein 2 homolog,41740,0.0623880446622288,0.0105547811522376,0.041700673603843,0.0830754157206145,3.48723464677478e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0397433618549372,0.00672297097154036,0.0265663387507181,0.0529203849591563,3.48875260331577e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SNU13,NHP2-like protein 1,39575,0.039226380139138,0.00663585740238715,0.0262200996304592,0.0522326606478169,3.49571673177636e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LTB,Lymphotoxin-beta,39919,0.0213895528731538,0.00361935038140277,0.0142956261256044,0.0284834796207032,3.52443047806556e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CD276,CD276 antigen,42123,-0.0223212910150377,0.00377780711331181,-0.0297257929571289,-0.0149167890729466,3.53473380737944e-09
NMR metabolomics,X23408.Triglycerides in VLDL,APOB,Apolipoprotein B-100,39990,0.014095799642239,0.00239798416264082,0.009395750683463,0.018795848601015,4.26412333438638e-09
NMR metabolomics,X23408.Triglycerides in VLDL,AZU1,Azurocidin,41751,0.0464664962707219,0.00791829999163173,0.0309466282871237,0.0619863642543201,4.5104795067866e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0601738879165584,0.0102740101421575,0.0400368280379298,0.080310947795187,4.85108147849357e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0158434719945494,0.00270833096153991,0.0105351433099312,0.0211518006791676,5.03348384584354e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.0252870716708502,0.00433441980279175,0.0167916088573784,0.033782534484322,5.53650569948712e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0318547993730115,0.00546041696077174,0.0211523821298989,0.0425572166161242,5.54559489818893e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SATB1,DNA-binding protein SATB1,39934,0.0179545331220831,0.00307821621980095,0.0119212293312732,0.023987836912893,5.60037615849891e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.041446192456369,0.00710830860402762,0.0275139075924749,0.0553784773202632,5.64543847670462e-09
NMR metabolomics,X23408.Triglycerides in VLDL,OSM,Oncostatin-M,42051,0.0422737536028216,0.00726653598299666,0.0280313430761482,0.0565161641294951,6.10590050206994e-09
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.0316883459356625,0.00544697584468466,0.0210122732800806,0.0423644185912444,6.10709738663938e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS1,Nephrin,39657,0.0203788154742737,0.00350278923174817,0.0135133485800472,0.0272442823685001,6.12510108957944e-09
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0246084875177588,0.00423334857806099,0.0163111243047593,0.0329058507307583,6.30596690991957e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00499140585862138,0.000860366471969226,-0.00667772414368106,-0.00330508757356169,6.75095603735458e-09
NMR metabolomics,X23408.Triglycerides in VLDL,S100A13,Protein S100-A13,39657,0.0216893885884433,0.0037459796818612,0.0143472684119953,0.0290315087648912,7.2283214366305e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CA7,Carbonic anhydrase 7,39757,-0.0202968772891006,0.0035300322176832,-0.0272157404357597,-0.0133780141424416,9.17094301708838e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SNX2,Sorting nexin-2,39919,0.0514646161268484,0.00898847707522565,0.0338472010594062,0.0690820311942907,1.05677345539555e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0187918302568672,0.00328221030112005,-0.0252249624470625,-0.012358698066672,1.0592762996934e-08
NMR metabolomics,X23408.Triglycerides in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0270082875946847,0.00472609434668414,0.0177451426751838,0.0362714325141856,1.12214711850098e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PRTG,Protogenin,42262,0.0147415916120106,0.00258253656237668,0.00967981994975231,0.0198033632742689,1.16562072265346e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0323596566235359,0.00567376725133364,0.021239072810922,0.0434802404361499,1.20396382325388e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0188280894344302,0.00330388258096497,-0.0253036992931215,-0.0123524795757388,1.23230604350913e-08
NMR metabolomics,X23408.Triglycerides in VLDL,EBI3_IL27,Interleukin-27,42247,-0.0183405147084259,0.0032192681964539,-0.0246502803734756,-0.0120307490433763,1.2437411480973e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.023749521402322,0.004176687318697,0.0155632142576759,0.0319358285469681,1.32542327937395e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0243288627450372,0.00429708285607966,-0.0327511451429534,-0.0159065803471211,1.53499195788351e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0184505709855613,0.00325896443660266,0.0120630006898201,0.0248381412813025,1.537100074002e-08
NMR metabolomics,X23408.Triglycerides in VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0160994471380085,0.00284567719632225,0.0105219198332169,0.0216769744428001,1.57319545728885e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0187536624618775,0.00331687301968416,-0.0252547335804585,-0.0122525913432966,1.60627393543923e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0162758609295931,0.002881699059975,0.0106277307720421,0.0219239910871441,1.65573167622355e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0194620430929872,0.00345324326248369,0.0126936862985191,0.0262303998874552,1.7844386965693e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0300251055118966,0.00534073772254074,0.0195572595757168,0.0404929514480765,1.92567880328655e-08
NMR metabolomics,X23408.Triglycerides in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0303405564864877,0.00539888354229008,0.0197587447435992,0.0409223682293763,1.95054543960905e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0183512561255142,0.00327395927574491,0.0119342959450542,0.0247682163059742,2.12976272888695e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CPQ,Carboxypeptidase Q,39960,0.022034337369949,0.00393934889545183,0.0143132135348634,0.0297554612050345,2.2781962433962e-08
NMR metabolomics,X23408.Triglycerides in VLDL,COPB2,Coatomer subunit beta',39575,0.025263842866439,0.00452712522597462,0.0163906774235288,0.0341370083093493,2.45449676355707e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF7,SLAM family member 7,42119,-0.0350134562410712,0.00628032961902032,-0.047322902294351,-0.0227040101877914,2.52127964865996e-08
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0383743295689745,0.00688299103415843,0.024883667142024,0.0518649919959251,2.53031351037076e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0267262187105392,0.00481091925919302,0.0172968169625209,0.0361556204585576,2.83348357068359e-08
NMR metabolomics,X23408.Triglycerides in VLDL,STC2,Stanniocalcin-2,42113,0.0140163891053411,0.00252447554449436,0.00906841703813214,0.01896436117255,2.87418042400808e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0458784870969649,0.00826580095557241,0.029677517224043,0.0620794569698869,2.90497024672149e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0184578456384928,0.00333063507820473,0.0119298008852115,0.024985890391774,3.06180780402637e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0205150693058905,0.00370293222059703,0.0132573221535204,0.0277728164582607,3.07658956166606e-08
NMR metabolomics,X23408.Triglycerides in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0214378962564441,0.00387151272051808,0.0138497313242286,0.0290260611886595,3.12746311106928e-08
NMR metabolomics,X23408.Triglycerides in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0379571109980945,0.00686227593074086,0.0245070501738424,0.0514071718223466,3.24979621777524e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0136136918694664,0.00246326995724973,-0.0184417009856759,-0.00878568275325697,3.32370107573613e-08
NMR metabolomics,X23408.Triglycerides in VLDL,JAM2,Junctional adhesion molecule B,42249,0.0158265833813496,0.0028725931030062,0.0101963008994575,0.0214568658632417,3.66348473132916e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0272183211103214,0.0049444161016471,0.0175272655510931,0.0369093766695497,3.7634764081111e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0306812770544338,0.00557486724266004,0.0197545372588201,0.0416080168500474,3.80384128719553e-08
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0258704516951536,0.00470611972457212,-0.035094446355315,-0.0166464570349922,3.92868024219256e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CST1,Cystatin-SN,38503,0.0616093558636575,0.0112089214559427,0.0396398698100097,0.0835788419173053,3.97107275903852e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2,Brorin,41973,0.0236307978032714,0.00430663728375385,0.0151897887271138,0.0320718068794289,4.16102569041713e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LUZP2,Leucine zipper protein 2,39919,0.0259378832105001,0.00472929628862408,0.0166684624847969,0.0352073039362033,4.23520162407573e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VIM,Vimentin,41900,0.0661693361921013,0.0120701247118238,0.0425118917569266,0.0898267806272759,4.28027614965121e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0322681411592206,0.00588685576420653,0.0207299038613758,0.0438063784570654,4.31334620993143e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0487726320787747,0.00890144553256508,0.0313257988349472,0.0662194653226023,4.3643588479757e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CD300C,CMRF35-like molecule 6,42249,0.0202593157114271,0.00370473181626803,0.0129980413515418,0.0275205900713124,4.61850098604623e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0220428737896616,0.00403322801796848,0.0141377468744434,0.0299480007048798,4.71881762781281e-08
NMR metabolomics,X23408.Triglycerides in VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0169003179498593,0.00309942875155351,-0.0229751983029042,-0.0108254375968144,5.046390193133e-08
NMR metabolomics,X23408.Triglycerides in VLDL,XG,Glycoprotein Xg,42261,0.0198040523598405,0.00364019844590237,0.0126692634058718,0.0269388413138091,5.40835970470918e-08
NMR metabolomics,X23408.Triglycerides in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0384903366442495,0.00707825423196323,0.0246169583496016,0.0523637149388975,5.50913903574218e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0247725749366477,0.00456099008505245,0.0158330343699449,0.0337121155033505,5.68946977488814e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.013421176210882,0.00247402025050525,0.00857209651989176,0.0182702559018723,5.90029370351549e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.0268898634784182,0.00496441959769988,0.0171596010669264,0.03662012588991,6.20329078471046e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0669347015474479,0.0123634794344437,0.0427022818559381,0.0911671212389576,6.27303359018475e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PSAP,Prosaposin,39886,0.016250604257062,0.00300257760237305,0.0103655521564108,0.0221356563577132,6.35224092580955e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0225736111674357,0.00418480086069317,0.0143714014804771,0.0307758208543943,6.99917939223494e-08
NMR metabolomics,X23408.Triglycerides in VLDL,IFNG,Interferon gamma,41913,0.0646490950833076,0.0120123199083313,0.0411049480629782,0.088193242103637,7.49529972332133e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MUC16,Mucin-16,42070,0.107782850046972,0.0200674056615546,0.0684507349503247,0.147114965143619,7.95842999995126e-08
NMR metabolomics,X23408.Triglycerides in VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.0526160694103892,0.00984031059702098,-0.0719030781805503,-0.0333290606402281,9.08817022640832e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN8,Septin-8,39906,0.0183461052113114,0.00343209139834514,0.0116192060705549,0.0250730043520679,9.19426427297172e-08
NMR metabolomics,X23408.Triglycerides in VLDL,STX3,Syntaxin-3,39929,0.0214049519991561,0.00401212943082218,0.0135411783147447,0.0292687256835676,9.73532397560964e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE3,Eosinophil cationic protein,42081,0.0610401870030864,0.0114503874177917,0.0385974276642147,0.0834829463419581,9.93354405709614e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CDH3,Cadherin-3,42249,0.0205969082961868,0.0038731557712741,0.0130055229844896,0.028188293607884,1.06649533246006e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3,Galectin-3,42196,0.0165314339765038,0.00311367098928508,0.0104286388375051,0.0226342291155026,1.11774563797829e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0158930380819296,0.0029959776587841,-0.0217651542931464,-0.0100209218707128,1.14577313270953e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ENSA,Alpha-endosulfine,39919,0.0295767767699307,0.00557801421353621,0.0186438689113997,0.0405096846284616,1.16451785234412e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CTSH,Pro-cathepsin H,41865,0.0415151857275445,0.0078467501070607,0.0261355555177055,0.0568948159373834,1.23754658713061e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CCN3,CCN family member 3,42299,0.0188782309400891,0.00357139736533704,0.0118782921040285,0.0258781697761497,1.26972987566872e-07
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.0164006796897246,0.00310749906064039,0.0103099815308694,0.0224913778485797,1.33237627520219e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0320657162471102,0.00608304092626499,0.0201429560316308,0.0439884764625896,1.37521305059656e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PVALB,Parvalbumin alpha,42208,0.0618740994796538,0.0117441392611002,0.0388555865278974,0.0848926124314102,1.39634692961591e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAP,Cartilage-associated protein,39649,0.0273229410673538,0.00519461742977061,0.0171414909050034,0.0375043912297042,1.46863302657248e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CA9,Carbonic anhydrase 9,42262,-0.0257845778764112,0.00490898250450789,-0.0354061835852467,-0.0161629721675757,1.52276748544906e-07
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0352430080121883,0.00671599230184053,0.0220796631005808,0.0484063529237957,1.56855966139319e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MMP13,Collagenase 3,41839,-0.0177900673949305,0.00339626566285018,-0.0244467480941169,-0.0111333866957441,1.64702691329737e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0155940649548624,0.00298402583813423,-0.0214427555976055,-0.00974537431211932,1.75901917863005e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0384480496588619,0.00735769225207164,-0.0528691264729223,-0.0240269728448015,1.76284172639215e-07
NMR metabolomics,X23408.Triglycerides in VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.036321569965156,0.00696145682110442,0.0226771145957914,0.0499660253345207,1.84615328113861e-07
NMR metabolomics,X23408.Triglycerides in VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0196858149568011,0.00378668559011968,0.0122639112001666,0.0271077187134357,2.04188939891302e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0151355079051916,0.00291590572266335,0.00942033268877147,0.0208506831216118,2.13261351449472e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D17,TBC1 domain family member 17,41839,0.0235239150886919,0.00453248815929103,0.0146402382964815,0.0324075918809023,2.13328798630787e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.0210938874772879,0.00406919081002494,0.013118273489639,0.0290695014649368,2.21149981082345e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0151497259340953,0.00292376759268654,0.00941914145242973,0.020880310415761,2.23252259755893e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL1B,Interleukin-1 beta,41825,0.0307453169649092,0.00593459506479027,0.0191135106379203,0.0423771232918982,2.24313492822048e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0170897640730785,0.00331342115100072,0.0105954586171171,0.0235840695290399,2.5428211950296e-07
NMR metabolomics,X23408.Triglycerides in VLDL,REG4,Regenerating islet-derived protein 4,42144,0.0275411221788265,0.00536397544082897,0.0170277303148018,0.0380545140428513,2.86877115069139e-07
NMR metabolomics,X23408.Triglycerides in VLDL,THBD,Thrombomodulin,42145,0.0159294183469176,0.00310738542671087,0.00983894291056426,0.0220198937832709,2.99548606562735e-07
NMR metabolomics,X23408.Triglycerides in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0204883422073574,0.00400487386165672,0.0126387894385103,0.0283378949762046,3.17564502399465e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0288972270786178,0.00566692806559678,0.0177900480700481,0.0400044060871875,3.45674490660543e-07
NMR metabolomics,X23408.Triglycerides in VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0119755733194207,0.00235366755123808,-0.0165887617198474,-0.0073623849189941,3.66579344365846e-07
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0255973575143412,0.0050393340499338,0.015720262776471,0.0354744522522114,3.84623274799174e-07
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0184291043038815,0.00364481435396851,0.0112852681701032,0.0255729404376597,4.34263674890233e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MYL3,Myosin light chain 3,39638,-0.0417844456754933,0.00827386600205889,-0.0580012230395287,-0.0255676683114579,4.48463224766434e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CTSB,Cathepsin B,42153,-0.0269356529847957,0.00533685877824023,-0.0373958961901465,-0.0164754097794448,4.54384285090572e-07
NMR metabolomics,X23408.Triglycerides in VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0263941190288613,0.0052436550246366,-0.036671682877149,-0.0161165551805735,4.87716800152071e-07
NMR metabolomics,X23408.Triglycerides in VLDL,S100A11,Protein S100-A11,42027,0.0244104910894417,0.00486731725430769,0.0148705492709986,0.0339504329078848,5.36591869155243e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MUC2,Mucin-2,39966,0.0486492491688904,0.00976422653780758,0.0295113651547876,0.0677871331829933,6.37257601912299e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PMS1,PMS1 protein homolog 1,39649,0.0259324362942415,0.00520581865974802,0.0157290317211354,0.0361358408673477,6.4070092079469e-07
NMR metabolomics,X23408.Triglycerides in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0100700574367607,0.00202252387707303,-0.0140342042358238,-0.00610591063769751,6.47098254264417e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,0.0324039103807482,0.00651330722159748,0.0196378282264172,0.0451699925350793,6.60387286121874e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CAPG,Macrophage-capping protein,42015,0.0307634454907073,0.00619080737201215,0.0186294630415635,0.0428974279398511,6.80538040259935e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0279567667568118,0.0056338422138545,0.016914436017657,0.0389990974959666,7.05273181223717e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0283512686863502,0.00575428943818648,0.0170728613875047,0.0396296759851957,8.47210824217925e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FABP6,Gastrotropin,41881,0.0293896847712223,0.00597340492117749,0.0176818111257145,0.0410975584167302,8.75415552421931e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0156980560963438,0.00319293372269248,0.00943990599986651,0.021956206192821,8.91318857702076e-07
NMR metabolomics,X23408.Triglycerides in VLDL,S100A14,Protein S100-A14,39934,0.0267470433163329,0.00544856531056321,0.016067855307629,0.0374262313250368,9.2814288115822e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0376069597186468,0.00769201881369709,0.0225306028438005,0.0526833165934931,1.02494829763983e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0323016369642983,0.00661949676629834,0.0193274233023535,0.0452758506262431,1.07693338087083e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CTSV,Cathepsin L2,42200,0.0205279543381472,0.00421143919645335,0.0122735335130986,0.0287823751631957,1.10409329231771e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IL15,Interleukin-15,42119,0.0168154975279208,0.00346652749387355,0.0100211036399287,0.023609891415913,1.24322942127294e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KEL,Kell blood group glycoprotein,41839,0.0184755598916798,0.00380978247854044,0.0110083862337406,0.0259427335496191,1.25177017361426e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KLK14,Kallikrein-14,42262,-0.0235113416085334,0.00487070692591362,-0.0330579271833241,-0.0139647560337427,1.40041462239265e-06
NMR metabolomics,X23408.Triglycerides in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0431781422842613,0.00895023850500581,0.0256356748144499,0.0607206097540727,1.42100525511835e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0154736413403714,0.00321410929729479,0.00917398711767359,0.0217732955630692,1.49311935616326e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRUNE2,Protein prune homolog 2,39757,0.0145969946249623,0.00303936169117591,0.0086398457102575,0.0205541435396671,1.58614598491411e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.021525071808537,0.00448371871359816,0.0127369831298846,0.0303131604871894,1.59816224513439e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS53,Serine protease 53,39929,0.0192875065470389,0.0040194476435068,0.0114093891657656,0.0271656239283123,1.61861122253596e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0209209893435339,0.00436422020477011,-0.0294748609448833,-0.0123671177421845,1.65414999028992e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0161840049915336,0.00337944086124894,-0.0228077090795815,-0.00956030090348564,1.69424000019259e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0118538853240111,0.00248647573817935,-0.0167273777708426,-0.00698039287717957,1.89055256852993e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.023863443357361,0.00501655376633857,-0.0336958887393846,-0.0140309979753374,1.98558281947167e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.025433980648571,0.00534989920947499,0.014948178198,0.035919783099142,2.01861689954101e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.0145570212441523,0.00306397945735508,0.00855162150773635,0.0205624209805683,2.04526951717329e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR2,TGF-beta receptor type-2,42181,0.0171079889371888,0.00360287906371881,0.0100463459723,0.0241696319020777,2.07104640955939e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ICOSLG,ICOS ligand,42070,0.00954444980924694,0.00201041950793837,0.00560402757368773,0.0134848720448061,2.08074713131356e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0223054264974175,0.0047037020346243,0.0130861705095539,0.0315246824852811,2.14156766638806e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH12,Protocadherin-12,39934,0.0127195446398456,0.00268271062611766,0.00746143181265498,0.0179776574670362,2.14934226265316e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0135654362919192,0.00286948982694616,-0.0191896363527336,-0.0079412362311047,2.30079876478587e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GNLY,Granulysin,42137,0.0267792055899305,0.00567641976279949,0.0156534228548435,0.0379049883250175,2.41001731210065e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0312992567633939,0.00663660472890004,0.0182915114947498,0.0443070020320379,2.43256967845378e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BLVRB,Flavin reductase,42137,0.0315569687098807,0.00670316613982096,0.0184187630758316,0.0446951743439298,2.52923754756933e-06
NMR metabolomics,X23408.Triglycerides in VLDL,AHCY,Adenosylhomocysteinase,42145,0.033289074666178,0.00707144505359749,0.0194290423611269,0.0471491069712291,2.53214322824976e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR1,Cadherin-related family member 1,41839,0.0204468038816793,0.00435418803688531,0.0119125953293841,0.0289810124339745,2.68108884283327e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TCN2,Transcobalamin-2,42286,-0.014928851248724,0.00318138114406674,-0.0211643582910948,-0.00869334420635316,2.72408169657714e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0167588723866421,0.00361019500162612,0.00968289018345491,0.0238348545898293,3.48755800553938e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PALM,Paralemmin-1,39859,0.014911928861073,0.00322229463022311,0.0085962313858357,0.0212276263363103,3.73813117037465e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL,Podocalyxin,42070,0.00735901612852396,0.0015913375060462,0.00423999461667341,0.0104780376403745,3.79138592803464e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CPE,Carboxypeptidase E,42134,-0.0190001876048629,0.00410967025048934,-0.027055141295822,-0.0109452339139037,3.81198761628066e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0126247509202882,0.00273374607701228,0.00726660860934416,0.0179828932312323,3.90821670221932e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.0131277639178144,0.00284753379860164,-0.0187089301630736,-0.00754659767255517,4.05871085993742e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CRYGD,Gamma-crystallin D,39929,0.0475365517777277,0.0103183890478382,0.0273125092439647,0.0677605943114907,4.13027080030359e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.016696808203223,0.0036342302757552,0.00957371686274285,0.0238198995437032,4.3813458658688e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SAFB2,Scaffold attachment factor B2,39934,0.0131673466903846,0.0028670783918154,0.00754787304242645,0.0187868203383428,4.42471298041827e-06
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0169758554137558,0.00370191183072706,0.00972010822553078,0.0242316026019809,4.57321162138708e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DSG3,Desmoglein-3,42196,0.016915492209777,0.0036943821724603,0.0096745031517548,0.0241564812677992,4.72009544497349e-06
NMR metabolomics,X23408.Triglycerides in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0129731752354964,0.00283845896404304,0.007409795665972,0.0185365548050207,4.90857316441208e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NTF4,Neurotrophin-4,41843,0.0181994333537114,0.00398676612292748,0.0103853717527735,0.0260134949546492,5.04083692239037e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KLK4,Kallikrein-4,42262,-0.0298861076515989,0.00658284861993061,-0.0427884909466629,-0.0169837243565349,5.67358450459931e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MPO,Myeloperoxidase,42137,0.0214670176467177,0.00473264213228047,0.012191039067448,0.0307429962259874,5.78381249762779e-06
NMR metabolomics,X23408.Triglycerides in VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0172605304893787,0.00380737018186287,0.00979808493292753,0.02472297604583,5.86228701922533e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NEO1,Neogenin,39934,0.0107704246756009,0.0023770082266272,0.00611148855141163,0.0154293607997902,5.92818703166772e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.0254192355713332,0.00561807877077974,0.0144078011806049,0.0364306699620615,6.11421330383932e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0140839157287336,0.0031184117051242,0.0079718287866902,0.0201960026707771,6.35644628568482e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN4,Contactin-4,42137,-0.0111657552729006,0.00247292148688899,-0.016012681387203,-0.0063188291585982,6.37886550841464e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL9,C-X-C motif chemokine 9,42185,0.0308060425079347,0.00683546366994158,0.0174085337148492,0.0442035513010202,6.63634925975029e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FOSB,Protein fosB,41839,0.0182098998413792,0.00404969099591071,0.0102725054893943,0.0261472941933642,6.96306834256095e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PROCR,Endothelial protein C receptor,39575,-0.016339064244297,0.00364564644425222,-0.0234845312750314,-0.00919359721356267,7.47651860321808e-06
NMR metabolomics,X23408.Triglycerides in VLDL,INSR,Insulin receptor,39657,0.00808204493942318,0.00180375026014234,0.00454669442954419,0.0116173954493022,7.51495289357017e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CR1,Complement receptor type 1,39970,0.0167072475486122,0.00373375185877259,0.00938909390541795,0.0240254011918065,7.72787446940857e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0358381214508389,0.00801120965943425,0.0201361505183478,0.0515400923833301,7.77256050058185e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0265668335844043,0.0059492933190633,0.0149062186790402,0.0382274484897683,8.05148923948843e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00823931741092938,0.00184562930691014,0.00462188396938551,0.0118567508524732,8.10055835746948e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0126845069999488,0.00286403175100514,0.00707100476797874,0.0182980092319189,9.54553803163846e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0894157594142554,0.0201968499684232,0.0498299334761458,0.129001585352365,9.62086186792971e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ULBP2,UL16-binding protein 2,42016,0.0183263346674994,0.00414191384727382,0.0102081835268427,0.0264444858081561,9.73802247406813e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SDC1,Syndecan-1,42145,0.018815428439897,0.00425682421665192,0.0104720529752593,0.0271588039045348,9.94396933036338e-06
NMR metabolomics,X23408.Triglycerides in VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.0156275924112243,0.00353917672367824,-0.0225643787896336,-0.00869080603281491,1.0150325166117e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GBP4,Guanylate-binding protein 4,41839,0.0227887669527579,0.00516300388592245,0.0126692793363499,0.0329082545691659,1.02348056264532e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0155453099619215,0.00352396354884529,0.00863834140618469,0.0224522785176582,1.03531243459564e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.032875329311885,0.00746444160498091,0.0182450237661224,0.0475056348576475,1.07135377401949e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SPARCL1,SPARC-like protein 1,42169,-0.0126373876036461,0.002875666686518,-0.0182736943092214,-0.00700108089807081,1.11822539909234e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MMP12,Macrophage metalloelastase,42146,0.0252504279846579,0.00574877520171998,0.0139828285892868,0.0365180273800291,1.13001584576188e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BOC,Brother of CDO,41900,-0.0106294470583088,0.00244462665293217,-0.0154209152980559,-0.00583797881856178,1.38352041482503e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN1,Nectin-1,39657,0.0150933793311161,0.0034736099064173,0.00828510391453822,0.021901654747694,1.40418783373215e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DCC,Netrin receptor DCC,39649,0.010227638634153,0.00235509865634219,0.00561164526772228,0.0148436320005837,1.41955368531623e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FGF16,Fibroblast growth factor 16,39657,0.0212550178278702,0.00489462753614277,0.0116615478570303,0.03084848779871,1.42112271300094e-05
NMR metabolomics,X23408.Triglycerides in VLDL,THBS2,Thrombospondin-2,42137,0.017583704296414,0.00406458113998641,0.00961712526204061,0.0255502833307873,1.52873814201449e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX1,Heme oxygenase 1,42007,-0.0224300925767558,0.00518517271032984,-0.0325930310890023,-0.0122671540645093,1.53068966825924e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.109811189961804,0.0253955679154354,0.0600358768475506,0.159586503076058,1.54514782913122e-05
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.017547111696321,0.00406104136329037,-0.0255067527683701,-0.00958747062427186,1.56533528211795e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.011971047823292,0.00277531501205706,0.00653143039966019,0.0174106652469238,1.62116362896918e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0389537173457152,0.00904213359642481,0.0212311354967226,0.0566762991947079,1.65908301906288e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0235537647327354,0.00547403009917147,0.0128246657383593,0.0342828637271114,1.70054539959918e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0156488361743401,0.00363807047892714,0.00851821803564295,0.0227794543130373,1.70905425681177e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX2,Peroxiredoxin-2,39819,0.0273406830630358,0.00635818254653991,0.0148786452718175,0.039802720854254,1.72181163919132e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0235669185018657,0.00549170352229817,0.0128031795981613,0.0343306574055701,1.7883744726518e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB6,Heat shock protein beta-6,42262,0.0183459923821781,0.00427789334392841,0.00996132142807842,0.0267306633362778,1.81072152269116e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0238879440588198,0.00557434207517098,-0.0348136545261549,-0.0129622335914847,1.83722198538667e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0171774418639371,0.00401431467759863,0.00930938509584379,0.0250454986320304,1.88984576074446e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL2,Fc receptor-like protein 2,42229,0.0225384613316932,0.00526727438676536,0.0122146035336331,0.0328623191297534,1.89049447990711e-05
NMR metabolomics,X23408.Triglycerides in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0391392106875994,0.00918942741403394,0.0211279329560928,0.0571504884191059,2.06909451104478e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BAX,Apoptosis regulator BAX,41814,0.0411161114752416,0.00966170553532177,0.0221791686260109,0.0600530543244722,2.09950192707433e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0225947288498258,0.00531250873572763,0.0121822117277996,0.033007245971852,2.12506186272246e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CA12,Carbonic anhydrase 12,42070,-0.0146372373751659,0.00344208845614062,-0.0213837307492015,-0.00789074400113026,2.12890282747926e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EDN1,Endothelin-1,39638,0.0131392563459146,0.00309499057994505,0.00707307480922234,0.0192054378826069,2.20057934173317e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0167446618025487,0.00395099705477226,0.00900070757519507,0.0244886160299023,2.27270579862777e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ANPEP,Aminopeptidase N,42187,0.012088491097125,0.00286883869209266,0.00646556726062343,0.0177114149336267,2.52817440867536e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0119091675998252,0.00282721090698097,0.00636783422214247,0.0174505009775079,2.54384907079546e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RAB44,Ras-related protein Rab-44,39919,0.0198827552640656,0.00472447237688523,0.0106227894053706,0.0291427211227607,2.5910075225966e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLASP1,CLIP-associating protein 1,39560,0.0332716029811598,0.00791293847991214,0.017762243560532,0.0487809624017876,2.63495030939231e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NRTN,Neurturin,41913,0.0218416514161401,0.00521482341552764,0.0116205975217059,0.0320627053105742,2.82764731758115e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0132991968271003,0.00317972598177084,0.00706693390282948,0.0195314597513712,2.9018112666541e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00807551681794071,0.00193213079902972,0.00428854045184246,0.011862493184039,2.9421734937304e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0137701329093989,0.00329718715474371,-0.0202326197326965,-0.0073076460861012,2.98543614232386e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CRH,Corticoliberin,41830,0.0376631078151744,0.00902816185246746,0.0199679105843381,0.0553583050460106,3.0421726981956e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.019020992367793,0.00456534159331622,0.0100729228448932,0.0279690618906928,3.11750381558424e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD99,CD99 antigen,42137,-0.0086971556489698,0.00209733235997152,-0.012807927074514,-0.00458638422342563,3.39253852201255e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0146160658708488,0.00352603473591302,0.00770503778845932,0.0215270939532384,3.4201074374987e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EGFLAM,Pikachurin,39930,0.0134283128232945,0.00325426474214311,0.007049953928694,0.019806671717895,3.71163832273683e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ERC2,ERC protein 2,39649,0.0320115375526191,0.00776758355740282,0.0167870737801096,0.0472360013251287,3.79703549114647e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE1,Ribonuclease pancreatic,39990,0.0107201322157243,0.00260147312398379,0.00562124489271607,0.0158190195387325,3.80242944083405e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0324750189377473,0.00788278219968498,0.0170247658263647,0.0479252720491298,3.82042284569073e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0124576008313136,0.00302826716870997,0.00652219718064209,0.0183930044819852,3.91990740346156e-05
NMR metabolomics,X23408.Triglycerides in VLDL,OLFM4,Olfactomedin-4,39347,0.0536704470651252,0.0130551619132559,0.0280823297151435,0.0792585644151068,3.96789204914465e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0246238401008693,0.00599041719520104,0.0128826223982753,0.0363650578034634,3.97116999042241e-05
NMR metabolomics,X23408.Triglycerides in VLDL,APOBR,Apolipoprotein B receptor,39638,-0.0185634213652076,0.00452375279290053,-0.0274299768392927,-0.00969686589112257,4.09792707187898e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP1,Dipeptidase 1,41997,-0.0197675556997879,0.00483377029421143,-0.0292417454764423,-0.0102933659231335,4.34887433544925e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0108838506098865,0.00266785870709672,-0.0161128536757961,-0.00565484754397697,4.53645143281047e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL3,Follistatin-related protein 3,42084,0.0140123335286922,0.00344425003969284,0.00726160345089419,0.0207630636064901,4.76215409752105e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00784802050079569,0.00193277196496822,0.00405978744945798,0.0116362535521334,4.92957479395282e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0167229312881708,0.00412280969932173,0.00864222427750022,0.0248036382988414,5.02121241028077e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0158691322610246,0.00391272776549461,-0.0235380786813941,-0.00820018584065517,5.03144832753041e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0184221512479477,0.00454413991736921,0.00951563700990407,0.0273286654859914,5.06193234773391e-05
NMR metabolomics,X23408.Triglycerides in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0349045687071506,0.00865208822091058,0.0179464757941658,0.0518626616201353,5.51488797331284e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0222842251412335,0.00553378753362989,0.0114380015753189,0.0331304487071481,5.687511091499e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD55,Complement decay-accelerating factor,41714,0.0111565815536598,0.00277446795886124,0.00571862435429174,0.0165945387530278,5.82363499405833e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0176969450550555,0.00440165087115174,-0.0263241807625129,-0.00906970934759811,5.84515263032757e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0125008881114259,0.00311948932933097,-0.0186150871969146,-0.00638668902593721,6.17304278999773e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0438833731594393,0.0109510307179077,0.0224193529523402,0.0653473933665384,6.18263342937163e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0299952602385306,0.00748777836410944,-0.0446713058321851,-0.0153192146448761,6.21777101401713e-05
NMR metabolomics,X23408.Triglycerides in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0163536171590547,0.00408370081245748,0.008349563566638,0.0243576707514713,6.25276404933765e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2,Ataxin-2,39586,0.0446502399935483,0.0111625535306421,0.0227716350734899,0.0665288449136068,6.37570073980903e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CCL21,C-C motif chemokine 21,42185,0.0161042671260096,0.00402719835053986,0.00821095835895145,0.0239975758930677,6.39808043760974e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0188850482607659,0.00472307072588288,-0.0281422668834964,-0.00962782963803548,6.40894141718597e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0127882122432569,0.0032032460053955,-0.0190665744138321,-0.00650985007268174,6.5863964294692e-05
NMR metabolomics,X23408.Triglycerides in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0236657186255604,0.00593549948573211,0.0120321396335255,0.0352992976175954,6.72919232496906e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH17,Protocadherin-17,42145,0.0156580225501717,0.00394019726071076,0.00793523591917862,0.0233808091811648,7.1066237944552e-05
NMR metabolomics,X23408.Triglycerides in VLDL,VWF,von Willebrand factor,42310,-0.0309299196569815,0.00778851907309849,-0.0461954170402546,-0.0156644222737085,7.18708488085113e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PRG3,Proteoglycan 3,39966,-0.0208008864563075,0.00523940278310183,-0.0310701159111871,-0.0105316570014279,7.22886292220034e-05
NMR metabolomics,X23408.Triglycerides in VLDL,THY1,Thy-1 membrane glycoprotein,42249,0.0122063485628958,0.00307505545525719,0.00617923987059169,0.0182334572551999,7.24008126087312e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0222045726845746,0.00559960304868792,0.0112293507091463,0.0331797946600029,7.3655043580278e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA1,Annexin A1,39699,0.0185410893801203,0.00467756542073987,0.00937306115547013,0.0277091176047704,7.42180381396626e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0153519299484966,0.00387960796615919,0.0077478983348246,0.0229559615621686,7.6264376071436e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.021841316151598,0.00551944205056428,0.011023209732492,0.032659422570704,7.63168430648707e-05
NMR metabolomics,X23408.Triglycerides in VLDL,S100G,Protein S100-G,39934,-0.0203410994717608,0.00514827027619664,-0.0304317092131063,-0.0102504897304154,7.82791215831016e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00922049441349846,0.00233479066298654,0.00464430471404485,0.0137966841129521,7.88188871197536e-05
NMR metabolomics,X23408.Triglycerides in VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.0165581964787112,0.00419705504129888,0.00833196859776536,0.024784424359657,8.02232804532415e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.0267678697379468,0.00678894230638252,0.013461542817437,0.0400741966584565,8.10110968569947e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0233542250548229,0.00593426496199586,0.011723065729311,0.0349853843803348,8.34436165947579e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GZMB,Granzyme B,42119,0.0280867270243812,0.00714140662166691,0.014089570045914,0.0420838840028483,8.43320306840691e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ECM1,Extracellular matrix protein 1,39720,0.0150806330255842,0.00384047542738189,0.00755330118791575,0.0226079648632528,8.66168414022073e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0432532744763899,0.0110618770229032,0.0215719955114995,0.0649345534412802,9.27040694224676e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BCAM,Basal cell adhesion molecule,42137,-0.010087624009102,0.00258344231998419,-0.015151170956271,-0.005024077061933,9.47915314188095e-05
NMR metabolomics,X23408.Triglycerides in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0293540104307667,0.00751942962109116,0.014615928373428,0.0440920924881054,9.52750232403833e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0426221181135504,0.0109296011838414,0.0212000997932213,0.0640441364338795,9.68837271405657e-05
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0182985746855567,0.00469689500878567,0.00909266046833684,0.0275044889027767,9.84111290090658e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0247945393868725,0.00639220564766809,-0.037323262456302,-0.0122658163174431,0.000105532900813231
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0298286316918092,0.00769851507631679,0.0147395421422283,0.0449177212413902,0.000107402703400183
NMR metabolomics,X23408.Triglycerides in VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0106263123335555,0.00274658253702396,-0.0160096141061225,-0.00524301056098854,0.000109950826530384
NMR metabolomics,X23408.Triglycerides in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0233252186828698,0.00603232169763016,0.0115018681555147,0.0351485692102249,0.000110941102556666
NMR metabolomics,X23408.Triglycerides in VLDL,CD27,CD27 antigen,42181,-0.0173603385347129,0.00449289709674097,-0.0261664168443252,-0.00855426022510061,0.000112085808382945
NMR metabolomics,X23408.Triglycerides in VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.0117688242183711,0.00304703429319799,0.00579663700370299,0.0177410114330391,0.000112805739830798
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0186966205406074,0.00486065180139172,0.00916974300987962,0.0282234980713352,0.000120482478459251
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0363284079525977,0.00945421965475386,0.0177981374292802,0.0548586784759153,0.000122312421352282
NMR metabolomics,X23408.Triglycerides in VLDL,KLK8,Kallikrein-8,41668,0.01480024244229,0.00385942021230315,0.00723577882617584,0.0223647060584042,0.000126238213196879
NMR metabolomics,X23408.Triglycerides in VLDL,SNX18,Sorting nexin-18,39930,0.0176395294341028,0.00460534667770431,0.00861304994580233,0.0266660089224032,0.000128714753155562
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0231461614316392,0.00604738560534558,0.0112932856451619,0.0349990372181165,0.000130189179952568
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.0185273118256709,0.00484187676941221,0.00903723335762298,0.0280173902937188,0.000130576277952205
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0249596533190686,0.00653199525976108,0.0121569426099369,0.0377623640282004,0.000133548060186144
NMR metabolomics,X23408.Triglycerides in VLDL,LIF,Leukemia inhibitory factor,41839,0.0201022450220744,0.00527188354708908,0.00976935326977975,0.030435136774369,0.000137854344582439
NMR metabolomics,X23408.Triglycerides in VLDL,CENPJ,Centromere protein J,39757,0.0281925312934687,0.00739818918111114,0.0136920804984909,0.0426929820884465,0.000139299045614003
NMR metabolomics,X23408.Triglycerides in VLDL,YAP1,Transcriptional coactivator YAP1,39929,0.0110628219909632,0.00290517705024582,0.00536867497248145,0.0167569690094451,0.000140852421664313
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0116220509876302,0.0030575921234828,0.0056291704256039,0.0176149315496565,0.00014473188481255
NMR metabolomics,X23408.Triglycerides in VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0332657443397259,0.00880051031167008,0.0160167441288525,0.0505147445505992,0.000157511124106398
NMR metabolomics,X23408.Triglycerides in VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0142450186800215,0.00377652764973782,-0.0216470128735076,-0.00684302448653536,0.000162797008246336
NMR metabolomics,X23408.Triglycerides in VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.0143421142705373,0.00380475398833642,0.0068847964533979,0.0217994320876767,0.000164268956504213
NMR metabolomics,X23408.Triglycerides in VLDL,MTPN,Myotrophin,41900,0.0128436599814463,0.00341713812946308,0.00614606924769869,0.019541250715194,0.000171596596755471
NMR metabolomics,X23408.Triglycerides in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.00945923225461026,0.00252322573861999,0.00451370980691508,0.0144047547023054,0.000178371910395813
NMR metabolomics,X23408.Triglycerides in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0117520664724254,0.00313557039946696,0.00560634848947018,0.0178977844553806,0.000179019472276309
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.030894906898692,0.00824270525680354,-0.047050609202027,-0.0147392045953571,0.000179027689904574
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0192076574096785,0.00513588077861272,-0.0292739837357595,-0.00914133108359761,0.000184853635175227
NMR metabolomics,X23408.Triglycerides in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0174365884014572,0.00466560492595513,0.00829200274658514,0.0265811740563292,0.000186971998149343
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0138548044649595,0.00370804929496581,-0.0211225810830924,-0.00658702784682646,0.000187425958276584
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB2,Lamin-B2,39929,0.0112616988112851,0.00301954105628965,0.00534339834095739,0.0171799992816128,0.000192714792898516
NMR metabolomics,X23408.Triglycerides in VLDL,SPON1,Spondin-1,42144,0.0127912550797921,0.00343266667342127,0.00606322839988637,0.0195192817596977,0.000195076481092941
NMR metabolomics,X23408.Triglycerides in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0140500038129631,0.00377225026189762,-0.0214436143262824,-0.00665639329964374,0.000196439473758304
NMR metabolomics,X23408.Triglycerides in VLDL,CLMP,CXADR-like membrane protein,42262,0.00864855044352822,0.00232811852621391,0.00408543813214896,0.0132116627549075,0.000204155302989829
NMR metabolomics,X23408.Triglycerides in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0237212759430301,0.00640983711574623,0.0111579951961675,0.0362845566898927,0.000215820974042413
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB1A1,Uteroglobin,42165,0.0208605259021887,0.00563833111244773,0.00980939692179116,0.0319116548825862,0.000216648025608048
NMR metabolomics,X23408.Triglycerides in VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.0130581596334267,0.00353347295039193,0.00613255265065857,0.0199837666161949,0.000220434338336457
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.0127422968392039,0.00344976092445273,0.00598076542727652,0.0195038282511312,0.000221914906018612
NMR metabolomics,X23408.Triglycerides in VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0165810550819229,0.0044944370897048,-0.0253901517777443,-0.00777195838610152,0.000226012523166182
NMR metabolomics,X23408.Triglycerides in VLDL,GUCA2A,Guanylin,42083,-0.013602120474231,0.00370538085424302,-0.0208646669485473,-0.00633957399991471,0.000242621208029175
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.00945592755690198,0.0025796411538178,0.00439983089541909,0.0145120242183849,0.000247884093738606
NMR metabolomics,X23408.Triglycerides in VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0131213105496794,0.00358833641026943,-0.0201544499138075,-0.00608817118555131,0.00025651182144706
NMR metabolomics,X23408.Triglycerides in VLDL,RCC1,Regulator of chromosome condensation,39919,0.0200566212443805,0.00548925051943143,0.00929769022629494,0.0308155522624661,0.000259555749157448
NMR metabolomics,X23408.Triglycerides in VLDL,DNPEP,Aspartyl aminopeptidase,39929,0.0216526118572588,0.0059935879264921,0.00990517952133426,0.0334000441931833,0.000304419461694839
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB1,Lamin-B1,39908,0.0232141057221943,0.00643365256587854,0.0106041466930723,0.0358240647513162,0.000309622242766119
NMR metabolomics,X23408.Triglycerides in VLDL,CD300E,CMRF35-like molecule 2,42232,0.0157982732734468,0.00439536983890571,0.00718334838919162,0.024413198157702,0.000326413587838699
NMR metabolomics,X23408.Triglycerides in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0243349557127245,0.00677279288766727,0.0110602816528966,0.0376096297725523,0.000328216303694977
NMR metabolomics,X23408.Triglycerides in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0289753674186251,0.00806533940367065,0.0131673021874306,0.0447834326498195,0.000328845864975559
NMR metabolomics,X23408.Triglycerides in VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0179580523260315,0.00500089320441271,0.00815630164538261,0.0277598030066804,0.000330889785375834
NMR metabolomics,X23408.Triglycerides in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0111672079891677,0.00311082210856279,0.0050699966563846,0.0172644193219507,0.000332373368003737
NMR metabolomics,X23408.Triglycerides in VLDL,CPA4,Carboxypeptidase A4,39518,0.0165639366752084,0.00462900739207617,0.00749108218673913,0.0256367911636777,0.00034734638073289
NMR metabolomics,X23408.Triglycerides in VLDL,CST7,Cystatin-F,42148,0.035432205534425,0.00993645267388592,0.0159567582936085,0.0549076527752414,0.000363885702365539
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0135786403490732,0.00382178534096285,0.00608794108078601,0.0210693396173604,0.000382513090295005
NMR metabolomics,X23408.Triglycerides in VLDL,NTF3,Neurotrophin-3,42119,0.0128395742645774,0.00362433642930467,0.00573587486314029,0.0199432736660146,0.000397538114637334
NMR metabolomics,X23408.Triglycerides in VLDL,FGA,Fibrinogen alpha chain,39735,0.0116073517413238,0.00327748129770483,0.00518348839782233,0.0180312150848253,0.000399414871884106
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0151689240917082,0.00428716440820685,-0.0235717663317936,-0.00676608185162278,0.000404195563950189
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN2,Prefoldin subunit 2,41839,0.0205489014902011,0.00581097556452536,0.00915938938373143,0.0319384135966708,0.000407280138931082
NMR metabolomics,X23408.Triglycerides in VLDL,ARG1,Arginase-1,42015,0.0187594904674773,0.00531848494549976,0.0083352599742978,0.0291837209606569,0.000421343429583248
NMR metabolomics,X23408.Triglycerides in VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.00980566225996431,0.00278110771774555,-0.0152566333867456,-0.00435469113318304,0.000423908778189894
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.027802579523176,0.00788563248242496,0.0123467398576231,0.043258419188729,0.00042398772733155
NMR metabolomics,X23408.Triglycerides in VLDL,ALPP,"Alkaline phosphatase, placental type",42070,0.0386196655127334,0.0109612545194895,0.017135606654534,0.0601037243709329,0.000427638803256321
NMR metabolomics,X23408.Triglycerides in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0100204253661384,0.00285583900204805,0.00442298092212421,0.0156178698101526,0.000451963692901438
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0124654427420548,0.00355696484824879,0.00549379163948717,0.0194370938446224,0.000458921191310067
NMR metabolomics,X23408.Triglycerides in VLDL,CALB1,Calbindin,42070,0.0166776874552043,0.00475953198254391,0.00734900476941824,0.0260063701409904,0.000459708924061114
NMR metabolomics,X23408.Triglycerides in VLDL,B2M,Beta-2-microglobulin,39979,0.0112156599721619,0.00320519010151682,0.00493348737318895,0.0174978325711349,0.000468408522867675
NMR metabolomics,X23408.Triglycerides in VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0134723955766426,0.00385157436539471,-0.0210214813328162,-0.00592330982046895,0.000470453803614992
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO4,Roundabout homolog 4,39638,-0.00671876108913946,0.00192200257851797,-0.0104858861430347,-0.00295163603524423,0.000474661380524631
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.022672407242756,0.00649238807204817,0.00994732662154159,0.0353974878639704,0.000481033060022334
NMR metabolomics,X23408.Triglycerides in VLDL,MILR1,Allergin-1,41913,-0.0187992905922961,0.00538371326909239,-0.0293513685997172,-0.00824721258487506,0.000481185384506019
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0184769134996169,0.0052964699716332,0.00809583235521582,0.0288579946440179,0.000487255529535028
NMR metabolomics,X23408.Triglycerides in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0133590900419742,0.00383040388892642,0.00585149841967846,0.02086668166427,0.000489146010706463
NMR metabolomics,X23408.Triglycerides in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0265068607266898,0.00761207037287901,-0.0414265186575326,-0.0115872027958469,0.00049916071077843
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.0114950451024007,0.00330629876920378,0.00501469951476128,0.0179753906900401,0.000509506994594004
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0134507722010911,0.00387027483219987,0.00586503352997938,0.0210365108722029,0.000512025599646713
NMR metabolomics,X23408.Triglycerides in VLDL,HCG22,Protein PBMUCL2,39575,-0.0212506746035525,0.00611568775779582,-0.0332374226088323,-0.0092639265982727,0.000513245515722917
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0161900713943114,0.0046700758975688,0.00703672263507655,0.0253434201535463,0.000528390490564353
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.00562415548435477,0.00162331435668277,0.00244245934525655,0.00880585162345299,0.000532952070053573
NMR metabolomics,X23408.Triglycerides in VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0306145017947642,0.00883659628388313,0.0132947730783533,0.0479342305111751,0.000533219681553755
NMR metabolomics,X23408.Triglycerides in VLDL,CD59,CD59 glycoprotein,41638,0.00859615016844488,0.00248279154524362,0.00372987873976738,0.0134624215971224,0.000537312741992464
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI1,Neuroserpin,39713,0.0105463323006131,0.00304748651861563,0.0045732587241265,0.0165194058770998,0.000540865617907022
NMR metabolomics,X23408.Triglycerides in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0148329976758878,0.00430833499327401,0.00638866108907074,0.0232773342627049,0.000577345137801399
NMR metabolomics,X23408.Triglycerides in VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.0111987017845512,0.00325989437658685,0.00480930880644098,0.0175880947626614,0.000594081577142333
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN10,Ataxin-10,41839,0.0264939073579244,0.0077247613770293,0.011353375058947,0.0416344396569019,0.000606006567878727
NMR metabolomics,X23408.Triglycerides in VLDL,SHISA5,Protein shisa-5,39966,0.00935810799848487,0.00273370181672156,0.00400005243771063,0.0147161635592591,0.000620984594761005
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0155698679987602,0.00455281063053982,-0.0244933768346183,-0.00664635916290219,0.000628439545201975
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE6,Ribonuclease K6,39937,0.0116027040363333,0.00339739839603047,0.00494380318011362,0.0182616048925531,0.000639648899643137
NMR metabolomics,X23408.Triglycerides in VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0223138898653841,0.00653469665864359,-0.0351218953163256,-0.00950588441444269,0.00064044850093993
NMR metabolomics,X23408.Triglycerides in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0204173977968266,0.00598412392501676,0.00868851490379371,0.0321462806898594,0.000647383014403818
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.00532191914148828,0.00156612177913959,-0.00839151782860188,-0.00225232045437468,0.000680759646917712
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM25,Transmembrane protein 25,39934,-0.0167480189066661,0.00493309459631371,-0.026416884315441,-0.00707915349789127,0.00068855688480032
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_DRA,,42060,-0.012984546509879,0.00383074255644992,-0.0204928019205208,-0.00547629109923711,0.000702048395179079
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G1B,Phospholipase A2,42299,-0.0158543092771934,0.00468743565360625,-0.0250416831582617,-0.00666693539612518,0.000720829538248538
NMR metabolomics,X23408.Triglycerides in VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.0129899138332967,0.0038432713574813,0.00545710197263335,0.0205227256939601,0.000727623527993477
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.015084327954615,0.00448130370117358,0.00630097270031483,0.0238676832089153,0.000765123092964945
NMR metabolomics,X23408.Triglycerides in VLDL,GZMH,Granzyme H,41900,0.0278181703865048,0.00827701644681093,0.0115952181507554,0.0440411226222542,0.000779094628576087
NMR metabolomics,X23408.Triglycerides in VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0156949771654947,0.00467521998956506,0.00653154598594715,0.0248584083450422,0.000790446575360318
NMR metabolomics,X23408.Triglycerides in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0236209860316384,0.00704009207994411,0.00982240555494789,0.0374195665083288,0.000795276521168456
NMR metabolomics,X23408.Triglycerides in VLDL,NDRG1,Protein NDRG1,41839,0.0232821298353816,0.00695302714559422,0.00965419663001694,0.0369100630407463,0.000814803443705495
NMR metabolomics,X23408.Triglycerides in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.0068243346890714,0.00203940212665877,-0.0108215628573226,-0.00282710652082022,0.000821798208873793
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA11,Serpin A11,42310,-0.0147019979967122,0.00439431779853555,-0.0233148608818419,-0.00608913511158257,0.000823003013640352
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0162064699082012,0.0048598806784594,0.00668110377842079,0.0257318360379816,0.000856515410869526
NMR metabolomics,X23408.Triglycerides in VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.0221604112045526,0.00665670041321249,-0.0352075440144491,-0.00911327839465614,0.000874333969947224
NMR metabolomics,X23408.Triglycerides in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0124472349079126,0.00375118503827731,0.00509491223288908,0.0197995575829361,0.000908382142663196
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK2,Protein AHNAK2,39638,0.0108905600159565,0.00328201479364747,0.00445781102040749,0.0173233090115056,0.000908749842529845
NMR metabolomics,X23408.Triglycerides in VLDL,IL18BP,Interleukin-18-binding protein,42217,0.0109388190931026,0.00330155642399796,0.00446776850206656,0.0174098696841386,0.00092465223625587
NMR metabolomics,X23408.Triglycerides in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0148707514766827,0.00448840515932653,0.00607347736440269,0.0236680255889627,0.000924940032661503
NMR metabolomics,X23408.Triglycerides in VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0365060150455849,0.011017992569692,0.0149107496089886,0.0581012804821812,0.000924951397045765
NMR metabolomics,X23408.Triglycerides in VLDL,FABP3,"Fatty acid-binding protein, heart",39958,0.0189775047383457,0.00572910220020665,0.0077484644259407,0.0302065450507508,0.000927634210366225
NMR metabolomics,X23408.Triglycerides in VLDL,LCP1,Plastin-2,39966,0.0166847105328998,0.00504470886891777,0.00679708114982096,0.0265723399159786,0.000944692485587423
NMR metabolomics,X23408.Triglycerides in VLDL,MB,Myoglobin,42310,-0.0194954511947852,0.00590162843769006,-0.0310626429326577,-0.0079282594569127,0.000957639884756028
NMR metabolomics,X23408.Triglycerides in VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.0269930670563123,0.00818799008959597,0.0109446064807042,0.0430415276319204,0.000981408249107414
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0167232317660185,0.00511387401107312,0.00670003870431522,0.0267464248277219,0.0010775663359421
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L15,Bcl-2-like protein 15,39657,0.0194765493964391,0.00596180208379325,0.00779141731220431,0.0311616814806738,0.00109067512875866
NMR metabolomics,X23408.Triglycerides in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00978500688546866,0.00299526827893963,0.003914281058747,0.0156557327121903,0.00109084707158758
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0133126475375714,0.00408806971641867,0.00530003089339077,0.021325264181752,0.00113093428893377
NMR metabolomics,X23408.Triglycerides in VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.023084210767509,0.00709876181100983,0.00917063761792976,0.0369977839170883,0.0011498825825487
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD1,Leiomodin-1,39934,-0.0118578814384956,0.00365204536075414,-0.0190158903455737,-0.00469987253141753,0.00117002295460106
NMR metabolomics,X23408.Triglycerides in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0176966363459272,0.00546643118120649,0.00698243123076244,0.0284108414610919,0.00121012985247959
NMR metabolomics,X23408.Triglycerides in VLDL,REN,Renin,42145,-0.0276160955401336,0.0085379282953184,-0.0443504349989577,-0.0108817560813096,0.00122139787574052
NMR metabolomics,X23408.Triglycerides in VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.0437104597179721,0.0135240192835304,-0.0702175375136916,-0.0172033819222526,0.00123192321119044
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.029390535994689,0.00909843488303507,0.0115576036239402,0.0472234683654377,0.00124028539799494
NMR metabolomics,X23408.Triglycerides in VLDL,APOA4,Apolipoprotein A-IV,39979,0.0117017208756966,0.00362326438452313,0.00460012268203125,0.0188033190693619,0.00124312284947768
NMR metabolomics,X23408.Triglycerides in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0189243644095641,0.00586031211107551,0.00743815267185611,0.0304105761472721,0.00124472694508061
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0112631491189173,0.00350251810587107,-0.0181280846064246,-0.00439821363140999,0.00130490186939903
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L2,Seizure 6-like protein 2,42070,-0.00816527097475676,0.00254486985913767,-0.0131532158986666,-0.00317732605084693,0.00133731367747294
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.00988131855853122,0.00309900551280732,0.00380726775342888,0.0159553693636336,0.00143316522109438
NMR metabolomics,X23408.Triglycerides in VLDL,GUK1,Guanylate kinase,39575,-0.0134994508427226,0.00423846633775646,-0.0218068448647253,-0.00519205682071997,0.00145166383669401
NMR metabolomics,X23408.Triglycerides in VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0122706831155984,0.00386285546874968,0.00469948639684903,0.0198418798343478,0.00149355802589438
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN2,Neuroligin-2,39586,-0.0156390436131448,0.00492443693686446,-0.0252909400093991,-0.00598714721689042,0.00149835139905611
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0119330817880067,0.00376574191288272,0.00455222763875652,0.0193139359372568,0.00153382338224689
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1,Programmed cell death protein 1,42232,0.0139459476295811,0.00441151181955664,0.00529938446325007,0.0225925107959121,0.00157430735502172
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0184489082145911,0.00583841036144301,0.00700562390616279,0.0298921925230194,0.00158234205183126
NMR metabolomics,X23408.Triglycerides in VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.00940779485338756,0.00298500547413824,0.00355718412407662,0.0152584055826985,0.00162691616072982
NMR metabolomics,X23408.Triglycerides in VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.0139040672495301,0.00442986924243721,0.0052215235343532,0.0225866109647071,0.0017014449955529
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY2,Protein canopy homolog 2,41900,0.0200272570387178,0.00640490034029613,0.00747365237173742,0.0325808617056982,0.00177062083061458
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0262340689358914,0.00840743490938301,-0.0427126413582821,-0.00975549651350073,0.00181110438165283
NMR metabolomics,X23408.Triglycerides in VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0152853223019281,0.00490368335566781,-0.024896541679037,-0.00567410292481916,0.00183104918393121
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0133719325682412,0.00429629839190931,0.00495118772009896,0.0217926774163835,0.00186012612881259
NMR metabolomics,X23408.Triglycerides in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0202414621846826,0.00652838037299323,-0.0330370877157493,-0.00744583665361589,0.00193661145568462
NMR metabolomics,X23408.Triglycerides in VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0121974223809073,0.00394491199131593,-0.0199294498838866,-0.00446539487792812,0.00199352607208899
NMR metabolomics,X23408.Triglycerides in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0131457435276325,0.00426882139201757,-0.021512633455987,-0.00477885359927809,0.00207875627884791
NMR metabolomics,X23408.Triglycerides in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0163543847083424,0.00532269806300958,0.00592189650484365,0.0267868729118412,0.00212737552032223
NMR metabolomics,X23408.Triglycerides in VLDL,OPTC,Opticin,42070,-0.0146448074946796,0.00477403577044126,-0.0240019176047445,-0.00528769738461472,0.0021621714486941
NMR metabolomics,X23408.Triglycerides in VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.00956329065783606,0.00312363470535235,0.00344096663534545,0.0156856146803267,0.00220594531973186
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0101245952844441,0.00331232009179126,0.00363244790453324,0.016616742664355,0.00224271193341054
NMR metabolomics,X23408.Triglycerides in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0180103675035217,0.00589354058216952,0.00645902796246942,0.0295617070445739,0.00224870401837842
NMR metabolomics,X23408.Triglycerides in VLDL,PI3,Elafin,41966,0.0180508763214096,0.0059135302645735,0.00646035700284556,0.0296413956399737,0.00227411796817043
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00964001567875145,0.003159319423431,-0.0158322817486762,-0.00344774960882668,0.00228292168144705
NMR metabolomics,X23408.Triglycerides in VLDL,RPS10,40S ribosomal protein S10,39575,-0.0133954280228307,0.00439705797469408,-0.0220136616532311,-0.00477719439243031,0.00232108979248861
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX1,Neuronal pentraxin-1,42137,0.0133745197807942,0.00439562713751039,0.00475909059127388,0.0219899489703146,0.00234925012940734
NMR metabolomics,X23408.Triglycerides in VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,0.00908238418240071,0.00298566742833986,0.00323047602285458,0.0149342923419468,0.00235462472903997
NMR metabolomics,X23408.Triglycerides in VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.0237601513446507,0.00781783360039225,0.00843719748788191,0.0390831052014195,0.00237650727046232
NMR metabolomics,X23408.Triglycerides in VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00925842802229795,0.00306182295453688,-0.0152596010131902,-0.00325725503140567,0.00250170232339083
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0127715092326197,0.00422754608529333,-0.0210574995597946,-0.00448551890544473,0.00252483740885807
NMR metabolomics,X23408.Triglycerides in VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,0.0395757301569268,0.0132011068741191,0.0137015606836534,0.0654498996302001,0.0027244213246516
NMR metabolomics,X23408.Triglycerides in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00656234586394234,0.00219255166176868,-0.010859747121009,-0.00226494460687572,0.00276848623381416
NMR metabolomics,X23408.Triglycerides in VLDL,DLL4,Delta-like protein 4,39638,0.0277529279496628,0.00929210675595313,0.00954039870799469,0.0459654571913309,0.00282606491016625
NMR metabolomics,X23408.Triglycerides in VLDL,CASP1,Caspase-1,41839,0.0216666065692167,0.0072566204132387,0.00744363055926886,0.0358895825791645,0.00283381712078592
NMR metabolomics,X23408.Triglycerides in VLDL,OGN,Mimecan,42137,0.0135816933174424,0.00455228899635468,0.00465920688458718,0.0225041797502975,0.00285492775777879
NMR metabolomics,X23408.Triglycerides in VLDL,IL17A,Interleukin-17A,41877,-0.0134247900941357,0.00451684238728206,-0.0222778011732085,-0.00457177901506286,0.0029624034968415
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH3,Neurexophilin-3,39657,0.00939125192980704,0.00315985014344892,0.00319794564864716,0.0155845582109669,0.00296449630406381
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00942245058628556,0.00317490905372157,0.00319962884099129,0.0156452723315798,0.00300596120756295
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1,DNA topoisomerase 1,39930,0.0376644697985038,0.0127036146345358,0.0127653851148137,0.0625635544821939,0.00303449089984935
NMR metabolomics,X23408.Triglycerides in VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0134411244643397,0.00453460236160677,0.00455330383559038,0.0223289450930889,0.00304193104618256
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.015996675144944,0.00539906736449395,-0.0265788471793521,-0.00541450311053585,0.0030533100553355
NMR metabolomics,X23408.Triglycerides in VLDL,IL36G,Interleukin-36 gamma,39624,0.0209431300765455,0.00707572052409606,0.00707471784931725,0.0348115423037738,0.00308435456515267
NMR metabolomics,X23408.Triglycerides in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.0074572463196939,0.0025203539616018,0.00251735255495438,0.0123971400844334,0.00309369519209832
NMR metabolomics,X23408.Triglycerides in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0113164965870869,0.00382499955933478,0.00381949745079078,0.0188134957233831,0.00309733152273922
NMR metabolomics,X23408.Triglycerides in VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0119178125444902,0.00403125930931281,0.0040165442982371,0.0198190807907433,0.00311852965399179
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,0.0148343137918926,0.00502851290918987,0.00497842848988045,0.0246901990939047,0.00318278243328348
NMR metabolomics,X23408.Triglycerides in VLDL,IDS,Iduronate 2-sulfatase,42296,0.002854327573961,0.000968088011630485,0.00095687507116525,0.00475178007675675,0.00319944749658373
NMR metabolomics,X23408.Triglycerides in VLDL,STX5,Syntaxin-5,39657,0.0122839350632747,0.00418855390072774,0.00407436941784838,0.0204935007087011,0.00336675556482023
NMR metabolomics,X23408.Triglycerides in VLDL,EXTL1,Exostosin-like 1,39575,0.014688974282368,0.00501245503741838,0.00486456240902797,0.024513386155708,0.00339119977314294
NMR metabolomics,X23408.Triglycerides in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0106598877991608,0.00364011502721033,0.00352526234582857,0.0177945132524931,0.00341229297877988
NMR metabolomics,X23408.Triglycerides in VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0161880384423559,0.00553015575509925,0.00534893316236134,0.0270271437223504,0.00342686302892406
NMR metabolomics,X23408.Triglycerides in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0122959722016513,0.00420685293762301,-0.0205414039593924,-0.0040505404439102,0.00347555019619749
NMR metabolomics,X23408.Triglycerides in VLDL,PRR4,Proline-rich protein 4,39652,-0.021792903784931,0.00747985637911475,-0.0364534222879959,-0.00713238528186608,0.0035806558345265
NMR metabolomics,X23408.Triglycerides in VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.0311538212374034,0.0107163721260419,0.0101497318703613,0.0521579106044455,0.00365499288060111
NMR metabolomics,X23408.Triglycerides in VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0117967788372425,0.00406127503921475,-0.0197568779141034,-0.00383667976038157,0.00368316154321881
NMR metabolomics,X23408.Triglycerides in VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0144685894524092,0.00498368201602658,-0.0242366062038213,-0.00470057270099716,0.00369982209301242
NMR metabolomics,X23408.Triglycerides in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0164103716029288,0.00566495326230537,-0.0275136799970474,-0.00530706320881031,0.00377708803687893
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0196233359332618,0.00682528997456528,0.00624576758311382,0.0330009042834097,0.00404681426249489
NMR metabolomics,X23408.Triglycerides in VLDL,COL3A1,Collagen alpha-1(III) chain,39966,0.00713584882660199,0.0024840793363417,0.00226705332737225,0.0120046443258317,0.00407819913744462
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00874310671260696,0.00304905964097304,0.0027669498162998,0.0147192636089141,0.00414523679801597
NMR metabolomics,X23408.Triglycerides in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00956284491751361,0.00334211497913511,0.00301229955840879,0.0161133902766184,0.00422683653681532
NMR metabolomics,X23408.Triglycerides in VLDL,RYR1,Ryanodine receptor 1,39575,-0.0101705805317544,0.00355555579161645,-0.0171394698833226,-0.00320169118018615,0.00423804670979357
NMR metabolomics,X23408.Triglycerides in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0186815799951363,0.00653146780018835,-0.0314832568835055,-0.00587990310676715,0.00424105308521431
NMR metabolomics,X23408.Triglycerides in VLDL,TMOD4,Tropomodulin-4,39560,-0.0120659873624201,0.00421885711955137,-0.0203349473167408,-0.00379702740809941,0.00424423615296528
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.0133841433021632,0.00468694360087141,0.00419773384445526,0.0225705527598712,0.00430330080005321
NMR metabolomics,X23408.Triglycerides in VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.0186948877759683,0.00655216800938899,0.00585263847756593,0.0315371370743708,0.00433430703209563
NMR metabolomics,X23408.Triglycerides in VLDL,MMP8,Neutrophil collagenase,42224,0.0214642484795268,0.00753307263418174,0.00669942611653056,0.036229070842523,0.0043876389525741
NMR metabolomics,X23408.Triglycerides in VLDL,FCRLB,Fc receptor-like B,41843,0.0184774505462111,0.0064931079081238,0.00575095904628843,0.0312039420461337,0.00443816699636358
NMR metabolomics,X23408.Triglycerides in VLDL,IL17C,Interleukin-17C,41913,-0.0212243037056893,0.00746261259487488,-0.0358510243916441,-0.00659758301973458,0.00446070615811935
NMR metabolomics,X23408.Triglycerides in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0172235413630107,0.00607325701412989,0.00531995761531612,0.0291271251107053,0.00457552565850431
NMR metabolomics,X23408.Triglycerides in VLDL,CD7,T-cell antigen CD7,39636,0.0133591321114588,0.00471474523700125,0.0041182314469364,0.0226000327759813,0.00461278422843261
NMR metabolomics,X23408.Triglycerides in VLDL,TFF3,Trefoil factor 3,42143,-0.0107470988313603,0.0037957113938757,-0.0181866931633567,-0.00330750449936394,0.00464160385463905
NMR metabolomics,X23408.Triglycerides in VLDL,ALCAM,CD166 antigen,42310,0.005843074356956,0.00207088491113016,0.00178413993114089,0.00990200878277111,0.00478631400099972
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0103024645800016,0.00365605795992074,0.00313659097855697,0.0174683381814463,0.00484056219377662
NMR metabolomics,X23408.Triglycerides in VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0183066137849581,0.00651225077197526,-0.0310706252980296,-0.00554260227188662,0.00494427793461119
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00805607957325064,0.00288026535977813,-0.0137013996784158,-0.0024107594680855,0.0051669105606461
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0164239470894877,0.0058851638231477,0.00488902599611821,0.0279588681828572,0.00526788193617665
NMR metabolomics,X23408.Triglycerides in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0139461921102868,0.00500184830648227,-0.023749814790992,-0.00414256942958154,0.00530745349056021
NMR metabolomics,X23408.Triglycerides in VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.00793935051611181,0.00286371375913425,-0.0135522294840149,-0.00232647154820867,0.00557213409480265
NMR metabolomics,X23408.Triglycerides in VLDL,CLPS,Colipase,42115,0.0215089627096635,0.00776456616511278,0.00629041302604241,0.0367275123932845,0.00561080828801207
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00800569512260701,0.00289162573893299,0.00233810867429835,0.0136732815709157,0.00563768926892588
NMR metabolomics,X23408.Triglycerides in VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.00718127095109871,0.00259704139929779,0.00209106980847504,0.0122714720937224,0.00569686082752314
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.0105395091659641,0.00381345453011535,0.00306513828693804,0.0180138800449902,0.00572326111981552
NMR metabolomics,X23408.Triglycerides in VLDL,KLK15,Kallikrein-15,39900,0.0152872178159362,0.00553827103109975,0.00443220659498072,0.0261422290368917,0.00578436832988102
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.00897619418483703,0.00326407100537457,0.00257861501430286,0.0153737733553712,0.00596744380508402
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.0164876691213843,0.00601813802157632,0.00469211859909472,0.0282832196436739,0.00615841410505438
NMR metabolomics,X23408.Triglycerides in VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00876368780075791,0.00320063646224549,0.00249044033475675,0.0150369352667591,0.00618756420768488
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0152472638385962,0.00556852185049035,-0.0261615666655573,-0.00433296101163513,0.00618902685070556
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.010640032839533,0.0038892813843575,0.00301704132619228,0.0182630243528737,0.00623382212796403
NMR metabolomics,X23408.Triglycerides in VLDL,SCGN,Secretagogin,41913,-0.0127713535532113,0.00467648554987372,-0.0219372652309638,-0.00360544187545884,0.00632308739817429
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.0139400021263911,0.00510807255877287,-0.023951824341586,-0.00392817991119631,0.00636061372751317
NMR metabolomics,X23408.Triglycerides in VLDL,ASPN,Asporin,39958,0.00799998724992556,0.00293255875127517,0.00225217209742622,0.0137478024024249,0.00638197372190968
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00781926790599776,0.00286655000273068,-0.0134377059113499,-0.00220082990064562,0.00638634025155615
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB5,Serpin B5,41900,0.0139702190706304,0.00512186063306914,0.00393137222981493,0.024009065911446,0.00638869673863334
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0200948964196462,0.00737382920286669,0.00564219118202746,0.0345476016572649,0.0064351025818674
NMR metabolomics,X23408.Triglycerides in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.0108924460639173,0.00401659812698047,0.00301991373503559,0.018764978392799,0.00669949666382392
NMR metabolomics,X23408.Triglycerides in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0230501295056089,0.00853300438107424,0.00632544091870341,0.0397748180925144,0.00691761986468118
NMR metabolomics,X23408.Triglycerides in VLDL,CDH6,Cadherin-6,42145,-0.0110243129282057,0.00409521261931866,-0.0190509296620703,-0.0029976961943411,0.00711122028755372
NMR metabolomics,X23408.Triglycerides in VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0173674689187107,0.0064522913890036,-0.0300139600411578,-0.00472097779626367,0.00711831275115816
NMR metabolomics,X23408.Triglycerides in VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0164624783576,0.00612145713606702,-0.0284605343442913,-0.00446442237090864,0.00717086169192765
NMR metabolomics,X23408.Triglycerides in VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.026136869483074,0.0097240096872464,0.0070778104960711,0.045195928470077,0.00720179607951242
NMR metabolomics,X23408.Triglycerides in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0206467042309186,0.00769469831216831,0.00556509553906867,0.0357283129227685,0.00730018871282842
NMR metabolomics,X23408.Triglycerides in VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0285861171956857,0.0106582758702505,-0.0494763379013767,-0.0076958964899947,0.00732802346806314
NMR metabolomics,X23408.Triglycerides in VLDL,RBP7,Retinoid-binding protein 7,39930,0.0176088976356298,0.006577482261988,0.00471703240213332,0.0305007628691263,0.00743586448126452
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0166631567289981,0.00622499231749815,-0.0288641416712945,-0.00446217178670172,0.00744150860603917
NMR metabolomics,X23408.Triglycerides in VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.0148488795821784,0.00558567480075535,0.00390095697269786,0.0257968021916588,0.00786279125145042
NMR metabolomics,X23408.Triglycerides in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.00834582071096634,0.00315177286886971,-0.014523295533951,-0.00216834588798171,0.00810686465250524
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.00580095769409511,0.00219626716597125,0.00149627404879147,0.0101056413393988,0.00826886552153608
NMR metabolomics,X23408.Triglycerides in VLDL,DPP7,Dipeptidyl peptidase 2,42054,0.0174068554505487,0.00661558785138298,0.00444030326183803,0.0303734076392593,0.00851839655271175
NMR metabolomics,X23408.Triglycerides in VLDL,ARTN,Artemin,41913,0.0124360001811898,0.00475898613498115,0.00310838735662675,0.0217636130057529,0.0089809719542344
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.0131952228977347,0.00505309855236969,0.00329114973509011,0.0230992960603793,0.00902964076908482
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0161662189471626,0.00619499048539903,0.00402403759578051,0.0283084002985447,0.00907577741256727
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0101149280934345,0.00388718566532042,-0.0177338119974625,-0.00249604418940644,0.00927500264225658
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.0108162944818778,0.00415727587078349,0.00266803377514219,0.0189645551886135,0.00928454702326515
NMR metabolomics,X23408.Triglycerides in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0317129528426296,0.0121932454550119,0.00781419175080629,0.0556117139344529,0.00930925738549869
NMR metabolomics,X23408.Triglycerides in VLDL,CD109,CD109 antigen,42137,-0.00932825171332495,0.00359191164529964,-0.0163683985381123,-0.00228810488853765,0.00941392791382581
NMR metabolomics,X23408.Triglycerides in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0187623874594867,0.00723106290908202,0.0045895041576859,0.0329352707612874,0.00947798499981617
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,0.0129431261667928,0.0049921233127887,0.00315856447372695,0.0227276878598586,0.00953277926029492
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN2,Calsyntenin-2,42296,-0.0109169501094523,0.00421387993376524,-0.0191761547796322,-0.00265774543927241,0.00958790657594699
NMR metabolomics,X23408.Triglycerides in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.010446059223885,0.00404501743425032,0.00251782505275435,0.0183742933950156,0.00982255806736047
NMR metabolomics,X23408.Triglycerides in VLDL,GSAP,Gamma-secretase-activating protein,41843,0.0228949229885685,0.0088743902960549,0.00550111800830088,0.0402887279688361,0.00989394179143425
NMR metabolomics,X23408.Triglycerides in VLDL,DLL1,Delta-like protein 1,42181,-0.00832479453858274,0.00323001607395862,-0.0146556260435416,-0.00199396303362384,0.00996733560243589
NMR metabolomics,X23408.Triglycerides in VLDL,SOX9,Transcription factor SOX-9,39649,0.00750636398813487,0.00291281940368693,0.00179723795690848,0.0132154900193613,0.00997876300916813
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN1,Calsyntenin-1,41839,0.0137508571935844,0.0053381225775472,0.00328813694159192,0.024213577445577,0.0100065981521893
NMR metabolomics,X23408.Triglycerides in VLDL,HRAS,GTPase Hras,39750,0.0267516635058151,0.0104377130679108,0.00629374589270986,0.0472095811189204,0.0103907675636615
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA6C,Semaphorin-6C,39657,0.00693971601798047,0.00271772489144785,0.00161297523074269,0.0122664568052183,0.0106778656248324
NMR metabolomics,X23408.Triglycerides in VLDL,PGA4,Pepsin A-4,39990,0.0201435951247787,0.00789273966159679,0.00467382538804903,0.0356133648615085,0.0107184344807951
NMR metabolomics,X23408.Triglycerides in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0122538698238498,0.00480506554634134,-0.0216717982946789,-0.00283594135302079,0.0107769565720332
NMR metabolomics,X23408.Triglycerides in VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0151617713706391,0.00596054046309006,0.00347911206298263,0.0268444306782957,0.0109830395901401
NMR metabolomics,X23408.Triglycerides in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0398063625578202,0.0156676761943828,0.00909771721682981,0.0705150078988105,0.0110754138755824
NMR metabolomics,X23408.Triglycerides in VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,0.0125747219649354,0.00496204039400551,0.00284912279268461,0.0223003211371862,0.0112843164491771
NMR metabolomics,X23408.Triglycerides in VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0109388868151815,0.00432026840984933,0.00247116073187678,0.0194066128984861,0.0113527851046822
NMR metabolomics,X23408.Triglycerides in VLDL,KLK11,Kallikrein-11,42062,0.00858114918182991,0.00339431652068372,0.00192828880128983,0.01523400956237,0.0114797215706111
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.00729636275133745,0.0028861955839054,0.00163941940688287,0.012953306095792,0.011484226563993
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA4,Ephrin type-A receptor 4,39736,0.00777059817170855,0.00307581807250985,0.00174199474958924,0.0137992015938279,0.0115391450286997
NMR metabolomics,X23408.Triglycerides in VLDL,S100A16,Protein S100-A16,41814,-0.0161689251035969,0.00641294254796113,-0.0287382924976007,-0.00359955770959303,0.0117040160550169
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,0.0071520833394266,0.00284163054311658,0.0015824874749181,0.0127216792039351,0.0118508563042573
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0118426168537428,0.00470790457920584,0.00261512387849939,0.0210701098289863,0.0119011378208358
NMR metabolomics,X23408.Triglycerides in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00875437200236401,0.00348198940857789,0.00192967276155135,0.0155790712431767,0.0119424279232353
NMR metabolomics,X23408.Triglycerides in VLDL,CPLX2,Complexin-2,39560,-0.00811117373094783,0.00322992647748125,-0.0144418296268111,-0.00178051783508457,0.0120444936996254
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO1,R-spondin-1,42016,0.00899375990639547,0.00358794144887438,0.0019613946666017,0.0160261251461893,0.0121994179729897
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0089215757456809,0.00356362618023426,0.00193686843242175,0.0159062830589401,0.012311099943311
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.020186516837189,0.00812281827488095,-0.0361072406559556,-0.00426579301842231,0.0129635425493708
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00887966248701504,0.00358507473842305,-0.0159064089743242,-0.00185291599970587,0.0132674067710671
NMR metabolomics,X23408.Triglycerides in VLDL,HEBP1,Heme-binding protein 1,41900,-0.0135359545406162,0.0054717646598608,-0.0242606132739434,-0.00281129580728905,0.0133815035132458
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0127412983733502,0.0051876933973988,0.00257341931444855,0.0229091774322519,0.0140617734509386
NMR metabolomics,X23408.Triglycerides in VLDL,LEG1,Protein LEG1 homolog,39398,-0.0182400775119611,0.00743650791397848,-0.032815633023359,-0.00366452200056331,0.0141916181423271
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.0207155782891828,0.00845230459783198,0.00414906127743211,0.0372820953009335,0.0142633935528536
NMR metabolomics,X23408.Triglycerides in VLDL,CST6,Cystatin-M,41864,0.012829443129186,0.00523605288753433,0.00256677946961869,0.0230921067887533,0.0142900136203002
NMR metabolomics,X23408.Triglycerides in VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.0108152255545118,0.00442134682686048,-0.0194810653351583,-0.00214938577386525,0.0144548962994368
NMR metabolomics,X23408.Triglycerides in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0102184526041945,0.00418030223701126,0.00202506021965247,0.0184118449887366,0.0145233067727617
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.014404046414335,0.00590024355076428,0.00283956905483699,0.025968523773833,0.0146489246444907
NMR metabolomics,X23408.Triglycerides in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0107731779626221,0.00441483527392542,-0.019426255099516,-0.00212010082572832,0.0146934543279548
NMR metabolomics,X23408.Triglycerides in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.0115964667576648,0.00475311226286449,0.00228036672245041,0.0209125667928792,0.0147123708857905
NMR metabolomics,X23408.Triglycerides in VLDL,MYO6,Unconventional myosin-VI,39934,0.00958591442091243,0.00393993015150124,0.00186365132397,0.0173081775178549,0.0149889850037125
NMR metabolomics,X23408.Triglycerides in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0137003004341765,0.00563892090810547,0.00264801545428976,0.0247525854140632,0.015128824430156
NMR metabolomics,X23408.Triglycerides in VLDL,GPC1,Glypican-1,42262,0.00753799672160102,0.00310950045694852,0.00144337582598193,0.0136326176172201,0.0153557817425899
NMR metabolomics,X23408.Triglycerides in VLDL,PLAU,Urokinase-type plasminogen activator,42137,-0.00726255209964042,0.00300646838105053,-0.0131552301264995,-0.00136987407278138,0.0157206398161734
NMR metabolomics,X23408.Triglycerides in VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.0152784556778223,0.00632535518246298,0.00288075952019489,0.0276761518354498,0.0157323600278132
NMR metabolomics,X23408.Triglycerides in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0170227223110174,0.00709484069508926,0.0031168345486424,0.0309286100733923,0.0164420464241831
NMR metabolomics,X23408.Triglycerides in VLDL,PRKCQ,Protein kinase C theta type,41913,0.0107883224059796,0.00450299482752573,0.0019624525440292,0.0196141922679301,0.0165973808256964
NMR metabolomics,X23408.Triglycerides in VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0109963647157755,0.00459688878763734,-0.0200062667395447,-0.00198646269200636,0.0167670146305507
NMR metabolomics,X23408.Triglycerides in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0135607204745139,0.00567006778508691,0.0024473876157436,0.0246740533332843,0.0167874045574905
NMR metabolomics,X23408.Triglycerides in VLDL,LY6D,Lymphocyte antigen 6D,42041,0.0100040541628066,0.00418298014728403,0.00180541307412989,0.0182026952514833,0.0167883511991279
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.00964452596962173,0.00403578842734561,0.00173438065202434,0.0175546712872191,0.0168732892816827
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.00995920206911583,0.00417633147555293,0.0017735923770321,0.0181448117611996,0.0171078155801693
NMR metabolomics,X23408.Triglycerides in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00978844038877535,0.00411382155843929,0.00172535013423435,0.0178515306433164,0.0173547744976905
NMR metabolomics,X23408.Triglycerides in VLDL,NCAN,Neurocan core protein,42249,0.00935818541900696,0.0039433821084954,0.00162915648635598,0.0170872143516579,0.0176514951240504
NMR metabolomics,X23408.Triglycerides in VLDL,GPA33,Cell surface A33 antigen,42070,0.0332530899563393,0.0140702108288646,0.00567547673176462,0.0608307031809139,0.0181237823696368
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN1,Contactin-1,42310,-0.00663048664994843,0.00281022390587567,-0.0121385255054647,-0.00112244779443212,0.0183176737551771
NMR metabolomics,X23408.Triglycerides in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0148781877457503,0.00631528249826424,-0.0272561414423482,-0.00250023404915235,0.0184921551358036
NMR metabolomics,X23408.Triglycerides in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.00966973396605303,0.00412573339362509,-0.0177561714175582,-0.00158329651454786,0.0191052014325768
NMR metabolomics,X23408.Triglycerides in VLDL,CYTL1,Cytokine-like protein 1,39966,0.00627250501888913,0.00268912858435751,0.00100181299354841,0.0115431970442299,0.0196895670974119
NMR metabolomics,X23408.Triglycerides in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0141018036014574,0.00605324406426217,-0.0259661619674112,-0.00223744523550351,0.01984387609496
NMR metabolomics,X23408.Triglycerides in VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,0.00774765959831394,0.00333254809189502,0.0012158653381997,0.0142794538584282,0.0200949231364561
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.01689658200447,0.00727667323975078,0.00263430245455849,0.0311588615543816,0.0202494868386908
NMR metabolomics,X23408.Triglycerides in VLDL,ADA2,Adenosine deaminase 2,42096,-0.0106963708335185,0.00461721960403035,-0.019746121257418,-0.00164662040961899,0.0205390133348862
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.0071589857238674,0.00309902647362666,-0.0132330776121756,-0.00108489383555915,0.0209024046281856
NMR metabolomics,X23408.Triglycerides in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0210208484692167,0.00910257743987599,0.00317979668705971,0.0388619002513736,0.0209438526533027
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0724598522021852,0.0315301930958119,0.0106606737343938,0.134259030669977,0.0215707153033735
NMR metabolomics,X23408.Triglycerides in VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.00897634586735646,0.00391084503964081,0.00131108958966047,0.0166416021450524,0.0217375787195893
NMR metabolomics,X23408.Triglycerides in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.00879366602154579,0.00384175932379384,0.00126381774690987,0.0163235142961817,0.0220994985130167
NMR metabolomics,X23408.Triglycerides in VLDL,RALB,Ras-related protein Ral-B,39657,0.00714715789214709,0.00312313312880602,0.0010258169596873,0.0132684988246069,0.0221296601612783
NMR metabolomics,X23408.Triglycerides in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0135302843102139,0.00592181914971315,-0.0251370498436517,-0.00192351877677615,0.0223423153118531
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0126123606874934,0.00552705717748009,0.00177932861963246,0.0234453927553544,0.0225092358524226
NMR metabolomics,X23408.Triglycerides in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0206001432641593,0.00903010317128968,0.00290114104843153,0.0382991454798871,0.0225511547790808
NMR metabolomics,X23408.Triglycerides in VLDL,AREG,Amphiregulin,42070,0.00939703998579116,0.00411978796191406,0.0013222555804396,0.0174718243911427,0.0225668089411758
NMR metabolomics,X23408.Triglycerides in VLDL,EVI2B,Protein EVI2B,39560,-0.00958681819131519,0.00421029528685994,-0.0178389969535607,-0.00133463942906971,0.0228057534514057
NMR metabolomics,X23408.Triglycerides in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0165476511380473,0.0072857891241432,0.00226750445472658,0.0308277978213679,0.023152638769473
NMR metabolomics,X23408.Triglycerides in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0169258604875385,0.00745319856189182,-0.0315341296688465,-0.00231759130623056,0.0231691156310232
NMR metabolomics,X23408.Triglycerides in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00750574086451474,0.0033088353685915,0.00102042354207541,0.0139910581869541,0.023321172720996
NMR metabolomics,X23408.Triglycerides in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0068787912596873,0.00303868027175559,-0.0128346045923282,-0.000922977927046353,0.0236058256785317
NMR metabolomics,X23408.Triglycerides in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00720316777521478,0.00319311656748677,-0.0134616762474888,-0.000944659302940713,0.0241000865520884
NMR metabolomics,X23408.Triglycerides in VLDL,DSG4,Desmoglein-4,42018,0.0113347457893529,0.00504026103777986,0.00145583415530439,0.0212136574234014,0.024538766848092
NMR metabolomics,X23408.Triglycerides in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0128230800163366,0.00570318003935778,0.00164484713919536,0.0240013128934778,0.0245665119968168
NMR metabolomics,X23408.Triglycerides in VLDL,SELENOP,Selenoprotein P,39979,0.00535471013686516,0.00238203673485251,0.000685918136554245,0.0100235021371761,0.0245981604770269
NMR metabolomics,X23408.Triglycerides in VLDL,MYOC,Myocilin,42137,-0.0105696200211151,0.0047083868301452,-0.0197980582081997,-0.00134118183403053,0.0247938733522815
NMR metabolomics,X23408.Triglycerides in VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.0122990248878403,0.00548473540772707,0.00154894348869526,0.0230491062869854,0.0249508455801695
NMR metabolomics,X23408.Triglycerides in VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,-0.0140206206939403,0.00626744198645629,-0.0263048069873946,-0.00173643440048596,0.025298723511001
NMR metabolomics,X23408.Triglycerides in VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.00980390176909175,0.00443417103557707,0.00111292653936068,0.0184948769988228,0.0270532219781446
NMR metabolomics,X23408.Triglycerides in VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00593977861994688,0.0026952626502926,-0.0112224934145204,-0.000657063825373387,0.027559470200021
NMR metabolomics,X23408.Triglycerides in VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0136408451416466,0.0061902975626198,-0.0257738283643814,-0.00150786191891178,0.0275707161984279
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171B,Protein FAM171B,39919,0.00612230459638765,0.00279682902725933,0.000640519702959361,0.0116040894898159,0.028616002314892
NMR metabolomics,X23408.Triglycerides in VLDL,MTR,Methionine synthase,39575,0.0150285114749711,0.00688097335442113,0.00154180370030569,0.0285152192496365,0.0289783688136438
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00723189788841826,0.00332154656633932,-0.0137421291584433,-0.000721666618393183,0.0294817691568556
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0115589758666588,0.00534716133188129,0.00107853965617152,0.0220394120771462,0.030662462540341
NMR metabolomics,X23408.Triglycerides in VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00888313197528332,0.00411556173486321,-0.0169496329756152,-0.000816630974951431,0.030916434931993
NMR metabolomics,X23408.Triglycerides in VLDL,REG1B,Lithostathine-1-beta,42310,-0.0129557363163178,0.00600327391320949,-0.0247221531862084,-0.00118931944642717,0.0309364466598713
NMR metabolomics,X23408.Triglycerides in VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0218472083976168,0.0101447858809032,0.00196342807104656,0.0417309887241871,0.031297803847415
NMR metabolomics,X23408.Triglycerides in VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0175703259285127,0.00816267100927857,0.00157149075032668,0.0335691611066987,0.0313778801201943
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.00639864937687851,0.00297360674555743,-0.0122269185981711,-0.000570380155585941,0.0314335877178918
NMR metabolomics,X23408.Triglycerides in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0214716677154863,0.0100285297037569,0.00181574949612285,0.0411275859348497,0.0322913208004932
NMR metabolomics,X23408.Triglycerides in VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.00766559933038244,0.00359232709363312,0.000624638226861526,0.0147065604339034,0.0328704147943457
NMR metabolomics,X23408.Triglycerides in VLDL,PALM3,Paralemmin-3,39575,0.0170315895315935,0.00798829504232344,0.00137453124863952,0.0326886478145474,0.033023383487191
NMR metabolomics,X23408.Triglycerides in VLDL,CD82,CD82 antigen,39757,-0.00929909847793159,0.00436484296177588,-0.0178541906830123,-0.000744006272850874,0.0331559347501313
NMR metabolomics,X23408.Triglycerides in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00895383233900049,0.00421116807067808,0.000699942920471444,0.0172077217575295,0.0335077920316254
NMR metabolomics,X23408.Triglycerides in VLDL,EPN1,Epsin-1,39757,0.00959753027210482,0.00455676485353033,0.00066627115918538,0.0185287893850243,0.0352078857715536
NMR metabolomics,X23408.Triglycerides in VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00899995933773573,0.00428661708484271,0.000598189851444015,0.0174017288240274,0.0357912070132614
NMR metabolomics,X23408.Triglycerides in VLDL,ACE,Angiotensin-converting enzyme,39990,-0.00596349784579369,0.00284507071867111,-0.0115398364543891,-0.00038715923719831,0.0360970420253138
NMR metabolomics,X23408.Triglycerides in VLDL,AMBN,Ameloblastin,41913,-0.00601752626986634,0.00288038586443148,-0.011663082564152,-0.000371969975580641,0.0367141582134325
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB2,Integrin beta-2,42079,-0.00631158469599363,0.00302453955701279,-0.0122396822277387,-0.000383487164248565,0.0369256916311565
NMR metabolomics,X23408.Triglycerides in VLDL,GSN,Gelsolin,39943,-0.00414846826187297,0.00199494571077285,-0.00805856185498776,-0.000238374668758176,0.0375948075269313
NMR metabolomics,X23408.Triglycerides in VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0163327513532376,0.00787649646912994,0.000894818273742916,0.0317706844327323,0.0381391520026322
NMR metabolomics,X23408.Triglycerides in VLDL,TTN,Titin,39575,-0.0150642398556753,0.00729444950328928,-0.0293613608821223,-0.000767118829228287,0.0389308441690784
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00849476366362187,0.00411402654132733,0.000431271642620303,0.0165582556846234,0.0389624354703795
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00675360127883071,0.00327116148504722,0.000342124768138157,0.0131650777895233,0.0389807469635285
NMR metabolomics,X23408.Triglycerides in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0126351937810661,0.00613639257893787,0.000607864326347868,0.0246625232357843,0.039508021926459
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD7,FERM domain-containing protein 7,39649,0.00734709494181706,0.00358285448022948,0.000324700160567266,0.0143694897230668,0.040326910052919
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00940771355660348,0.0045987344586355,0.000394194017677898,0.0184212330955291,0.0408033468651051
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3D,Protein FAM3D,39930,0.0188139368030372,0.00921806116406906,0.000746536921461823,0.0368813366846125,0.0412753110845255
NMR metabolomics,X23408.Triglycerides in VLDL,MYH4,Myosin-4,39575,-0.00983071180322034,0.00482655775853911,-0.019290765009957,-0.000370658596483673,0.0416944742477055
NMR metabolomics,X23408.Triglycerides in VLDL,VASN,Vasorin,41975,-0.00587288936871555,0.00288511632142175,-0.0115277173587022,-0.00021806137872893,0.0418120677980267
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GL3,Endophilin-A3,39690,0.0182658011613364,0.00897590410440199,0.000673029116708478,0.0358585732059643,0.0418764409548238
NMR metabolomics,X23408.Triglycerides in VLDL,TEX101,Testis-expressed protein 101,39649,0.0131580052234897,0.00649292351683132,0.000431875130500279,0.0258841353164791,0.0427360354713206
NMR metabolomics,X23408.Triglycerides in VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0102757300292697,0.00507359996620436,0.000331474095509141,0.0202199859630302,0.0428565679344879
NMR metabolomics,X23408.Triglycerides in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0149496233799609,0.00738403583954515,0.00047691313445241,0.0294223336254694,0.0429292174122132
NMR metabolomics,X23408.Triglycerides in VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00467133612936738,0.00231076434239908,-0.00920043424046957,-0.000142238018265187,0.0432464353613895
NMR metabolomics,X23408.Triglycerides in VLDL,SYT1,Synaptotagmin-1,39929,0.00850673465106445,0.00421891912162717,0.000237653172675205,0.0167758161294537,0.0437889979668516
NMR metabolomics,X23408.Triglycerides in VLDL,TSC1,Hamartin,39657,0.0157138338658198,0.00779366731740588,0.00043824592370423,0.0309894218079353,0.0437999587398896
NMR metabolomics,X23408.Triglycerides in VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.00735437898855566,0.00365102676130281,0.000198366536402165,0.0145103914407092,0.043998296439759
NMR metabolomics,X23408.Triglycerides in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.00842263679153778,0.00418801676325918,0.000214123935549782,0.0166311496475258,0.0443355953955931
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.00727176182526128,0.00362641960978869,-0.0143795442604471,-0.000163979390075458,0.0449639911927403
NMR metabolomics,X23408.Triglycerides in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0176850019621818,0.00882518914324174,-0.0349823726829356,-0.000387631241427953,0.0451028100952311
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0144402414688708,0.00720880474707447,0.000310984164604842,0.0285694987731368,0.045186462032532
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00662516173028626,0.00330752623156218,-0.0131079131441481,-0.000142410316424378,0.0451956116145454
NMR metabolomics,X23408.Triglycerides in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00517186930330237,0.00258613562171551,0.000103043484739975,0.0102406951218648,0.0455414677182109
NMR metabolomics,X23408.Triglycerides in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00726314379975965,0.00363711639193843,-0.014391891927959,-0.000134395671560337,0.0458551147462625
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0171416705703307,0.00859923835709631,-0.0339961777502395,-0.000287163390421952,0.046243060280901
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.015883934113024,0.00797043202444848,0.000261887345104963,0.031505980880943,0.0462975617569469
NMR metabolomics,X23408.Triglycerides in VLDL,GKN1,Gastrokine-1,41538,0.0059516889324454,0.00298766868340604,9.58583129695616e-05,0.0118075195519212,0.0463827514958952
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1B,Protein phosphatase 1B,39657,0.0129415417421612,0.00649721633721679,0.000206997721216344,0.0256760857631062,0.0464110356505589
NMR metabolomics,X23408.Triglycerides in VLDL,MUCL3,Mucin-like protein 3,39560,-0.00893562371998001,0.00449033377861345,-0.0177366779260624,-0.000134569513897649,0.0466191860099637
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0116714144565568,0.00588093701346188,-0.023198051002942,-0.000144777910171473,0.0472118044101148
NMR metabolomics,X23408.Triglycerides in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00475525313649001,0.00240449096299006,4.24508490294998e-05,0.00946805542395052,0.0479876545937526
NMR metabolomics,X23408.Triglycerides in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0129709748701456,0.00656132195114856,0.00011078384589445,0.0258311658943968,0.0480795051019122
NMR metabolomics,X23408.Triglycerides in VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00660041999319775,0.00334110672236619,-0.0131489891690355,-5.18508173600269e-05,0.0482342865877256
NMR metabolomics,X23408.Triglycerides in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0256780072988354,0.0130394531069918,0.000120679209131423,0.0512353353885394,0.0489446381902296
NMR metabolomics,X23408.Triglycerides in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0173320296578672,0.00882383461823099,3.73138061344619e-05,0.0346267455095999,0.0495288021764555
NMR metabolomics,X23408.Triglycerides in VLDL,CAPS,Calcyphosin,39929,0.0196361557732103,0.0100046514497984,2.70389316054144e-05,0.0392452726148153,0.0497051710651318
NMR metabolomics,X23408.Triglycerides in VLDL,NEB,Nebulin,39575,-0.00821887259631082,0.00419260988997766,-0.016436387980667,-1.35721195461749e-06,0.0499832269768345
NMR metabolomics,X23408.Triglycerides in VLDL,PGM2,Phosphoglucomutase-2,39649,0.0125261673459779,0.00639865192333251,-1.51904237538757e-05,0.0250675251157096,0.0502990498354788
NMR metabolomics,X23408.Triglycerides in VLDL,ACRV1,Acrosomal protein SP-10,39657,0.0219156061150267,0.0111951413483076,-2.68709276563042e-05,0.0438580831577097,0.0503021119490382
NMR metabolomics,X23408.Triglycerides in VLDL,FBLN2,Fibulin-2,39966,-0.00662298454339762,0.0033850949262346,-0.0132577705988174,1.18015120221891e-05,0.0504291235333747
NMR metabolomics,X23408.Triglycerides in VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0081053734954967,0.00414906148400945,-0.0162375340041552,2.67870131618192e-05,0.0507805582353146
NMR metabolomics,X23408.Triglycerides in VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.0140302211389819,0.007253745825104,-0.0282475629561857,0.000187120678221983,0.0531136046052907
NMR metabolomics,X23408.Triglycerides in VLDL,OTOA,Otoancorin,39586,-0.0106597650760152,0.00553639806460236,-0.0215111052826358,0.000191575130605389,0.054205474386208
NMR metabolomics,X23408.Triglycerides in VLDL,IL1A,Interleukin-1 alpha,41913,0.0117222488632943,0.00609305456613175,-0.000220138086323924,0.0236646358129125,0.0543920939504317
NMR metabolomics,X23408.Triglycerides in VLDL,TFF2,Trefoil factor 2,42166,0.011822056463885,0.00615036001524364,-0.000232649165992527,0.0238767620937626,0.0546049015946183
NMR metabolomics,X23408.Triglycerides in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0103866373361884,0.00540499385283862,-0.0209804252877521,0.000207150615375311,0.0546676928961546
NMR metabolomics,X23408.Triglycerides in VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00938019260110466,0.00489367866464595,-0.000211417581601404,0.0189718027838107,0.0552895600474827
NMR metabolomics,X23408.Triglycerides in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00657633010755202,0.00343789466055463,-0.000161943427135059,0.0133146036422391,0.0557875440246106
NMR metabolomics,X23408.Triglycerides in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0140076630295011,0.00733188260884488,-0.000362826883834865,0.0283781529428371,0.0560883839083964
NMR metabolomics,X23408.Triglycerides in VLDL,CCL28,C-C motif chemokine 28,42075,0.0118180368859871,0.00620514598273022,-0.000344049240164105,0.0239801230121384,0.0568593165503465
NMR metabolomics,X23408.Triglycerides in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00604695675153498,0.00317729550315324,-0.000180542434645363,0.0122744559377153,0.0570387934956652
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAV,Integrin alpha-V,42262,-0.00332178276415602,0.00174895802167226,-0.00674974048663364,0.000106174958321602,0.0575470775577221
NMR metabolomics,X23408.Triglycerides in VLDL,TLR1,Toll-like receptor 1,39657,0.00535327963057347,0.00281885828983532,-0.000171682617503755,0.0108782418786507,0.0575779917834388
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0252356111926891,0.0133036588044776,-0.000839560064086975,0.0513107824494653,0.0578638584067226
NMR metabolomics,X23408.Triglycerides in VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00530793021995349,0.00280585653002409,-0.000191548578893721,0.0108074090188007,0.0585527267003698
NMR metabolomics,X23408.Triglycerides in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.00763768872451103,0.00404047079830505,-0.000281634040166876,0.0155570114891889,0.0587396931378824
NMR metabolomics,X23408.Triglycerides in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0118314225999155,0.0062698825020986,-0.000457547104197721,0.0241203923040288,0.0591834194152623
NMR metabolomics,X23408.Triglycerides in VLDL,PKLR,Pyruvate kinase PKLR,42143,0.0123496608701766,0.00655904465896413,-0.000506066661393099,0.0252053884017463,0.0597428655897859
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR1,Folate receptor alpha,42110,0.00584476829757315,0.0031048732409195,-0.00024078325462907,0.0119303198497754,0.0597964291094186
NMR metabolomics,X23408.Triglycerides in VLDL,GBP2,Guanylate-binding protein 2,41913,0.0119894780684713,0.00638571497758726,-0.000526523287599721,0.0245054794245423,0.0604650484925389
NMR metabolomics,X23408.Triglycerides in VLDL,NINJ1,Ninjurin-1,41843,0.0107330303133708,0.00572351235271428,-0.000485053897949205,0.0219511145246908,0.0607799940050107
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN3,Perilipin-3,42145,0.00843249916102833,0.00450740213350843,-0.000402009020648192,0.0172670073427049,0.0613927758884708
NMR metabolomics,X23408.Triglycerides in VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.0136168373613021,0.00728405737225039,-0.0278935898109129,0.000659915088308611,0.0615932046973137
NMR metabolomics,X23408.Triglycerides in VLDL,MYH7B,Myosin-7B,39560,-0.00844737392612812,0.00451957613900702,-0.0173057431585819,0.000410995306325651,0.061640657026604
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB118,Beta-defensin 118,39586,0.0111482757870454,0.00600450722561405,-0.000620558375158108,0.022917109949249,0.0633875386279844
NMR metabolomics,X23408.Triglycerides in VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,0.00951788375412075,0.00513071432892149,-0.000538316330565378,0.0195740838388069,0.0636066071538849
NMR metabolomics,X23408.Triglycerides in VLDL,RTKN2,Rhotekin-2,39575,-0.0099245763569329,0.00536406548854264,-0.0204381447144765,0.000588992000610673,0.06431206129358
NMR metabolomics,X23408.Triglycerides in VLDL,FZD8,Frizzled-8,39586,0.0083926534999357,0.00453750121125849,-0.000500848874130939,0.0172861558740023,0.0643951616932487
NMR metabolomics,X23408.Triglycerides in VLDL,UNG,Uracil-DNA glycosylase,39919,0.00685508653130544,0.00371022968204948,-0.000416963645511541,0.0141271367081224,0.0646837224903243
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0127781217703437,0.00692793902093522,-0.0263568822513767,0.000800638710689331,0.0651418054282693
NMR metabolomics,X23408.Triglycerides in VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0221095862585866,0.0120037486993216,-0.00141776119208362,0.0456369337092569,0.0655172311333837
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00941214899680757,0.00511048764676075,-0.000604406790843507,0.0194287047844586,0.0655412892101165
NMR metabolomics,X23408.Triglycerides in VLDL,EDNRB,Endothelin receptor type B,39657,0.00849411349522533,0.0046157316939624,-0.00055272062494097,0.0175409476153916,0.0657579050192668
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.0101251890455705,0.00551653545192521,-0.000687220440202941,0.0209375985313439,0.0664689108094959
NMR metabolomics,X23408.Triglycerides in VLDL,GFAP,Glial fibrillary acidic protein,41820,0.00880445134677031,0.00479975453233103,-0.000603067536598501,0.0182119702301391,0.0666238497682618
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.00577528756689185,0.0031502445367193,-0.000399191725077974,0.0119497668588617,0.0667872771461583
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO3,R-spondin-3,42262,0.00541196954996506,0.00295687719975275,-0.000383509761550324,0.0112074488614805,0.0672270063798849
NMR metabolomics,X23408.Triglycerides in VLDL,PMCH,Pro-MCH,39575,-0.0158859074787219,0.00869253323180968,-0.0329232726130689,0.00115145765562505,0.0676465282140754
NMR metabolomics,X23408.Triglycerides in VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0157510058288219,0.00862525153315431,-0.0326564988338043,0.00115448717616059,0.0678543340562939
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.00457668509063066,0.00251153493909874,-0.0094992935712642,0.00034592339000288,0.0684367039103178
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00898094199601857,0.00493453259190772,-0.0186526258761577,0.000690741884120556,0.0687834083195671
NMR metabolomics,X23408.Triglycerides in VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.00867192431275365,0.00477178374398992,-0.0180246204509739,0.000680771825466591,0.0691930589711385
NMR metabolomics,X23408.Triglycerides in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00559340651941411,0.00310029605349064,-0.000483173745427545,0.0116699867842558,0.0712346239077991
NMR metabolomics,X23408.Triglycerides in VLDL,FSHB,Follitropin subunit beta,39638,-0.0077995654089364,0.00432363875751901,-0.0162738973736737,0.000674766555800864,0.0712686719437652
NMR metabolomics,X23408.Triglycerides in VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0104726473568342,0.0058152425311033,-0.000925228004128297,0.0218705227177966,0.0717467056831268
NMR metabolomics,X23408.Triglycerides in VLDL,INHBB,Inhibin beta B chain,39736,0.00990149692153197,0.00549951466528477,-0.00087755182242618,0.0206805456654901,0.0718196525445322
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B4,Protein ATP1B4,39560,-0.00793676278992537,0.00441329730625818,-0.0165868255101914,0.000713299930340656,0.0721451351036654
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN4,Nectin-4,42181,-0.00635537590764448,0.00353808355861151,-0.013290019682523,0.000579267867234072,0.0724727893784562
NMR metabolomics,X23408.Triglycerides in VLDL,C8B,Complement component C8 beta chain,39979,0.00572028307760178,0.00318499476091021,-0.000522306653782222,0.0119628728089858,0.072519412803873
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS5,Transmembrane protease serine 5,41946,-0.00728584378990084,0.00405889932647025,-0.0152412864697825,0.000669598889980864,0.0726716275217894
NMR metabolomics,X23408.Triglycerides in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00698882119860943,0.00389772980615769,-0.000650729221459644,0.0146283716186785,0.0729877536215256
NMR metabolomics,X23408.Triglycerides in VLDL,VCAN,Versican core protein,42249,-0.00567484121732439,0.003166607564744,-0.0118813920442226,0.000531709609573853,0.0731409209365819
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD9,COMM domain-containing protein 9,39919,0.00752488286701618,0.00419909802162352,-0.00070534925536593,0.0157551149893983,0.0731558809682006
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0160173123703252,0.00896640381695088,-0.00155683911089854,0.0335914638515489,0.0740618158259329
NMR metabolomics,X23408.Triglycerides in VLDL,IL5,Interleukin-5,41913,0.0259336831749146,0.0145455850247912,-0.00257566347367605,0.0544430298235053,0.0746213359960718
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00515071651328092,0.00290112071550615,-0.000535480089111137,0.010836913115673,0.0758509278557937
NMR metabolomics,X23408.Triglycerides in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00838414264557496,0.00472720590833269,-0.000881180934757104,0.017649466225907,0.076153362509859
NMR metabolomics,X23408.Triglycerides in VLDL,PRL,Prolactin,42249,0.0137268591726685,0.00774538411878516,-0.00145409370015037,0.0289078120454874,0.0763731814702183
NMR metabolomics,X23408.Triglycerides in VLDL,EP300,Histone acetyltransferase p300,39657,0.00572050907416046,0.00324306676694025,-0.000635901789042437,0.0120769199373634,0.0777731252200666
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00957234972392165,0.00543113592439505,-0.00107267668789264,0.020217376135736,0.0780130827706377
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS2,Podocin,39657,-0.0188454610905968,0.0107322300279335,-0.0398806319453464,0.00218970976415276,0.0791214199125725
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD9,Enhancer of filamentation 1,39657,0.0062168090422848,0.00356635013491048,-0.000773237222139745,0.0132068553067093,0.0813290527434876
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR1,Interferon gamma receptor 1,42185,0.00391704968157072,0.00227707680722989,-0.000546020860599866,0.00838012022374131,0.0854170986415571
NMR metabolomics,X23408.Triglycerides in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0106034028201841,0.00616904367053713,-0.00148792277406865,0.0226947284144369,0.0856723703489595
NMR metabolomics,X23408.Triglycerides in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.0057409317894183,0.00335034425347774,-0.0123076065262347,0.000825742947398064,0.086637582521519
NMR metabolomics,X23408.Triglycerides in VLDL,FGF7,Fibroblast growth factor 7,39560,-0.0140177860768694,0.00819010129530668,-0.0300703846156705,0.00203481246193166,0.0870075120015337
NMR metabolomics,X23408.Triglycerides in VLDL,MBL2,Mannose-binding protein C,39826,-0.0198582396479257,0.011614713099752,-0.0426230773234397,0.0029065980275883,0.0873400034092435
NMR metabolomics,X23408.Triglycerides in VLDL,ACAN,Aggrecan core protein,41994,0.0049198426281264,0.00287809308017717,-0.000721219809020845,0.0105609050652736,0.0873980948816127
NMR metabolomics,X23408.Triglycerides in VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.00656597834118308,0.00386909947329145,-0.00101745662646817,0.0141494133088343,0.0897191308300088
NMR metabolomics,X23408.Triglycerides in VLDL,TLR4,Toll-like receptor 4,39657,0.00506709966436701,0.0029900666493812,-0.000793430968420128,0.0109276302971542,0.0901710610326958
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0110128966386571,0.00651705031830009,-0.00176052198521111,0.0237863152625253,0.0910832904415372
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00963661049597298,0.00570284898457926,-0.0208141945057483,0.00154097351380236,0.091096572981599
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0156552164927237,0.0092737905430045,-0.0338318459570126,0.00252141297156509,0.0914175794065582
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00841113023885071,0.00498959394389198,-0.00136847389117757,0.018190734368879,0.0918705296990655
NMR metabolomics,X23408.Triglycerides in VLDL,S100A3,Protein S100-A3,39919,0.00757342949230668,0.00449687991471079,-0.00124045514052646,0.0163873141251398,0.092179860420161
NMR metabolomics,X23408.Triglycerides in VLDL,ANK2,Ankyrin-2,39575,-0.012387061844888,0.00736295380485499,-0.0268184513024037,0.00204432761262782,0.0925295292930744
NMR metabolomics,X23408.Triglycerides in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00473143046009677,0.00281511890668175,-0.010249063517193,0.000786202596999465,0.092840236290451
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.00578782668113811,0.00347051328250943,-0.00101437935258036,0.0125900327148566,0.0954008669221956
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00745717895227661,0.00448028058384649,-0.0162385288966157,0.00132417099206251,0.0960519422026545
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,0.00357506674128304,0.00214942812592844,-0.000637812385536709,0.00778794586810278,0.0962879123080941
NMR metabolomics,X23408.Triglycerides in VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.0144190723807512,0.0086707340746113,-0.00257556640548697,0.0314137111669893,0.0963492346015026
NMR metabolomics,X23408.Triglycerides in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00633819009044882,0.00381628840304962,-0.0138181153604261,0.00114173517952845,0.0967768189740476
NMR metabolomics,X23408.Triglycerides in VLDL,RBM25,RNA-binding protein 25,39560,-0.0081677445330667,0.00493410289515604,-0.0178385862075725,0.00150309714143914,0.0978789760233787
NMR metabolomics,X23408.Triglycerides in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00799464780086964,0.0048318562818414,-0.0174650861132788,0.0014757905115395,0.0980399950379432
NMR metabolomics,X23408.Triglycerides in VLDL,BMP10,Bone morphogenetic protein 10,39736,0.00490624448486232,0.00297760208735298,-0.000929855606349526,0.0107423445760742,0.0994390454881933
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.00940397032862831,0.00573608730930659,-0.0018387607976126,0.0206467014548692,0.101149443307401
NMR metabolomics,X23408.Triglycerides in VLDL,SAG,S-arrestin,39586,-0.00903221815384929,0.00550935461320521,-0.0198305531957315,0.00176611688803292,0.101151731064071
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00441799910015765,0.00269977041250065,-0.00970954910865892,0.000873550908343618,0.101777064564165
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00529918569501347,0.00325436457057601,-0.00107936886331551,0.0116777402533424,0.103478187677697
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA1,Ephrin-A1,42113,0.00504598477160782,0.00309950189212245,-0.00102903893695217,0.0111210084801678,0.10354849332591
NMR metabolomics,X23408.Triglycerides in VLDL,SLC4A1,Band 3 anion transport protein,39966,0.00810342565875034,0.00501769222426346,-0.00173125110080605,0.0179381024183067,0.106344808173608
NMR metabolomics,X23408.Triglycerides in VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00881071768780486,0.00550558340010816,-0.0196016611520169,0.00198022577640713,0.109555461613557
NMR metabolomics,X23408.Triglycerides in VLDL,HSP90B1,Endoplasmin,41774,0.010712160454991,0.00669610196881282,-0.00241219940388214,0.0238365203138641,0.109675670246589
NMR metabolomics,X23408.Triglycerides in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00786066618560971,0.00496514110933936,-0.00187101038869543,0.0175923427599149,0.11341048879147
NMR metabolomics,X23408.Triglycerides in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.0083867055857293,0.00531368350592897,-0.0188015252573501,0.00202811408589149,0.114519973280542
NMR metabolomics,X23408.Triglycerides in VLDL,ELAVL4,ELAV-like protein 4,39586,0.0135682923896921,0.00863767306782152,-0.00336154682323804,0.0304981316026223,0.116251574762505
NMR metabolomics,X23408.Triglycerides in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.0101751388846075,0.00648344254667699,-0.0228826862760944,0.00253240850687934,0.116582724999613
NMR metabolomics,X23408.Triglycerides in VLDL,CLGN,Calmegin,39649,0.00754753715749752,0.00481573130845155,-0.00189129620706752,0.0169863705220626,0.117080912987488
NMR metabolomics,X23408.Triglycerides in VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.00913328026753061,0.00584573572070443,-0.00232436174505007,0.0205909222801113,0.118226342019557
NMR metabolomics,X23408.Triglycerides in VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.00876548778248148,0.00561615982663134,-0.00224218547771594,0.0197731610426789,0.118607917826678
NMR metabolomics,X23408.Triglycerides in VLDL,TG,Thyroglobulin,39919,-0.0171631978466446,0.0110349917024503,-0.0387917815834473,0.00446538589015808,0.119892343232566
NMR metabolomics,X23408.Triglycerides in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0137941777256726,0.0088753259423142,-0.0311898165726084,0.00360146112126328,0.120156946078475
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL1,Interferon lambda-1,41839,0.00741966220296981,0.00478930150995238,-0.00196736875653687,0.0168066931624765,0.121353723687605
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.00711713508808481,0.00459801221090781,-0.00189496884529451,0.0161292390214641,0.121681951702961
NMR metabolomics,X23408.Triglycerides in VLDL,GM2A,Ganglioside GM2 activator,39733,0.00627665707744377,0.00405637431903336,-0.00167383658786161,0.0142271507427491,0.121805733940881
NMR metabolomics,X23408.Triglycerides in VLDL,OBP2B,Odorant-binding protein 2b,41979,-0.00931896595246573,0.00603172058483668,-0.0211411382987456,0.00250320639381417,0.122371613395934
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00716159390845847,0.00464269289265223,-0.0162612719780568,0.00193808416113991,0.122967534781476
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4C,Semaphorin-4C,42070,-0.00451661646769915,0.0029300806674365,-0.0102595745758747,0.00122634164047639,0.123227172576089
NMR metabolomics,X23408.Triglycerides in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00951297362585789,0.00619043863285854,-0.00262028609454485,0.0216462333462606,0.124390580003058
NMR metabolomics,X23408.Triglycerides in VLDL,PRR5,Proline-rich protein 5,39657,0.00763726030067489,0.00497001696569143,-0.00210397295208032,0.0173784935534301,0.124403527025373
NMR metabolomics,X23408.Triglycerides in VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00519504512296187,0.0033854021143298,-0.0118304332670483,0.00144034302112453,0.124919300851074
NMR metabolomics,X23408.Triglycerides in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00790361802609283,0.00515164419016326,-0.0180008406388128,0.00219360458662717,0.125010968652292
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00625743420244365,0.00408391412189581,-0.00174703747647214,0.0142619058813594,0.1254982277638
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00460819756853811,0.00300765528867395,-0.0105032019343391,0.00128680679726283,0.125511755746751
NMR metabolomics,X23408.Triglycerides in VLDL,CAPN3,Calpain-3,39919,-0.00628697201185139,0.00410978709409135,-0.0143421547162704,0.00176821069256766,0.126105048012029
NMR metabolomics,X23408.Triglycerides in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00518717788086186,0.00339193305635084,-0.0118353666713095,0.00146101090958579,0.12622113702205
NMR metabolomics,X23408.Triglycerides in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.00612947047855423,0.00400965151300366,-0.00172944648693294,0.0139883874440414,0.126367380087453
NMR metabolomics,X23408.Triglycerides in VLDL,DCN,Decorin,41900,-0.00369947809251485,0.00242028630477354,-0.00844323924987098,0.00104428306484128,0.126405000582598
NMR metabolomics,X23408.Triglycerides in VLDL,TEX33,Testis-expressed protein 33,39757,-0.00620384130297826,0.00406292134499627,-0.014167167139171,0.00175948453321443,0.12680402255551
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.0089256529423442,0.00585311144017659,-0.00254644548040191,0.0203977513650903,0.12729755917627
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00847900564801595,0.00556192254871596,-0.0193803738434992,0.00242236254746734,0.127419229912271
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00630977223324284,0.00413946913406228,-0.00180358726951923,0.0144231317360049,0.127458504225051
NMR metabolomics,X23408.Triglycerides in VLDL,CBX2,Chromobox protein homolog 2,39575,-0.00633716996589231,0.00415813074192744,-0.0144871062200701,0.00181276628828546,0.127526788022126
NMR metabolomics,X23408.Triglycerides in VLDL,LTO1,Protein LTO1 homolog,41913,0.00661827004791835,0.00434920327066464,-0.00190616836258435,0.0151427084584211,0.12810297846852
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,0.00673858721872031,0.00442953044143081,-0.00194329244648408,0.0154204668839247,0.12821246673098
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.00907467661619763,0.00598059934062191,-0.00264729809142131,0.0207966513238166,0.129206379135957
NMR metabolomics,X23408.Triglycerides in VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00457520732416115,0.00301608032307112,-0.0104867247573805,0.00133631010905825,0.12931107168119
NMR metabolomics,X23408.Triglycerides in VLDL,GAL,Galanin peptides,42185,-0.0106130025005918,0.00700989958216399,-0.0243524056816332,0.00312640068044964,0.130048577527457
NMR metabolomics,X23408.Triglycerides in VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.00978524530798785,0.00646963328824165,-0.0224657265529415,0.00289523593696579,0.130432791526786
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00791572365649023,0.00526704456951331,-0.0182391310127363,0.00240768369975586,0.13289933613484
NMR metabolomics,X23408.Triglycerides in VLDL,TJP3,Tight junction protein ZO-3,39586,-0.00657866197237767,0.0043828898328601,-0.0151691260447835,0.00201180210002812,0.133387585152343
NMR metabolomics,X23408.Triglycerides in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00797936825098363,0.0053163180385293,-0.00244061510453379,0.0183993516065011,0.133404820237305
NMR metabolomics,X23408.Triglycerides in VLDL,NXPE4,NXPE family member 4,39575,-0.00505450341800016,0.00337044760030659,-0.0116605807146011,0.00155157387860076,0.133732954846441
NMR metabolomics,X23408.Triglycerides in VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00795766450353629,0.00530906074203019,-0.0183634235579155,0.00244809455084288,0.133932612047356
NMR metabolomics,X23408.Triglycerides in VLDL,IL4,Interleukin-4,41913,0.0148780130540447,0.00993842025250095,-0.00460129064085717,0.0343573167489465,0.134411782602155
NMR metabolomics,X23408.Triglycerides in VLDL,PCDHB15,Protocadherin beta-15,39919,-0.00628234675825646,0.00419735156999287,-0.0145091558354425,0.00194446231892956,0.134488634255047
NMR metabolomics,X23408.Triglycerides in VLDL,CD5L,CD5 antigen-like,39925,0.00754118960650103,0.00505687594904921,-0.00237028725363541,0.0174526664666375,0.135917321519239
NMR metabolomics,X23408.Triglycerides in VLDL,CD177,CD177 antigen,42123,-0.0202140605100123,0.0135606473499463,-0.0467929293159071,0.00636480829588254,0.13607902813802
NMR metabolomics,X23408.Triglycerides in VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.0100160489782733,0.00672851022947721,-0.0232039290280487,0.00317183107150198,0.13661686245069
NMR metabolomics,X23408.Triglycerides in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0108372067302369,0.00728854329399834,-0.00344833812599986,0.0251227515864736,0.137074132133443
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00683194992094543,0.00460455956115243,-0.0158568866608042,0.00219298681891333,0.137907709192724
NMR metabolomics,X23408.Triglycerides in VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0143652895848539,0.00968594438061388,-0.00461916140114928,0.0333497405708571,0.138074733867792
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.00736628587470799,0.0049912159107957,-0.0171490690598676,0.00241649731045157,0.14001269612083
NMR metabolomics,X23408.Triglycerides in VLDL,BEX3,Protein BEX3,39560,-0.00725298716724781,0.00492930218261271,-0.0169144194451687,0.0024084451106731,0.141211029465398
NMR metabolomics,X23408.Triglycerides in VLDL,CLSPN,Claspin,41820,0.00550378170628845,0.00374466349926376,-0.00183575875226851,0.0128433221648454,0.141648748425145
NMR metabolomics,X23408.Triglycerides in VLDL,TNNI3,"Troponin I, cardiac muscle",41900,0.0129759231750247,0.00883402798693432,-0.00433877167936659,0.0302906180294159,0.1418952512504
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.00616248273422425,0.00419998117866872,-0.00206948037596643,0.0143944458444149,0.142327906802212
NMR metabolomics,X23408.Triglycerides in VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,0.00728257096076715,0.00497605705786533,-0.00247050087264889,0.0170356427941832,0.143347823300242
NMR metabolomics,X23408.Triglycerides in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00333055929092524,0.002278679358248,-0.00779677083309132,0.00113565225124083,0.143874322698968
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0107669346064826,0.00737044833269509,-0.00367914412559977,0.025213013338565,0.144091214701657
NMR metabolomics,X23408.Triglycerides in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00832682992991717,0.00570879212370871,-0.0028624026325519,0.0195160624923862,0.144704577396901
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00878607816294075,0.00603931731943161,-0.0206231401090267,0.0030509837831452,0.145749599810205
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00529177599810181,0.00364186097589799,-0.00184627151465825,0.0124298235108619,0.146235157160594
NMR metabolomics,X23408.Triglycerides in VLDL,SHPK,Sedoheptulokinase,39757,-0.00610993517007415,0.00421065584709897,-0.0143628206303881,0.00214295029023984,0.146789886325792
NMR metabolomics,X23408.Triglycerides in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00426974602341947,0.00294800439403995,-0.00150834258889884,0.0100478346357378,0.147547180204026
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00811610999284496,0.00564492081930625,-0.0191801547986852,0.00294793481299529,0.150526792502682
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.00647226716893642,0.00451770356030766,-0.00238243180926658,0.0153269661471394,0.151982503622264
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.0101637740185773,0.00710003818733603,-0.0240798488657559,0.00375230082860134,0.152312454003808
NMR metabolomics,X23408.Triglycerides in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.00612626632721718,0.00430078814313686,-0.00230327843333107,0.0145558110877654,0.154343235387856
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0104028166308599,0.00730391808397134,-0.0247184960754437,0.00391286281372396,0.154394147466405
NMR metabolomics,X23408.Triglycerides in VLDL,CD48,CD48 antigen,42166,0.00460433642197698,0.00323631500863465,-0.00173884099494694,0.0109475138389009,0.154843350878434
NMR metabolomics,X23408.Triglycerides in VLDL,MATN3,Matrilin-3,41992,-0.00494344268032681,0.00347520810919824,-0.0117548505743554,0.00186796521370174,0.154907853060258
NMR metabolomics,X23408.Triglycerides in VLDL,YY1,Transcriptional repressor protein YY1,39657,0.0041487725534507,0.00293811332072926,-0.00160992955517865,0.00990747466208005,0.157962415387691
NMR metabolomics,X23408.Triglycerides in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00525249160730804,0.00372016739270324,-0.00203903648239031,0.0125440196970064,0.158003911513573
NMR metabolomics,X23408.Triglycerides in VLDL,TYMP,Thymidine phosphorylase,42070,0.00988387032212179,0.00700142134226346,-0.00383891550871459,0.0236066561529582,0.15806293449053
NMR metabolomics,X23408.Triglycerides in VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00687998207384998,0.00487779520446817,-0.00268049652690763,0.0164404606746076,0.158424540869323
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00376588517885405,0.00267071012109435,-0.00900047701619897,0.00146870665849088,0.158546803827356
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.00535057635230038,0.00379769941288502,-0.012794067201555,0.00209291449695425,0.1588878913493
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00871470209522234,0.00619865460227386,-0.00343466092523441,0.0208640651156791,0.159781479655243
NMR metabolomics,X23408.Triglycerides in VLDL,NRXN3,Neurexin-3,39649,0.00532781540289415,0.00379138014377842,-0.00210328967891156,0.0127589204846999,0.159976755089406
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00502910772158301,0.00358394490095464,-0.0120536397274541,0.00199542428428808,0.160575829564891
NMR metabolomics,X23408.Triglycerides in VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00439522201231244,0.00314692173192464,-0.00177274458225986,0.0105631886068847,0.162535854888679
NMR metabolomics,X23408.Triglycerides in VLDL,EXOSC10,Exosome component 10,39575,-0.00854471743307066,0.00614089707057325,-0.0205808756913942,0.00349144082525291,0.164118881598455
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.00993838566406412,0.00715956383909576,-0.00409435946056356,0.0239711307886918,0.165126476250581
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.0105727383948751,0.00762476272138657,-0.0255172733287928,0.0043717965390426,0.165582204999004
NMR metabolomics,X23408.Triglycerides in VLDL,SCG3,Secretogranin-3,42144,-0.0048535622755438,0.00350420509661958,-0.0117218042649182,0.00201467971383057,0.166054493729974
NMR metabolomics,X23408.Triglycerides in VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00701601276209665,0.00506585383339485,-0.0169450862755506,0.00291306075135726,0.166092376562411
NMR metabolomics,X23408.Triglycerides in VLDL,PZP,Pregnancy zone protein,39979,0.0047851361330871,0.00349651616961273,-0.00206803555935384,0.011638307825528,0.171168885158337
NMR metabolomics,X23408.Triglycerides in VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.0103035598153125,0.00752935765712647,-0.00445398119265534,0.0250611008232804,0.171198637206098
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00472720203257777,0.00347577556868359,-0.0115397221471976,0.00208531808204208,0.17384404895669
NMR metabolomics,X23408.Triglycerides in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.009836869732848,0.00724298498684392,-0.0043593808413661,0.0240331203070621,0.174447175803487
NMR metabolomics,X23408.Triglycerides in VLDL,DRAXIN,Draxin,42016,0.00606897592578143,0.00447790330082705,-0.00270771454383959,0.0148456663954024,0.17533957871521
NMR metabolomics,X23408.Triglycerides in VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.00429874857579482,0.00320030325615676,-0.00197384580627242,0.0105713429578621,0.179223885160209
NMR metabolomics,X23408.Triglycerides in VLDL,TPSG1,Tryptase gamma,39657,0.00370552736000773,0.00275988535003196,-0.00170384792605491,0.00911490264607038,0.179416733470454
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00675441211252667,0.00503166727048983,-0.00310765573763339,0.0166164799626867,0.179495560668873
NMR metabolomics,X23408.Triglycerides in VLDL,IL36A,Interleukin-36 alpha,39657,-0.00810953778344574,0.0060508883400127,-0.0199692789298706,0.00375020336297915,0.18020049879366
NMR metabolomics,X23408.Triglycerides in VLDL,REST,RE1-silencing transcription factor,39560,-0.00481613409914105,0.00360744099012688,-0.0118867184397897,0.00225445024150763,0.181885896685648
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00392325192572932,0.00294157044710068,-0.00968873000204665,0.00184222615058802,0.182315598189508
NMR metabolomics,X23408.Triglycerides in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00649839141517278,0.00488314368335644,-0.00307257020420584,0.0160693530345514,0.183288958544655
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00495533890520434,0.00373522137262868,-0.0122763727955566,0.00236569498514788,0.184646204663699
NMR metabolomics,X23408.Triglycerides in VLDL,STX1B,Syntaxin-1B,39649,0.00560791941882368,0.00423329122326956,-0.00268933137878466,0.013905170216432,0.185291914833793
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.004965159473932,0.00374942504336826,-0.0123140325589338,0.00238371361106979,0.185448150468479
NMR metabolomics,X23408.Triglycerides in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0147446415894714,0.0111614431423779,-0.036621070148532,0.00713178696958917,0.186517697680898
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00549542176393227,0.00416000115358706,-0.0136490240249629,0.00265818049709836,0.186524077453036
NMR metabolomics,X23408.Triglycerides in VLDL,LY96,Lymphocyte antigen 96,42016,-0.00508091724347177,0.0038484123396205,-0.0126238054291279,0.0024619709421844,0.186769676794995
NMR metabolomics,X23408.Triglycerides in VLDL,CFD,Complement factor D,39979,0.00281013362473651,0.00213298887077867,-0.00137052456198968,0.0069907918114627,0.187710047245141
NMR metabolomics,X23408.Triglycerides in VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00615638840949119,0.0047103819427889,-0.0153887370173574,0.00307596019837506,0.191245919813529
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM1,Myomesin-1,39586,0.00674188143866787,0.00516018667190443,-0.00337208443826481,0.0168558473156006,0.191403504848654
NMR metabolomics,X23408.Triglycerides in VLDL,FBN2,Fibrillin-2,39649,0.00819640910069265,0.00633383875641069,-0.0042179148618723,0.0206107330632576,0.195669469233619
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00492374306125694,0.00381560215023418,-0.0124023232757159,0.00255483715320205,0.196929946831938
NMR metabolomics,X23408.Triglycerides in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00834302572590699,0.00646762390544147,-0.0210195685805723,0.00433351712875829,0.197088620509331
NMR metabolomics,X23408.Triglycerides in VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,0.00855095677769726,0.00663545858131947,-0.00445454204168889,0.0215564555970834,0.197537884134785
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.00701087779457417,0.00544483911049324,-0.0176827624511409,0.00366100686199257,0.197905804428896
NMR metabolomics,X23408.Triglycerides in VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00546373254442495,0.0042467809828045,-0.0137874232707218,0.00285995818187188,0.198275323063352
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00349619021248622,0.00273090862655237,-0.00185639069555642,0.00884877112052885,0.200486424706249
NMR metabolomics,X23408.Triglycerides in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00666736170037176,0.00523181779380421,-0.00358700117548449,0.016921724576228,0.202553003812282
NMR metabolomics,X23408.Triglycerides in VLDL,CD58,Lymphocyte function-associated antigen 3,42100,-0.00233394230253761,0.00183430291493314,-0.00592917601580656,0.00126129141073135,0.203257735732638
NMR metabolomics,X23408.Triglycerides in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.0039318477688198,0.00309840352310011,-0.00214102313645642,0.010004718674096,0.20446629896424
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN5,Contactin-5,42170,0.00492942200358815,0.00389730687563668,-0.00270929947265974,0.012568143479836,0.205954791266364
NMR metabolomics,X23408.Triglycerides in VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00405878023092,0.00320922876634882,-0.0103488686129637,0.0022313081511237,0.205998114919885
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0100912332633849,0.00798011165214937,-0.0257322521015977,0.00554978557482789,0.206060272675628
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00878820931105324,0.00694981761870505,-0.0224098518437151,0.00483343322160866,0.206068960373654
NMR metabolomics,X23408.Triglycerides in VLDL,TLR2,Toll-like receptor 2,39757,-0.00306806602749893,0.00243841000379032,-0.00784734963492795,0.00171121757993009,0.208337082095175
NMR metabolomics,X23408.Triglycerides in VLDL,RELB,Transcription factor RelB,39657,0.00621580547790146,0.00494097731887002,-0.00346851006708378,0.0159001210228867,0.20841422205015
NMR metabolomics,X23408.Triglycerides in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00913534038654658,0.00726512919858644,-0.00510431284268285,0.023374993615776,0.208626832767404
NMR metabolomics,X23408.Triglycerides in VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00514436128757432,0.00409457833921039,-0.0131697348324267,0.00288101225727803,0.209003647473222
NMR metabolomics,X23408.Triglycerides in VLDL,CDH23,Cadherin-23,39929,-0.00353257069224684,0.00281871561157219,-0.00905725329092832,0.00199211190643465,0.210138621305765
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.0063803533759473,0.00509248556359215,-0.00360091832869332,0.0163616250805879,0.210269541237114
NMR metabolomics,X23408.Triglycerides in VLDL,FGF9,Fibroblast growth factor 9,39539,0.00540027008437377,0.00434234020452364,-0.00311071671649255,0.0139112568852401,0.213661950621383
NMR metabolomics,X23408.Triglycerides in VLDL,KLK3,Prostate-specific antigen,39966,0.0149851211909008,0.012064880806207,-0.0086620451892648,0.0386322875710664,0.214245699543787
NMR metabolomics,X23408.Triglycerides in VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00681406248622044,0.00549268855418596,-0.00395160707998404,0.0175797320524249,0.214791340439398
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00970370493981359,0.00783207584478331,-0.00564716371596171,0.0250545735955889,0.215382362913347
NMR metabolomics,X23408.Triglycerides in VLDL,BRK1,Protein BRICK1,41839,0.00589960008330184,0.00478531522739422,-0.00347961776239084,0.0152788179289945,0.217651736432622
NMR metabolomics,X23408.Triglycerides in VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.0118750877867729,0.00964929396665199,-0.00703752838786504,0.0307877039614108,0.218472833768303
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL6,Fc receptor-like protein 6,42119,0.00887879336868643,0.00722918100310487,-0.00529040139739912,0.023047988134772,0.219397783455618
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00535901412455355,0.00439145340319628,-0.00324823454571115,0.0139662627948183,0.222362245621306
NMR metabolomics,X23408.Triglycerides in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00444495160216673,0.00366324322166994,-0.00273500511230636,0.0116249083166398,0.225005505618652
NMR metabolomics,X23408.Triglycerides in VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00461436799912686,0.00380438830049581,-0.0120709690680986,0.00284223306984492,0.225191691401273
NMR metabolomics,X23408.Triglycerides in VLDL,IFNW1,Interferon omega-1,39575,-0.00449830826978125,0.00371712352134379,-0.0117838703716151,0.00278725383205258,0.226244178708281
NMR metabolomics,X23408.Triglycerides in VLDL,UBQLN3,Ubiquilin-3,39575,0.00716806127114906,0.00592395371205557,-0.00444288800447985,0.018779010546778,0.22629994793128
NMR metabolomics,X23408.Triglycerides in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00463093309686221,0.00383913070402151,-0.0121556292767444,0.00289376308301995,0.227748950806974
NMR metabolomics,X23408.Triglycerides in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00745006565062986,0.00619709276062939,-0.0195963674614635,0.00469623616020374,0.229316749021109
NMR metabolomics,X23408.Triglycerides in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00523673326226674,0.00438572234523266,-0.00335928253438926,0.0138327490589227,0.232486833475208
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.011204364048376,0.00939557291439772,-0.0296196869605955,0.00721095886384355,0.23308427045741
NMR metabolomics,X23408.Triglycerides in VLDL,NOP56,Nucleolar protein 56,39575,0.0140238140230579,0.0118006911998847,-0.00910554072871611,0.0371531687748318,0.234705822322701
NMR metabolomics,X23408.Triglycerides in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00838421633967588,0.00706999367294231,-0.0222414039386428,0.00547297125929105,0.235692447285484
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00515814465609054,0.00435743043531546,-0.0136987083093088,0.00338241899712776,0.236534182289531
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.00823544882584603,0.00695953243042552,-0.00540523473778799,0.0218761323894801,0.236702387665552
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.00345602598805716,0.0029284450252047,-0.00228372626134405,0.00919577823745836,0.237958595925434
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0094264063224552,0.0079951728047437,-0.00624413237484246,0.0250969450197529,0.238414406737892
NMR metabolomics,X23408.Triglycerides in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00951430502051527,0.0081322610522606,-0.00642492664191549,0.025453536682946,0.242047998784038
NMR metabolomics,X23408.Triglycerides in VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.00729577222314263,0.00624917437335223,-0.00495260954862774,0.019544153994913,0.243042047364144
NMR metabolomics,X23408.Triglycerides in VLDL,MMP9,Matrix metalloproteinase-9,42125,0.00734537397912534,0.00629912989116325,-0.00500092060755463,0.0196916685658053,0.243597234873942
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.00807212002201626,0.00692742171120619,-0.00550562653194788,0.0216498665759804,0.243942201378881
NMR metabolomics,X23408.Triglycerides in VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00892931516084785,0.00767156015588774,-0.00610694274469212,0.0239655730663878,0.244469408682149
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.00330127043404439,0.00284241750121256,-0.00226986786833223,0.00887240873642101,0.245487330052852
NMR metabolomics,X23408.Triglycerides in VLDL,TNPO1,Transportin-1,39757,0.00432884066543927,0.00373789973149542,-0.00299744280829175,0.0116551241391703,0.246850313405842
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00435533705793399,0.0037670842093171,-0.0117388221081955,0.00302814799232753,0.247642515055118
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00500145458650277,0.0043261897254308,-0.0034778772753416,0.0134807864483471,0.247670054968356
NMR metabolomics,X23408.Triglycerides in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00804191671876561,0.00696834009137168,-0.0216998632978541,0.00561602986032288,0.248498281616043
NMR metabolomics,X23408.Triglycerides in VLDL,TNN,Tenascin-N,39966,0.00525653732403232,0.00455500207371951,-0.00367126674045791,0.0141843413885226,0.248518589176626
NMR metabolomics,X23408.Triglycerides in VLDL,MRC1,Macrophage mannose receptor 1,39990,0.00343214856251714,0.00299259943675076,-0.00243334633351436,0.00929764345854864,0.251455846558713
NMR metabolomics,X23408.Triglycerides in VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,0.0120177340317492,0.0105127158906688,-0.00858718911396168,0.03262265717746,0.252996401520453
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT2,Angiopoietin-2,42262,-0.00445219936164912,0.0039291958753919,-0.0121534232774172,0.00324902455411901,0.257189205201276
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS4,Galectin-4,42123,0.00667629901272015,0.00594026127942469,-0.00496661309495225,0.0183192111203925,0.261072590462474
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00901677813445769,0.00803393362528337,-0.0247632880400131,0.00672973177109771,0.26174348188356
NMR metabolomics,X23408.Triglycerides in VLDL,BCAN,Brevican core protein,42016,0.00405952067307757,0.00363460956658303,-0.00306431407742517,0.0111833554235803,0.264054116201045
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP2,Dipeptidase 2,42070,-0.00352470172564153,0.00316542547960897,-0.0097289356656751,0.00267953221439204,0.265513556039812
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3G,Semaphorin-3G,39736,0.00532341908915752,0.00479403916698033,-0.00407289767812394,0.014719735856439,0.266840072604044
NMR metabolomics,X23408.Triglycerides in VLDL,EPB41L5,Band 4.1-like protein 5,39649,0.00722947610831345,0.00655644748361734,-0.00562116095957654,0.0200801131762034,0.270202588680969
NMR metabolomics,X23408.Triglycerides in VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00447497803114931,0.00408037202626883,-0.00352255114033761,0.0124725072026362,0.272792835066155
NMR metabolomics,X23408.Triglycerides in VLDL,CTNNA1,Catenin alpha-1,39586,-0.00390120567716336,0.00356361228281446,-0.0108858857514797,0.00308347439715298,0.273657416465267
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,0.00686189219411691,0.00628277515211124,-0.00545234710402112,0.0191761314922549,0.274775795846513
NMR metabolomics,X23408.Triglycerides in VLDL,FABP1,"Fatty acid-binding protein, liver",42123,0.0109165881885008,0.010013168002417,-0.00870922109623657,0.0305423974732382,0.275634256330101
NMR metabolomics,X23408.Triglycerides in VLDL,SSB,Lupus La protein,41839,0.00676069636758423,0.00620276732763309,-0.00539672759457663,0.0189181203297451,0.275755709553866
NMR metabolomics,X23408.Triglycerides in VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.00458074163221175,0.00420293380950021,-0.0128184918988322,0.00365700863440866,0.275784924364798
NMR metabolomics,X23408.Triglycerides in VLDL,RBP1,Retinol-binding protein 1,39649,0.00806512956470729,0.00740546987885297,-0.00644959139784454,0.0225798505272591,0.27614352693763
NMR metabolomics,X23408.Triglycerides in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00552751514599664,0.00514481744258917,-0.00455632704147814,0.0156113573334714,0.282673742611468
NMR metabolomics,X23408.Triglycerides in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00554527770261728,0.00516661526052072,-0.0156718436132379,0.00458128820800333,0.283160477961735
NMR metabolomics,X23408.Triglycerides in VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.00375579820639816,0.003506088383702,-0.00311613502565776,0.0106277314384541,0.284088957769325
NMR metabolomics,X23408.Triglycerides in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00693291583961007,0.00648375919259718,-0.0196410838571005,0.0057752521778804,0.284969666077474
NMR metabolomics,X23408.Triglycerides in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0061846937432203,0.00578609238401226,-0.0175254348158843,0.00515604732944373,0.285142921838979
NMR metabolomics,X23408.Triglycerides in VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00664122790924077,0.00627089200263554,-0.00564972041592488,0.0189321762344064,0.289597407904604
NMR metabolomics,X23408.Triglycerides in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,0.00389433440074577,0.00369494526771353,-0.00334775832397275,0.0111364271254643,0.291918755965253
NMR metabolomics,X23408.Triglycerides in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00652400894816029,0.00619510587615946,-0.00561839856911226,0.0186664164654328,0.292322598918701
NMR metabolomics,X23408.Triglycerides in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00691663460995817,0.00659511736127489,-0.00600979541814061,0.0198430646380569,0.294315749471713
NMR metabolomics,X23408.Triglycerides in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00619752755491974,0.00591813159108374,-0.00540201036360438,0.0177970654734439,0.295025751699128
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG4,Proteasome assembly chaperone 4,39657,0.00616560378885299,0.00589358774183764,-0.00538582818514879,0.0177170357628548,0.295512539522162
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.00359890631775488,0.00344400148110079,-0.00315133658520267,0.0103491492207124,0.296051614972041
NMR metabolomics,X23408.Triglycerides in VLDL,ACTA2,"Actin, aortic smooth muscle",41900,0.00478432141733246,0.00458899550275817,-0.00421010976807356,0.0137787526027385,0.297169228720646
NMR metabolomics,X23408.Triglycerides in VLDL,CHGB,Secretogranin-1,42210,0.00463718100538629,0.00444874935915651,-0.00408236773856046,0.013356729749333,0.29726512924768
NMR metabolomics,X23408.Triglycerides in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.00653261550970904,0.00628381281431709,-0.0188488886257705,0.00578365760635246,0.298551209594796
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB5,Integrin beta-5,42181,0.00419452652515658,0.0040443687584452,-0.00373243624139601,0.0121214892917092,0.299694851985315
NMR metabolomics,X23408.Triglycerides in VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.0075722839778749,0.00732039491246563,-0.0219202580063075,0.00677569005055773,0.300967688698104
NMR metabolomics,X23408.Triglycerides in VLDL,PGR,Progesterone receptor,39657,0.0108627650771814,0.0105565584557717,-0.00982808949613101,0.0315536196504939,0.303499226633828
NMR metabolomics,X23408.Triglycerides in VLDL,MYL4,Myosin light chain 4,39638,0.00558625649677843,0.00543443237978546,-0.00506523096760107,0.0162377439611579,0.304001782174507
NMR metabolomics,X23408.Triglycerides in VLDL,GH2,Growth hormone variant,41843,0.0175442914329051,0.0170789261162297,-0.0159304037549051,0.0510189866207153,0.304322498021982
NMR metabolomics,X23408.Triglycerides in VLDL,DUOX2,Dual oxidase 2,41900,0.00743223650097425,0.00739516140778185,-0.00706227985827818,0.0219267528602267,0.314908668999928
NMR metabolomics,X23408.Triglycerides in VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00468245418277363,0.00467816175819369,-0.0138516512288333,0.004486742863286,0.316888380649635
NMR metabolomics,X23408.Triglycerides in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00461314149501132,0.00461192173057572,-0.0136525080869397,0.0044262250969171,0.317203893415682
NMR metabolomics,X23408.Triglycerides in VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00285832517168609,0.00286715294058683,-0.00847794493523627,0.00276129459186409,0.318820539138603
NMR metabolomics,X23408.Triglycerides in VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00291556113857489,0.00295700801854023,-0.00288017457776397,0.00871129685491374,0.324162262569988
NMR metabolomics,X23408.Triglycerides in VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.0040666692837036,0.00412568446623347,-0.00401967227011399,0.0121530108375212,0.324304207912946
NMR metabolomics,X23408.Triglycerides in VLDL,CHAD,Chondroadherin,39736,0.00485933779743966,0.00493954260849225,-0.00482216571520515,0.0145408413100845,0.325253573298209
NMR metabolomics,X23408.Triglycerides in VLDL,LAYN,Layilin,41997,-0.00369906288810894,0.00376902619254973,-0.0110863542255064,0.00368822844928854,0.326394862953906
NMR metabolomics,X23408.Triglycerides in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00589820715549674,0.00602181686738402,-0.0177009682155694,0.00590455390457594,0.32736788120926
NMR metabolomics,X23408.Triglycerides in VLDL,CASQ2,Calsequestrin-2,39575,0.0048635378150937,0.0050129265262221,-0.00496179817630162,0.014688873806489,0.331968539292532
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00633947000814476,0.00656706295264407,-0.00653197337903762,0.0192109133953271,0.334390778900829
NMR metabolomics,X23408.Triglycerides in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00482352364142457,0.0050087078940459,-0.0146405911137545,0.00499354383090539,0.335554778244623
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.00217973101116741,0.00226556055785953,-0.00226076768223727,0.00662022970457209,0.336012103262011
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2B,Alpha-amylase 2B,41300,-0.00503163720839141,0.00527233131147394,-0.0153654065788803,0.00530213216209752,0.339925839440057
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00419551444315413,0.00440638966494933,-0.0128320381864548,0.00444100930014656,0.341045134331211
NMR metabolomics,X23408.Triglycerides in VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0117787875938812,0.0123827642902614,-0.0124914304150311,0.0360490056027935,0.341511398246011
NMR metabolomics,X23408.Triglycerides in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.00344847041718432,0.00365761902597241,-0.0037204628737216,0.0106174037080902,0.345790629285388
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.00417105622202832,0.0044454543762408,-0.00454203435540365,0.0128841467994603,0.348120130822884
NMR metabolomics,X23408.Triglycerides in VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00307282990084305,0.00328806319619018,-0.00337177396368971,0.00951743376537581,0.35004548066131
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.00605048094003301,0.00647742610308263,-0.00664527422200895,0.018746236102075,0.350275715019504
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00332037378140698,0.00355512599902173,-0.00364767317667561,0.0102884207394896,0.350340850000046
NMR metabolomics,X23408.Triglycerides in VLDL,CD70,CD70 antigen,42119,-0.00433669025474393,0.00465608921968071,-0.0134626251253181,0.00478924461583027,0.351662350755731
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00432570723620451,0.0046690413769407,-0.00482561386259927,0.0134770283350083,0.354220747766158
NMR metabolomics,X23408.Triglycerides in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00453592253176882,0.00491502381081121,-0.00509752413742115,0.0141693692009588,0.356091851767136
NMR metabolomics,X23408.Triglycerides in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00357425179800913,0.00388315175144869,-0.0111852292308486,0.00403672563483031,0.357356502553558
NMR metabolomics,X23408.Triglycerides in VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.00408808757964371,0.00444280556910969,-0.0127959864950987,0.00461981133581127,0.357509279748658
NMR metabolomics,X23408.Triglycerides in VLDL,MSMB,Beta-microseminoprotein,42103,-0.00675731570495256,0.00734934145000158,-0.0211620249469557,0.00764739353705054,0.357879252774787
NMR metabolomics,X23408.Triglycerides in VLDL,DNLZ,DNL-type zinc finger protein,39586,-0.00817815787211881,0.00890076371060843,-0.0256236547449113,0.0092673390006737,0.358212360900481
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC8,Histone deacetylase 8,39657,0.00578956351017228,0.00634219817263702,-0.00664114490819629,0.0182202719285408,0.361334049744356
NMR metabolomics,X23408.Triglycerides in VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.0104255226356328,0.0114493333724621,-0.012015170774393,0.0328662160456586,0.362537212687807
NMR metabolomics,X23408.Triglycerides in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00566971757533865,0.00623512755683368,-0.00655113243605537,0.0178905675867327,0.363201933687673
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.00466255646975336,0.00517526005412145,-0.0148060661758314,0.00548095323632469,0.367644094036785
NMR metabolomics,X23408.Triglycerides in VLDL,IL13,Interleukin-13,41913,-0.00460358814132485,0.00511739310640454,-0.0146336786298777,0.00542650234722804,0.368351373382981
NMR metabolomics,X23408.Triglycerides in VLDL,BSND,Barttin,39560,0.00316081941102944,0.00353628970362697,-0.00377030840807943,0.0100919472301383,0.371435873569595
NMR metabolomics,X23408.Triglycerides in VLDL,IL22,Interleukin-22,39919,0.00660999329265737,0.00741731686545677,-0.00792794776363791,0.0211479343489526,0.372863931400446
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.003140943332659,0.00355276971059617,-0.0101043719654275,0.0038224853001095,0.376667276211163
NMR metabolomics,X23408.Triglycerides in VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0248320314807581,0.0280992148230315,-0.0799064925338998,0.0302424295723836,0.376862912937944
NMR metabolomics,X23408.Triglycerides in VLDL,TFRC,Transferrin receptor protein 1,42200,0.0034810510106017,0.00394461797830897,-0.00425040022688388,0.0112125022480873,0.377532266210624
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN2,Contactin-2,42262,0.00408286989108454,0.00463194365967494,-0.00499573968187833,0.0131614794640474,0.378084771714295
NMR metabolomics,X23408.Triglycerides in VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00453990704962197,0.00516195305284315,-0.0146573350331946,0.00557752093395061,0.379152708292692
NMR metabolomics,X23408.Triglycerides in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.0080597671936362,0.00920396944381765,-0.0260995473035188,0.0099800129162464,0.381220961677878
NMR metabolomics,X23408.Triglycerides in VLDL,PTTG1,Securin,39757,0.00381230648271591,0.00438437583443329,-0.00478107015277333,0.0124056831182052,0.384580979355635
NMR metabolomics,X23408.Triglycerides in VLDL,TEF,Thyrotroph embryonic factor,39575,0.00391780017858437,0.00451189058387909,-0.00492550536581864,0.0127611057229874,0.385233875579841
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN7,Tetraspanin-7,39586,-0.00892472461631626,0.0102805382037852,-0.0290745794957353,0.0112251302631028,0.385348469061647
NMR metabolomics,X23408.Triglycerides in VLDL,IL24,Interleukin-24,41913,-0.00440401952968603,0.00507784243792049,-0.0143565907080102,0.00554855164863813,0.385792556882362
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX2,Neuronal pentraxin-2,39966,-0.00310474134783846,0.00360681264284509,-0.0101740941278148,0.00396461143213791,0.389366816966493
NMR metabolomics,X23408.Triglycerides in VLDL,IL9,Interleukin-9,39757,-0.00508555818062925,0.00591570009936751,-0.0166803303753896,0.00650921401413107,0.389988675731765
NMR metabolomics,X23408.Triglycerides in VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00196528737656438,0.00228781958656642,-0.00251883901310581,0.00644941376623456,0.390343691874475
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.0029574998199126,0.00344514675865142,-0.00379498782704419,0.00970998746686939,0.390657060352496
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,0.00274602080840881,0.0032155054559366,-0.00355636988522693,0.00904841150204455,0.393126639068257
NMR metabolomics,X23408.Triglycerides in VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00648623105572974,0.00761549460632019,-0.0214126004841173,0.00844013837265783,0.394390568884202
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00326223359284621,0.00383200268849654,-0.0107729588622994,0.00424849167660702,0.394610833645916
NMR metabolomics,X23408.Triglycerides in VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.00363530662534478,0.00427892547673118,-0.00475138730904833,0.0120220005597379,0.395574362943065
NMR metabolomics,X23408.Triglycerides in VLDL,ESPL1,Separin,39560,-0.00474896363982361,0.00562467212341363,-0.0157733210017143,0.00627539372206712,0.398514953812851
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00558311109106538,0.00661547911268765,-0.00738322796980243,0.0185494501519332,0.398717536880546
NMR metabolomics,X23408.Triglycerides in VLDL,NEFL,Neurofilament light polypeptide,41797,0.00420395920014445,0.00498560512760439,-0.00556782684996014,0.013975745250249,0.399121006589973
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.00430180959150722,0.00510750165052161,-0.00570889364351513,0.0143125128265296,0.399661142424006
NMR metabolomics,X23408.Triglycerides in VLDL,CA3,Carbonic anhydrase 3,42287,-0.00520195011461298,0.00618757336382968,-0.0173295939077192,0.00692569367849319,0.400525527919986
NMR metabolomics,X23408.Triglycerides in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.00885093280333433,0.0105635711725485,-0.0118536666948607,0.0295555323015294,0.402119633518935
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN4,Alpha-actinin-4,41913,0.00277409731578984,0.00332195162113145,-0.00373692786162781,0.00928512249320748,0.403687320590731
NMR metabolomics,X23408.Triglycerides in VLDL,WNT9A,Protein Wnt-9a,41913,-0.00255993329469442,0.00306893232127258,-0.00857504064438868,0.00345517405499984,0.40421447699918
NMR metabolomics,X23408.Triglycerides in VLDL,GLI2,Zinc finger protein GLI2,39657,-0.0029162936392377,0.00349633418543812,-0.00976910864269642,0.00393652136422101,0.40424244552395
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00373636810853832,0.00448900529958532,-0.0125348184957256,0.00506208227864891,0.405236496956019
NMR metabolomics,X23408.Triglycerides in VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00639544366867932,0.00777767782156962,-0.00884880486159714,0.0216396921989558,0.410934323724652
NMR metabolomics,X23408.Triglycerides in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0035195952280242,0.0042909029188789,-0.00489057449297844,0.0119297649490268,0.412090240327898
NMR metabolomics,X23408.Triglycerides in VLDL,SHC1,SHC-transforming protein 1,39560,-0.0100634190959763,0.0123295884423435,-0.0342294124429695,0.0141025742510169,0.414403077649037
NMR metabolomics,X23408.Triglycerides in VLDL,TNR,Tenascin-R,42016,-0.00359350759433131,0.00440910153380666,-0.0122353466005924,0.00504833141192975,0.41507511385828
NMR metabolomics,X23408.Triglycerides in VLDL,MYL6B,Myosin light chain 6B,39649,0.00775588936980648,0.00962105963218306,-0.0111013875092723,0.0266131662488853,0.420181375596238
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0100063441457667,0.0124164448000499,-0.0143298876623312,0.0343425759538645,0.420320610241077
NMR metabolomics,X23408.Triglycerides in VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.00359553129665763,0.00447062636796061,-0.00516689638454517,0.0123579589778604,0.421266147983567
NMR metabolomics,X23408.Triglycerides in VLDL,CDSN,Corneodesmosin,42246,0.00368502969282128,0.00461117140131434,-0.00535286625375482,0.0127229256393974,0.424215832163528
NMR metabolomics,X23408.Triglycerides in VLDL,ENG,Endoglin,42310,0.00145282745141695,0.00181857912240162,-0.00211158762849023,0.00501724253132412,0.424373529020571
NMR metabolomics,X23408.Triglycerides in VLDL,LPO,Lactoperoxidase,41647,0.00517514880362491,0.00648334150944745,-0.00753220055489209,0.0178824981621419,0.424755934799485
NMR metabolomics,X23408.Triglycerides in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00649470210610352,0.0081397950486559,-0.00945929618926205,0.0224487004014691,0.424948548829893
NMR metabolomics,X23408.Triglycerides in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0125984529460195,0.0158019322432392,-0.0183733342507294,0.0435702401427683,0.425306535812731
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1,Integrin beta-1,42167,0.00175725186123661,0.0022198326159166,-0.00259362006595992,0.00610812378843314,0.428599283182866
NMR metabolomics,X23408.Triglycerides in VLDL,RETN,Resistin,42105,0.00357995999293816,0.00452276584818542,-0.00528466106950526,0.0124445810553816,0.428641567020724
NMR metabolomics,X23408.Triglycerides in VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.0036762019013269,0.00464644209595102,-0.00543082460673711,0.0127832284093909,0.42885179097036
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00404615726327037,0.00514829748247581,-0.0141368203289229,0.00604450580238221,0.431927778334044
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.0027045050207914,0.00344554770046991,-0.00945777851371242,0.00404876847212962,0.432509660955397
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN7,Septin-7,39757,-0.00439883632968997,0.00560557549274423,-0.0153857642954687,0.00658809163608873,0.432631367844761
NMR metabolomics,X23408.Triglycerides in VLDL,TCN1,Transcobalamin-1,39806,-0.0029289081928845,0.0037540163715746,-0.0102867802811707,0.00442896389540171,0.435285781660588
NMR metabolomics,X23408.Triglycerides in VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.00684371545708344,0.00877223041367131,-0.0240372870678792,0.0103498561537123,0.435315377795162
NMR metabolomics,X23408.Triglycerides in VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00513563130076759,0.00661548757556477,-0.00783072434733935,0.0181019869488745,0.437586100277383
NMR metabolomics,X23408.Triglycerides in VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00415912408924957,0.00536582186661319,-0.00635788676931227,0.0146761349478114,0.438286095232641
NMR metabolomics,X23408.Triglycerides in VLDL,MN1,Transcriptional activator MN1,39649,-0.0047775848134751,0.00621015440792974,-0.0169494874530174,0.00739431782606719,0.441720880370719
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00603143987413584,0.00787481652775498,-0.00940320052026393,0.0214660802685356,0.443743352410052
NMR metabolomics,X23408.Triglycerides in VLDL,OMP,Olfactory marker protein,39586,-0.00385162959140738,0.00505279285389693,-0.0137551035850454,0.0060518444022306,0.445910849089626
NMR metabolomics,X23408.Triglycerides in VLDL,BRD2,Bromodomain-containing protein 2,39586,0.00280810425101717,0.00369160223727362,-0.00442743613403912,0.0100436446360735,0.446868390631432
NMR metabolomics,X23408.Triglycerides in VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.00191815191739716,0.00252911862125966,-0.0068752244150661,0.00303892058027178,0.448208604398448
NMR metabolomics,X23408.Triglycerides in VLDL,CGN,Cingulin,39649,0.00299092550725393,0.00394622222004468,-0.00474367004403365,0.0107255210585415,0.448514318400356
NMR metabolomics,X23408.Triglycerides in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00273962460208628,0.00361776214613692,-0.00435118920434208,0.00983043840851464,0.448903948749655
NMR metabolomics,X23408.Triglycerides in VLDL,PRND,Prion-like protein doppel,39929,0.00388139212655674,0.0051491754834459,-0.00621099182099722,0.0139737760741107,0.450991562206009
NMR metabolomics,X23408.Triglycerides in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.00504455905759443,0.00671951142081625,-0.0182148014423943,0.00812568332720543,0.452826449919398
NMR metabolomics,X23408.Triglycerides in VLDL,IGLON5,IgLON family member 5,39560,-0.0073153142697867,0.00976466595913588,-0.026454059549693,0.0118234310101196,0.453775796499946
NMR metabolomics,X23408.Triglycerides in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00399910751266411,0.00536568414588614,-0.00651763341327272,0.0145158484386009,0.456096502651011
NMR metabolomics,X23408.Triglycerides in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00388655404199463,0.00524441820276279,-0.0141656137194097,0.00639250563542043,0.458658409567119
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L,Seizure 6-like protein,42181,0.00214457368879446,0.00289691889266746,-0.00353338734083376,0.00782253471842268,0.459133996512926
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00713997544724008,0.0096461926059541,-0.01176656206043,0.0260465129549101,0.459203076441689
NMR metabolomics,X23408.Triglycerides in VLDL,CASP4,Caspase-4,39757,-0.0128854968070252,0.0174857959431579,-0.0471576568556146,0.0213866632415643,0.461191224007036
NMR metabolomics,X23408.Triglycerides in VLDL,CD33,Myeloid cell surface antigen CD33,42181,0.0060696923449663,0.00836308373756707,-0.0103219517806651,0.0224613364705977,0.46799103637951
NMR metabolomics,X23408.Triglycerides in VLDL,SPRING1,SREBP regulating gene protein,39560,0.00474772210093826,0.0065422919913351,-0.00807517020207854,0.0175706144039551,0.4680399961636
NMR metabolomics,X23408.Triglycerides in VLDL,NME3,Nucleoside diphosphate kinase 3,42144,0.00181598095808228,0.00251618979008618,-0.00311575103048664,0.00674771294665119,0.470479966648274
NMR metabolomics,X23408.Triglycerides in VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.00364689983918607,0.00509562608813084,-0.00634052729355037,0.0136343269719225,0.474196702077744
NMR metabolomics,X23408.Triglycerides in VLDL,POF1B,Protein POF1B,39657,0.0034260656587665,0.00478734629787893,-0.00595713308507619,0.0128092644026092,0.474222438350785
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00413277559963351,0.00580052522065599,-0.0155018050321193,0.00723625383285224,0.476180903064154
NMR metabolomics,X23408.Triglycerides in VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00362591910259761,0.0050958760080444,-0.0136138360783646,0.00636199787316941,0.476764857978813
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00229130402723611,0.0032249960950692,-0.00402968831909952,0.00861229637357174,0.477419462209015
NMR metabolomics,X23408.Triglycerides in VLDL,IL19,Interleukin-19,41756,0.00547897646899531,0.00772465335243921,-0.00966134410178554,0.0206192970397761,0.478160548281401
NMR metabolomics,X23408.Triglycerides in VLDL,PAEP,Glycodelin,42016,-0.00781427737010688,0.0110271225956792,-0.029427437657638,0.0137988829174243,0.478559250888542
NMR metabolomics,X23408.Triglycerides in VLDL,MSLNL,Mesothelin-like protein,39649,-0.00283019165661617,0.00399804964123758,-0.0106663689534418,0.00500598564020948,0.479026592059162
NMR metabolomics,X23408.Triglycerides in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00193583686515627,0.00274394566391028,-0.00731397036642041,0.00344229663610788,0.480517399042784
NMR metabolomics,X23408.Triglycerides in VLDL,NENF,Neudesin,39919,0.00829617862707225,0.0118415200098656,-0.0149132005922643,0.0315055578464088,0.483566567289683
NMR metabolomics,X23408.Triglycerides in VLDL,DAND5,DAN domain family member 5,39657,-0.00402828785223048,0.00576080139517522,-0.0153194585867739,0.00726288288231296,0.484405367699243
NMR metabolomics,X23408.Triglycerides in VLDL,FZD10,Frizzled-10,39649,0.00439351580284896,0.00628912894164857,-0.00793317692278224,0.0167202085284802,0.484823672389234
NMR metabolomics,X23408.Triglycerides in VLDL,COPE,Coatomer subunit epsilon,41839,0.0034087492621639,0.00488775575536763,-0.00617125201835665,0.0129887505426844,0.485561113163664
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF174,Zinc finger protein 174,39657,0.0026860176544678,0.00387375253459878,-0.00490653731334581,0.0102785726222814,0.488079986477379
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00433833508440679,0.00626286117251733,-0.0166135429825408,0.00793687281372719,0.488504457539747
NMR metabolomics,X23408.Triglycerides in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00510100888732442,0.00736639235176955,-0.00933712012214391,0.0195391378967927,0.488656501546571
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,-0.0032175560439285,0.00469677261338963,-0.0124232303661722,0.00598811827831518,0.493319820777561
NMR metabolomics,X23408.Triglycerides in VLDL,NMI,N-myc-interactor,39875,-0.00524938954308428,0.00767925965351712,-0.0203007384639778,0.00980195937780926,0.494254363558646
NMR metabolomics,X23408.Triglycerides in VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00310217706194386,0.00454635337447689,-0.0120130296759186,0.00580867555203084,0.495035734810149
NMR metabolomics,X23408.Triglycerides in VLDL,MELTF,Melanotransferrin,39958,0.00215511766226099,0.00317060383510523,-0.00405926585454526,0.00836950117906723,0.496696656248264
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA10,Annexin A10,41839,0.00584905770783198,0.00861366641736203,-0.0110337284701976,0.0227318438858615,0.497121911955713
NMR metabolomics,X23408.Triglycerides in VLDL,CYTH3,Cytohesin-3,39560,0.00522947502907517,0.00770363077948543,-0.00986964129871628,0.0203285913568666,0.497258325061444
NMR metabolomics,X23408.Triglycerides in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00487895783536457,0.00719272257594102,-0.018976694084209,0.00921877841347982,0.497583999937893
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN6,Prefoldin subunit 6,39649,0.00461831330089178,0.00683728739635737,-0.00878276999596867,0.0180193965977522,0.499397770412972
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00230428563263987,0.00341677019442426,-0.00900115521371142,0.00439258394843168,0.500068291682932
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.00535060099981032,0.00794502437008709,-0.020922848765181,0.0102216467655604,0.500673267072241
NMR metabolomics,X23408.Triglycerides in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00380599653878112,0.0056830498137551,-0.0149447741737411,0.00733278109617889,0.503056644082425
NMR metabolomics,X23408.Triglycerides in VLDL,IL31,Interleukin-31,39657,-0.00390101984024733,0.00585647785805913,-0.0153797164420432,0.00757767676154857,0.505358905033979
NMR metabolomics,X23408.Triglycerides in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00350776194845852,0.00527612700507385,-0.00683344698148623,0.0138489708784033,0.506169012815624
NMR metabolomics,X23408.Triglycerides in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.00207730567278492,0.00312475814966943,-0.00404722030056716,0.008201831646137,0.506198820274193
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00278246680376276,0.00421203302871201,-0.00547311793251277,0.0110380515400383,0.508883090285618
NMR metabolomics,X23408.Triglycerides in VLDL,HMCN2,Hemicentin-2,39721,-0.00403042853139485,0.00610938009289276,-0.0160048135134647,0.00794395645067496,0.509452623000745
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB2,Beta-crystallin B2,39929,0.00484403869282349,0.00736684396970263,-0.00959497548779368,0.0192830528734407,0.510843270357891
NMR metabolomics,X23408.Triglycerides in VLDL,OSTN,Osteocrin,39649,0.00280324867693771,0.00426596450210553,-0.00555804174718912,0.0111645391010645,0.511117735938555
NMR metabolomics,X23408.Triglycerides in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00184660976936476,0.00281076783890506,-0.00366249519488916,0.00735571473361868,0.511209512440401
NMR metabolomics,X23408.Triglycerides in VLDL,TFF1,Trefoil factor 1,42084,0.00554894655823452,0.0084728410154991,-0.0110578218321437,0.0221557149486128,0.512537005849056
NMR metabolomics,X23408.Triglycerides in VLDL,UNC5D,Netrin receptor UNC5D,39657,-0.00179860431470019,0.00275066766259554,-0.00718991293338744,0.00359270430398706,0.513203246964357
NMR metabolomics,X23408.Triglycerides in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.00195407231737665,0.00299907146383596,-0.00392410775174183,0.00783225238649512,0.514696777577985
NMR metabolomics,X23408.Triglycerides in VLDL,GDF15,Growth/differentiation factor 15,42310,-0.00312675801630664,0.0048169555651041,-0.0125679909239107,0.00631447489129739,0.516274933242451
NMR metabolomics,X23408.Triglycerides in VLDL,PRTN3,Myeloblastin,41800,-0.00326882058350515,0.00506711580256242,-0.0132003675565275,0.0066627263895172,0.518870503540388
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00512759548983545,0.00799937598103312,-0.0105511814329895,0.0208063724126604,0.521536420460346
NMR metabolomics,X23408.Triglycerides in VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00274123110652834,0.00428514985922844,-0.0111401248306161,0.0056576626175594,0.522377771226254
NMR metabolomics,X23408.Triglycerides in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00171190258837052,0.00267803694588282,-0.00696085500230084,0.0035370498255598,0.52268156990783
NMR metabolomics,X23408.Triglycerides in VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00242939693603947,0.0038550982996467,-0.009985389603347,0.00512659573126806,0.528591367177099
NMR metabolomics,X23408.Triglycerides in VLDL,CD2,T-cell surface antigen CD2,39575,-0.00258351530377945,0.00409976311019575,-0.0106190509997631,0.00545202039220422,0.528601657052407
NMR metabolomics,X23408.Triglycerides in VLDL,ERVV_1,,39575,-0.00288319734291853,0.0045911482970145,-0.0118818480050669,0.00611545331922989,0.53002325448306
NMR metabolomics,X23408.Triglycerides in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00227688326090854,0.00363672824805965,-0.00940487062710545,0.00485110410528838,0.531275398711771
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00430735600586414,0.00692237921602429,-0.0178752192692717,0.00926050725754346,0.533799180204912
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0024754872079711,0.00398030822580433,-0.0102768913305476,0.0053259169146054,0.533998502801894
NMR metabolomics,X23408.Triglycerides in VLDL,KHDC3L,KH domain-containing protein 3,39560,-0.00439554689957242,0.00707217122391806,-0.0182570024984518,0.00946590869930698,0.534265719402366
NMR metabolomics,X23408.Triglycerides in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00423440155357761,0.00684976416768725,-0.00919113621508941,0.0176599393222446,0.53646812741123
NMR metabolomics,X23408.Triglycerides in VLDL,CDH4,Cadherin-4,39586,0.0030168419193105,0.00490233190946405,-0.00659172862323903,0.01262541246186,0.538310495331206
NMR metabolomics,X23408.Triglycerides in VLDL,KLK1,Kallikrein-1,42016,-0.00825106715955956,0.0134497575418429,-0.0346125919415715,0.0181104576224524,0.539573831616981
NMR metabolomics,X23408.Triglycerides in VLDL,AKAP12,A-kinase anchor protein 12,39736,-0.00137209285359224,0.0022385025010127,-0.00575955775557713,0.00301537204839265,0.539921107315531
NMR metabolomics,X23408.Triglycerides in VLDL,RUVBL1,RuvB-like 1,41843,0.00636202992678292,0.0104277975561711,-0.0140764532833125,0.0268005131368783,0.541804089104011
NMR metabolomics,X23408.Triglycerides in VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.00434734399173619,0.0071433872051172,-0.0183483829137659,0.00965369493029353,0.542811121588217
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN15,Tetraspanin-15,39575,-0.00320104541689631,0.00529815870933128,-0.0135854364871856,0.00718334565339299,0.545735977093118
NMR metabolomics,X23408.Triglycerides in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00385073291885981,0.0063842357928386,-0.00866236923510384,0.0163638350728235,0.546412908062947
NMR metabolomics,X23408.Triglycerides in VLDL,CDH17,Cadherin-17,42145,0.00433025691113094,0.00717931504192509,-0.00974120057104224,0.0184017143933041,0.54641409092303
NMR metabolomics,X23408.Triglycerides in VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00499130878954642,0.0083216598877037,-0.0213017621694457,0.0113191445903528,0.54865354108992
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00336921807103736,0.00565371423197816,-0.0144504979657146,0.00771206182363983,0.551234250352975
NMR metabolomics,X23408.Triglycerides in VLDL,IL6,Interleukin-6,42070,0.00465628471574465,0.00785852426007933,-0.0107464228340108,0.0200589922655001,0.553516473733736
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.00159506202390112,0.00270428956322768,-0.00689546956782738,0.00370534552002514,0.555318639066686
NMR metabolomics,X23408.Triglycerides in VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00400465601628472,0.00679508993886654,-0.00931372026389369,0.0173230322964631,0.555641642297059
NMR metabolomics,X23408.Triglycerides in VLDL,ISM2,Isthmin-2,39966,0.00266666932854739,0.00457379842870411,-0.00629797559171267,0.0116313142488074,0.559883548896634
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00225247146422682,0.00387026286163815,-0.00983818667303761,0.00533324374458396,0.560582300682509
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00239346270052065,0.00415155004665787,-0.0105305007919701,0.00574357539092878,0.564273584433688
NMR metabolomics,X23408.Triglycerides in VLDL,SHH,Sonic hedgehog protein,39657,-0.00257645674055203,0.00449388802466528,-0.011384477268896,0.00623156378779191,0.566436563688035
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.00836177302267348,0.0146067814150125,-0.0369910645960979,0.020267518550751,0.567022862412874
NMR metabolomics,X23408.Triglycerides in VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00201322641645855,0.00352267831784814,-0.0048912230865238,0.0089176759194409,0.567669448332538
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3A,Uroplakin-3a,39586,-0.00288832651514946,0.00510487917674121,-0.0128938897015622,0.00711723667126331,0.571543183080428
NMR metabolomics,X23408.Triglycerides in VLDL,PALLD,Palladin,39657,-0.00227125008527822,0.00401646974806616,-0.0101435307914879,0.00560103062093145,0.571755958585382
NMR metabolomics,X23408.Triglycerides in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00178962381519237,0.0031728414250425,-0.00442914537789093,0.00800839300827567,0.572734971629375
NMR metabolomics,X23408.Triglycerides in VLDL,MAPT,Microtubule-associated protein tau,41839,0.00312806582808945,0.00556685585827223,-0.00778297165412411,0.014039103310303,0.574187604937124
NMR metabolomics,X23408.Triglycerides in VLDL,IL20,Interleukin-20,41913,-0.00276027446029406,0.00491301573496032,-0.0123897853008163,0.00686923638022817,0.574242025261073
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00270072667154757,0.00481297529758165,-0.00673270491171247,0.0121341582548076,0.574715082672518
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5A,Cytochrome b5,39560,0.00419169318148517,0.00750264343657953,-0.0105134879542107,0.018896874317181,0.576380959961124
NMR metabolomics,X23408.Triglycerides in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00154546188714487,0.00276948385133909,-0.00697365023576949,0.00388272646147974,0.576833601419005
NMR metabolomics,X23408.Triglycerides in VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00199652412783195,0.00357807399791527,-0.00501650090808199,0.00900954916374588,0.576863261036935
NMR metabolomics,X23408.Triglycerides in VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00265065384664702,0.0047574592875295,-0.0066739663569108,0.0119752740502048,0.577431141667641
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA5,Annexin A5,41780,0.00176780158445882,0.00320240136339416,-0.00450890508779373,0.00804450825671136,0.580941446667182
NMR metabolomics,X23408.Triglycerides in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00164093680104829,0.00298044510730104,-0.00420073560926176,0.00748260921135833,0.581939137124178
NMR metabolomics,X23408.Triglycerides in VLDL,SLC1A4,Neutral amino acid transporter A,39649,0.00293308634413617,0.00535659639137883,-0.00756584258296633,0.0134320152712387,0.58400147721721
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.00351081975318398,0.00644408003915625,-0.0161412166299302,0.00911957712356226,0.585892900668921
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR1B,Cornifin-B,39757,0.00494112126747558,0.00910266605907525,-0.0129001042083119,0.0227823467432631,0.58726367098259
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00978594138513134,0.0181317196180466,-0.0257522290662399,0.0453241118365026,0.58940494867965
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.00164534990427669,0.00306835320863585,-0.00436862238464958,0.00765932219320295,0.591806867628119
NMR metabolomics,X23408.Triglycerides in VLDL,NRN1,Neuritin,39934,0.00196380340588047,0.00366238638327807,-0.00521447390534454,0.00914208071710548,0.591824851250763
NMR metabolomics,X23408.Triglycerides in VLDL,IL17F,Interleukin-17F,41913,-0.00413448315168765,0.00772830917413513,-0.0192819691329925,0.0110130028296172,0.592673310343174
NMR metabolomics,X23408.Triglycerides in VLDL,MLLT1,Protein ENL,39560,-0.00371582277434216,0.00699260009776866,-0.0174213189659687,0.00998967341728441,0.595156840987756
NMR metabolomics,X23408.Triglycerides in VLDL,SELL,L-selectin,39979,0.00129173419230418,0.0024539549084856,-0.0035180174283276,0.00610148581293597,0.598628408394817
NMR metabolomics,X23408.Triglycerides in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00224324070340318,0.0042968402622647,-0.00617856621063563,0.010665047617442,0.601633784010811
NMR metabolomics,X23408.Triglycerides in VLDL,ESR1,Estrogen receptor,39657,0.00313695955119883,0.0060206946927644,-0.0086636020466194,0.0149375211490171,0.602356654630146
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,0.00349241826399906,0.00670542099840051,-0.00965020689286594,0.0166350434208641,0.602490151074574
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.00251599974852768,0.00484087556645316,-0.0120041158587759,0.00697211636172051,0.603254509739972
NMR metabolomics,X23408.Triglycerides in VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,-0.00274993685849302,0.00529647375584877,-0.0131310254199566,0.00763115170297057,0.603630408855571
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00369742436753177,0.00719028961840726,-0.01779039201961,0.0103955432845464,0.607105100476558
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.00408539311626855,0.00796435689665782,-0.0196955326337179,0.0115247464011808,0.607989610337224
NMR metabolomics,X23408.Triglycerides in VLDL,NGF,Beta-nerve growth factor,42016,0.000655250118229434,0.00128254819859942,-0.00185854435102543,0.00316904458748429,0.609431538898754
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_A,,39934,0.00175760032268654,0.00345637280821493,-0.00501689038141472,0.0085320910267878,0.611105587611629
NMR metabolomics,X23408.Triglycerides in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00192340771189765,0.00381842094682933,-0.00556069734388784,0.00940751276768314,0.614469535875981
NMR metabolomics,X23408.Triglycerides in VLDL,GAGE2A,G antigen 2A,39560,-0.00345413261329338,0.00688805361344905,-0.0169547176956535,0.0100464524690668,0.616052463592661
NMR metabolomics,X23408.Triglycerides in VLDL,TPSD1,Tryptase delta,39934,0.00193094474041056,0.00385091778667424,-0.00561685412147095,0.00947874360229206,0.616082100365914
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00250265272746952,0.00499136315231261,-0.0122857245060022,0.0072804190510632,0.616102058780196
NMR metabolomics,X23408.Triglycerides in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00332607810363176,0.00667141916264822,-0.00974990345515876,0.0164020596624223,0.618101820457778
NMR metabolomics,X23408.Triglycerides in VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00392419455449038,0.00787238123335776,-0.0193540617718716,0.0115056726628908,0.618158440978547
NMR metabolomics,X23408.Triglycerides in VLDL,HEPACAM2,HEPACAM family member 2,39929,0.00229083216819275,0.00460213582418373,-0.00672935404720737,0.0113110183835929,0.618651686318136
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF8,SLAM family member 8,41843,0.00275322572005064,0.00567540943157501,-0.00837057676583638,0.0138770282059377,0.6276028625902
NMR metabolomics,X23408.Triglycerides in VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00266293707798225,0.00550333188492149,-0.0134494675724284,0.00812359341646386,0.628482657073325
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR3,Folate receptor gamma,42132,-0.00977805822245122,0.020209408468141,-0.0493884988200075,0.0298323823751051,0.628509430585461
NMR metabolomics,X23408.Triglycerides in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00229705762843478,0.004790004625805,-0.0116854666950126,0.00709135143814301,0.631555278631866
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00162593142354245,0.0033938299074667,-0.00827783804217719,0.00502597519509229,0.631886401437423
NMR metabolomics,X23408.Triglycerides in VLDL,ENO1,Alpha-enolase,42119,-0.00393284154733114,0.0082805190029639,-0.0201626587931404,0.0122969756984781,0.634829505695057
NMR metabolomics,X23408.Triglycerides in VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00152279541701486,0.00321561680889276,-0.00782540436244466,0.00477981352841494,0.635819754579253
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA2,Ephrin type-A receptor 2,41614,0.00160205312883624,0.00340226809900498,-0.00506639234521351,0.00827049860288599,0.637735766108128
NMR metabolomics,X23408.Triglycerides in VLDL,CTRC,Chymotrypsin-C,42122,0.00323514120134231,0.00688052421624361,-0.0102506862624952,0.0167209686651798,0.638228156788781
NMR metabolomics,X23408.Triglycerides in VLDL,DCLRE1C,Protein artemis,39560,-0.00148680549139144,0.00320851884380723,-0.00777550242525362,0.00480189144247073,0.643091825683243
NMR metabolomics,X23408.Triglycerides in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.00234028975410328,0.00509891447474376,-0.0123341621246011,0.00765358261639449,0.646259040280075
NMR metabolomics,X23408.Triglycerides in VLDL,TNXB,Tenascin-X,42137,-0.00126098237797533,0.0027526540260161,-0.00665618426896688,0.00413421951301622,0.64689015256147
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.0027435709044425,0.0060149604491383,-0.0145328933847536,0.00904575157586858,0.648309402341199
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.0023301683314512,0.00512556828253524,-0.0123762821652203,0.00771594550231787,0.649392370579934
NMR metabolomics,X23408.Triglycerides in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00339280493504299,0.00747163751266585,-0.018037214459868,0.0112516045897821,0.649772148652932
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,0.00190897696278619,0.00423766978334299,-0.00639685581256607,0.0102148097381384,0.652374575050499
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.00198173550926831,0.00441520272315341,-0.00667206182811237,0.010635532846649,0.653551606476113
NMR metabolomics,X23408.Triglycerides in VLDL,FGF6,Fibroblast growth factor 6,39657,0.00183656131950413,0.00411595859221582,-0.00623071752123887,0.00990384016024713,0.65545790634356
NMR metabolomics,X23408.Triglycerides in VLDL,IL10,Interleukin-10,41913,0.0035994354739861,0.00809865178067885,-0.0122739220161444,0.0194727929641166,0.656725415582497
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00299344699547935,0.00676572672849205,-0.0102673773923651,0.0162542713833238,0.658177553008373
NMR metabolomics,X23408.Triglycerides in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00158051799458197,0.00362341460555026,-0.00868241062146049,0.00552137463229655,0.662703302445799
NMR metabolomics,X23408.Triglycerides in VLDL,PADI2,Protein-arginine deiminase type-2,41913,0.00261849245347018,0.00600445659514284,-0.00915024247300978,0.0143872273799501,0.662777418783807
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL1,Follistatin-related protein 1,39638,0.00105900592759728,0.00245074252135095,-0.00374444941425058,0.00586246126944514,0.665665288650198
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3B,Sodium channel subunit beta-3,39586,-0.00211362011182262,0.00490939188485055,-0.0117360282061297,0.00750878798248446,0.666821612853999
NMR metabolomics,X23408.Triglycerides in VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.00169639563301417,0.00394502291665193,-0.00942864054965195,0.00603584928362361,0.667195897848305
NMR metabolomics,X23408.Triglycerides in VLDL,PSCA,Prostate stem cell antigen,39930,0.0117290846615466,0.0273734304659104,-0.0419228390516379,0.0653810083747311,0.668306721119831
NMR metabolomics,X23408.Triglycerides in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00248433634894445,0.00583651320736913,-0.0139239022353879,0.00895522953749905,0.670368187713991
NMR metabolomics,X23408.Triglycerides in VLDL,RASA1,Ras GTPase-activating protein 1,41839,0.00144704757592823,0.0034344454773763,-0.00528446555972931,0.00817856071158577,0.673518274792404
NMR metabolomics,X23408.Triglycerides in VLDL,CNTF,Ciliary neurotrophic factor,39586,-0.00150027351667912,0.00364131338914715,-0.00863724775940753,0.00563670072604929,0.680336914185301
NMR metabolomics,X23408.Triglycerides in VLDL,KLHL41,Kelch-like protein 41,39934,-0.0022705369293267,0.00552393306421073,-0.0130974457351797,0.00855637187652632,0.681053699010258
NMR metabolomics,X23408.Triglycerides in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0072231542247867,0.0178024746987966,-0.0276696961848546,0.0421160046344281,0.684941060083334
NMR metabolomics,X23408.Triglycerides in VLDL,MORN4,MORN repeat-containing protein 4,39560,0.00332681165982289,0.00824878927333992,-0.0128408153159234,0.0194944386355691,0.686728726078919
NMR metabolomics,X23408.Triglycerides in VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00150230301808205,0.00372719226161557,-0.00880759985084858,0.00580299381468448,0.686907811152124
NMR metabolomics,X23408.Triglycerides in VLDL,MAG,Myelin-associated glycoprotein,39649,0.00206501306465116,0.00512918532635118,-0.00798819017499715,0.0121182163042995,0.687249860572891
NMR metabolomics,X23408.Triglycerides in VLDL,TP53BP1,TP53-binding protein 1,39657,-0.00362169189086671,0.0090584609671816,-0.0213762753865426,0.0141328916048092,0.689301861161863
NMR metabolomics,X23408.Triglycerides in VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.0025653339632452,0.00647253282832289,-0.0101208303802677,0.0152514983067581,0.691860519607495
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00207208010093911,0.00523412375118311,-0.00818680245137979,0.012330962653258,0.692201929272372
NMR metabolomics,X23408.Triglycerides in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00333599633185252,0.00843518487521556,-0.019868958687275,0.01319696602357,0.692491917565671
NMR metabolomics,X23408.Triglycerides in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00109664029901188,0.00277987310228813,-0.00435191098147285,0.00654519157949661,0.693224528331111
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC9,Histone deacetylase 9,39586,0.00274372754461587,0.00703086914459334,-0.0110367759787871,0.0165242310680188,0.696366528815034
NMR metabolomics,X23408.Triglycerides in VLDL,RLN1,Prorelaxin H1,39934,0.00181935441002433,0.00466720352371474,-0.00732836449645656,0.0109670733165052,0.69667933402513
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00174751923735786,0.00452141583996683,-0.0106094942836929,0.00711445580897713,0.699133793072402
NMR metabolomics,X23408.Triglycerides in VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.00254085301970972,0.00657691887616224,-0.0154316140169877,0.0103499079775683,0.699260690820502
NMR metabolomics,X23408.Triglycerides in VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00292306448413172,0.00771470918780189,-0.0180438944922234,0.01219776552396,0.704773071641439
NMR metabolomics,X23408.Triglycerides in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.0021378808417832,0.00567248564443159,-0.0132559527048691,0.00898019102130272,0.706265550496491
NMR metabolomics,X23408.Triglycerides in VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.00331184986634753,0.00881360303905652,-0.0205865118228983,0.0139628120902032,0.707096994170649
NMR metabolomics,X23408.Triglycerides in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.00136579752157363,0.00365449740600629,-0.00579701739419869,0.00852861243734595,0.708610705397664
NMR metabolomics,X23408.Triglycerides in VLDL,TCP11,T-complex protein 11 homolog,39757,-0.00225291703247234,0.00609356396496642,-0.0141963024038065,0.00969046833886184,0.711597587383429
NMR metabolomics,X23408.Triglycerides in VLDL,HYAL1,Hyaluronidase-1,42077,0.000896995297826925,0.002428824651321,-0.00386350101876223,0.00565749161441608,0.711900613490528
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00117957335726144,0.00319971187000965,-0.00745100862248036,0.00509186190795747,0.712395608446858
NMR metabolomics,X23408.Triglycerides in VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00110382468111409,0.00300259605189922,-0.00698891294283656,0.00478126358060837,0.713160867069341
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,0.00135007166956792,0.00374808040813412,-0.00599616593037496,0.0086963092695108,0.71870168067055
NMR metabolomics,X23408.Triglycerides in VLDL,CDH22,Cadherin-22,39757,0.00103264545031296,0.00290419510114947,-0.00465957694794,0.00672486784856592,0.722169129959339
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN1,Cerebellin-1,39586,-0.0034520095907927,0.00976385841803666,-0.0225891720901445,0.0156851529085591,0.723683131339538
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,-0.00193457637412718,0.00558840843364927,-0.0128878569040797,0.00901870415582539,0.729215310829259
NMR metabolomics,X23408.Triglycerides in VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.0014542932437046,0.00422160034073384,-0.00972862991154293,0.00682004342413374,0.730485468080992
NMR metabolomics,X23408.Triglycerides in VLDL,IL33,Interleukin-33,41913,0.00142716847433772,0.00415389148424859,-0.00671445883478952,0.00956879578346496,0.731172221833538
NMR metabolomics,X23408.Triglycerides in VLDL,TBR1,T-box brain protein 1,39649,0.00172962989521912,0.00505816207137578,-0.0081843677646774,0.0116436275551156,0.732396307396746
NMR metabolomics,X23408.Triglycerides in VLDL,CADPS,Calcium-dependent secretion activator 1,39649,-0.00146726281859106,0.00430115026775373,-0.00989751734338837,0.00696299170620625,0.733010204050799
NMR metabolomics,X23408.Triglycerides in VLDL,EFNB2,Ephrin-B2,39649,-0.00206894048440105,0.00609949400843519,-0.014023948740934,0.00988606777213192,0.734466489254096
NMR metabolomics,X23408.Triglycerides in VLDL,CORO6,Coronin-6,39586,-0.00137263629021974,0.00411458292261894,-0.00943721881855286,0.00669194623811337,0.738685689136712
NMR metabolomics,X23408.Triglycerides in VLDL,PAPPA,Pappalysin-1,41913,0.00166614812199738,0.00499538758085517,-0.00812481153647875,0.0114571077804735,0.738733985870502
NMR metabolomics,X23408.Triglycerides in VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.00266907664405702,0.0081390044314565,-0.0186215253297118,0.0132833720415977,0.742965949950888
NMR metabolomics,X23408.Triglycerides in VLDL,HBZ,Hemoglobin subunit zeta,39958,-0.00369108458523442,0.0113195280358719,-0.0258773595355434,0.0184951903650746,0.74436897485934
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.00125428573750547,0.00386824847483591,-0.00883605274818385,0.00632748127317292,0.745753701087614
NMR metabolomics,X23408.Triglycerides in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00214391792639808,0.00662228999772245,-0.0108357704691379,0.0151236063219341,0.746139022614507
NMR metabolomics,X23408.Triglycerides in VLDL,TAP1,Antigen peptide transporter 1,39757,0.00195332556996628,0.00614661304663766,-0.0100940360014435,0.0140006871413761,0.750650997276969
NMR metabolomics,X23408.Triglycerides in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00179969054440916,0.00566547035260438,-0.00930463134669542,0.0129040124355137,0.750749171391771
NMR metabolomics,X23408.Triglycerides in VLDL,TSLP,Thymic stromal lymphopoietin,41900,0.00200735741228444,0.00633671694193036,-0.0104126077938991,0.014427322618468,0.751414049552093
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF830,Zinc finger protein 830,39919,0.00259001659587964,0.00817700921915433,-0.0134369214736629,0.0186169546654221,0.751443887337923
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00142103719947956,0.00449715673857132,-0.0102354644070793,0.00739339000812023,0.752019329947293
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00156725813428871,0.00505549052454356,-0.00834150329381667,0.0114760195623941,0.756558312132003
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC1,Sialoadhesin,42185,0.00134526314237871,0.00437742056246129,-0.00723448116004542,0.00992500744480283,0.758605523592173
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN1,Neuroligin-1,39649,-0.00217317095527972,0.0070824859344532,-0.016054843386808,0.0117085014762485,0.758972987630642
NMR metabolomics,X23408.Triglycerides in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0011927025482026,0.00391444865547684,-0.00886502191293721,0.006479616816532,0.76060616191818
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.000919666732993204,0.00302203485568727,-0.00500352158415384,0.00684285505014024,0.760888497067225
NMR metabolomics,X23408.Triglycerides in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00135022185317306,0.00444390504672518,-0.00735983203840829,0.0100602757447544,0.761257900976818
NMR metabolomics,X23408.Triglycerides in VLDL,ABO,Histo-blood group ABO system transferase,39990,0.00462922253094589,0.0152675312827251,-0.0252951387831952,0.034553583845087,0.761737643718779
NMR metabolomics,X23408.Triglycerides in VLDL,TPT1,Translationally-controlled tumor protein,41913,-0.00204328220369389,0.0067466669029256,-0.0152667493334281,0.0111801849260403,0.762002794081941
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAC1,Cartilage acidic protein 1,42310,-0.000975057325726382,0.00325875785380378,-0.00736222271918179,0.00541210806772903,0.764783327696222
NMR metabolomics,X23408.Triglycerides in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00146831785482156,0.00491117315289039,-0.0081575815248436,0.0110942172344867,0.764964803044162
NMR metabolomics,X23408.Triglycerides in VLDL,CLNS1A,Methylosome subunit pICln,39649,0.00104717977335189,0.00354151354365439,-0.00589418677221072,0.0079885463189145,0.767474626809032
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00502122568531361,0.0174956373808464,-0.0393126749517725,0.0292702235811453,0.774118541936473
NMR metabolomics,X23408.Triglycerides in VLDL,ZPR1,Zinc finger protein ZPR1,39586,-0.00290861346711098,0.0101551322329021,-0.0228126726435992,0.0169954457093772,0.774563330209205
NMR metabolomics,X23408.Triglycerides in VLDL,MSLN,Mesothelin,42048,0.00174643417309667,0.00611563640320355,-0.0102402131771823,0.0137330815233756,0.775212898005474
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A14,Zinc transporter ZIP14,41839,0.00101180077383453,0.00355420057676711,-0.005954432356629,0.00797803390429806,0.775895717412859
NMR metabolomics,X23408.Triglycerides in VLDL,EPGN,Epigen,39919,-0.00138211211039036,0.00487893036972533,-0.010944815635052,0.00818059141427129,0.776966018756169
NMR metabolomics,X23408.Triglycerides in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00119681055924233,0.00426539459154098,-0.00716336284017799,0.00955698395866265,0.779033109210618
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00123764001687355,0.00443001360071882,-0.00744518664053534,0.00992046667428243,0.779961423450778
NMR metabolomics,X23408.Triglycerides in VLDL,LHB,Lutropin subunit beta,41843,-0.00257260031281983,0.0093224651688349,-0.0208446320437362,0.0156994314180966,0.782585333948573
NMR metabolomics,X23408.Triglycerides in VLDL,MAGEA3,Melanoma-associated antigen 3,39757,0.00249635675250574,0.00907834903516341,-0.0152972073564145,0.020289920861426,0.783337344311783
NMR metabolomics,X23408.Triglycerides in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.0018293624864611,0.0066924671444605,-0.0112878731166815,0.0149465980896037,0.784592022608932
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,-0.000931069888574491,0.00342371854063241,-0.00764155822821402,0.00577941845106504,0.785667871147268
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00136758190791361,0.00508071841355833,-0.00859062618266071,0.0113257899984879,0.78780318489478
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00157721410577526,0.00609156113687897,-0.0135166739340581,0.0103622457225075,0.795702525513463
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00134856529803867,0.00521363549379177,-0.0088701602697932,0.0115672908658705,0.795901496918734
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.0017188648883238,0.00679236596340621,-0.0150319021766,0.0115941723999524,0.800227835239602
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.000818744885218523,0.0032806812242561,-0.00561139031432343,0.00724888008476047,0.802927129021877
NMR metabolomics,X23408.Triglycerides in VLDL,PXDNL,Peroxidasin-like protein,39919,-0.00148925002714791,0.00602833136508576,-0.013304779502716,0.0103262794484202,0.804880329909152
NMR metabolomics,X23408.Triglycerides in VLDL,RRP15,RRP15-like protein,39586,0.00235157588034414,0.00961015684017181,-0.0164843315263926,0.0211874832870809,0.806695674926535
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00070786636682172,0.00290796014024077,-0.00499173550805018,0.00640746824169362,0.807680875785409
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00123261679051209,0.00509610337095522,-0.00875574581656014,0.0112209793975843,0.808882029665592
NMR metabolomics,X23408.Triglycerides in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.00104415610921842,0.00435794214804743,-0.00958572271939137,0.00749741050095454,0.810646049658913
NMR metabolomics,X23408.Triglycerides in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.0013568018061832,0.0058000159200725,-0.0100112293971589,0.0127248330095253,0.815043135180594
NMR metabolomics,X23408.Triglycerides in VLDL,NCLN,Nicalin,41913,0.00122862821542254,0.00539276441813426,-0.0093411900441206,0.0117984464749657,0.819782666433789
NMR metabolomics,X23408.Triglycerides in VLDL,SHD,SH2 domain-containing adapter protein D,39554,0.00197025182961721,0.00868935649029092,-0.015060886891353,0.0190013905505874,0.820627723813611
NMR metabolomics,X23408.Triglycerides in VLDL,IL11,Interleukin-11,41913,-0.00141297850298374,0.00641537197940344,-0.0139871075826145,0.011161150576647,0.825680706380155
NMR metabolomics,X23408.Triglycerides in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00137183581841646,0.00624765042088562,-0.0108735590065194,0.0136172306433523,0.826205128289055
NMR metabolomics,X23408.Triglycerides in VLDL,HK2,Hexokinase-2,41900,0.000624988382271593,0.00287217886538365,-0.00500448219388035,0.00625445895842354,0.827743509104339
NMR metabolomics,X23408.Triglycerides in VLDL,CHIT1,Chitotriosidase-1,42207,-0.00358349273160594,0.0164830919923198,-0.0358903530365528,0.0287233675733409,0.827896650952371
NMR metabolomics,X23408.Triglycerides in VLDL,IL21R,Interleukin-21 receptor,39657,-0.00122587941346459,0.00570339162698026,-0.0124045270023459,0.00995276817541671,0.829819098754116
NMR metabolomics,X23408.Triglycerides in VLDL,CD160,CD160 antigen,42296,0.00109152722555757,0.00510017545130732,-0.00890481665900478,0.0110878711101199,0.830536531121883
NMR metabolomics,X23408.Triglycerides in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.000907130241114905,0.00424490674604259,-0.00741288698112857,0.00922714746335838,0.830786140026071
NMR metabolomics,X23408.Triglycerides in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.000661116409876268,0.00312873384929679,-0.00547120193474544,0.00679343475449797,0.832652653481503
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD2,Leiomodin-2,39586,0.00136595615653546,0.0064799232444727,-0.011334693402631,0.0140666057157019,0.833048652745447
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR1,TGF-beta receptor type-1,39657,0.000485579531506725,0.00231578290085442,-0.00405335495416794,0.00502451401718139,0.833919218792801
NMR metabolomics,X23408.Triglycerides in VLDL,IL2,Interleukin-2,41913,-0.000698387313931044,0.00336766787690966,-0.00729901635267398,0.00590224172481189,0.83571619157779
NMR metabolomics,X23408.Triglycerides in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00074063305482471,0.003602546509858,-0.00780162421414639,0.00632035810449697,0.837117436632968
NMR metabolomics,X23408.Triglycerides in VLDL,LCN15,Lipocalin-15,39934,-0.00131262233103929,0.00638707152290488,-0.0138312825159329,0.0112060378538543,0.837175510039444
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL2,Podocalyxin-like protein 2,42181,-0.000603031005551587,0.00300715488138634,-0.00649705457306882,0.00529099256196564,0.841067478633819
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.000634730736034116,0.00318555197209596,-0.00560895112927396,0.00687841260134219,0.842067914051052
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.00248728196539569,0.0125082674050933,-0.0220289221485872,0.0270034860793786,0.842382256371886
NMR metabolomics,X23408.Triglycerides in VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.00111471888095587,0.00569741453299635,-0.0122816513656287,0.010052213603717,0.844884414503353
NMR metabolomics,X23408.Triglycerides in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00155042662385879,0.00813197720710266,-0.0143882487020624,0.01748910194978,0.848797066487803
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL2,Interferon lambda-2,39586,-0.00116789681418206,0.0061685223715643,-0.0132582006624481,0.010922407034084,0.849836350843045
NMR metabolomics,X23408.Triglycerides in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00105871392020801,0.00570711430495968,-0.012244657957929,0.010127230117513,0.852834206678989
NMR metabolomics,X23408.Triglycerides in VLDL,CDAN1,Codanin-1,39929,0.000418671334691611,0.0023027618499615,-0.00409474189123292,0.00493208456061614,0.855732975263455
NMR metabolomics,X23408.Triglycerides in VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00162378889263632,0.00903065292698246,-0.0160762908442493,0.0193238686295219,0.857306170471333
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.000474438381290774,0.0028023643658245,-0.00501819577572525,0.0059670725383068,0.865564340728975
NMR metabolomics,X23408.Triglycerides in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.000522922146600325,0.00316075849059381,-0.00567216449496354,0.00671800878816419,0.868599063419032
NMR metabolomics,X23408.Triglycerides in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.000879675887189117,0.00532210255710278,-0.0113109968991106,0.00955164512473233,0.868720909797832
NMR metabolomics,X23408.Triglycerides in VLDL,JUN,Transcription factor AP-1,41913,0.000839366958283109,0.00508406298168912,-0.00912539648582757,0.0108041304023938,0.868869612701567
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2BP,LRP2-binding protein,39649,-0.00134456608569034,0.00819256770143176,-0.0174019987804966,0.0147128666091159,0.869639499431911
NMR metabolomics,X23408.Triglycerides in VLDL,NPTN,Neuroplastin,41843,0.00135140354709709,0.00825120875180602,-0.0148209656064427,0.0175237727006369,0.869904872769358
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.00132209894870653,0.00825310509687199,-0.0174981849385756,0.0148539870411626,0.872730600530121
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,0.000898115868429639,0.00565920863858426,-0.0101939330631955,0.0119901648000548,0.873908144953385
NMR metabolomics,X23408.Triglycerides in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00112427201927586,0.00718852675521997,-0.015213784459507,0.0129652404209553,0.875722101175716
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.000510656170952755,0.00333625814112504,-0.00704972212755783,0.00602840978565232,0.878351243079929
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,0.000819085206509246,0.00539904074558351,-0.00976303465483443,0.0114012050678529,0.879418916409248
NMR metabolomics,X23408.Triglycerides in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.00107371146816409,0.00720684176431328,-0.0151991213262181,0.0130516983898899,0.881567658033724
NMR metabolomics,X23408.Triglycerides in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00101495359993743,0.00688157498623194,-0.014502840572952,0.0124729333730772,0.882749072165125
NMR metabolomics,X23408.Triglycerides in VLDL,FGF12,Fibroblast growth factor 12,39657,0.000695333582515114,0.00477576970995377,-0.00866517504899427,0.0100558422140245,0.884242878033703
NMR metabolomics,X23408.Triglycerides in VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.00133488465357725,0.00934008561704104,-0.0196414524629777,0.0169716831558232,0.886355999590779
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,0.000604519199338296,0.00441605831051836,-0.00805095508927768,0.00925999348795428,0.891119344720427
NMR metabolomics,X23408.Triglycerides in VLDL,CRNN,Cornulin,41749,-0.000965304446980552,0.00709392846664737,-0.0148694042416094,0.0129387953476483,0.891764282166423
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.000840427455788761,0.00619942136046901,-0.012991293322308,0.0113104384107305,0.892167289929122
NMR metabolomics,X23408.Triglycerides in VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,-0.000677094697120242,0.00507377846562871,-0.0106217004897525,0.00926751109551202,0.893839694380351
NMR metabolomics,X23408.Triglycerides in VLDL,IL3,Interleukin-3,39560,0.000849087304898856,0.00645453288096966,-0.0118017971418017,0.0134999717515994,0.895343446564361
NMR metabolomics,X23408.Triglycerides in VLDL,TP73,Tumor protein p73,39649,-0.00047430659188299,0.00361318502641927,-0.00755614924366475,0.00660753605989877,0.89556328243149
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.000891224981970727,0.00694906007007351,-0.0145113827193148,0.0127289327553734,0.897952125928947
NMR metabolomics,X23408.Triglycerides in VLDL,SKIV2L,Helicase SKI2W,39575,-0.000523576210847291,0.00416927807175687,-0.00869536123149076,0.00764820880979618,0.900067023827473
NMR metabolomics,X23408.Triglycerides in VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.000516311050110915,0.00425356329564104,-0.00885329510956735,0.00782067300934552,0.903389758934832
NMR metabolomics,X23408.Triglycerides in VLDL,SLC51B,Organic solute transporter subunit beta,39575,0.000910413624451584,0.00764375287674179,-0.0140713420139623,0.0158921692628655,0.905193889445148
NMR metabolomics,X23408.Triglycerides in VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.00124825045418844,0.0105842355033259,-0.0219933520407072,0.0194968511323303,0.906121386894614
NMR metabolomics,X23408.Triglycerides in VLDL,TAGLN3,Transgelin-3,39560,-0.000722148899035656,0.00632505723090116,-0.0131192610716019,0.0116749632735306,0.909102979259441
NMR metabolomics,X23408.Triglycerides in VLDL,IL25,Interleukin-25,39510,-0.000407349876337115,0.00362137805357826,-0.00750525086135051,0.00669055110867628,0.910441114582102
NMR metabolomics,X23408.Triglycerides in VLDL,KLK12,Kallikrein-12,41843,0.00155241930167008,0.0140564840320703,-0.0259982894011878,0.029103128004528,0.912060908924925
NMR metabolomics,X23408.Triglycerides in VLDL,PYDC1,Pyrin domain-containing protein 1,39638,0.000480047756030835,0.00434786004746524,-0.00804175793700103,0.0090018534490627,0.912086133707788
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB116,Beta-defensin 116,39586,0.000870937092251651,0.00791212229471857,-0.0146368226053967,0.0163786967899,0.9123508799181
NMR metabolomics,X23408.Triglycerides in VLDL,CLINT1,Clathrin interactor 1,39560,0.000575267839102226,0.00526697039810786,-0.00974799414118918,0.0108985298193936,0.91302859173856
NMR metabolomics,X23408.Triglycerides in VLDL,CEP350,Centrosome-associated protein 350,39560,-0.000419092881776776,0.00385261121604042,-0.007970210865216,0.00713202510166245,0.913377777715813
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD4,Sushi domain-containing protein 4,39919,-0.000438889099088278,0.00405966149849227,-0.00839582563613313,0.00751804743795658,0.913910528928223
NMR metabolomics,X23408.Triglycerides in VLDL,SCIN,Adseverin,39586,-0.000837666837761015,0.00777598916989194,-0.0160786056107492,0.0144032719352272,0.914215967721011
NMR metabolomics,X23408.Triglycerides in VLDL,PI16,Peptidase inhibitor 16,39990,-0.000272101183243105,0.00254261169075905,-0.00525562009713084,0.00471141773064463,0.914777843480197
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,0.00115005551581314,0.0111277404135497,-0.0206603156947442,0.0229604267263705,0.917686816696875
NMR metabolomics,X23408.Triglycerides in VLDL,IKZF2,Zinc finger protein Helios,41843,0.000915985562052515,0.00936606384335039,-0.0174414995709142,0.0192734706950193,0.922093900028522
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAX,Integrin alpha-X,39757,0.000463209359407956,0.00544104496818022,-0.0102012387782253,0.0111276574970412,0.932157638978475
NMR metabolomics,X23408.Triglycerides in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.000448418245053634,0.00535012339105916,-0.0109346600915296,0.0100378236014223,0.933205399133599
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.000189591673608963,0.00231791963187743,-0.0043535308048708,0.00473271415208872,0.934812051594916
NMR metabolomics,X23408.Triglycerides in VLDL,EVPL,Envoplakin,39757,-0.00027676488107752,0.00351803784269785,-0.00717211905276531,0.00661858929061027,0.93729632803636
NMR metabolomics,X23408.Triglycerides in VLDL,MMP15,Matrix metalloproteinase-15,39958,0.000396356396027443,0.0051271372280434,-0.00965283257093763,0.0104455453629925,0.938381801435552
NMR metabolomics,X23408.Triglycerides in VLDL,FGF3,Fibroblast growth factor 3,39657,0.000232737361797231,0.00312028608611471,-0.0058830233669876,0.00634849809058206,0.940543498330945
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.000230874109184586,0.00314679082056204,-0.00593683589911701,0.00639858411748618,0.94151451725905
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,0.000197237314685163,0.00281270516526246,-0.00531566480922925,0.00571013943859958,0.94409623729465
NMR metabolomics,X23408.Triglycerides in VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.000302077448959628,0.00432149239594922,-0.0087722025450201,0.00816804764710085,0.94427356331575
NMR metabolomics,X23408.Triglycerides in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000312987731018414,0.00463687885882487,-0.00940127029431516,0.00877529483227833,0.946185166600171
NMR metabolomics,X23408.Triglycerides in VLDL,INSL4,Early placenta insulin-like peptide,39919,0.000339460729940047,0.00507127665799307,-0.00960024151972637,0.0102791629796065,0.94663230423624
NMR metabolomics,X23408.Triglycerides in VLDL,GAD1,Glutamate decarboxylase 1,39560,0.000180223751219212,0.00277557484367299,-0.00525990294237985,0.00562035044481827,0.948229290266411
NMR metabolomics,X23408.Triglycerides in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.000227318842938506,0.00353614147551087,-0.0071581561349398,0.00670351844906279,0.948744922386057
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171A2,Protein FAM171A2,39934,-0.00104173919991824,0.0164484166430435,-0.0332806358202835,0.031197157420447,0.949501892192915
NMR metabolomics,X23408.Triglycerides in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.00095373384375875,0.0154637494808829,-0.0293552151387717,0.0312626828262892,0.95082240841143
NMR metabolomics,X23408.Triglycerides in VLDL,SOX2,Transcription factor SOX-2,39915,0.000153039429959479,0.00258588112148116,-0.0049152875681436,0.00522136642806256,0.952807633004916
NMR metabolomics,X23408.Triglycerides in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.000233736387575708,0.00403387005708826,-0.00767264892431728,0.0081401216994687,0.953794690404359
NMR metabolomics,X23408.Triglycerides in VLDL,DLGAP5,Disks large-associated protein 5,39934,0.000292121850353339,0.00520418973613402,-0.00990809003246935,0.010492333733176,0.955237599583949
NMR metabolomics,X23408.Triglycerides in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.000221097840756518,0.00402591149256235,-0.00811188436617872,0.00766968868466568,0.956204230533876
NMR metabolomics,X23408.Triglycerides in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000126209807053895,0.00318842801350265,-0.00637552871351909,0.0061231090994113,0.96842571071674
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6,Seizure protein 6 homolog,39649,-0.000130429711446792,0.00330156456745964,-0.00660149626366768,0.0063406368407741,0.968488142111587
NMR metabolomics,X23408.Triglycerides in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.000127424915543897,0.0054417975722521,-0.0105384983260702,0.010793348157158,0.981318909246948
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-7.0388162179318e-05,0.00345564881760216,-0.00684345984467954,0.00670268352032091,0.983749371545913
NMR metabolomics,X23408.Triglycerides in VLDL,CRX,Cone-rod homeobox protein,41900,0.000170393692506192,0.0113151541407705,-0.0220073084234039,0.0223480958084163,0.98798542195845
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB7,Integrin beta-7,42262,6.26928846115683e-05,0.00485504573775323,-0.00945319676138476,0.0095785825306079,0.989697444289048
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,-4.69102688582422e-05,0.00514832648440166,-0.0101376301782855,0.010043809640569,0.99273014061961
NMR metabolomics,X23408.Triglycerides in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,2.86502169459962e-05,0.00477504339341617,-0.00933043483414969,0.00938773526804168,0.995212837554724
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,3.45541673324584e-05,0.00636198210920626,-0.0124349307667118,0.0125040391013767,0.995666510849383
NMR metabolomics,X23408.Triglycerides in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-1.08961065385354e-05,0.0025436471676236,-0.00499644455508079,0.00497465234200372,0.996582223769735
